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The genus Helichrysum (Asteraceae) consists of approximately 500 species worldwide, 
with 245 indigenous to South Africa. As a result of the large number of species, the 
chemistry and biological activity of several species have not yet been investigated. The aim 
of this project was to investigate the phytochemistry of three species and propose a 
synthetic route to one of the antibacterial compounds isolated. 
 
An extensive literature review regarding the widespr ad traditional uses, biological activity 
and phytochemistry of the South African Helichrysum species is provided. 
 
From Helichrysum splendidum, a plant used traditionally to treat rheumatism, two 
monomeric guaianolides and a dimeric guaianolide, helisplendidilactone, were isolated. 
The stereochemistry of these known compounds was confirmed and the NMR assignments 
for certain peaks of helisplendidilactone were corrected. An X-ray structure for 
helisplendidilactone was obtained for the first time.  
 
The phytochemistry of Helichrysum montanum was investigated for the first time and new 
diastereoisomers of known guaianolides were isolated. The phytochemistry of H. 
splendidum and H. montanum is remarkably similar and supports their morphological 
classification in the same taxonomic group. The chloroform:methanol extract of H. 
montanum yielded a new dimeric guaianolide, 13’-epihelisplendidilactone, which is related 
to helisplendidilactone, as well as three monomeric guaianolides (of which one is a new 
diastereomer of a known compound). The extract also yielded spathulenol (a 
sesquiterpene), umbelliferone (a coumarin) and 4’,5,7-trihydroxy-3,3’,8-trimethoxyflavone 
(a flavonoid). 
 
Thirty-five Helichrysum species were screened for antimicrobial activity against six micro-
organisms and a preliminary cytotoxic assay, which included the use of “normal” and 
cancer cell lines, was performed. H excisum was selected for further study based on the 
fact that it exhibited promising antimicrobial activity and relative low toxicity. 
Furthermore, with the exception of the essential oil, the phytochemistry of this species has 




From the aerial parts of H. excisum, five flavonoids, identified as pinocembrin, gnaphliin, 
lepidissipyrone, 5-hydroxy-7,8-dimethoxyflavone and isoscutellarein 7-O-β-glucoside 
were isolated. Four of these flavonoids have an unsubstituted B-ring, a phenomenon often 
observed in flavonoids isolated from Helichrysum species. The active antimicrobial 
component of H. excisum has been identified as lepidissipyrone.  
 
Owing to the interesting biological activities reported for phloroglucinol α-pyrones and the 
synthetic challenges associated with these molecules, lepidissipyrone was selected for a 
synthetic study. Both the flavanone and pyrone moieties present in lepidissipyrone have 
been successfully synthesised. A successful strategy towards the CH2 linker between the 
two units has been illustrated. The strategy could be used to synthesise similar 
phloroglucinol-derived pyrones.  
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Why do Natural Product Research? 
 
“A small collection of smart compounds may be more valuable than a much larger 
hodgepodge collection mindlessly assembled’’ – S.J. Danishefsky  
 
1.1 Natural products as drugs 
 
Natural products formed the basis of most early medicines and still serve as an important 
source of new pharmaceutical agents today. Novel drugs approved for use in oncology, as 
anti-infectives, as anti-inflammatories and drugs used in the treatment of cardiovascular 
and metabolic diseases are often natural products, na ural product derivatives, or inspired 
by natural products (Butler, 2005; Newman et al., 2003; Newman and Cragg, 2007; Wilson 
and Danishefsky, 2007).  
 
The advent of computers, automation, robotics, the sequencing of the human and 
pathogenic genomes, and the introduction of high-throughput screens based on large 
numbers of molecular targets, led to a demand for huge libraries of compounds to satisfy 
the capacity of the screens. This meant that chemistry became the rate-limiting step in the 
drug discovery process (Newman et al., 2003; Newman and Cragg, 2007; Rouhi, 2003a). 
The tedious and expensive nature of traditional natural products isolation, legalities 
associated with source (e.g. plant) collection and difficult intellectual property issues 
surrounding compounds obtained from natural products are further deterrents associated 
with natural product research (Balunas and Kinghorn, 2005; Cordell, 1995). The 
advantages offered by rational drug design and combinatorial chemistry have therefore 
prompted most pharmaceutical companies to reduce or terminate their natural product drug 
discovery programmes (Butler, 2005; Gullo and Hughes, 2005, Newman et al., 2003; 
Newman and Cragg, 2007, Rouhi, 2003a).  
 
Combinatorial chemistry has, however, failed as a source of de novo synthetic small 
molecules that were developed from hit to lead to approved drug. For the period of 1981-
 2 
2006, Newman and Cragg (2007) stated that “Although combinatorial chemistry in one or 
more of its manifestations has now been used as a discovery source for approximately 70% 
of the time covered by this review, to date, we canfind only one de novo new chemical 
entity (NCE) reported in the public domain as resulting from this method of chemical 
discovery and approved for drug use anywhere”. The decline in the number of new active 
substances (and new natural product templates) in the past decade correlates with a 
decreased interest in natural product drug discovery by pharmaceutical companies (Butler, 
2005).  
 
Despite the current low level of natural product drug discovery programmes of 
pharmaceutical companies, natural products still play an important role as a source of 
drugs. The recent survey by Newman and Cragg (2007) showed that approximately 70% of 
the 974 small-molecule NCE’s introduced as drugs during 1981-2006 can be traced to or 
were inspired by natural products. Even the best-selling drug, atorvastatin (Lipitor), is a 
direct descendent of a natural product (Newman and Cragg, 2007). Natural products 
feature in high percentages especially in approvals as antimicrobials (77% of small 
chemical entities) and anticancer drugs (78% of small chemical entities).  
 
The reason for the success of natural products as drugs can be attributed to their unique 
structural characteristics. These compounds have diverse skeletons, often contain 
numerous stereogenic centres (associated with stereo pecific binding), frequently have 
many rings (fused and bridged), and are therefore rigid. This rigidity is associated with 
stronger protein binding due to a thermodynamic advantage over more flexible compounds 
that can form the same pattern of hydrogen bonds an hydrophobic interactions. They 
generally contain more nitrogen and oxygen atoms than combinatorial compounds, which 
is important for hydrogen bonding during ligand-receptor binding. Another interesting 
difference between natural products and combinatorial compounds is their lipophilicity, a 
property that affects the pharmacokinetics of a drug. Combinatorial compounds are 
generally more hydrophilic than both drugs and natural products (Feher and Schmidt, 
2003; Lee and Schneider, 2001).  
 
Although still labour intensive, practical difficulties associated with natural product drug 
discovery are increasingly overcome by advances in screening, separation and structural 
elucidation technologies. Smaller biotechnology companies in particular, are exploring 
 3 
natural resources as drug candidates, filling the gap left by large pharmaceutical companies 
(Gullo and Hughes, 2005; Rouhi, 2003a).  
 
1.2 Plants as sources of drugs 
 
In a 2000 report by Newman et al., it was stated that approximately 119 chemical 
substances obtained from 90 plant species were important drugs in one or more countries. 
Of these, 74% was the result of chemical studies directed at isolation of active components 
from plants used in traditional medicine (Newman et al., 2000). Plants provided 
humankind with some of the best-known medicines, including quinine, aspirin, and 
morphine while important new drugs such as taxol and vincristine were both recently 
isolated from plants (Van Wyk and Wink, 2004; Balunas and Kinghorn, 2005). In 2006 for 
example, the botanical preparation Hemoxin® was approved as a treatment for sickle cell 
anaemia in Nigeria. This preparation includes a mixture of plants directly derived from 
indigenous knowledge and may be classified as a true “ethnobotanical preparation”. 
According to Meinwald, of the 250 000 described flowering plants, only about 10% have 
been examined chemically and many have been investigated decades ago, when techniques 
were relatively crude (Rouhi, 2003b).  
 
South Africa has a remarkable biodiversity with more than 30 000 species of flowering 
plants (accounting for 10% of the world’s higher plants), 3000 of which are used 
medicinally (Van Wyk et al., 2000; Van Wyk and Gericke, 2000). World renowned South 
African plant remedies include Cape aloes (Aloe ferox), “buchu” (Agathosma betulina) and 
devil’s claw (Harpagophytum procumbens). If the remarkable number of South African 
plant species is taken into account, the almost complete absence of drug leads obtained 
from South African plants is quite surprising. Two examples of lead compounds obtained 
from South African plants are that of the appetite suppressant P57 isolated from Hoodia 
gordonii (Van Heerden et al., 2007; Van Wyk and Wink, 2004) and anticancer compound 























Figure 1.1 Structures of P57 from Hoodia gordonii and combretastatin from Combretum 
caffrum 
 
1.3 Plants as sources of antimicrobials and resistance-modifying agents 
 
There is a vast amount of literature available on plant-derived antimicrobial compounds. 
Compound classes with antimicrobial activity include terpenes, phenylpropanoids and 
stilbenoids, simple phenols and tropolones, flavonoids, alkaloids, polyketides, poly-ynes, 
sulfur-containing compounds, and acylphloroglucinols. Despite the large amount of 
literature available on the antibacterial activity of extracts and their compounds, no single 
plant-derived chemical entity is used clinically as n anti-staphylococcal agent - most 
likely because of perceived resupply issues (Gibbons, 2004).  
 
It is postulated that secondary metabolites are produced by plants as defence against 
microbes and other enemies in their environment (Schreiber, quoted by Rouhi, 2003a), 
thus explaining the presence of antimicrobial compounds. Micro-organisms, however, have 
the natural ability to acquire resistance against atimicrobials and this may have caused 
plants to evolve biosynthetic routes to synthesise compounds which evade these multi-drug 
resistant mechanisms. Consequently, compounds isolated from plants may play an 
important role as resistance-modifying agents, acting for instance on membrane proteins 
responsible for efflux of antibiotics out of cells that create ineffective intracellular 
concentrations of drugs (Gibbons, 2004). For example, epicatechin gallate, a polyphenolic 
constituent of green tea inhibits the synthesis of penicillin binding protein 2’, thus 




Significant characteristics associated with compounds that modify multi-drug resistance 
include a large size and high degree of lipophilicity, mportant for solubility in bacterial 
membranes and binding to efflux transporters (Gibbons, 2004). Isoflavones isolated from 
Lupinus argenteus, for example, have been shown to potentiate the activity of berberine 
and norfloxacin by inhibiting multi-drug resistance (MDR) pumps (Morel et al., 2003).  
 
1.4 Why investigate the genus Helichrysum?  
 
The Asteraceae is the largest plant family in southern Africa with 253 genera 
encompassing 2253 species. In this family, there are relatively few large genera and only 
three genera (representing 1% of the Asteraceae) hav  more than 100 taxa, namely Senecio 
L., Helichrysum Mill and Euryops Cass. (Koekemoer, 1996). In South Africa, the genus 
Helichrysum encompass a large number of species that is used traditionally, often in 
conditions associated with infections. There are numerous reports on the antimicrobial 
activity and other activities of extracts of these sp cies and the vast and interesting number 
of compounds isolated from the South African Helichrysum species. However, due to the 
large number of species and the taxonomic complexity of the genus, the phytochemistry 
and biological activity of many species have not been investigated. Furthermore, most of 
the phytochemical research was done in the 1970’s and 1980’s by the group of Bohlmann 
and often no connection was established between compounds isolated and any biological 
activity (See Chapter 2 for an extensive literature review). 
 
1.5 Natural product synthesis 
 
Compound availability has in the past been a serious concern associated with natural 
product-based drug discovery (Wilson and Danishefsky, 2007). The low supply, especially 
in the case of anti-infectives, may be overcome by using recombinant technology 
(biosynthesis) or by organic synthesis. Total synthesis, semi-synthesis and in some cases, 
manipulation of biosynthesis, also provide ways to obtain natural product derivatives with 
improved therapeutic indexes and enables the assembly of compounds inspired by the 
original natural product (Gullo and Hughes, 2005; Nicolaou and Snyder, 2004; Wilson and 
Danishefsky, 2007). By combining synthesis and a process known as “dynamic 
combinatorial screening” for example, a set of vancomycin dimers was synthesised that 
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showed improved activity when compared to vancomycin, an antibiotic used against 
methicillin-resistant strains of S. aureus (Nicolaou and Snyder, 2004). In the synthesis of 
cycloproparadicicol (inspired by the natural resorcinylic macrolide, radicicol), the 
replacement of an epoxide functionality with a cyclopropyl group resulted in improved in
vivo anticancer activity (Wilson and Danishefsky, 2007). 
 
A complex total synthesis of a natural product may lead to the additional reward of 
developing novel methodologies and still provides the absolute proof of the assigned 
structure. For example, efforts directed towards the total synthesis of quinine led to the 
knowledge of the construction of heteroaromatic system , while attempts to synthesise 
progesterone provided insights into the formation and cleaving of carbon-carbon bonds 
(Nicolaou and Snyder, 2004). In recent years, there has been a huge increase in the 
capacity of chemical synthesis. These advances include recognising the importance 
transition metals and the generation of enantiopure substances through reagent control. 
Due to advances made in synthetic methodology, synthesis of compounds with a high level 
of complexity is now possible and timelines for accomplishing total syntheses have been 
significantly improved. Creative approaches during retrosynthetic analysis, such as 
“pattern recognition” using the concept of identifying substructural motifs, have further 
enabled medicinal chemists to effectively synthesise complex natural products, such as the 
anticancer agent migrastatin (Wilson and Danishefsky, 2007).  
 
In 2003 and again in 2007, Newman and Cragg reported that there was a tendency to move 
away from large combinatorial libraries and emphasis was placed on small, focused 
collections that were structurally more natural product-like in terms of their combination of 
heteroatoms and significant numbers of stereogenic centers within a single molecule. It is 
postulated that scaffolds of natural origin, which presumably have undergone evolutionary 
selection over time, might confer favourable bioactivities and bioavailibilities to library 
members (Rouhi, 2003c, Nicolaou and Snyder, 2004). Small combinatorial libraries have 
yielded derivatives of taxol for example (Xiao et al., 1997), while a combinatorial library 
of 10 000 structures based on the privileged structu e of the 2,2-dimethylbenzopyran 
scaffold that occurs widely in nature and are associated with a wide range of biological 
activities was recently successfully completed (Nicolaou et al., 2000). A possible solution 
to the low yield of small novel chemical entities approved as drugs might lie in this 
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approach that combines the advantages offered by nature with those offered by synthetic 
and combinatorial chemistry and rational drug design.  
 
1.6 Aims of this study 
 
This investigation aims to combine plant natural product research with organic synthesis, 
with the main focus on the South African species of the medicinally important genus 
Helichrysum. 
 
The main aims of the project are: 
•  To isolate and identify the secondary metabolites of three South African 
Helichrysum species, namely H. splendidum, H. montanum and H. excisum. 
•  To identify biologically-active components present in Helichrysum species  
•  To develop synthetic methodologies for the synthesis of a bio-active molecule 
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South African Helichrysum species: A review of the 




The genus Helichrysum Mill. derives its name from the Greek words helios (sun) and 
chrysos (gold) which is appropriate considering the attracive yellow flowers displayed by 
several species (Pooley, 2003). It belongs to the family Asteraceae, tribe Inuleae and 
subtribe Gnaphaliinae (Hilliard, 1983). This large nus consists of approximately 500 
species and although Helichrysum species are also found in southern Europe, south-west 
Asia, southern India, Sri Lanka (previously Ceylon), and Australia, most species occur in 
Africa, including Madagascar (Hilliard, 1983). In South Africa (including Namibia), the 
ca. 244-250 species are widely distributed and the tremendous morphological diversity 
displayed by these species resulted in their division into 30 morphological groups, using 
the shape and size of the flower heads as differentiating characteristics (Hilliard, 1983). 
The flower heads occur as either solitary or in compact or spreading inflorescences. The 
aerial parts are usually hairy or woolly and plants occur as herbs or shrublets that are 
sometimes dwarfed and cushion forming. They are also often aromatic (Pooley, 1998; 
Pooley, 2003; Van Wyk et al., 2000).  
 
In South Africa, the genus is widely used in traditional medicine. The uses are well 
documented although renaming of species and the resulting confusing taxonomic 
nomenclature may cause uncertainty as to which specific species was referred to in some 
reports. The chemistry of the genus has been studied extensively and there are several 




The aims of this chapter are:  
•  To present a collated and coherent overview of the documented traditional uses of    
South African Helichrysum species and the compounds isolated from them. 
•  To summarise biological activities of extracts (excluding essential oils) and isolated 
compounds from South African Helichrysum species. 
 
2.2 Traditional uses 
 
Several Helichrysums are widely used in Southern African traditional medicine as 
summarised in Table 2.1. The first written record of the medicinal use of Helichrysum 
dates back to 1727 when Boerhaave (Professor of Botany and Medicine at the University 
of Leiden from 1701 to 1738) noted that a Helichrysum species was used to treat 
nervousness and hysteria. The report of a Helichrysum species in the early literature could 
have been based on knowledge acquired from the local Khoi and San people, but is most 
probably due to the fact that European botanists used their knowledge of medicinal 
properties of European genera (Scott and Hewett, 2008). In European medicine, flower 
heads from Helichrysum arenarium (Helichrysi flos; synon. Flores Stoechados citrinae or
Flores Gnaphalii arenarii) are used to treat peptic discomfort and are also used as an 
additive to tea mixtures, mainly to improve their appearance. This diuretic tea has value in 
the supportive treatment of cholecystitis and spastic disorders of the gall bladder and 
urinary tract (Van Wyk and Wink, 2004). Other species such as H. angustifolium, H. 
italicum and H. stoechas are well known in folk medicine and are used for their anti-
inflammatory and anti-allergenic properties (Carini et al., 2001).  
 
2.2.1 Ambiguities in nomenclature 
As is the case for all ethnobotanical data, the fact that plant names are changed 
(Germishuizen and Meyer, 2003) and frequently incorrectly cited (Arnold et al., 2002) is 
quite problematic. To complicate matters further, variation in spelling of names also 
occurs. Special care needs to be taken to consult the original texts to unambiguously 
confirm that a plant selected for a particular study is in fact the same species cited by, for 
example, Watt and Breyer-Brandwijk (1962). In Table 2.1, current names are given and 
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previously accepted names are shown in parenthesis. For the sake of clarity, the name as it 
appears in the reference is sometimes indicated in brackets after the reference. 
 
In some cases, one species name was changed to another, f r example H. adscendens Less. 
var. cephaloideum Moeser. in Watt and Breyer-Brandwijk (1962) is now known as H. 
cephaloideum DC. In other instances, a Helichrysum species now belongs to a different 
genus for example, H. capillaceum (Thunb.) Less (Watt and Breyer-Brandwijk, 1962) is 
now classified as Troglophyton capillaceum subsp. capillaceum (Hilliard, 1983). 
 
Sometimes the same species name with only a different author name refers to a different 
species, for example H. calocephalum Schltr., which is now classified as H. ecklonis and 
not H. calocephalum Klatt (Germishuizen and Meyer, 2003; Gibbs Russell et al., 1987). 
Batten and Bokelmann, (1966), Jacot Guillarmod, (1971), Phillips, (1917) and Watt and 
Breyer-Brandwijk (1962) all used H. calocephalum Schltr., which is now recognised as H. 
ecklonis, but in Arnold et al. (2002) there is no reference to H. ecklonis yet the above-
mentioned sources are used as references under H. calocephalum Klatt. 
 
The specific Helichrysum species referred to when H. crispum is used in ethnobotanical 
literature is also ambiguous. Germishuizen and Meyer (2003) stated that H. crispum of 
authors other than (L.) D Don is H. patulum (L.) D. Don. and not H.  crispum (L.) D. Don. 
In Watt and Breyer-Brandwijk (1962) and Smith (1966), the name appears as H. crispum 
Less. therefore indicating H. patulum, although Arnold et al. (2002) cited the name H. 
crispum (L.) D. Don (with reference to Smith, 1966) as well as H. patulum with reference 
to Watt and Breyer-Brandwijk (1962). Roberts (1990) used H. crispum without an author 
name, causing uncertainty as to which particular species is referred to; the cited medicinal 
uses are however similar to those indicated by Watt and Breyer-Brandwijk (1962) for H. 
crispum Less. Salie and co-workers (1996) determined that H. crispum (L.) D. Don had 
moderate (10 mg/ml) antimicrobial activity against Pseudomonas aeruginosa. Both Salie 
et al. (1996) and Swanepoel (1997) use the name H. crispum (L.) D. Don., but when 
indicating its traditional uses refer to Watt and Breyer-Brandwijk (1962). Scott et al. 
(2004) showed that H. patulum had antimicrobial activity against Staphylococcus aureus in 
the disc diffusion assay that was comparable to that of the ciprofloxacin control, while the 
traditional uses indicated correspond very well to th se of Watt and Breyer-Brandwijk for 
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H. crispum Less. Both species occur in the same region making exclusion of one species 
on the basis of distribution impossible. 
 
H. pedunculare DC. is another name with an unfortunate and confusig history. In this 
case, it seems that H. pedunculare DC. in ethnobotanical literature could refer to eith r H. 
pedunculatum Hilliard and Burtt or H. nudifolium var pilosellum (previously known as H. 
pedunculare (L.) DC. var. pilosellum, (Germishuizen and Meyer, 2003; Hilliard, 1983; 
Arnold et al., 2002). The vernacular name and uses indicated by e.g. Watt and Breyer-
Brandwijk (1962) for H. pedunculare DC. and Bhat and Jacobs (1995) for H. 
pedunculatum Hilliard and Burtt. are similar. According to Hilliard (1983), H. pedunculare 
(L.) DC. is also a synonym for H. odoratissimum (L.) Sweet. 
 
In some instances it is impossible to decide to which species an author refers to, for 
example H. agrostophilum Klatt (Watt and Breyer-Brandwijk, 1962) that was in part 
changed to H. pallidum DC. and in part to Helichrysum griseum Sond (Germishuizen and 
Meyer, 2003). 
 
2.2.2 Administration routes 
Plant parts used include the leaves, stems, flowers, roots, and sometimes the whole plant. 
The plant remedies are administered in different ways, including the preparation of teas, 
inhalation of smoke and vapours, and placement of leaves in the form of a poultice on 
wounds to prevent infection (Table 2.1). Several of these species are known by the same 
vernacular names, for example H. cymosum, H. nudifolium, H. odoratissimum and H. 
petiolare are all known as imphepho which indicates that they can be used interchangeably, 
as Van Wyk et al., (2000), noted that “use often depends on local availability rather than 
preference for a particular species”. 
 
2.2.3 Traditional uses of South African Helichrysum species 
The traditional uses of Helichrysum in South Africa are summarised in Table 2.1. There 
are several recurring South African traditional uses for plants from this genus. Smoke is 
often inhaled to induce trances or to invoke the goodwill of the ancestors. They are often 
used to treat respiratory conditions and leaves are often applied as wound dressings. They 
are used in the treatment of gastro-intestinal disor ers such as abdominal pain and colic 
and also eye conditions. They also seem to have an ffect on the relief of pain and 
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inflammation as they are used to treat menstrual pain, rheumatism, and headaches. The 
plants are used to fumigate huts and also used as bedding to repel insects. 
 
2.2.4 Correlation between medicinal uses and morphological groups 
Plants from almost all morphological groups are used medicinally and the broad spectrum 
of uses seems to cross the different morphological roups. In some cases there does seem 
to be a relationship between the morphological group (according to Hilliard, 1983) or 
adjacent morphological classes and the traditional uses of these plants. H. epapposum 
(Group 3), H. natalitium (Group 3) H. gymnocomum (Group 4) and H. odoratissimum 
(Group 4) all share the Zulu/Xhosa name i phepho and all are burnt as incense to invoke 
the goodwill of the ancestors. However, this particular use applies to many species for 
example, H. cymosum (Group 8), H. petiolare (Group 18), H. dregeanum (Group 30) and 
in some sources H. nudifolium (Group 23) share the same vernacular name and use. H. 
cymosum (Group 8), H. kraussii (Group 8), H. melanacme (Group 8), H. athrixiifolium 
(Group 9) and H. dregeanum (Group 9) are all used to treat respiratory complaints such as 
coughs and colds. The administration route of these r medies does however vary; for H.
arthrixiifolium the leaf is smoked, for H. kraussii the dried flowers and seeds are smoked 
in a pipe, for H. cymosum a decoction of leaves is drunk, for H. dregeanum the leaf is 
smoked and the administration route is not indicated in the source for H. melanacme. 
 
South African species are not often used to treat hart and kidney ailments. Both H. 
pandurifolium and H. patulum belongs to Group 18, and are indicated in the treatm nt of 
kidney disease and heart disorders. Both are also used to treat backpain and respiratory 
conditions by the same administration route. Plants from Groups 23 and 24 are often used 
to treat wounds. The leaves of H. miconiifolium (Group 23), H. nudifolium (Group 23), H. 
pedunculatum (Group 23), H. appendiculatum (Group 24) and H. longifolium (Group 24) 
are all used as wound dressings. However, H. foetidum (Group 30) is mentioned as a 
replacement for H. pedunculatum in the treatment of circumcision wounds (Gerstner, 
1938). The species constituting Group 23 are also ued for respiratory conditions 
including, H. mundtii, H. nudifolium and H. pedunculatum. Root decoctions of both H. 
adenocarpum and H. ecklonis belonging to Group 28 are used to treat diarrhoea in 
children, while a root infusion from H. argyrophyllum (Group 29) is used to treat intestinal 
troubles. It is interesting to note that the only two species indicated for the treatment of 




The chemistry of this genus is complex with a wide variety of chemical classes occurring 
as is illustrated in the three major publications by Bohlmann and Jakupovic (Bohlmann et 
al., 1980b; Jakupovic et al., 1986; Jakupovic et al., 1989b) in which the phytochemistry  of 
a total of 63 South African Helichrysum species was investigated. The classes of 
compounds isolated from the South African Helichrysum species are summarised in Table 
2.2 and Figures 2.1 to 2.11. Acylphloroglucinols are commonly found, often with prenyl or 
geranyl side chains. The replacement of the cinnamic acid starter unit by other acyl CoA 
derivatives in the biosynthesis of the main constituen s seems to be characteristic 
(Jakupovic et al., 1989b). The appearance of humulone derivatives, such as helihumulone 
(49) is also widespread (Jakupovic et al., 1989b). 
 
Flavonoids derived from phloroglucinol are very common and often have unsubstituted B 
rings (Bohlmann and Abraham, 1979a; Bohlmann and Abraham, 1979d; Jakupovic et al., 
1986) which is a characteristic feature of plants from the Inuleae tribe (Harborne, 1977). 
The presence of 6- and 8-hydroxyflavonols and their methyl ethers are also frequent as in 
other members of the tribe (Harborne, 1977). A wide variety of chalcones are also found, 
including those substituted with prenyl or geranyl groups, dihydrochalcones and 
pyranochalcones. As in other Inuleae species, these chalcones are often accompanied by 
their structurally and biogenetically related flavanones (Harborne, 1977) as can be seen for 
H. acutatum (Bohlmann and Abraham, 1979c), H. cymosum (Jakupovic et al., 1989b) and 
H. oreophilum (Jakupovic et al., 1986). 
 
The presence of α-pyrones is rather common (they occur in plants from morphologic 
Groups 1, 2, 4, 12, 15, 18, 19 and 24) and are often isolated from the roots of these plants 
(Hänsel et al., 1980; Jakupovic et al., 1986; Jakupovic et al., 1989b). Different types of 
diterpenes occur; these include the kaurenoic acid type (Jakupovic et al., 1989b) as well as 
helifulvenic acid derivatives (Bohlmann et al., 1980a). Sesquiterpenes from a variety of 
skeletal types occur, as is characteristic for the rest of the family (Hegnauer, 1977). Some 
skeletal types, such as the humulenes, are widely distributed across the genus, whereas 
others such as the guaianolides are restricted to a few species (morphological Groups 10 
and 22). Helichrysum species are known for their aromaticity and a variety of 
 15 
monoterpenes are reported in the essential oils of some species (Lourens et al., 2004; Van 
Vuuren et al., 2006; Frum and Viljoen, 2006; Asekun et al., 2007). Squalene (309) is the 
most common triterpene found and is often present in high concentration. 
  
Other unusual compounds that occur is thiophene derivatives which have been isolated 
from the roots of these plants (H. acutatum and H. tenuifolium). These thiophenes are the 
result of addition reactions of a common chloro-acetylene precursor with H2S (Bohlmann 
and Abraham, 1979b; Bohlmann and Abraham, 1979c). Simple polyacetylenes are 
widespread and acetylenics with pyran and furan moieties, some with epoxy and/or 
chlorine substitution, occur in these plants and are characteristic of the Gnaphalineae 
(Harborne, 1977). 
 
As for the traditional uses, one particular class of compound is not restricted to a particular 
morphological group. However, there are some compounds that occur mainly in a 
particular morphological class. For example, phloroglucinols (excluding those belonging to 
the flavonoid class) feature as major compounds in morphological classes 2, 3, 4, 12, 14, 
15, 20, 24 and 28. Flavonoids are present in basically all morphologic groups, but a large 
number are found in plants from Groups 8, 9 and 27. Diterpenes were isolated in large 
quantities from species in Groups 23, 25 and 30 (all 10 plants investigated in this group 
had this type of compound as the major chemical species). H. umbraculigerum from Group 
5 seems to be the only species investigated that contains compounds of the cannabigerol 
type as the major constituent and H. dasyanthum (Group 10) and H. splendidum (Group 
22) contain mainly sesquiterpenes of the guaianolide type (which is absent in the other 
species). Plants from Groups 6, 18 and 19 are also rich in sesquiterpenes (Table 2.2). 
 
Although there seem to be similarities in the chemistry of the European and South African 
species, the Australian species are chemically different from their South African 
counterparts (Jakupovic et al., 1989a; Jakupovic et al., 1989b). 
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2.4 Biological activity 
 
2.4.1 Anti-infective activity 
Considering the traditional uses of this genus (specifically the treatment of wounds and 
respiratory infections and the application as a fumigant for example), there seems to be a 
strong indication that these plants and their compounds should exhibit antimicrobial 
activity. A large amount of antimicrobial work on Helichrysum species was done by the 
group of Meyer from the University of Pretoria, South Africa. Extracts of several species 
(Table 2.1) were submitted to antibacterial testing using a group of randomly selected 
bacteria which normally included the Gram-positive bacteria: Bacillus cereus, Bacillus 
pumilis, Bacillus subtilis, Micrococcus kristinae, Staphylococcus aureus, and the Gram-
negatives: Enterobacter cloaceae, Escherichia coli, Klebsiella pneumoniae, Pseudomonas 
aeruginosa, and Serratia marcescens. Acetone extracts were mostly tested, but in a few 
cases methanol, water and dichloromethane extracts were used. Assays involving agar 
dilution and direct autobiography were employed (Afolayan and Meyer, 1997; Bremner 
and Meyer, 2000; Dilika et al., 1997; Mathekga and Meyer, 1998; Mathekga et al., 2000; 
Mathekga, 2001; Meyer and Dilika, 1996; Meyer and Afolayan, 1995).  
 
For example, when dichloromethane, acetone, methanol d water extracts of H. 
aureonitens were tested against the above-mentioned micro-organisms, the water extract 
displayed no activity whereas the dichloromethane extract showed the most promising 
activity against Gram-positive organisms such as B. cereus and M. kristinae at a 
concentration of 0.5 mg/ml (Meyer and Afolayan, 1995, Mathekga, 2001). Since 0.5 
mg/ml was the lowest concentration tested, the MIC for this extract could in fact be lower 
than that. An acetone extract of H. caespititium was active against all the above-mentioned 
organisms at 1 mg/ml (the highest concentration tested) except K. pneumoniae and S. 
marcescens (Mathekga et al., 2000). Acetone extracts of H. appendiculatum, H. 
argyrosphaerum, H. aureonitens, H. bellum, H. caespititium, H. callicomum, H. 
candolleanum, H. chionosphaerum, H. decorum, H. glomeratum, H. herbaceum, H. 
hypoleucum, H. kraussii, H. longifolium, H. melanacme, H. miconiifolium, H. montanum, 
H. monticola, H. nudifolium, H. odoratissimum, H. oreophilum, H. pilosellum, H. 
psilolepis, H. rugulosum, H. simillimum, H. sutherlandi, H. trilineatum, and H. 
umbraculigerum were tested against the same organisms and again activity was mainly 
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observed against the Gram-positive bacteria. K. pneumoniae and S. marscecens were 
resistant to all the extracts. H. glomeratum, H. montanum, H. monticola, H. oreophilum 
and H. pilosellum were all inactive at the maximum concentration tested against all the 
bacterial species used in the assay (Mathekga and Meyer, 1998; Mathekga, 2001). 
Antifungal activity was also determined for the 28 acetone extracts mentioned above. 
Extracts were tested against Aspergillus flavus, Aspergillus niger, Cladosporium 
cladosporioides, Cladosporium cucumerinum, Cladosporium sphaerospermum and 
Phytophthora capsici (Mathekga, 2001). The most active extracts were those of H. 
caespititium, H. callicomum, H. glomeratum (which showed no antibacterial activity), H.
hypoleucum, H. melanacme, H. oreophilum, and H. rugulosum, all of which had MIC’s of 
0.01 mg/ml against one or more of the fungal species tested (Mathekga, 2001).  
 
A dichloromethane extract of H. pedunculatum displayed activity against three Bacillus 
species (10 mg/ml), M. kristinae (10 mg/ml), S. aureus (20 mg/ml) and the Gram-negative 
E. cloaceae (50 mg/ml) after incubation on agar plates (Meyer and Dilika, 1996). The 
lowest concentration tested was 10 mg/ml which may indicate that lower concentrations 
could still inhibit the growth of these micro-organisms. Antibacterial activity was also 
observed against S. aureus for both H. pedunculatum and H. longifolium with a direct 
autobiography method on thin-layer chromatograms (2 mg of extract applied). It is 
however difficult to deduct qualitative data from this paper (Dilika et al., 1997). Gerstner 
(1938) stated that H. foetidum is sometimes used as an alternative for H. pedunculatum. 
Methanol and water extracts of H. foetidum had MIC’s of more than 4 mg/ml against S. 
aureus, Streptococcus pyogenes, E. coli and P. aeruginosa in the 96-well plate assay 
(Steenkamp et al., 2004) indicating that this plant has weak (Gibbons, 2004) in vitro 
antibacterial activity. 
 
In a disc diffusion assay, extracts of solvents with different polarity of H. crispum 
displayed antibacterial activity against the Gram-negative P. aeruginosa, Mycobacterium 
smegmatis, and the yeast Candida albicans, but was surprisingly enough inactive against S. 
aureus. MIC’s of 10 mg/ml were reported against P. aeruginosa and C. albicans (Salie et 
al., 1996).  
 
Activity ranging from 0.078 mg/ml – 0.3 mg/ml against Gram-positive and Gram-negative 
bacteria and yeasts was also reported for a H. cymosum extract (Van Vuuren et al., 2006). 
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Acetone and methanol extracts of H. odoratissimum (incorrectly identified as H. 
dasyanthum in Lourens et al., 2004), H. excisum, H. felinum, and H. petiolare displayed 
activity against S. aureus and B. cereus. The species with the best activity was the acetone 
extract of H. odoratissimum with an MIC of 0.016 mg/ml against S. aureus (which 
correlates well with the values obtained by Matheka and Meyer, 1998). 
 
Helichrysum species are often used to treat respiratory conditi s and tuberculosis (Table 
2.1). Extracts of H. odoratissimum and H. melanacme showed activity against 
Mycobacterium tuberculosis at concentrations of 0.5 mg/ml (Lall and Meyer, 1999; Lall et 
al., 2006). The acetone extract of H. caespititium inhibited a drug-sensitive strain of M. 
tuberculosis at a concentration of 0.5 mg/ml in the agar plate method and a MIC of 0.1 
mg/ml was observed using the rapid radiometric method (Meyer et al., 2002). The water 
extract caused partial inhibition at the highest concentration of 5 mg/ml. 
 
In some cases the antimicrobial activity of isolated compounds was determined. 
Flavonoids are generally one of the largest classes of antibacterial compounds (Gibbons, 
2004). Galangin (54) isolated from H. aureonitens (Meyer and Afolayan, 1995), inhibited 
the growth of four Gram-positive bacteria (three Bacillus species and M. kristinae) as well 
as the Gram-negative E. cloaceae (Afolayan and Meyer, 1997). The highest activity 
observed was against B. cereus, M. kristinae and E. cloaceae at 0.1 mg/ml. In other studies 
by Cushnie et al. (2003) and Cushnie and Lamb (2006), the activity of galangin (54) was 
shown against six strains of β-lactam sensitive and resistant strains of S. aureus and 16 
strains of 4-quinolone resistant strains of the bacterium at MIC’s of approximately 50 
µg/ml. Galangin (54) also displays some antifungal activity against fungi such as 
Aspergillus tamari (35% growth inhibition at 0.5 mg/ml) (Afolayan and Meyer, 1997). 
These results support the use of H. aureonitens in the treatment of skin infections, often 
caused by S. aureus. 
 
Another flavonoid, 3-O-methylquercetin (64) was isolated from H. odoratissimum and 
antimicrobial activity determined for a broad range of micro-organisms including Gram-
negative bacteria such as Salmonella typhimurium (MIC = 50 µg/ml), Gram-positive 
bacteria, such as S. aureus (MIC = 6.25 µg/ml) and fungi, for example C. albicans (MIC = 
12.5 µg/ml), in the microdilution method (Van Puyvelde et al., 1989). Bremner and Meyer 
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(1998) also reported on the anti-staphylococcal activity for pinocembrin chalcone (22) 
(isolated from H. trilineatum), as well as pinocembrin (1) that was obtained as an artifact 
during the isolation procedure.  
 
Flavonoids (21, 35) isolated from the flowers of H. gymnocomum exhibited promising 
antimicrobial activity against a wide variety of Gram-positive and Gram-negative 
organisms as well as yeasts. An MIC of 8 µg/ml was for example observed against 
Cryptococcus neoformans for 5,7-dibenzyloxyflavanone (35) (Drewes and Van Vuuren, 
2008). Two chalcones (23, 39) isolated from H. melanacme exhibited MIC’s of 0.05 
mg/ml against the drug sensitive H37Rv strain of M. tuberculosis. The activity of the 
chalcones was higher than the extract but a combination of the two chalcones did not result 
in an improved MIC (Lall et al., 2006). 
 
A study on the structure-activity relationships responsible for the anti-staphylococcal 
activity of flavonoids indicated that chalcones are generally more active than flavones, 
which has similar or better activity than flavanones. The most important structural feature 
for activity is the presence of the α,β-unsaturated carbonyl group (in chalcones and 
flavones) that favours π-electron delocalization of phenyl ring B. Furthermore, a hydroxy 
group at postion 2’ of chalcones and 5 of flavones improves antibacterial activity (Alcaráz 
et al., 2000). A hydroxy group exerts an effect opposite to that of a methoxy group, while 
the presence of OH groups induce and enhance activity against methicillin resistant S. 
aureus, replacing them with methoxy groups drastically reduces or even eliminates anti-
staphylococcal activity (Alcaráz et al., 2000).  
 
There are also reports on the antimicrobial activity of compounds other than flavonoids. 
Activity against Gram-positive bacteria was observed for both linoleic and oleic acids, 
isolated from antibacterial extracts of H. pedunculatum (a plant used to treat circumcision 
wounds, Dilika et al., 2000). The MIC of both fatty acids was 1.0 mg/ml for S. aureus and 
M. kristinae in the agar diffusion assay. The MIC’s was 0.05 mg/ml of each fatty acid 
when they were administered at the same time (Dilika et al., 2000). 
 
Kaurenoic acid (195) (a diterpene), isolated from H. kraussii, exhibited a MIC as low as 1 
µg/ml against E. coli and MIC’s of 10 µg/ml against B. cereus, B. subtilis, S. aureus and S. 
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marcescens (Bremner and Meyer, 2000). Significant antimicrobial activity was also 
observed for monomeric and dimeric diterpenes (228-232) from H. tenax var tenax. MIC 
values as low as 3.1 and 3.6 µg/ml were determined against B. cereus whereas MIC’s as 
low as 41.5 µg/ml were determined for a Gram-negative organism such as P. aeruginosa 
(Drewes et al., 2006). 
 
MIC’s of 100 µg/ml were observed for a prenylated butyrylphloroglucinol (90) isolated 
from H. kraussii against B. cereus, B. pumilis, B. subtilis, M. kristinae, S. aureus, S. 
marcescens and E. coli in an agar diffusion assay (Bremner and Meyer, 2000). The same 
phloroglucinol analogue (90) was isolated from H. gymnocomum and MIC’s of below 100 
µg/ml (6 - 45 µg/ml) were reported for Enterococcus faecalis, Staphylococcus epidermidis, 
S. aureus, B. cereus, P. aeruginosa, C. neoformans, and C. albicans (Drewes and Van 
Vuuren, 2008). A difference in assays employed, inoculum size and possibly different 
strains of the micro-organism used may account for he observed difference in activity. A 
structurally related phloroglucinol (102) also exhibited promising antibacterial activity 
against E. faecalis, S. aureus P. aeruginosa, and C. neoformans (Drewes and Van Vuuren, 
2008). Caespitin (127) and caespitate (98) (both phloroglucinols) exhibited antimicrobial 
activity against several bacteria as well as fungi (Dekker et al., 1983; Mathekga et al., 
2000). Caespitin (127) was active against S. aureus, Streptococcus pyogenes, C. 
neoformans, Trichophyton rubrum, T. mentagrophytes, and Microsporum canis although 
neither the method used, nor the level of activity, are indicated in the relevant article 
(Dekker et al., 1983). Caespitate (98) exhibited antibacterial activity against the Gram-
positive B. cereus, B. pumilis, B. subtilis, M. kristinae and S. aureus at concentrations of 
0.5 µg/ml in the agar dilution method (Mathekga et al., 2000). This compound also 
exhibited antifungal activity which ranged from 0.5 - 1.0 µg/ml against A. flavus, A. niger, 
C. cladosporioides, C. cucumerinum, C. sphaerospermum, and Phytophtora capsici 
(Mathekga et al., 2000). Caespitate (98) was also active against several M. tuberculosis 
strains at a concentration of 0.1 mg/ml which was similar to the MIC observed for the 
crude extract of H. caespititium (Meyer et al., 2002). Several caespitin derivatives were 
synthesised with MIC values as low as 2 µg/ml against Staphylococcus aureus and 
Streptococcus pyogenes. These compounds also exhibit antifungal activity. The possible 
development of antimicrobial resistance was examined as well as the development of cross 
resistance with known antimicrobials (Van der Schyff et al., 1986).  
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For helihumulone (49), a phloroglucinol derivative of the humulone type, activity was 
exhibited for a broad range of micro-organisms with some promising results, for example 
16 µg/ml against P. aeruginosa. The antimalarial activity of this compound was 
determined to be 15 µg/ml (Van Vuuren et al., 2006). As previously mentioned, the South 
African Helichrysums contain a large amount of phloroglucinol derivatives and 
considering the promising antimicrobial activity observed for this type of compound, it 
seems a class well worth investigating. 
 
Aqueous extracts of H. aureonitens exhibited antiviral activity against the Herpes simplex 
virus type I in vitro at a concentration of 1.35 mg/ml (Meyer et al., 1996). The flavone, 
galangin (54), isolated from this plant also exhibited antiviral activity against H. simplex 
virus type I and the Coxsackie virus at concentrations of 6 µg/ml (Meyer et al., 1997). The 
antiviral activity was also determined for a crude ethanolic extract of H. melanacme and its 
isolated constituents. The activities of the isolated prenylated chalcone (23) and a 
pyranochalcone (39) were lower (IC50 = 0.1 mg/ml) against the Influenza A virus than that 
of the crude extract (0.01 mg/ml) although a combination of the two chalcones resulted in 
an improved IC50 (0.01 mg/ml, Lall et al., 2006). 
 
In summary, the crude extracts generally show some degree of antimicrobial activity, 
which is usually higher against Gram-positive organisms than against Gram-negative 
organisms. Although the antibacterial and antifungal activities of these plants are well 
documented, antimalarial, antimycobacterial, and antiviral data are scarce. Isolated 
compounds sometimes exhibit more superior activity when compared to the crude extract, 
but often the crude extract has similar activity. Correct identification of plant material is 
crucial as misidentification of plant material can lead to incorrect reporting (Lourens et al., 
2004). The selected range of concentrations is often on the high side (Gibbons, 2004, 
considered values of below 1 mg/ml for extracts and64 µg/ml for single chemical entities 
as significant); for example a range of 10-100 mg/ml was used for H. pedunculatum 
extracts (Meyer and Dilika, 1996). Positive controls (antibiotics) are absent in some of the 
assays (Mathekga et al., 2000), making it difficult to comparatively assess the activity of a 
particular extract or compound. The fact that different assays are employed impairs 
comparison of data between different laboratories (a says relying on diffusion are 
especially suspect since a low rate of diffusion would present a low activity, which is not 
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always a true representation). Microbial strains are often not referenced and the number of 
colony forming units not mentioned (Meyer and Afolayan, 1995). Extracts also often do 
not dissolve completely in the solvents used and as Cu hnie and co-workers (2003) 
illustrated with galangin (54), this can have a profound effect on the MIC’s observed 
(Cushnie et al., 2003). Chemical classes such as the flavonoids, acylphloroglucinols, and 
diterpenes from South African Helichrysum species exhibit promising antimicrobial 
activity and plants that contain these compounds seem  potential candidates for further 
study. 
 
2.4.2 Other biological data 
Unpublished work done by Noristan laboratories indicates that fractions of the extract of 
H. caespititium exhibits anti-inflammatory activity of up to 82% at 360 mg/kg in the 
carrageenan test done on rats and prevents platelet aggregation (Swanepoel, 1997). 
Ethanolic extracts of H. subglomeratum and H. nudifolium inhibited cyclo-oxygenase 
enzymes in vitro by 69% and 96% (50 µg of plant extract used) respectively, indicating 
inhibition of prostaglandin synthesis (Jäger et al., 1996). The group at Noristan determined 
that fractions of a H. nudifolium extract also reduced edema in the carrageenan assay by 
approximately 30% at 300 mg/kg in rats (Swanepoel, 1997). These results indicate that H. 
nudifolium has both in vitro and in vivo anti-inflammatory activity, probably partly due to 
the inhibition of the cyclo-oxygenase enzymes. 
 
The group at Noristan observed that the second of three fractions obtained after gradient 
column chromatography (using petroleum ether, ethyl acetate and methanol) of a 
dichloromethane/methanol extract from H. panduratum showed a 79% reduction in pain 
experienced in the writhing pain test at 500 mg/kg. Edema was also reduced by 50% in the 
carrageenan test indicating that this plant has both anti-inflammatory and analgesic 
properties. It was also antihypertensive (a reduction of 6% in mean blood pressure was 
observed after administering a dose of 300 mg/kg) and weakly antimicrobial (Swanepoel, 
1997).  
 
A fraction from a dichloromethane/methanol extract of H. petiolare investigated by the 
Noristan group determined that administration of 300 mg/kg of extract to mice reduced 
mean blood pressure by 21% and resulted in a 6% reduction in heart rate (Swanepoel, 
1997). Acetone extracts of H. excisum (IC50 = 35 µg/ml) and H. felinum (IC50 = 39 µg/ml) 
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inhibited the 5-lipoxygenase enzyme which also plays  role in inflammation. Antioxidant 
activity (as indicated with the DPPH assay) of aceton  and methanol extracts of H. 
odoratissimum, H. excisum, H. felinum and H. petiolare was comparable to that of vitamin 
C, as expected for species rich in phenolic compounds (Lourens et al., 2004). 
 
European research further highlights the antioxidant d anti-inflammatory effects 
displayed by plants from this genus. It is quite often the flowers that are investigated, a 
plant part that are seldom investigated in South African research (Drewes and Van Vuuren, 
2008; Table 2.2). Anti-oxidant activity was reported for flower extracts from H. stoechas 
(Carini et al., 2001), H. arenarium (Czinner et al., 2000; Czinner et al., 2001) and H. 
italicum (Facino et al., 1990). In vivo (topical) anti-inflammatory activity comparable to 
that of the indomethacin standard was observed for an acetophenone derivative, gnaphaliin 
(67) and ursolic acid isolated from H. stoechas (Recio et al., 1991). In vivo and in vitro 
anti-inflammatory activity was also observed for acetophenone glucosides, flavonoids, and 
other compounds isolated from H. italicum (Sala et al., 2001; Sala et al., 2002; Sala et al., 
2003a, Sala et al., 2003b) as well as for extracts from H. compactum (Süzgeç, et al., 2005). 
These promising results indicate that more research should be undertaken on the anti-
inflammatory activity of South African species, as many similar compounds appear in the 
South African and European species. 
 
As previously mentioned, Helichrysum species are often burnt as incense to invoke the 
goodwill of the ancestors, in protective and other charms, and to induce trances. It is also 
used in the treatment of insanity, possession, useda  a sedative to treat insomnia, and as a 
protective cleanser (Table 2.1). Their traditional uses indicate that these plants may exhibit 
psychotropic effects. Stafford et al. (2005) determined the GABA-receptor binding effect 
of extracts from H. argyrolepis, H. herbaceum, H. nudifolium, H. ruderale, H. rugulosum, 
H. simillimum, and H. umbraculigerum by using the 3H-Ro 15-1788 binding assay. H. 
ruderale and H. umbraculigerum exhibited the most pronounced effects, while H. 
herbaceum, H. rugulosum, and H. simillimum showed moderate to good dose dependant 
activity. 
 
There appears to be a large divide between the rich chemical data available and biological 
testing on compounds isolated from the South African species. One chemical class, the α-
pyrones will be discussed as an example. By our rough estimate, 28 different pyrones were 
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isolated from South African Helichrysum species. The same class of compound was 
isolated from European species and rather interesting b ological activity was observed. 
Italipyrone (370), plicatipyrone (371), and a mixture of homoarenol (372) and arenol (373) 
were all active against B. subtilis, S. aureus, S. epidermidis, and Mycobacterium phlei 
using the agar diffusion method with the highest MIC being 25 µg/ml and the lowest 3 
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Antifungal activity was also reported for α-pyrones isolated from H. decumbens (Tomás-
Lorente et al., 1989). Pyrones [like arzanol (374) and helipyrone (375)] showed significant 
anti-oxidant activity and arzanol was not toxic at all concentrations tested (Rosa et al., 
2007). Most interesting though, are the findings by Appendino et al. (2007) that arzanol 
(374) inhibits HIV-I replication in T-cells and inhibited NF-κB (IC50 = 5 µg/ml) 
indicating that this group of compounds may exhibit bo h antiviral and anti-inflammatory 
properties. To our knowledge, none of the unique pyrones isolated from South African 
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Most concerning is the almost complete absence of toxici y data for the South African 
species of this genus. In very few cases, for example where antiviral and antimalarial 
activity was determined (Lall et al., 2006; Meyer et al., 1996; Meyer et al., 1997; Van 
Vuuren et al., 2006) toxicity is mentioned. Toxicity of the diterpenes is well known (for 
example IC50 values of below 4 µg/ml was reported for three diterpene lactones from 
Parinari capensis; Uys et al., 2002), and several Helichrysum species contain high 
amounts of these compounds. Furthermore, Reid et al. (2006) screened 42 medicinal South 
African plants for mutagenicity, which included H. herbaceum, H. nudifolium, H. ruderale, 
H. rugulosum, H. simillimum, and H. umbraculigerum. The only three plants that showed 
mutagenic activity were all Helichrysums, namely H. herbaceum (at 5 mg/ml), H. 
rugulosum (at 5 mg/ml), and H. simillimum (at 0.05 mg/ml). These results highlight both 
the need and importance of toxicity and safety data for plants of this genus. In general, 
there also seems to be a large need for in vivo validation of in vitro results since the 





Helichrysum species are used extensively in ethnomedicine in South Africa and many of 
the uses are associated with the treatment of infect ons, e.g. it is used widely for treatment 
of respiratory diseases and wound dressing (Table 2.1). The large morphological diversity 
of the genus is mirrored by the diversity of chemical ompounds isolated from the genus. 
However, determining the biological activity of the plant extracts and isolated compounds 
has, up to now, not received the same attention as the phytochemical studies.  Furthermore, 
there are sometimes confusion as to exactly which species have been used and in any 
studies based on reported traditional uses, the identity of the species should be verified 
first.  There is an interesting relationship between the morphological classification and the 
classes of chemical compounds isolated from a specific morphological group and there are 
certain classes of compounds, e.g. diterpenes, guaianolides, acylated phloroglucinols and 
α-pyrone derivatives, for which one can predict in which species they are most likely to 
occur. This may be important in the search of new plant-derived drugs, e.g. acylated 
phloroglucinols show potential as anti-staphylococcal drug leads (Gibbons, 2004) and α-
pyrone derivatives have anti-HIV properties (McClacken and Fairlamb, 2005; Appendino 
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et al., 2007).  It is clear that Helichrysum is an interesting genus from an ethnobotanical, 
phytochemical and pharmacological perspective but tha biological data to correlate the 
ethnobotany to the chemistry is often still lacking. To complete the picture, a 
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H. acutatum DC. 
21c 
  Widely used as traditional medicine, sold 
commercially in large quantities 
NS  Arnold et al., 2002; Cunningham, 1988; 
Hutchings et al., 1996. 
H. adenocarpum DC. 
28  
Root Decoction Used to treat diarrhoea and vomiting n 
children. 
 
GIT  Arnold et al., 2002; Jacot Guillarmod, 
1971; Neuwinger, 1996; Phillips, 1917; 
Pooley, 2003; Walker, 1996; Watt and 





Chest problems or infection of the respiratory 
tract 
Plant  Smallpox 
Plant  Anthelmintic 




Applied externally to wounds. Ground leaves 
are rubbed into areas which cramps or on 
wounds  
Roots  Ground and burnt and smeared on body to relax
body and to reduce swelling 
H. appendiculatum (L.f.) 
Less.   
24 








Arnold et al., 2002; Githens, 1949; 
eMathekga, 2001; Smith, 1895; Smith, 
1966; Swanepoel, 1997; Walker, 1996; 
Watt and Breyer-Brandwijk, 1962. 
Root Infusion  Intestinal troubles H. argyrophyllum DC. 
29 
  Not grazed by stock, preventing soil erosion in 
overgrazed areas. 
GIT  Arnold et al., 2002; Batten and 
Bokelmann, 1966; Smith, 1966; Walker, 
1996; Watt and Breyer-Brandwijk, 
1962. 
H. argyrosphaerum DC.  
15 
  Browsed by animals but poisonous if large 
quantities is ingested. 
Poi dB, dF Hutchings et al., 1996; eMathekga, 
2001; Pooley, 1998; Van Wyk et al., 
2002. 
H. asperum (Thunb.)   The plants are casually browsed by sheep and Poi  Smith, 1966 f, (H. ericaefolium DC.). 
 33 
 34
Hilliard and Burtt. ( = H. 
ericifolium Less) 
12 
said to be a cause of “Geilsiekte“.  
H. athrixiifolium (Kuntze) 
Moeser  
9 
Leaf Smoked Chest complaints. 
 
 
Resp  Arnold et al., 2002; Jacot Guillarmod, 
1971 f(H. athrixifolium O. Hoffm.); 
Phillips, 1917 f(H. athrixiifolium O. 
Hoffm.); Watt and Breyer-Brandwijk, 







Used to invoke the goodwill of the ancestors 
and to induce trances  
Leaves 
and stems 
 Commercially sold 
 
 Decoction A remedy for inuresis in children  
 Extracts 
 
Used topically for skin infections especially 
against Herpes zoster and infections associated 
with Herpes simplex 
  Used to keep red mites away 
H. aureonitens Sch. Bip. 
8 







eAfolayan and Meyer, 1997; 
Cunningham, 1988; Hutchings et al., 
1996; Jacot Guilllarmod, 1971; 
eMathekga, 2001; eMeyer and Afolayan, 
1995; eMeyer et al., 1996; eMeyer et al., 
1997; Phillips, 1917; Pooley, 1998; 
Pooley, 2003; Swanepoel, 1997; 




gH. aureum Houtt. Merr. 
var. aureum/ 
monocephalum ( = H.  
fulgidum (L.f.) Willd.) 
30 
 Decoction  Used for washing sore eyes. Eye   Arnold et al., 2002 f(H. fulgidum L.f.) 
Willd.); Batten and Bokelmann, 1966 
f(H. fulgidum Willd.); Jacot Guillarmod, 
1971 f(H. fulgidum (L.) Willd.); Phillips, 
1917 f(H. fulgidum Willd.). 
H. bellum Hilliard 
28 













Drunk by the Kwena and the Kgatla to treat 
gonorrhoea 
Root Decoction Nausea 
Roots  Virility 
Plant Ointment Ointment is applied to the roof of the mouth for 
a depressed fontanelle 
H. caespititium (DC.) 
Harv  
12 











Arnold et al., 2002; eDekker et al., 1983; 
Gelfand et al., 1985 f(H. caespitium 
Sond.);  Hutchings and Van Staden, 
1994; Jacot Guillarmod, 1971 f(H. 
caespitium Sond.); eMathekga et al., 
2000; eMathekga, 2001; eMeyer et al., 
2002; Neuwinger, 1996; Phillips, 1917 
f(H. caespitium Sond); Pooley, 1998; 
Pooley, 2003; eSwanepoel, 1997; Watt 
and Breyer-Brandwijk, 1962. 
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 35




Protective charm. Mixed with Aster bakerianus 
(hispidis) and H. rugulosum 
 Used for fuel in winter 










Arnold et al., 2002; Jacot Guillarmod, 
1971; eMathekga and Meyer, 1998; 
eMathekga, 2001; Phillips, 1917; 
Pooley, 2003; Watt and Breyer-
Brandwijk, 1962.  







   Arnold et al., (2002) refers to others 
using H. calocephalum Schltr, which is 
classified as H. ecklonis Sond 




Root  Used for hyperfunction of the lower gastro-
intestinal tract. 
GIT  Swanepoel, 1997, information obtained 
from TRAMED database. It is not clear 
to these authors whether this use 
pertains to H. calocephalum Klatt or H. 
ecklonis Sond. 
H. candolleanum Buek 
15 
    dB, dF eMathekga, 2001 
H. chionosphaerum DC. 
25 
    dB, dF eMathekga, 2001 
H. cephaloideum DC. 
( = H. adscendens Less. 
var. cephaloideum   
Moes.) 
24 
  Irritant poisoning in sheep demonstrated. 
Known to be poisonous to sheep (symptoms 
similar to that of poisoning caused by Geigera). 





Demulcent in coughs and other pulmonary 
affections. In the Western Cape area the plant is 
used to treat whooping cough, other coughs, 
bronchial catarrh and bronchitis 
H. cochleariforme DC. 




Decoction Drunk for infections of the respiratory tact 
Resp  Arnold et al., 2002; Neuwinger 1996; 
Smith, 1966; Swanepoel 1997; Watt and 
Breyer-Brandwijk, 1962. 











Used as love charm. The ointment is applied 
after bathing and as a result the desired lady 









Arnold et al., 2002; Hutchings et al., 
1996; Pooley, 1998; Pooley, 2003; 




Leaves  Used to make Zulu headdress distinctive to 
married women 
H. cooperi Harv. 
30 
  Used as a fumigant and as part of a traditional 
remedy for snakebite. 
   




Used medicinally as a calming tea. 




B Arnold et al., 2002 (with reference to 
Smith, 1966); Kling as quoted by eSalie 
et al., 1996; Roberts, 1990 f(H. 
crispum). 
These authors are not certain whether 
Kling is referring to H. crispum (L.) D. 
Don or H. crispum Less. 
  Used to invoke the goodwill of the ancestors 






Used to treat colds and coughs 
Root Extract Used as emetic and purgative  
Leaf 
 
 Filtrate drunk to treat colds and fever 














Arnold et al., 2002; Bhat and Jacobs, 
1995; Kokwaro as quoted by 
Neuwinger, 1996; Neuwinger, 1996; 
Pooley, 2003; eVan Vuuren at el., 2006; 
Van Wyk et al., 2000. 
H. dasymallum Hilliard  
 ( = H. lanatum Harv.) 
21 
  Used as medicinal tea 
Woolly coat used for tinder boxes. 
NS  Arnold et al., 2002; Lucas and Pike, 
1971; Smith, 1966. 





Used to induce trances. Psy dB, dF Arnold et al., 2002; Hutchings et al., 
1996; eMathekga, 2001; Neuwinger, 
1996. 
Smoked  Used to treat head colds  
Infusion Used to treat hiccups. 




 Browsed by stock. 
Resp 
GIT 
 Arnold et al., 2002; Hutchings and Van 
Staden, 1994; Jacot Guillarmod, 1971; 
Neuwinger, 1996; Phillips, 1917; Smith, 
1966; Watt and Breyer-Brandwijk, 
1962. 
H. ecklonis Sond 
( = H. calocephalum 
  Used by the Xhosas to ward of evil magic 
spells, which follow on seeing iChanti, the 
M 
GIT 
 Batten and Bokelmann, 1966; Jacot 
Guillarmod, 1971; Phillips, 1917; 
 36 
 37
water snake  Schltr.) 
28 
Root Decoction Used to treat diarrhoea in children. 
Pooley, 2003; Watt and Breyer-
Brandwijk, 1962. 




Used to invoke the goodwill of the ancestors , 
commercially sold 
M  Arnold et al., 2002; Cunningham, 1988; 
Hutchings et al., 1996. 
H. excisum (Thunb.) Less 
12 
    dB, I eLourens et al., 2004 
H. felinum Less 
17 
    dB, I eLourens et al., 2004 
H. flanaganii Bolus 
13 







Used to induce trances  
 
 










Applied to treat Herpes 
Root 
 
Extract Eye problems, used to bath eyes  
Leaf 
 
 Used in making headdress distinctive of 
married women 
Plant  Aromatic and astringent (used to draw out 
infection). 
H. foetidum (L.) Moench  
30 









Arnold et al., 2002; Batten and 
Bokelmann, 1966 f(H. foetidum Cass.); 
Gerstner, 1938 f(H. foetidum Cass); 
Hulme, 1954; Hutchings et al., 1996; 
Kokwaro quoted by Neuwinger, 1996; 
Neuwinger, 1996 Roberts, 1990; 
Rwangabo, quoted by Neuwinger, 1996; 
eSteenkamp et al., 2004; Swanepoel 
1997; Van Wyk and Gericke, 2000; 
Watt and Breyer-Brandwijk, 1962 f(H. 
foetidum Cass.). 
H. glomeratum Klatt 
6 
    B, dF eMathekga and Meyer, 1998; 
eMathekga, 2001. 
gH. griseum Sond 
( = H. agrostophilum 
Klatt) 
23 
  Preventative charm against illness 
Burnt as fuel in winter. 











Mixed with fat, only the wives of chiefs were 
previously allowed to use it 
  Used to fumigate sick rooms. 
H. gymnocomum DC. 
 4 




dB, dF Cunningham, 1988; eDrewes and Van 






Used to invoke the goodwill of the ancestors  H. herbaceum (Andrews) 
Sweet  
29 Stems and 
leaves 
 Commercially sold 
M dB, dF Arnold et al., 2002; Cunningham, 1988; 
Hutchings et al., 1996; eMathekga, 
2001; Neuwinger, 1996; Pooley, 1998; 
Pooley, 2003. 
H. hypoleucum Harv 
16 
    dB, dF eMathekga and Meyer, 1998; 
eMathekga, 2001. 
H. indicum (L.) Grierson ( 






Mixed with Conyza pinnata. Crushed and burnt 
to drive sickness from a room. 
M  Arnold et al., 2002; Jacot Guillarmod, 
1971. 
Leaf Decoction Use to wash keloid scars 
Root and 
leaves 







The Karanga smoke this as a remedy for coughs 
and pulmonary tuberculosis 
H. kraussii  Sch. Bip 
8 
Plant Burnt, salt 
is added 







dB, dF Arnold et al., 2002; Arnold and 
Gulumian as quoted by Neuwinger, 
1996; eBremner and Meyer, 2000; 
eMathekga, 2001; Gelfand et al., 1985; 
Mabogo, 1990; Neuwinger, 1996; 
Swanepoel, 1997; Walker, 1996; Watt 
and Breyer-Brandwijk, 1962. 
 
 
Root  Venereal disease  H. kraussii  Sch. Bip 





Applied to child’s side with small amount given 
orally 
  Arnold et al., 2002; Arnold and 
Gulumian as quoted by Neuwinger, 
1996; eBremner and Meyer, 2000; 
eMathekga, 2001; Gelfand et al., 1985; 
Mabogo, 1990; Neuwinger, 1996; 
Swanepoel, 1997; Walker, 1996; Watt 




H. lepidissimum S. Moore 
19 
 Powder or 
ointment 
Used as a body perfume Skin  Dlamini, 1981; Watt and Breyer-
Brandwijk, 1962. 
H. litorale Bolus ( = 
Leontonyx angustifolius 
DC. = Leontonyx 
spathulatus Less) 
14 
Plant  Dried and pounded or mixed with lard or fat,
was used for applying to ulcers 
In the Western Cape Province an ointment for 
boils, carbuncles and abscesses is made from 




 Smith, 1966; Swanepoel, 1997; Watt 




Leaf  Used by the Pondos to treat circumcision 
wounds. The leaves are heated over very hot 
ash before being used as a bandage for the 
treatment of wounds after circumcision.  
W dB, dF eDilika et al., 1997; eMathekga, 2001. 
 
H. lucilioides Less. 
12 
  Excellent stock feed   Smith, 1966. 




  Used as bedding 
Used medicinally as tea 








Arnold et al., 2002; eLall and Meyer, 
1999; eLall et al., 2006; eMathekga, 
2001; Smith, 1966. 
 
 
Tea Used medicinally as tea 
 
Leaf  The Xhosa grind and boil the leaves and use it 
as a wash for pain after circumcision.  
H. miconiifolium DC. 
23 
Root  The powdered root is used for intestinal 
parasites and for ticks on poultry. 
P 
Anthel 
dB, dF Smith, 1966 f(H. miconiaefolium DC); 
Arnold et al., 2002; eMathekga, 2001; 
Swanepoel, 1997. 
H. montanum DC. 
22 
    B, dF eMathekga, 2001. 
H. monticola Hilliard 
28 




Plant  Decoction Chest complaints Resp  Arnold et al., 2002; Jacot Guillarmod, 
1971; Pooley, 1998; Pooley, 2003; 
Phillips, 1917 f(H. mundii, Harv.); Watt 













 Commercially sold 
M  Arnold et al., 2002; Cunningham, 1988; 
Hutchings et al., 1996; Pooley, 2003. 
 
Leaf Burnt as 
incense  
To invoke the goodwill of the ancestors 
 Infusion 
 











Regarded as demulcent, used to treat catarrh, 
phthisis and other pulmonary affections 
Leaf/ 
plant 
 Respiratory infections 

















H. nudifolium (L.) Less 
var. nudifolium (= H 
coriaceum Harv. = also H. 
gerberifolium A. Rich, = 
also H. leiopodium DC. = 
also H. nudifolium var. 
quinquenerve = also H. 
nudifolium var. leiopodium 
) 
23 










Arnold et al., 2002; Gerstner, 1938 f(H. 
undifolium, also H. leiopodium DC.); 
Githens, 1949 f(H. nudifolium, also H. 
leiopodium); Glover et al quoted by 
Neuwinger, 1996; Hulme, 1954; 
Hutchings et al., 1996; Hutchings and 
Johnson, 1986; Hutchings and Van 
Staden, 1994; Jacot Guillarmod, 1971 
f(H. nudifolium var. leiopodium); eJäger 
et al., 1996; Mabogo, 1990; Phillips 
1917 f(H. leiopodium DC.); Rood, 1994; 
Smith, 1895 f(H. nudiflorum), Smith, 
1966 f(H. coriaceum Sond. and H. 
nudifolium var. quinquenerve); 
eSwanepoel 1997 f(H. gerberifolium), 
Van Wyk et al., 2000; Neuwinger, 1996 
(also fH. gerberifolium Sch. Bip); Watt 
and Breyer-Brandwijk, 1962 f(H. 












Chest problems, used as emetic by the Zulu 
Leaf Decoction 
 
To encourage weaning in babies 




on  hot 
stones 
Used as steam bath to treat fever and 
nightmares 
H. nudifolium (L.) Less 
var. nudifolium (H 
coriaceum Harv.= also H. 
gerberifolium A. Rich, = 
also H. leiopodium DC. = 
also H. nudifolium var. 
quinquenerve = also H. 














Arnold et al., 2002; Gerstner, 1938 f(H. 
undifolium, also H. leiopodium DC.); 
Githens, 1949 f(H. nudifolium, also H. 
leiopodium); Glover et al., quoted by 
Neuwinger, 1996; Hulme, 1954; 
Hutchings et al., 1996; Hutchings and 
Johnson, 1986; Hutchings and Van 
Staden, 1994; Jacot Guillarmod, 1971 
f(H. nudifolium var. leiopodium); eJäger 
et al., 1996; Mabogo, 1990; Phillips 
1917 f(H. leiopodium DC.); Rood, 1994; 
Smith, 1895 f(H. nudiflorum), Smith, 
1966 f(H. coriaceum Sond. and H. 
 40 
 41
 Decoction Colic in children (administered as enema) 
  Rubbed into scarifications over bruises 




Internal sores (intestinal ulceration) 
  nudifolium var. quinquenerve); 
eSwanepoel 1997 f(H. gerberifolium), 
Van Wyk et al., 2000; Neuwinger, 1996 
(also fH. gerberifolium Sch. Bip); Watt 
and Breyer-Brandwijk, 1962 f(H. 
gerberaefolium Sch. Bip. Ex A.Rich). 
H. nudifolium var. 
oxyphyllum ( = H. 
oxyphyllum DC. = also H. 
undatum Less.) 
23 
  Protective charm against thunder    
  Used for “doctoring’ people who wish some 
deed concealed and who are afraid of being 
found out 
  Ingredient in colic remedy 
Leaf Infusion Stomach ache in children 
H. nudifolium var. 
pilosellum ( = H. 
latifolium (Thunb.) Less. =  








B, dF Arnold et al., 2002 f(H. pilosellum); 
Hulme, 1954 f(H. latifolium); Hutchings 
et al., 1996 f(H. pilosellum (L.f.) Less); 
Jacot Guillarmod, 1971 f(H. latifolium 
(Thunb.) Less.); eMathekga and Meyer, 
1998; eMathekga, 2001; Neuwinger, 
1996 f(H. pilosellum (L.f.) Less); 
Phillips, 1917 f(H. latifolium Less.); 
Phillips, 1917 f(H. latifolium Less.); 
Pooley, 2003 f(H. pilosellum); 
Swanepoel 1997; Walker, 1996 f(H. 
pilosellum (L.f.) Less); Watt and 
Breyer-Brandwijk, 1962 f(H. latifolium 
Less.). 
gH. nudifolium var. 
pilosellum ( = H. 
pilosellum (L.f.) Less = H. 




  As an antiseptic and to induce fast healing: 
Used after circumcision to prevent 
inflammation externally  
Also externally applied to wounds and used for 
infections of the respiratory tract 





 Arnold et al., 2002; the sources below 
are indicated in Arnold et al., under H.
pedunculare DC.:  
Batten and Bokelmann, 1966 h(isicwe, 
isiGqutsi); Githens, 1949 f(H. 
pedunculare); Smith, 1895 h( isi-Cwe.); 









Wounds and burns 
 















Adjanohoun quoted by Neuwinger, 
1996; Arnold et al. 2002; Baerts and 
Lehmann quoted by Neuwinger, 1996; 
Cunningham, 1988; Dlamini, 1981; 




 Ointment It is mixed with fat to form pleasantly smelling 











 Burnt as 
incense 









Used as a sedative and to treat insomnia and as 
protective cleanser. 













 Decoction Abdominal pain 
Aerial 
parts 
Extract Used to treat dehydration 
Leaf Sap Heartburn, flatulence 
Root Extract Purgative (extract is drunk) 
Leaf Ash is 
eaten 
Vomiting 
 Tea Colic and stitch 

















Decoction Used to treat female sterility, menstrual pain 













Hutchings et al., 1996; Hutchings and 
Van Staden, 1994; Jacot Guillarmod, 
1971; Kokwaro quoted by Neuwinger, 
1996; eLall and Meyer, 1999; eLourens 
et al., 2004; eMathekga and Meyer, 
1998; eMathekga, 2001; Neuwinger, 
1996; Pooley, 1998; Pooley, 2003; 
Rwangabo quoted by Neuwinger, 1996; 
Smith, 1966; Swanepoel, 1997; Van 
Puyvelde et al., 1989; Van Wyk et al., 
2000; Van Wyk and Gericke, 2000; 





Decoction Tonic for pregnant women 
Leaf Decoction Galactagoque. 
 
  Used a bedding material since it is an effective 
insect repellent. Sold commercially. 
The Xhosa also use the plant for spiritual 
purposes, as a fumigant when a baby is born 
   
H. oreophilum Klatt 
21 
    B, dF eMathekga and Meyer, 1998; 
eMathekga, 2001. 
  Preventative charm for illness. 
  Burnt as fuel in winter 
gH. pallidum DC. ( = H. 
agrostophilum Klatt (in 
part) =  
H. undatum (Thunb.) Less 
var. agrostophilum (Klatt) 
Moeser =  
H. undatum var. pallidum 
23 
Roots Bathing in 
decoction 
The act of forgetting, The bath is suppose to 
make a person invisible/or forgotten by his 
enemies, witchcraft. 
M  Arnold et al., 2002; Jacot Guillarmod, 
1971 f(H. undatum var. agrostophilum); 
Phillips, 1917 f(H. undatum Less., var. 
pallidum and H. agrostophilum Klatt).  
Leaf 
 
Decoction Febrile convulsions in children (part of a 
preparation) 
Plant Sap Used to treat malaria in children   
H. panduratum O. Hoffm.  
18 
  Used to make herbal tea 
P 
Infect 
A, I Adjanohoun quoted by Neuwinger, 
1996; Haerdi quoted by Neuwinger, 
1996; Neuwinger, 1996; Neuwinger, 
1996; Pooley, 1998; eSwanepoel, 1997. 
Infusion, 
demulcent 
 Respiratory conditions  
  Backpain, heart trouble, kidney disease, kidney 
stones 
H. pandurifolium Schrank. 
 ( = Helichrysum 
auriculatum Less.) 
18 





 Arnold et al. 2002; Roberts, 1990 f(H. 
auriculatum Less.); Rood, 1994; Smith, 
1966 f(H. auriculatum Less.); 
Swanepoel, 1997; Watt and Breyer-





Heart trouble, backache, kidney disease, also 
‘heart weakness’ (also heart treatment in 
animals). Stress and fatigue. 
Infusion Hyperpiesa, (hyperpepsia is probably a spelling 
error in Neuwinger), coronary thrombosis, 
bladder conditions/infections.  
H. patulum (L.). Don ( = 
H. crispum Less) 
18 
 







Neuwinger, 1996 f(H. crispum Less.); 
Roberts, 1990 f(H. crispum); Scott et al., 
2004; Smith, 1966 f(H. crispum Less.); 







 Gynaecological disorders   
 Used as bedding. 
   
 
H. pedunculatum  Hilliard 





 As an antiseptic and to induce fast healing: 
Used after circumcision to prevent 
inflammation externally.  
Also externally applied to wounds and used for 
infections of the respiratory tract 







B Arnold et al., 2002; Batten and 
Bokelmann, 1966 (fH. pedunculare DC., 
hisiCwe, hisiGqutsi, Xhosa); Bhat and 
Jacobs, 1995 (fH. pedunculatum  
Hilliard and Burtt, hisiCwe, hsiGgutsi, 
Xhosa); eDilika et al., 1997; Gerstner, 
1938 (fH. pedunculare DC., hisiCwe, 
Zulu); Githens, 1949 (fH. pedunculare, 
hisicwe, Zulu); Hutchings et al., 1996 
(fH. pedunculatum  Hilliard et Burtt); 
eMeyer and Dilika, 1996; Rood, 1994 
(fH. pedunculatum, hery’kue, Fingo); 
Smith, 1895 (fH. pedunculare DC., eisi-
Cwe); Smith, 1966 (fH. pedunculare 
DC.); Neuwinger, 1996 (fH. 
pedunculatum Hilliard and Burtt); 
Swanepoel, 1997; Watt and Breyer-
Brandwijk, 1962 (fH. pedunculare DC.). 
  Coughs, colds, catarrh, headache, fever, 
menstrual disorders, urinary tract infections.. 
Leaf  Antiseptic wound dressing 
 Tea 
 
Tea taken for heart conditions, stress, 
hypertension, anxiety and over-excitement. 
H. petiolare Hilliard and 
Burtt 
18 
  Used as bedding 
 dB Arnold et al. 2002; eLourens et al., 
2004; Kirstenbosch Botanical Garden; 
Neuwinger, 1996; Roberts, 1990 f(H. 
peteolatum); Scott et al., 2004; Smith, 
1966 f(H. petiolatum DC.); Van Wyk et 
al., 2000. 





Renew virility in men Vi  Arnold et al. 2002; Jacot Guillarmod, 




Dysmenorrhoea  H. psilolepis Harv. 
22 
Root Decoction 
Used to weave hats 
P dB, dF Arnold et al., 2002; Jacot Guillarmod, 
1971; eMathekga, 2001; Phillips, 1917; 
Neuwinger, 1996; Watt and Breyer-
Brandwijk, 1962. 
H. rotundatum ( = H 
coriaceum (DC.) Harv.) 
  Used as tea NS  Smith, 1966 f(H. coriaceum Sond.). 
 Protective charm (with H. callicomum and Aster 
bakerianus;  










dB, dF Arnold et al., 2002; Dlamini, 1981; 
Jacot Guillarmod, 1971; eMathekga and 
Meyer, 1998; eMathekga, 2001; Phillips, 
1917; Pooley, 1998; Pooley, 2003; Watt 
and Breyer-Brandwijk, 1962. 
  Love potion 
Leaf Decoction Epilepsy 
  Fumigate rooms 







Snakebite, roots are also mixed with the flesh of 





 Chabra quoted by Neuwinger, 1996; 
Jacot Guillarmod, 1971; Lucas and Pike, 
1971; Neuwinger, 1996; Phillips, 1917; 
Watt and Breyer-Brandwijk, 1962. 
H. simillimum DC. 
8 
    dB, dF eMathekga, 2001. 




Fuel plant in the mountains 
 
The leaves are boiled and the steam inhaled to 
induce sweating. 








 Arnold et al., 2002; Dlamini, 1981; 




















Powder applied to cuts in the skin of a sick 
person 
M dB, dF Arnold et al., 2002; Jacot Guillarmod, 
1971; eMathekga, 2001; Phillips, 1917; 
Pooley, 1998; Pooley, 2003; Watt and 
Breyer-Brandwijk, 1962. 
gH. tenax M.D. Hend var. 
tenax ( = H. fulgidum (L.f) 
Willd. 
30 
 Decoction  Used for washing sore eyes. Eye  dB, dF Arnold et al., 2002 f(H. fulgidum (L.f) 
Willd.); Batten and Bokelmann, 1966 
f(H. fulgidum Willd.); eDrewes et al., 
2006; Jacot Guillarmod, 1971 f(H. 
fulgidum (L.) Willd.); Phillips, 1917 f(H. 
fulgidum Willd.). 





Twigs are pounded in water and used as mouth 






The entire plant is placed on red hot coals and 
smoke inhaled for body pain. The same 
treatment is used by pregnant women suffering 
from antepartum haemorrhage 
Root Decoction Bladder problems (dribbling) 
 
H. tomentosulum (Klatt) 
Merxm 
1 
  Used as thatching. 
P 
Renal 
 Neuwinger, 1996; Van Wyk and 
Gericke, 2000; Von Koenen, 2001. 
H. trilineatum DC. 
22 
    dB, dF eBremner and Meyer, 1998; eMathekga, 
2001. 
H. umbraculigerum Less. 
5 




  The Swazi use the plant as a purgative or an 
emetic. They add one teaspoon of the plant to 
soft porridge which is then eaten by the patient. 
GIT  Swanepoel, 1997. 
                                               
a Where the species name has been changed, the previously accepted name is given in brackets. The following species are no longer classified as Helichrysum: H. capillaceum 
(Thunb.) Less (Phillips, 1917; Jacot Guillarmod, 197 ; Watt Breyer-Brandwijk, 1962) accepted name now Troglophyton capillaceum subsp. capillaceum (Thunb.) Hilliard 
and B.L.Burtt (Gibbs Russell et al., 1987); H. orbiculare (Thunb.) Druce (Smith, 1966) accepted name now Plecostachys serpyllifolia (P.J,Bergius) Hilliard and B.L.Burtt 
(Gibbs Russell et al., 1987); H. sesamoides Willd. (Smith, 1966) accepted name now Edmondia sesamoides (L.) Hilliard (Gibbs Russell et al., 1987); H. vestitum (L.) Willd. 
 46 
 47
                                                                                                                                                                                                                
(Smith 1966) accepted name now Syncarpha vestita (L.) B.Nord. (Gibbs Russell et al., 1987); H. hochstetteri (A. Rich) Hook. F.) (Githens, 1949), H. stenopterum DC 
(Dlamini, 1981) accepted name now Achyrocline stenoptera (DC.) Hilliard (Gibbs Russell et al., 1987). 
 
bAbbreviations used:  
A = Analgesic activity determined My = Antimycobacterial activity determined 
Anth = Anthelmintic NS = Not specified 
B = Antibacterial activity determined P = Conditions associated with pain, inflammation and fever, which include 
headache, convulsions and dysmenorrhoea 
Ca = Cardiac conditions Pl = Antiplasmodial (antimalarial) activity determined 
Eye = Used in eye conditions Psy = Psychotropic use – plants that are used to induce trances  
F = Antifungal activity determined Psyc = Psychological conditions such as inuresis in ch ldren and insomnia 
Fum = Used as fumigant, often plants are burnt in room of a sick person Poi = Possible poison, mainly when stock ingest excessive amounts 
GIT = Gastrointestinal conditions, which include mainly colic, nausea and vomiting, 
diarrhoea and stomach pain 
Renal = Conditions associated with kidney and bladder problems 
I = Anti-inflammatory activity determined Resp = Respiratory conditions, which include colds, coughs, flu, tuberculosis 
Infect = Conditions associated with infections, such as gonorrhoea and smallpox Skin = Used for skin conditions such as keloid scars, abscesses, as ointments 
Inflam = Conditions associated with inflammation such as swelling, menstrual pain W = Used to dress wounds 
Insect = Plants are used to deter insects such as red mites V = Antiviral activity determined 
M = Used in a magical sense, to invoke the goodwill of the ancestors and as charms 
(protective, love) 
Vi = Used for virility in men 
 
c The number refers to the morphological group according to Hilliard (1983). 
d Antimicrobial activity of 1 mg/ml or less observed for one or more micro-organisms. 
e Reference associated with biological activity 
f In some cases the author name as indicated in the source, is not present in either Hilliard (1983) or Germishuizen and Meyer (2003). The current author was then chosen. 
g In cases where the name in the source and the currnt name differ, the name used in the source is indcated in brackets for clarification. 























a b c d e f       
gH. acutatum DC. 
Roots and aerial parts 
21 1 22      
 







gH. adenocarpum DC. 
Roots and aerial parts 
28           338 
340 
Bohlmann et al., 
1980b 
H. albirosulatum Killick 
Roots and aerial parts 
6         192, 193, 
194 
284  Bohlmann et al., 
1980b 
Bohlmann et al., 
1978b 
H. allioides Less 
Roots 
23           334 Bohlmann and Zdero, 
1973 
H. anomalum Less 
Aerial parts 
9       91, 94 
 
  250  Jakupovic et al., 
1989b 
gH. appendiculatum (L.f.) Less 
Roots and aerial parts 
24          309  Bohlmann et al., 
1980b 
H. argentissimum J.M. Wood. 
Roots 
28         195 305 338 Bohlmann et al., 
1980b 
H. argyrolepis MacOwan 
Aerial parts 
29  23 42 
48 
49 
    
 
    Bohlmann et al., 
1984b 
gH. argyrophyllum DC. 
Aerial parts and roots 
29    56 
57 







Jakupovic et al., 
1989b 














a b c d e f 
Phloro- 
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
H. asperum (Thunb.) Hilliard et 
Burtt. var. albidulum (DC) 
Hilliard  
aerial parts 
12       90, 93, 96, 










    Jakupovic et al., 
1989b 
 
gH. athrixiifolium (Kuntze) 
Moeser 







         Bohlmann and Ates, 
1984 
gH. aureonitens Sch. Bip. 
Roots and aerial parts 
8    54      250, 253,  
264, 265 
309 
323 Bohlmann and 
Ziesche, 1979; 
Afolayan and Meyer, 
1997;  
Meyer et al., 1997 
gH. aureum (Houtt.) Merr. 
Aerial parts  and roots 
30         195, 204 
206, 207 
209 
280  Jakupovic et al., 
1989b 
(stach-15-en-19-oic 
acid also isolated) 
 
H. aureum  (Houtt.) Merr. var 
monocephalum (DC.) Hilliard 
Aerial parts and roots 





 Bohlmann et al., 
1978b 
 
H. auriceps  Hilliard 
Roots 




  339 Bohlmann and Zdero, 
1980a 
H. bellum Hilliard 
Aerial parts and roots 
28       166 
167 
 195 270 339 Bohlmann and Zdero, 












a b c d e f 
Phloro-
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
gH. caespititium DC. Harv. 
Whole plant 
Aerial parts 
12       98 
127 
    Dekker et al., 1983 
Mathekga et al., 2000 
gH. callicomum Harv. (= H. 
calliconum ) 
Aerial parts and roots 
2 1      89, 103, 












338 Bohlmann and 
Abraham, 1979a 
Bohlmann et al., 
1984b, *structures 
drawn without double 
bonds in reference, 
but names indicate 
pyrones 
  
H. candolleanum H. Buek.  
Aerial parts 
15       87 
128 
 226   Jakupovic et al., 
1989b 
H. cephaloideum DC. 
Roots and aerial parts 










 270  Hänsel et al., 1980; 
Bohlmann and Zdero, 
1980a 
Jakupovic et al., 1986 
H. cerastioides DC. (1984) 
Aerial parts 
15       88, 141 
181 
 
181   345 
347 
Bohlmann et al., 
1984b 




Merxm. et A. 
Schreiber) 
H. chionosphaerum  DC. 
Aerial parts and roots 
 












Bohlmann et al., 
1980a 













a b c d e f 
Phloro-
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
H. chrysargyrum Moeser 
Aerial parts and roots 
22    61   145, 146,  
147, 148 
149, 150 
  270 
309 
311 
 Bohlmann et al., 
1979b 
H. confertum N.E.Br 
Roots 
17         195, 213 
214, 215 
221 
  Bohlmann et al., 
1978b 
gH. cooperi Harv. 
Roots and aerial parts 
30     79    195, 197 
198 
  Bohlmann et al., 
1978b 
H. cooperi ps. aff. H. cooperi 
Harv.  





gH. cymosum  (L.) D. Don.  
Aerial parts 
 








      350 Jakupovic et al., 
1989b 
 
gH. cymosum (L.) Don ssp. 
calvum, 1979b 
Roots and aerial parts 












gH. cymosum (L.) D. Don ssp. 
cymosum, 2006) 
 
8   49         Van Vuuren et al., 
2006 
 
H. dasyanthum (Willd.) Sweet 
Aerial parts 










351 Jakupovic et al., 
1989b 
H. dasymallum Hilliard (=H. 
lanatum Harv. )  
roots 
21           334 Bohlmann and Zdero, 













a b c d e f 
Phloro-
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
gH. decorum DC. 
aerial parts 
30  30          Bohlmann et al., 
1980b 
H. drakensbergense  Killick 
Roots and aerial parts 
19        188 233 256, 258 
271, 309 
353 Bohlmann and 
Suwita, 1979a 
gH. dregeanum Sond. & Harv. 
Aerial parts 
9  23  58   140   250, 264  Jakupovic et al., 
1989b 
 




   67 
72 
80 
  19    Lourens et al., in 
preparation 
H. felinum Less 
Aerial parts 
17  23  58   140     Jakupovic et al., 
1989b 
gH. flanaganii Bolus 
Aerial parts and roots 
13       90 
105 
    Bohlmann et al., 
1980b 
gH. foetidum (L.) Moench.  
Roots 
30           338 Bohlmann and Zdero, 
1973 
H. fulvum N. E. Br. 
Aerial parts and roots 
30         195, 203 
210, 211 
 338 Bohlmann et al., 
1979a 




          Bohlmann et al., 
1980b 
H. glomeratum Klatt 
Aerial parts 
6  36       233 250, 256 
258, 309 
318 
 Bohlmann and 
Suwita, 1979a 
H. grandiflorum (L.) D. Don. 
Roots 
17           338 Bohlmann and Zdero, 
1973 
gH. gymnocomum DC 
Roots and aerial parts 
4       90, 95 
101, 105, 
107, 111 
  312  Bohlmann and 
Mahanta, 1979 h(H. 
gymnoconum DC.) 
gH. gymnocomum DC 
Flowers 













a b c d e f 
Phloro-
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
gH. herbaceum  (Andrews) 
Sweet 
Aerial parts 





    254, 256, 
309 
 
 Bohlmann et al., 
1979b 
H. heterolasium  Hilliard 
Aerial parts 






338 Bohlmann and 
Abraham, 1979a 
H. hyphocephalum Hilliard 
Aerial parts and roots 
27 2, 3 
4, 5 
9 
    82    309 324 Bohlmann and 
Abraham, 1979d h (H. 
hypocephalum) 
gH. indicum (L.) Grierson 
Aerial parts 
15       90 
105 
    Jakupovic et al., 
1989b 
H. infaustum J.M. Wood. & 
M.S. Evans 
Aerial parts 
4       90, 91 
105 
  250, 266 
267 
 Bohlmann and 
Suwita, 1979a 
gH. kraussii Sch. Bip. 
Aerial parts, flowers and roots 








 90  195 250, 251 
261, 263 
264, 265 
 Jakupovic et al., 
1989b 
Bremner and Meyer, 
2000 
Candy et al., 1975; 
Candy and Wright, 
1975. 
H. krebsianum Less 
Aerial parts 
23         234, 235   Bohlmann et al., 
1980b 
H. krookii Moeser 
Roots and aerial parts 
5       91, 92 
108, 109 
  270 
309 
338 Bohlmann et al., 
1980b 




    83  19 
20 
  325 
326 
Jakupovic et al., 
1989b 
gH. litorale  Bolus 
(= Leontonyx angustifolius 
DC., = Leontonyx spathulatus 
Less.) 
14       120, 129 
132, 136 
157 















a b c d e f 
Phloro-
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
gH. melanacme (DC.) Harv. 
Shoots 




       Lall et al., 2006 
gH. miconiifolium DC. 
Roots 
23         195, 205   Bohlmann et al., 
1980b 
H. mimetes S. Moore 
Aerial parts 




 Jakupovic et al., 1986 
  
 
H. mixtum (Kuntze.) Moeser 
Roots 







   Jakupovic et al., 1986 
H. moeseranium Thell. 
Aerial parts 
22       90, 105 
136 
 195   Jakupovic et al., 
1989b 
H. montanum DC. 22          286 
300, 301 
304, 307 
 Lourens et al., in 
preparation 
H. monticola Hilliard 
Aerial parts and roots 
28   45 
46 
47 
   91, 108 
129, 130 
156 
  309  Jakupovic et al., 
1989b 
Bohlmann and Zdero, 
1980b 
gH. mundtii Harv. 
Roots and aerial parts 





   236 313 
314 
 Bohlmann et al., 
1978a, 
Bohlmann et al., 
1980b 
h(H. mundii Harv.) 
H. nanum Klatt 
Aerial parts 
6       104  236 250 
318 
 Bohlmann and 
Suwita, 1979a 
gH. natalitium  DC.  
Aerial parts and roots 
3       91, 92 
108, 109 














a b c d e f 
Phloro-
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
gH. nudifolium L. Less var. 
nudifolium 
Aerial parts and roots 
23       142, 143 
144, 155,  
158 











Jakupovic et al., 1986 
Bohlmann et al., 
1978b h(H. nudifolium 
L. Less) 
Bohlmann and Zdero, 
1973 h(H.nudifolium 
L. Less) 
H.nudifolium L.Less var. 
nudifolium 
(= H. coriaceum Harv.) 
Roots 




335 Bohlmann et al., 
1984a 
gH. nudifolium var. oxyphyllum 
(= H. oxyphyllum DC.  
Aerial parts 
23 1 28 
29 
      235 265  Bohlmann et al., 
1980b h(H. 
oxyphyllum Klatt) 
gH. nudifolium var. pilosellum 
(=H. latifolium Less.) 
23           334 Bohlmann and Zdero, 
1973 h(H. latifolium 
Less.) 
H. nudifolium var. pilosellum 
(= H. pilosellum (L.f.) Less) 
Roots 
23         195, 196 
197, 204 
205 
  Jakupovic et al., 1986 
gH. odoratissimum (L.) Sweet 
Aerial parts and roots 
4  31  58 
64 








Van Puyvelde et al., 
1989; Hänsel et al., 
1980; Bohlmann and 
Zdero, 1973 
H. oreophilum Klatt. 
Aerial parts 
21 1 22 
28 
29 
    87  235 
238 
251  Jakupovic et al., 1986 
Bohlmann et al., 
1980b 
H. pagophilum M.D. Hend. 
Aerial parts 
27    58        Bohlmann et al., 
1980b 
gH. pallidum DC. 
Aerial parts and roots  




 Bohlmann et al., 
1980b 
gH. panduratum O.Hoffm. 
Aerial parts 
18          256 
314 














a b c d e f       
gH. patulum (L.) D. Don  
(= H. crispum Less)  
Aerial parts 
18       110, 117 
129, 136 
  285  Bohlmann and 
Suwita, 1979a h (H. 
crispum Less) 
gH. pedunculatum  Hilliard & 
Burtt Leaves 
 
23            Dilika et al., 2000 
Linoleic and oleic 
acids 
gH. petiolare Hilliard & B.L.. 
Burtt. 
Aerial parts 
18  28   72  140 190  250, 251 
265, 275 
286, 287 
334 Jakupovic et al., 
1989b 
Bohlmann and Zdero, 
1973 (H. petiolatum 
DC.) 
gH. platypterum DC.  
Aerial parts  and roots 
20    55 70 83 90, 105 
107, 114,  
116, 151,  
152, 153, 
154, 159,  








Jakupovic et al., 1986 
Bohlmann et al., 
1980b 
Bohlmann and Zdero, 
1979a 
Jakupovic et al., 1987 
H. polycladum Klatt  









   162    330 Bohlmann et al., 
1980b 
H. populifolium DC.  
Roots 
16           331 Bohlmann et al., 
1980b 
H. reflexum  N. E. Br.  
(=H. refluxum N. E. Br.) 
Aerial parts 




 Bohlmann et al., 1985 
**other terpenes also 
isolated, see reference 
H. revolutum (Thunb.) Less  
Aerial parts 
9    58    140     Jakupovic et al., 
1989b 
H. retortoides N.E. Br. 
Aerial parts 
26           338 Bohlmann et al., 
1980b 
H. rosum (Berg.) Less.  
Aerial parts 












a b c d e f 
Phloro-
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
H. ruderale Hilliard & B.L. 
Burtt. 
Aerial parts 
30         196 
197 
  Bohlmann et al., 
1980b 
gH. rugulosum Less. 
Aerial parts and roots 








     
 
 
    Bohlmann and Misra, 
1984 
H. scabrum (Thunb.) Less 
Aerial parts 
9  22     140     Jakupovic et al., 
1989b 
gH. setosum Harv. 
Aerial parts 
30         218, 219 
220 
  Jakupovic et al., 1986 
H. spiralepis Hilliard and 
Burtt. (= Leontonyx 
squarrosus) 
14       93, 110, 
118, 131, 
136, 157 
   332 Bohlmann and 
Suwita, 1978 
gH. splendidum (Thunb.) Less. 
Aerial parts and roots 






330 Bohlmann and 
Suwita, 1979b 
Jakupovic et al., 
1989b 
H. subfalcatum  Hilliard 
Aerial parts 
6         236 308  Bohlmann et al., 
1980b 
gH. subglomeratum Less 
Aerial parts 
6  22 49     
 
  264 
272 
 Jakupovic et al., 
1989b 
gH. sutherlandii  Harv.  
Aerial parts and roots 
17  33 
37 
50      213 
 
 338 Bohlmann et al., 
1978a 
Bohlmann et al., 
1980b (H. suterlandii 
Harv.) 
H. swynnertonii S. Moore 
Aerial parts and roots  













a b c d e f 
Phloro-
glucinols 
Pyrones Diterpenes Terpenes Other Reference 
H. tenax var tenax  M.D. Hend. 
leaves 
30         228, 229 
230, 231,232 
  Drewes et al., 2006 
H. tenuiculum DC. 
Aerial parts and roots 
8 2 23 
24 
38 
48     
 
  250, 315 
309 
 Bohlmann et al., 
1979c 
H. tenuifolium  Killick. 
Aerial parts and roots 
22 1  41 54 
55 







Bohlmann et al.,1984a 
H. thapsus (O. Kuntze) Moeser 
Aerial parts 
23 9     84 
85 
86 
     Bohlmann and Zdero, 
1983. 
H. tomentosulum Klatt. Merxm 
subsp. aromaticum (Dinter) 
Merxm.  
Aerial parts 
1  25  62        Jakupovic et al.,  
1989b 
H. tricostatum (Thunb.) Less 
Aerial parts 
11    58 
66 
       Jakupovic et al., 
1989b 
H. trilineatum DC. 
Shoots and roots 
 
22          316 327 
333 
Bremner and Meyer, 
1998; Bohlmann et 
al., 1980b 
H. umbraculigerum Less. 
Aerial parts 










H. vernum Hilliard 
Roots 
28         193, 195 260  Bohlmann et al., 
1980b 
H. zeyheri Less. 
Aerial parts 




 250, 264  Jakupovic et al., 1986 
a: Flavanone, b: Chalcone, c: Dihydrochalcone, d: Flavonol, e: Flavone, f: Other flavonoids, gUsed traditionally, hName used in reference 
 58 
 59 










 R1 R2 R3 R4 R5 Plant 
1 H H H H H H. acutatum 
H. callicomum 
H. cymosum 










H H H H H. hyphocephalum 
4 Oxo- 
isopentenyl 
H H H H H. hyphocephalum 
5 Geranyl H H H H H. hyphocephalum 
6 H Isopentenyl H H H H. arthrixiifolium 
H. rugulosum 
7 OCH3 Isopentenyl H H H H. cymosum 
8 H Isopentenyl H CH3 H H. rugulosum 
9 H H Isopentenyl H H H. hyphocephalum  
H. polycladum  
H. rugulosum 
H. thapsus 
10 Isopentenyl Isopentenyl H H H H. rugulosum 
11 Isopentenyl H Isopentenyl H H H. rugulosum 
12 H CH3 H H H H. polycladum 
13 OH CH3 H H H H. cymosum 
14 OCH3 H H H H H. cymosum 
H. glaciale 
15 H H OCH3 H H H. glaciale 
16 H H H CH3 H H. herbaceum 
17 Isopentenyl H H H OH H. arthrixiifolium 
18 H Isopentenyl H H OH H. arthrixiifolium 
19 H H CH2-lactone H H H. excisum 
H. lepidissimum 
20 Isopentenyl H CH2-lactone H H H. lepidissimum 
21 H Benzyl H Benzyl H H. gymnocomum 
 










           Benzyl = 
R
 60 










 R1 R2 R3 R4 R5 Plant 





 H. scabrum 
H. subglomeratum 










24 Isopentenyl CH3 H H H H. cymosum 
H. rugulosum 
H. tenuiculum 
25 H Isopentenyl H H H H. athrixiifolium 
H. rugulosum 
H. tomentosulum 
26 H Isopentenyl H CH3 H H. rugulosum 
27 H H Geranyl H H H. umbraculigerum 






29 H CH3 H CH3 H H. oreophilum 
H. oxyphyllum 
30 H CH3 H CH3 OH H. decorum 
31 H H H CH3 OH H. heterolasium 
H. odoratissimum 
32 H Glucose H CH3 OH H. ps. Aff. H.cooperi 
Harv. 
33 H CH3 OCH3 CH3 H H. sutherlandii 
34 H Isopentenyl H H OH H. athrixiifolium 































39 H. kraussii, H. melanacme 
              










 R1 R2 R3 R4 R5 R6 Plant 
40 H H H H OH H H. splendidum 
41 H H H H H H H. tenuifolium 
42 H H Isopentenyl H H H H. argyrolepis 
43 H Isopentenyl H H H H H. polycladum 
44 Isopentenyl H Isopentenyl H H H H. polycladum 
45 E-Geranyl  H OH H OH H H. monticola 















                48 R = CH2CH=C(CH3)2 
               H. tenuiculum,H. argyrolepis 
                49  R = OCH3 
               H. argyrolepis, H. cymosum,  












O OH  






OH OH  






OH OH  

















 R1 R2 R3 R4 R5 R6 Plant 
54 H H H H H H H. aureonitens 
H. tenuifolium 
55 H H H CH3 H H H. platypterum 
H. tenuifolium 
56 OCH3 H H CH3 H H H. argyrophyllum  
H. cymosum 
57 OCH3 H H Angeloyl H H H. argyrophyllum 








59 OCH3 CH3 OCH3 CH3 H H H. cephaloideum 
60 H H OCH3 CH3 H H H. heterolasium 
61 H CH3 OH CH3 H H H. chrysargyrum 
62 H CH3 OCH3 CH3 OH H H. tomentosulum 
63 H H H H OH OH H. melanacme 
64 H H H CH3 OH OH H. kraussii 
H. melanacme 
H. odoratissimum 
65 OCH3 CH3 H H OH H H. cymosum 
66 OCH3 CH3 H CH3 OH OH H. splendidum 
H. tricostatum 
67 OCH3 H H OCH3 H H H. excisum 
68 H CH3 OCH3 CH3 OCH3 OCH3 H. chionosphaerum 
69 H H H p-coumaroyl 
glucoside 
























     
 
 R1 R2 R3 R4 R5 R6 Plant 













71 H CH3 H H H H H. kraussii 
72 OCH3 CH3 H H H H H. excisum 
H. petiolare 
73 OCH3 CH3 H CH3 H H H. mundtii 
74 OH CH3 OCH3 H H H H. herbaceum 
H. mimetes 
75 OCH3 CH3 OCH3 CH3 H H H. herbaceum 
76 OCH3 H OCH3 CH3 OCH3 H H. herbaceum 
77 H CH3 H CH3 H H H. herbaceum 
78 OH CH3 OCH3 CH3 H H H. herbaceum 
79 H H H H OH H H. cooperi 






81 H. mundtii 
 
 













      82 H  hyphocephalum                 83-86 
 
 R1 R2 R3 R4 R5 Plant 
83 H H H H H H. lepidissimum 
H. platypterum 
H. tenuifolium 
84 H H Isopentenyl H H H. thapsus 
85 H H Geranyl H H H. thapsus 
86 H H Isopentenyl Ac H H. thapsus 
 








 R1 R2 R3 R4 R5 R6 Plant 
87 CH3 H Isopentenyl H H H H. candolleanum 
H. oreophilum 
88 CH3 H Geranyl H H CH3 H. cerastioides 












 R1 R2 R3 R4 R5 R6 Plant 
















92 CH(CH3)2 H (Z)-Geranyl H H H H. krookii 
H. natalitium 
93 CH(CH3)2 H H Isopentenyl H H H. asperum 
H. spiralepis 
94 CH(CH3)2 H H Geranyl H H H. anomalum 
95 CH(CH3)2 CH3 H Geranyl H H H. gymnocomum 
96 CH(CH3)2 H H Hydroxy-
isopentenyl 
H H H. asperum 
97 CH(CH3)2 H H Acetoxy 
isopentenyl 
H H H. asperum 
98 CH(CH3)2 H Acetoxy- 
isopentenyl 
H H H H. asperum 
H. caespititium 
99 CH(CH3)2 H H CH2CH2CH- 
(CH3)COOH 
H H H. asperum 
100 CH(CH3)2 H H CH2CH2CH- 
(CH3)COOMe 
H H H. asperum 
101 CH(CH3)2 H Isopentenyl H H CH3 H. gymnocomum 
102 CH(CH3)2 H CH2CH(OH) 
C(CH3)=CH2 
H H H H. gymnocomum 
103 CH(CH3)CH2
CH3 




CH3 CH3 H H H H. nanum 
105 CH(CH3)CH2
CH3 










H Isopentenyl CH3 H H H. cephaloideum 
107 CH(CH3)CH2
CH3 
H Isopentenyl H H CH3 H. gymnocomum 
H. platypterum 















 R1 R2 R3 R4 R5 R6 Plant 
108 CH(CH3)CH2
CH3 























H H H. asperum 
113 CH(CH3)CH2
CH3 
H H Acetoxy- 
isopentenyl 
H H H. asperum 
114 CH2CH(CH3)2 H Isopentenyl H H H H. platypterum 
115 CH2CH(CH3)2 H Isopentenyl CH3 H H H. cephaloideum 
116 CH2CH(CH3)2 H Isopentenyl H H CH3 H. platypterum 
117 CH=C(CH3)2 H H Isopentenyl H H H. patulum (H. 
crispum in 
reference) 
118 CH2CH3 H H Isopentenyl H H H. spiralepis 




Isopentenyl H OCH3 H H. litorale 
121 CH2CH2CH3 H Acetoxy- 
isopentenyl 
H H H H. asperum 
122 CH2CH2CH3 H H Isopenteny H H H. asperum 
123 CH2CH2CH3 H H Hydroxy-
isopentenyl 
H H H. asperum 
124 CH2CH2CH3 H H Acetoxy- 
isopentenyl 
H H H. asperum 
125 CH2CH2CH3 H H Dihydroxy-
isopentenyl 
H H H. asperum 
126 CH2CH2CH3 H H CH2CH2CH- 
(CH3)COOH 
H H H. asperum 
127 CH2CH2CH(C
H3)2 
H Isopentenyl H H H H. caespititium 
128 Ph H Isopentenyl H H H H. asperum 
H. candolleanum 
129 Ph H E-Geranyl H H H H. litorale 
H. monticola 
H. patulum (H. 
crispum in ref) 
130 Ph H Z-Geranyl H H H H. monticola 
 
131 Ph H H Isopentenyl H H H. asperum 
H. spiralepis 











133 Ph H H Hydroxy-
isopentenyl 
H H H. asperum 
134 Ph H H CH2CH2CH- 
(CH3)COOH 
H H H. asperum 
135 Ph H H CH2CH2CH- 
(CH3)CO2CH3 
H H H. asperum 
136 Ph H Isopentenyl H Isopen- 
tenyl 
H H. litorale 
H. moeseranium 
H.patulum 

















 R Plant 
137 CH(CH3)2 H. callicomum 
138 CH(CH3)CH2CH3 H. cephaloideum 
H. mixtum 
























144 H. nudifolium 
 R1 R2 R3 Plant 
141 CH3 CH3 H H. cerastioides 
142 CH(CH3)2 H H H. nudifolium 
















 R1 R2 Plant 
145 CH(CH3)2 H H. chrysargyrum 
146 CH(CH3)2 CH3 H. chrysargyrum 
147 CH(CH3)CH2CH3 H H. chrysargyrum 
148 CH(CH3)CH2CH3 CH3 H. chrysargyrum 










 R  
149 CH(CH3)2 H. chrysargyrum 
150 CH(CH3)CH2CH3 H. chrysargyrum 
























157 H. litorale, H. spiralepis 
 
 R1 R2 R3 R4 Plant 
151 CH(CH3)CH2CH3 H H CH3 H. platypterum 
152 CH(CH3)CH2CH3 CH3 H CH3 H. platypterum 
153 CH2CH(CH3)2 H H CH3 H. platypterum 
154 CH2CH(CH3)2 CH3 H CH3 H. platypterum 









OH O  
 























         
160 H. platypterum 
 
























































































 R1    R2 R3      R4                 
 
 
170   CH(CH3)2           H H Isopentenyl H. odoratissimum 
171 CH(CH3)2           CH3 H Isopentenyl H. auriceps    
H. cephaloideum                
172 CH(CH3)CH2CH3           H H Isopentenyl H. odoratissimum 
H. mixtum 
173 CH(CH3)CH2CH3           CH3 H Isopentenyl H. auriceps  
H. cephaloideum                
174 CH(CH3)CH2CH3           H CH3 Isopentenyl H. cephaloideum 
175 CH(CH3)CH2CH3           H CH3 H H. cephaloideum 
176 CH2CH(CH3)2 H H Isopentenyl H. mixtum 
177 CH2CH(CH3)2 H CH3 H H. cephaloideum 
178 CH2CH(CH3)2 H CH3 Isopentenyl  H. cephaloideum 
 



















 R1    R2  
179 CH(CH3)CH2CH3           H H. cephaloideum 
H. mixtum 
180 CH2CH(CH3)2 H H. cephaloideum 
H. mixtum 










 R1    R2 R3  
181 CH3 H CH2CH2CHC(CH3)2 H. cerastioides 
182 CH(CH3)CH2CH3           H CH3 H. mixtum 
183 CH2CH(CH3)2 H CH3 H. mixtum 







 R1    R2 R3  
184 CH2CH3 CH3 CH3 H. callicomum 
185 CH(CH3)2 CH3 CH3 H. callicomum 
H. zeyheri 
186 CH(CH3)2 CH2OH CH3 H. callicomum 





188  H. drakenbergense    

















191 H. zeyheri 
 
 












 R1  
192 O H. albirosulatum 
193 H H. albirosulatum 
H. vernum 













 R1 R2 R3 R4 R5 R6 R7 R8 R9 Species 


















196 COOH H H    CH2 9,11-
double 
bond 




197 COOH  H  OCO 
CH3 








    CH2   H. aureum 
H. cooperi 
H. heterolasium 
199 COOH  OCO
CH3 
   CH2   H. 
chionosphaerum 











 R1 R2 R3 R4 R5 R6 R7 R8 R9 Species 
201 COOH      CH2 OH  H. 
chionosphaerum 
H. dasyanthum 
202 COOH   OH   CH2 OH OH H. dasyanthum 





H H    CH2   H. aureum 
H. heterolasium 
H. pilosellum 








H H    CH2   H. aureum 
207 CH3     OH CH2
OH 
  H.aureum 
H. 
chionosphaerum 
208 CH3      H, 
OH 





 R1 R2  
209 COOH H H. aureum 
H. chionosphaerum 
210 COOH OH H. fulvum 
211 COOH OCOCH3 H. fulvum 
212 CH2OH H H. chionosphaerum 





216 abienol, H. nudifolium 




217 (isoabienol, H. nudifolium (H. 
coriaceum in reference) 
 
 R1 R2  
213 CH3 CH3 H. confertum 
H. sutherlandii 
214 H COOCH3 H. confertum 




 R1 R2  
218 CH3 CH2OH H. setosum 
219 CH2OCOCH2COOH CH3 H. setosum 
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233 H. drakenbergense, H. glomeratum 
 











236 H. mundtii, H. nanum, H. subfalcatum 
 
 






















242 H. acutatum 
CHO
 
243 H. callicomum                           
CH2OH
 
244 H. callicomum 
COOH
 
245 H. callicomum                         
OH
 




247 H. argyrophyllum 
 




248  H. heterolasium 
CH2OAc
 
249 H. heterolasium 
 
*Configuration not indicated in source 
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Figure 2.10 Sesquiterpenes                                
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H. chionospaerum 
       
258 H drakenbergense 
H. glomeratum 
 
259 H. pallidum 
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H. aureonitens,  
H. dregeanu 
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H. dasyanthum,  
H. kraussi,i H.petiolare 
H.oxyphyllum 
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H. infaustum 
 H. mimetes 
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275 H. petiolare 
 
 
276 H. nudifolium 
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  278 H. nudifolium 
O  
 
279 H. nudifolium   
H  
silphiperfolene 
280 H. aureum                        
H  
silphinene 
281  H. nudifolium            
 
modhephene 
282 H. nudifolium            
 
  α-bergamotene 
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H. dasyanthum 
H. heterolasium, 
H. montanum,  
H. petiolare 
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  300* stereoisomer of 
298, from H. 
montanum      




































306 H. splendidum                             
307* Stereoisomer of 306, from H. montanum 
OH
 
308 H. subfalcatum (diterpene)                             
    * These compounds are described in Chapter 5.                                  
 





H. acutatum, H. appendiculatum, H. aureonitens, 
H. callicomum, H. chrysargyrum, H. cymosum, H. 
drakenbergense, H. glomeratum, H. 
hypocephalum, H. krookii, H. mimetes, H. 
monticola, H. natalitium, H. nudifolium, H. 
pallidum, H. tenuiculum, H. umbraculigerum 
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313 H. mundtii 
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314 H. mundtii, H. panduratum 
HO
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318 H. glomeratum, H. nanum 
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S SS  
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H. allioides, H. argenteum, H. 
argyrophyllum, H. lanatum, H. 
latifolium, H. nudifolium, H. 
odoratissimum, H. paniculatum, 
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H3C[C C]5CH CH2  
 
338 H. adenocarpum, H. 
argentissimum, H. callicomum, H. 
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heterolasium, H. krookii, H. 
natalitium, H. platypterum, H. 
retortoides, H. sutherlandii, H. 
tenuifolium* 
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There are two main reasons why researchers should cncern themselves with antimicrobial 
research. Firstly, it is well established that resistance of bacteria, especially those 
associated with serious infections, are increasing against antibiotics worldwide (Alanis, 
2005; Chander et al., 2007; Jansen et al., 2006; Overbye and Barret, 2005). Secondly, 
another alarming trend is the global decrease in antib cterial and antibiotic research by 
large pharmaceutical companies. There are various reasons for this decrease: 1) 
development of resistance against any antimicrobial drug is almost guaranteed as the most 
resistant individuals in a bacterial population is naturally selected, 2) antibiotics are taken 
as short courses and are therefore at an economic disadvantage when compared to drugs 
directed at chronic conditions such as cardiovasculr disease which is taken daily over a 
long period of time, and 3) due to the AIDS epidemic shared anti-infective resources has 
been mostly used for antiviral research, decreasing the funding available for antimicrobial 
research. Furthermore, an increase in regulatory requir ments have led to an increase in 
developmental costs, patents expire soon after market introduction and the reservation of 
new drugs for special situations result in decreased revenues (Overbye and Barret, 2005; 
Norrby et al., 2005).  Some of the most useful antibio ics have been obtained from natural 
products (Butler, 2005; Silverman, 1992) and it seems reasonable to use nature as a source 
of inspiration to search for chemical entities in the fight against the ever evolving 
microbes.  
 
Even if compounds isolated from plants cannot claim the same success in the clinical 
setting as those isolated from soil bacteria for insta ce, several phytochemicals exhibit 
antimicrobial activity (Gibbons, 2004). As set out in Chapter 2, the antimicrobial activities 
of extracts from the genus Helichrysum have been determined by different laboratories and 
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this genus is rich in anti-infective compounds such as phloroglucinols, diterpenes, and 
flavonoids (Dekker et al., 1983; Drewes et al., 2006; Drewes and Van Vuuren, 2008; 
Süzgeç et al., 2005).  Helichrysum species are also widely used in traditional medicine to 
treat ailments associated with antimicrobial infections. It is often used to dress wounds and 
to treat patients with respiratory diseases. These facts indicate that the genus is a potential 
promising source of antimicrobial compounds. Moreover, although there are several 
reports on the antimicrobial activities of Helichrysum extracts, comparative toxicity values 
are often not available (Drewes et al., 2006; Lourens t al., 2004; Mathekga and Meyer, 
1998), indicating the importance of a study to determine relative toxicity. 
 
The aims of this chapter are: 
•  To report on the antimicrobial activity of extracts of selected Helichrysum species 
•  To report on preliminary observations regarding cytotoxicity against “normal” and 
cancer cell lines for extracts of the selected Helichrysum species 
•  Based on biological activity, select Helichrysum species for phytochemical 
investigations. 
 
3.2 Results and discussion 
 
Thirty-five indigenous Helichrysum species were collected on the basis of availability. 
Plant material was collected in various provinces of South Africa during 2002 to 2004. The 
plant species, voucher numbers and localities are indicated in Table 3.1. Some of the 




       H. herbaceum              H. cf. swynnertonii    H. oreophilum 
H. cephaloideum           H. krebsianum    H. odoratissimum 




The antimicrobial and cytotoxicity of extracts of the species tested are collated in Table 
3.2. Of the 35 species screened, seven (H. aureum, H. excisum, H. cf. foetidum, H. 
kraussii, H. odoratissimum, H. platypterum, and the H. rugulosum flower extract) 
exhibited MIC’s ≤ 0.1 mg/ml against one or more micro-organisms. Activity was mainly 
observed against the two Gram-positive micro-organisms, S. aureus and B. cereus. A few 
extracts had activity against S. epidermidis (H. excisum and the H. rugulosum flower 
extract), K. pneumoniae (H. rugulosum flower extract) and the yeast C. neoformans (H. 
herbaceum and H. rugulosum flower extract). None of the extracts were active against P. 
aeruginosa. These results support the trend observed by Mathekga and Meyer (1998) that 
Helichrysum extracts are generally more active against Gram-positive than Gram-negative 
micro-organisms.  
 
The extracts of H. herbaceum and H. rugulosum flowers were the only extracts active 
against the yeast C. neoformans and exhibited MIC’s of 0.5 and 1.0 mg/ml, respectively. 
The flower extract of H. rugulosum showed much better activity against S. aureus, S. 
epidermidis, and K. pneumoniae than the extract of the leaves and stems of the same plant. 
Since this flower extract had much better activity than the stems and leaves, investigating 
the flower extracts of other species may yield interesting results in a future study. There 
are reports on the traditional use of six of the seven most active species relating to 
antimicrobial use. For example, H. foetidum is used to treat festering sores while H. 
odoratissimum is used to treat wounds and burns, indicating that the traditional use should 
be considered in species selection.  
 
Although the MIC values observed for some species seem promising, in several cases 
toxicity (inhibition of Graham cell growth) was also observed at 0.1 mg/ml. The MIC’s for 
H. aureum extract, for example, are 0.02 and 0.01 mg/ml against S. aureus and B. cereus, 
respectively, but only 5% Graham cell growth is observed at a concentration of 0.1 mg/ml. 
Species with potential toxicity include H. acutatum, H. aureum var aureum, H. 
platypterum and H. rugulosum, since less than 10% Graham cell growth was observed at 
the test concentration (100 µg/ml).  
 
With extracts of H. adenocarpum, H. appendiculatum, H. cephaloideum and H. indicum 
more than 80% growth was observed for the Graham cells, a ‘normal’ cell line, while the 
growth of the MCF-7 breast cancer cells were less than half of that at the same 
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concentration of extract, indicating a degree of selectivity. In general, the MCF-7 cells 




The antimicrobial activities of 35 Helichrysum species have been shown in relation to their 
cytoxicity. The results of this study enabled us to select Helichrysum species for further 
study. Criteria used for selection included biological activity, availability of plant material, 
whether phytochemical studies have been performed on the species previously, and the 
presence of promising phytochemicals in related species. Based on these criteria, the 
species selected for further study included Helichrysum splendidum, H. montanum, and H. 
excisum. 
 
Although the extract of H. splendidum did not exhibit potent antimicrobial or anticancer 
activity (the extract was relatively non-toxic to normal cells) an interesting class of 
compounds, namely guaianolides, was previously isolated from this species. These types 
of compounds are used as anticancer agents and exhibit anti-inflammatory activity, which 
is interesting considering its traditional use to trea  rheumatism. The ambiguities that exist 
in literature regarding the stereochemistry of these isolated compounds prompted us to 
reinvestigate this species (Chapter 4).  
 
It was proposed that the morphologically related species, H. montanum, would exhibit 
phytochemistry similar to that of H. splendidum. No previous phytochemical investigations 
have been carried out on this species and it was anticipated that it would be a source of 
exciting sesquiterpenoids. Furthermore, this species inhibited the growth of all three cell 
lines in the cytotoxicity assay, indicating the possible presence of cytotoxic compounds 
(Chapter 5).  
 
Helichrysm excisum was selected for further study based on the fact tha it exhibited 
promising antimicrobial activity, relative low toxicity and except for the essential oil, has 





3.4 Experimental  
 
3.4.1 Plant collection 
Localities and voucher numbers of collected plant material is displayed in Table 3.1 
Specimens of each plant were sent to the South African National Biodiversity Institute in 
Pretoria for identification by Ms M. Welman and Ms. J.A. Ready. Voucher specimens 
were deposited in the University of KwaZulu-Natal herbarium (NU) in Pietermaritzburg. 
 
3.4.2 Instrumentation and chemicals 
Culture media and fetal calf serum (FCS) were obtained from Highveld Biological, while 
other chemicals were obtained from Sigma and Saarchem. An automated 
spectrophotometric plate reader (Labsystems iEMS reader MF), connected to Ascent 
version 2.4 software, was used to read absorbences i  the sulforhodamine B (SRB) assay.  
 
3.4.3 General extraction 
Plant material was air dried (protected from sunlight), ground and extracted twice with 
chloroform:methanol (1:1) for 24 hours at room temprature where after the solvent was 
removed under vacuum.  
 
3.4.4 Antimicrobial bioassays 
Determination of minimum inhibitory concentration (MIC) values 
Six microorganisms, including three Gram-positive bacteria (Bacillus cereus ATCC 
11778, Staphylococcus aureus ATCC 12600, and Staphylococcus epidermidis ATCC 
2223), two Gram-negative bacteria (Klebsiella pneumoniae NCTC 9633 and Pseudomonas 
aeruginosa ATCC 9027, and a yeast (Cryptococcus neoformans ATCC 90112) were used 
in the screening of the crude extracts. Selection of test organisms were undertaken 
according to the traditional use of species of the genus i.e. treatment of respiratory 
disorders and wounds. The reference stock cultures w re obtained from the National 
Health Laboratory Service (NHLS) (Johannesburg) and were maintained in the 
microbiology laboratory of the Department of Pharmacy nd Pharmacology, University of 
the Witwatersrand, Johannesburg, South Africa. Cultures were maintained in tryptone soya 
broth (TSB) prepared by dissolving 30 g in 750 ml of sterile water. The agar was sterilised 
by autoclaving for 15 minutes at 121 ºC. 
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MIC values were determined by the 96-well microplate method (Fig. 3.2) as described by 
Eloff (1988) and adapted by Magee et al. (2006). Stock solutions were prepared by 
dissolving samples in DMSO (64 mg/ml) since dissoluti n problems occurred with 
solvents such as acetone. Sterile water (100 µl) was added to all wells of the microtitre 
plate. The stock solutions (100 µl) of 10 different extracts were added to the first row 
(wells A1-A10) of the 96-well plate, mixed with the water and 100 µl of the resulting 
solution transferred to the next row of the plate. This process of serial dilution was 
repeated for all rows until the last row, where the remaining 100 µl was discarded. A fixed 
bacterial culture (100 µl) of approximate inoculum size of 1 × 106 colony forming units 
(CFU)/ml in TSB was added to all wells to obtain a concentration range of 16 to 0.125 
mg/ml of extract. Further dilutions were prepared when activity below these ranges were 
observed.  
 
The plates were incubated at 37 ºC for 24 h for bacteria and 48 h for the yeast. MIC values 
were determined at least in duplicate. Positive controls included ciprofloxacin for bacteria 
and amphotericin B for the yeast (column 11). A solvent control (column 12) was included 
with the assay since DMSO has antimicrobial activity and samples with MIC values equal 
to that found for DMSO were considered not susceptible (NS, Table 5.2). After the 
incubation period, 50 µl of a 0.4 mg/ml p-iodonitrotetrazolium violet (INT) solution was 
added to all wells and left for 6 h (except Cryptococcus which was left for 12 h) at room 
temperature before reading the MIC’s.  
 
The method is based on the principle that the colourless tetrazolium compound (INT) acts 
as an electron acceptor and is reduced to a coloured p oduct by biologically active 
organisms (Eloff, 1998).  The MIC value was determined as the lowest concentration of 
sample required to inhibit the growth of test organisms. Wells where bacterial growth 
occurred stained red in the presence of INT and the concentration in the first unstained 






Figure 3.2 Example of a 96 well plate used to determine MIC’s. Wells where red staining 
occurs are indicative of bacterial growth. In clear (yellow) wells no bacterial growth 
occurs. The concentration in the first clear well is taken as the MIC. Column 11 is used for 
the negative control (solvent) and column 12 for the positive control (e.g. ciprofloxacin). 
 
3.4.5 Cytotoxicity screening against normal and cancer cell lines 
Cytotoxicity was determined with the sulforhodamine B (SRB) assay (Monks et al., 1991; 
Wu et al., 1993; Kamatou et al., 2008). SRB is a water-soluble dye that binds to basic 
amino acids of cellular proteins that are only synthesised by viable cells (Voigt, 2005). The 
absorbance can therefore be used as an indication of cell growth.  
 
Cell lines 
Breast adenocarcinoma (MCF-7) and neuronal (glioblastoma) (SF-268) cell lines were 
obtained from the Division of Cancer Treatment and Diagnosis, National Cancer Institute 
(NCI), Fairview Centre, Frederick Maryland in the United States of America. Transformed 
human kidney epithelial cells (Graham cells) were obtained from Dr. Robyn van Zyl from 
the Department of Pharmacy and Pharmacology, University of the Witwatersrand. 
 
Preparation of media and solutions 
The Graham cells were cultured in Ham F10 media containi g 5% (v/v) heat inactivated 
fetal calf serum (FCS) and 0.1% gentamicin. The SF-268 and MCF-7 cells were 
maintained in RPMI-1640 media containing 5% FCS and 0.01% L-glutamine, while media 
used in the assay included 0.1% gentamicin. A 0.4% (w/v) SRB solution was prepared 
using 1% acetic acid and a 50% trichloroacetic acid(TCA) solution prepared with distilled 
Millipore water. The phosphate buffer saline (PBS) (pH 7.4) was prepared with NaCl (8 g), 
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KCl (0.3 g), Na2HPO4.2H2O (0.73 g) and KH2PO4 (0.2 g) in one litre of distilled Millipore 
water which was then autoclaved. Trypan blue was prepared at a concentration of 2 mg/ml 
in PBS and the solution of tris(hydroxymethyl)aminomethane (Tris base) was prepared at a 
concentration of 10 mM (pH 10.5) with distilled Millipore water. All solutions were stored 
at 4 ºC until required. 
 
Preparation of cells 
The cells were maintained at 37 °C in a 5% CO2 humidified incubator. The media was 
replaced three times a week and the cells were trypsinised weekly, and then allowed to 
reach confluency before being used in the assay. After trypsinisation, a single cell 
suspension was obtained, stained with trypan blue and cell density determined on a 
haemacytometer. The stock cell suspension was then diluted to the required cell 
concentration with culture media. The experiment was c rried out only when at least 95% 
of cells were viable. The Graham cells were seeded at 25 000 cells/well, while the MCF-7 
and SF-268 cells were seeded at 15 000 cells/well. 
 
Preparation of samples for the SRB assay 
Crude extracts were weighed and dissolved in dimethyl sulfoxide (DMSO) to prepare 
stock solutions of ca. 10 mg/ml. These solutions were diluted further with RPMI-1640 
media containing 0.1% gentamicin sulfate (a 50 folddi ution was prepared, e.g. 20 µl of 
stock solution and 980 µl of media).  
 
SRB assay 
A volume of 100 µl of the prepared cell suspension was plated out in all wells of the 96 
well plate except rows A and H. Wells A1, A2, H1 and H2 served as blanks, while wells A3-
A12 and H3-H12 were used as colour controls for samples. Media without cells were 
therefore transferred to these wells. A duplicate plate was prepared to serve as a time zero 
plate (reference plate to indicate cell growth at time of sample addition). The plates were 
then incubated for 24 hours at 37 °C in 5% CO2 at 100% relative humidity to allow for 
attachment of cells. After incubation, 100 µl of the prepared samples was added to the 
appropriate wells (Fig 3.3) to obtain concentrations f 100 µg of sample per well.  Samples 





 1 2 3 4 5 6 7 8 9 10 11 12 
A Blank Blank C1 C2 C3 C C C C C C C 
B Cell control S1 S1         
C Cell control S1 S1         
D Cell control S2 S2         
E Cell control S2 S2         
F Cell control S3 S3         
G Cell control S3 S3         
H Blank Blank C1 C2 C3 C C C C C C C 
 
Figure 3.3 Representation of a microtitre plate used in the SRB assay. Blank = only 
culture media without cells; Cell control = cells with only media and no sample; C = 
sample control, sample and culture media, no cells; S = cells and sample. 
 
Plates were then incubated for a further 48 hours. The time zero plate was however, not 
incubated, but the cells were fixed after the first 24 hour incubation period to establish that 
adequate cell growth occurred before addition of samples. At the end of the 48 hour 
incubation period, cells were fixed with TCA. Ice-cold TCA (50 µl) was added to all wells 
and the plates incubated for a further hour at 4 °C, where after the supernatant was 
discarded and the plates washed copiously (five tims) to remove all TCA, growth medium 
and extract residues. Plates were then air dried at room temperature. To stain the fixed 
cells, the SRB solution (100 µl) was added to all wells and left for approximately 10 
minutes, where after the SRB solution was discarded and the plates washed thoroughly 
with 1% acetic acid to remove all unbound dye. The plates were again air dried. The bound 
dye was solubilised through the addition of 200 µl Tris base. The absorbance was read at 
492 nm against a Tris base blank after the plates were shaken at 960 rpm for 3 minutes. 
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Determination of percentage cell growth 
The percentage cell growth in reference to control g wth was calculated as follows: 
 
% cell growth = (mean abs test sample – mean abs background) *100 
    (mean abs control – mean abs blank) 
 
where “mean abs test sample” refers to the mean absorbance at 492 nm obtained for the 
three similar sample wells (100 µl cell suspension + 100 µl sample) 
  “mean abs background” refers to the mean absorbance t 492 nm of the wells 
containing only media (100 µl) and sample (100 µl) 
  “mean abs control” refers to absorbance of wells containing only cell suspension 
and no sample. 
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Table 3.1 Helichrysum species collected. 
 
 Plant species Voucher number Locality/ date collected 
1. H. acutatum DC. A. Lourens and A. Viljoen 1 Mpumulanga, 4 km from Graskop, on the road to Hazyview, Kowyns pass. S 24 57 54.0; 
E 30 51 08.1; 4756 ft.; 27/09/2003 
2. H. adenocarpum DC. subsp. 
adenocarpum  
S.N. Unknown locality 
3. H. appendiculatum (L.f.) Less. A. Lourens and A. Viljoen 28 Mpumalanga, approximately 2 km on God’s Window turn-off (R534). Turn-off from 
road from Blyderivierspoort to Graskop; 25/01/2004 
4. H. aureonitens Sch. Bip. J. E. Victor 2439 Amatolas 
5. H. aureum (Houtt.) Merril var. 
aureum 
J. E. Victor 2428 Amatolas 
6. H. cephaloideum DC. 
 
A. Lourens and A. Viljoen 20 KwaZulu-Natal, approximately 5 km from Underberg on road to Bulwer. S 29 18 57.2; E 
29 32 41.5; 4759 ft.; 10/01/2004 
7. H. callicomum Harv. DBH 6565 Transkei 
8. H. dasyanthum (Willd.) Sweet A. Lourens 33 (ex. J. Manning) Western Cape, Cape Agulhas, Red Hill; 01/2004 
9. H. excisum (Thunb.) Less. J. Vlok 2830 and J. Vlok 2830A Western Cape, northern base of Robinson pass, near Paardebont; 20/11/2002; 23/08/2004 
10. H. felinum Less. J. Vlok 2828 Western Cape, northern base of Robinson pass; 11/2002 
11. H. cf. foetidum (L.) Moench. J. Vlok 2833 Eastern Cape, George 
12. H. herbaceum (Andr.) Sweet A. Lourens and A. Viljoen 17 KwaZulu-Natal, Alpine Heath, on walk to waterfall; 04/01/2004 
13.  H. indicum (L.) Grierson A. Lourens 34 (ex. J. Manning) Cape Agulhas 
14. H. kraussii Sch. Bip.  
 
A. Lourens and A. Viljoen 4 
 
Mpumalanga, Robber’s pass. Shortly after turn-off to Pelgrim’s Rest. (Sign 6/6). 
Everywhere along pass. S 24 53 57.9; E 30 37 20.4; 4402 ft.; 03/10/2003 
15. H. melanacme DC. 
 
A. Lourens and A. Viljoen 12 Free State, 2 km from Clarens on road to Koster. S 28 31 12; E 28 26 45; 6062 ft.; 
03/01/2004 
16. H miconiifolium DC. 
 
A. Lourens and A. Viljoen 24 Kwa-Zulu Natal, On gravel road from Loteni to Himeville. S 29 36 49.5; E 29 33 48.6; 
4439 ft.; 10/01/2004 
17. H. montanum DC. F. van Heerden 1 Western Cape, Koueveld mountains, on farm Weltevrede Murraysburg; 25/12/2003 
18. H. nudifolium (L.) Less. 
 
A. Lourens and A. Viljoen 13 Free State, 2 km from Clarens on road to Koster. S 28 31 12; E 28 26 45; 6062 ft.; 
03/01/2004 
19. H. odoratissimum (L.) Sweet  
 
A. Lourens and A. Viljoen 6 Mpumalanga, Robbers pass, approx. 2 km after Crystal Springs turn-off on rad from 
Lydenburg to Pelgrims Rest (approx. 9 km from Pelgrim’s Rest); 04/10/2004 
20. H. oreophilum Klatt.  A. Lourens and A. Viljoen 10 Mpumalanga, frm Aantree, Draaikraal; 14/12/2003 
21. H. pallidum DC. 
 
A. Lourens and A. Viljoen 7 Mpumalanga, On road from Graskop to Sabie, approx. 1 km after turn-off to Sabie, just 
after “The Bonnet”. S 24 56 18.2; E 30 48 41.6; 4833 ft.; 04/10/2004 
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Plant species Voucher number Locality/ date collected 
22. H. pandurifolium Schrank  A. Lourens 35 (ex. J. Manning) Cape Agulhas; 01/2004 
23. H. patulum (L.) D. Don. A. Lourens 36 (ex. J. Manning) Cape Agulhas; 01/2004 
24. H. petiolare Hilliard and Burtt J. Vlok 2827 Western Cape, Oudtshoorn, base of Robinson pass, near farm Moerasrivier; 20/12/2002 
25. H. platypterum DC. 
 
A. Lourens and A. Viljoen 30 Mpumalanga, Just outside Dullstroom on road to Belfast. (Sign 56/0). Farm dam on left 
hand side of road. Approx.  500 m from Uitvlugt turn-off; 25/01/2004 
26. H. psilolepis Harv. 
 
A. Lourens and A. Viljoen 11 Free State, 2 km from Clarens on road to Koster. S 28 31 12; E 28 26 45; 6062 ft.; 
03/01/2004 
27. H. retortum (L.) Willd. A. Lourens 37 (ex. J. Manning) Cape Agulhas; 01/2004 
28. H. rosum (Berg.) Less. cf. var. 
rosum 
J. E. Victor 2436 Amatolas 
29. Helichrysum ruderale Hilliard 
and Burtt 
A. Lourens and A. Viljoen 32 KwaZulu-Natal, Hilton, Weir street; 14/11/2004 
30. H. rugulosum Less.  
 
A. Lourens and A. Viljoen 8 North West, on Derby road, from Klerkskraal dam, 19 km from turn-off. Along road side. 
S 26 05 33; E 27 07 04; 4933 ft.; 12/12/2003. 
31. H scitilum Hiliard and Burtt  F. van Heerden 2 Western Cape, Koueveld mountains, on farm Weltevrede Murraysburg; 25/12/2003. 
32. H. simillimum DC. 
 
A. Lourens and A. Viljoen 23 KwaZulu-Natal, on road from Loteni to Himeville. Near Loteni stock theft unit. S 29 33 
44.3; E 29 35 45.6; 4652 ft.; 10/01/2004 
33. H. splendidum (Thunb.) Less. A. Lourens and A. Viljoen 2 Mpumalanga, 2.6 km from God’s Window at stop point near “Staircase”, 27/09/2 03 
34. H. wilmsii  Moeser 
 
 
A. Lourens and A. Viljoen 5 Mpumalanga, Robbers pass, approx. 2 km after crystal Springs turn-off on road from 
Lydenburg to Pelgrims Rest. (Approx. 9 km from Pelgrims Rest). S 24 52 34.2; E 30 42 
13.8; 04/10/2004 
35. H. zeyheri Less. F. van Heerden 3 Western Cape, Koueveld mountains, on farm Weltevrede Murraysburg 
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Table 3.2 Antimicrobial activity (MIC, mg/ml) and cytotoxicty (at 0.1 mg/ml ± standard deviation) of Helichrysum extracts  
Plant Species 





























H. acutatum DC. NSc NS 0.5 1 NS NS 0.1±0.1 15.8±1.0 6.6±0.1 
H. adenocarpum DC.  NS NS NS NS NS NS 98.3±0.6 88.1±3.6 37.2±3.2 
H. appendiculatum (L.f.) Less NS NS NS 4 NS NS 91.7±2.1 81.0±2.8 37.5±2 4 
H. aureonitens Sch. Bip. NS NS 4 4 4 NS 75.6±0.9 76.0±4.7 37.5±3.7 
H. aureum (Houtt.) Merril  NS NS 0.02 0.01 NS NS 5.0±0.2 35.9±1.9 7.0d 
H. callicomum Harv. NS NS 1 0.25 4 NS 27.3±2.9 56.1±2.8 11.2d 
H. cephaloideum DC. NS NS NS 1 4 NS 93.7±4.6 83.8±2.6 46.1d 
H. dasyanthum (Willd.) Sweet NS NS NS 4 NS NS 91.3±0.7 81.7±3.6 52.8d 
H. excisum (Thunb.) Less NS NS 0.2 0.03 0.1 NS 63.6±1.1 71.9±3.1 31.4±0.8 
H. felinum Less NS NS 2 0.16 2 NS 48.0±1.4 54.1±2.3 23.2±0.2 
H. cf. foetidum (L.) Moench NS NS 0.5 0.01 NS NS 32.7±2.1 57.8±2.1 24.9±0.4 
H. herbaceum (Andr.) Sweet 0.5 NS 0.5 1 4 NS 50.8±3.0 46.4±1.6 22.9±0.3 
H. indicum (L.) Grierson NS NS 1 0.5 4 NS 81.1±2.3 70.6±4.2 35.8±0.8 
H. kraussii Sch. Bip. NS NS 0.5 0.004 4 2 28.6±1.4 45.2±4.4 9.0d 
H. melanacme DC. NS NS 0.5 0.25 4 2 18.1±0.4 53.3±2.7 12.2d 
H. miconiifolium DC. NS NS 2 1 4 NS 37.9±6.6 52.4±1.8 20.9d 
H. montanum DC. NS NS 1 4 NS NS 29.4±0.7 46.1±4.0 19.2d 
H. nudifolium (L.) Less NS NS NS 4 NS NS 73.1±2.5 83.9±1.8 35.3±0.4 
          
        
     




Antimicrobial activity a 


























H. odoratissimum (L.) Sweet NS NS 0.02 0.03 4 2 17.5±0.4 48.2±1.4 7.4±0.7 
H. oreophilum Klatt NS NS 4 4 NS NS 63.4±2.2 82.9±3.0 34.8±0.1 
H. pallidum DC. NS NS NS NS NS NS 88.6±0.9 83.9±9.7 49.0±1.7 
H. pandurifolium Schrank NS NS 2 4 NS NS 57.1±1.2 71.8±0.8 34.2±0.1 
H. patulum (L.) D. Don NS NS 4 4 NS NS 63.8±1.3 75.2±2.0 37.8d 
H. petiolare Hilliard and Burtt NS NS 4 2 NS NS 59.3±3.4 76.6±3.0 33.4d 
H. platypterum DC. NS NS 0.05 0.5 NS NS 0.8±0.3 35.1±1.5 4.6 
H. psilolepis Harv. NS NS 1 1 NS NS 25.9±1.9 58.4±7.4 23.1d 
H. retortum (L.) Willd. NDe NS 4 NS NS NS 79.6±3.4 87.3±4.8 NDe 
H. rosum (Berg.) Less.  NS NS 1 1 4 NS 47.5±1.8 54.8±5.0 22.5±0.7 
H. ruderale Hilliard & Burtt. ND NS 2 1 NS NS 45.1±1.2 75.8±3.9 NDc 
H. rugulosum Less.  NS NS 0.5 0.25 4 NS 3.0±1.2 44.7±3.6 12.7±2.7 
H. rugulosum Less. Flowers 1.0 NS 0.01 0.33 0.01 0.22 ND ND ND 
H. scitilum Hilliard & Burtt. NS NS NS NS 4 NS 58.6±1.2 85.3±6.8 46.8d 
H. simillimum DC. NS NS 1 4 4 NS 54.6±2.6 66.8±3.9 26.8d 
H. splendidum (Thunb.) Less NS NS 4 NS NS NS 82.3±3.2 72.8±3.3 49.2±2.5 
H. wilmsii Moeser NS NS 1 1 4 NS 22.5±2.1 64.1±6.1 15.3±0.5 
H. zeyheri Less. NS NS 2 4 NS NS 54.4±9.5 58.2±3.1 37.4d 
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Antimicrobial controlf  0.3 x 10-3 0.3 x 10-3 1.0 x 10-3 2.5 x 10-3 0.7 x 10-3    
Antimicrobial controlf 2.5 x 10-3         
DMSO controlg 2 4 8 8 16 4    
 
aExperiments done at least in duplicate. Exceptions include determination of cytotoxicty against MCF-7 cells for extracts of H. aureum, H. calliconum, H. cephaloideum, H. 
dasyanthum, H. kraussii, H. melanacme, H. miconiifolium, H. montanum, H. patulum, H. petiolare, H. platypterum, H. psilolepis, H. scitilum, H. simillimum. 
bAt a concentration of 0.1 mg/ml of 5-flourouracil, more than 80% growth was observed for the SF-268 cells, while an IC50 of 1.1 µg/ml was determined for the same drug 
against the MCF-7 cell line (Kamatou et al., 2008). 
cNot susceptible, MIC observed equal to that of solvent control 
dExperiments done only once, using the SRB assay 
eNot determined 
fCiprofloxacin used as a positive control against bacteria and Amphotericin B used as a positive control against the yeast 
gSolvent control 
 
              
         









Helichrysum splendidum (Thunb.) Less. (Fig. 4.1) is a slender, erect aromtic shrub which 
is distributed widely on the high mountains of East Africa and Malawi to Zimbabwe. In 
South Africa the plant occurs in the eastern parts of the country, with distribution ranging 
from the highlands of Mpumalanga to the Swartberg near Oudtshoorn and George 
(Hilliard, 1983). This plant is used traditionally to treat rheumatism (Pooley, 2003; Jacot-




Figure 4.1 Habitat and flowers of H. splendidum 
 
The phytochemistry of H. splendidum has been studied previously by Bohlmann and 
Suwita (1979) and Jakupovic and co-workers (1989). In addition to the normal terpenes 
and flavones, guaianolides and secoguaianolides were isolated from the plant (Bohlmann 
and Suwita, 1979, Jakupovic et al., 1989). Guaianoldes rarely occur in Helichrysum 
species and apart from H. splendidum, the only other Helichrysum species from which 
guaianolides were isolated was H. dasyanthum (Jakupovic et al., 1989). Guaianolides are a 
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large class of sesquiterpenoids which can be divided into simple guaianes, 12,8-
guaianolides, 12,6-guaianolides (introduction of a lactone moiety changes the name from 
guaiane to guaianolide), guaiane-dimers and seco-, cyclo- and abeo-guaianes (Dictionary 
































Guaiane (Dictionary of Natural Products) Secoguaiane from Nephthea           













12,8-Guaianolide from H. splendidum 
(Jakupovic et al., 1989) 
 
  12,6-Guaianolide from Artemisia      
myriantha (Wong and Brown., 2002) 
Figure 4.2 Examples of different guaianes 
 
Various biological activities, such as anti-inflammatory (Hilmi et al., 2003; Siedle et al., 
2003), cytotoxic (Hilmi et al., 2002), and antiviral effects (Kim et al., 2002; Hwang et al., 
2006) have been attributed to guaianolides.  In the case of guaianolides from Warionia 
saharae and Artemisia argyi, all of the cytotoxic guaianolides have an exo-methylene 
moiety adjacent to the lactone carbonyl (Hilmi et al., 2002, Kim et al., 2002), which 
probably results in the alkylation of biological nucleophiles (Kim et al., 2002). The same 
interaction is believed to be responsible for the inhibition of NF-κΒ (Jin et al., 2004) 
associated with anti-inflammatory effects of these compounds.  
 
The medical relevance of the guaianolides is illustrated by the almost 10 000 publications 
on the subject of thapsiargin (376), a highly oxygenated guaianolide which acts as a 
selective, irreversible inhibitor of sarco-endoplasmic reticulum Ca2+ ATP dependant 
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pumps, thus initiating apoptosis and rendering it an efficient anticancer agent (Ball et al., 
2007). Arglabin (377), a guaianolide isolated from Artemisia myriantha, is also used 
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This chapter describes the confirmation of the structures of guaianolides isolated from H. 
splendidum, a species that was previously studied (Bohlmann and Suwita, 1979; Jakupovic 
et al., 1989). An important part of this project was the investigation of the sesquiterpenoids 
of H. montanum (Chapter 4). However, problems experienced with the determination of 
the relative configuration of the sesquiterpenes in this species and the ambiguity that exists 
in literature on the stereochemistry and NMR assignme ts of the isolated guaianolides 
from H. splendidum prompted us to reinvestigate this species. An initial TLC (thin-layer 
chromatographic) investigation of the extracts of H. splendidum and H. montanum 
revealed the presence of compounds that stained red with anisaldehyde spray reagent (Fig. 
4.3). These sesquiterpenoids were targeted during th s investigation. 
 
 
Figure 4.3 TLC of extracts of H. montanum (MO1 locality unknown, MO2 collected in the 




To study the conformations of these compounds, molecular modelling was employed. The 
most stable conformation of different stereoisomers, determined with the AM1 method, 
was used in conjunction with observed NOESY correlations to determine the relative 
configuration of the isolated sesquiterpenoids. 
 
4.2 Results and discussion  
 
The chloroform:methanol (1:1) extract of H. splendidum yielded the monomeric 
guaianolides, 302 and 304, as well as the dimeric guaianolide h lisplendidilactone (306). 
 
High-resolution mass spectrometry of compound 302 confirmed the molecular formula of 
C15H22O3. The presence of 15 carbons in the 
13C NMR spectrum (Plate 2) indicated a 
possible sesquiterpene structure. To the best of our knowledge, this is the first report on the 
13C data of compound 302. Inspection of the DEPT NMR spectrum (Plate 4) revealed the 
presence of two CH3, four CH2, six CH and three quaternary carbons. There were no 
aromatic protons present in the 1H NMR spectrum (Plate 1), but a doublet of doublets wa  
observed in the region characteristic for alkenes (δH 5.44). A deshielded proton was also 
observed at (δH 4.61) indicating the proximity of an oxygen atom to this proton. The 
remaining protons were present in the aliphatic region, confirming the proposed 
sesquiterpene structure.  
 
After careful consideration of the COSY (Plate 3), HSQC (Plate 5) and HMQC (Plate 6, 
Fig. 4.4) NMR spectra, the structure of compound 302 was assigned as 11α,13-
dihydroxanthalongin, previously isolated from H. splendidum (Jakupovic et al., 1989) and 



















The 7,8-cis-configuration of the lactone ring was unequivocally established by the 
observed NOESY correlations (Plate 7) in conjunction with the AM1 calculated structure 
(Fig. 4.5).  A NOESY experiment captures the through-space nuclear Overhauser effect 
(NOE) between a proton and its neighbouring proton hat are within a distance of 
approximately 5 Å (Claridge, 1999). Important NOESY correlations for the assignment of 
the relative configuration of 11α,13-dihydroxanthalongin (302) are those observed 
between H-8 (δH 4.61) and H-7 (δH 2.65) as well as between H-11 (δH 2.79) and H-7 (δH 
2.65). Furthermore, the NOESY correlation observed b tween H-10 (δH 2.34) and H-8 (δH 
4.61) confirmed the α-orientation of H-10. 
 
The assignment of the stereochemistry of 11α, 3-dihydroxanthalongin (302) is the same as 
that proposed by Jakupovic et al. (1989) and Marcinek-Hüpen-Bestendonk et al. (1990). 
Based on NMR data, the relative configuration of the compounds is unambiguous. 
However, we do not have proof for the absolute configuration. The absolute configurations 
of guaianolides rest on the assumption that H-7 always has α-orientation if the structure is 
drawn with the lactone on the right-hand side and the 14-methyl at the top. For a few 
guaianolides (Ulubelen et al., 1995; Hamada et al., 1980) the absolute configuration was 
confirmed, but in most of the published literature, this is just assumed without any proof. 
One method of determining the absolute configuration would have been to reduce the 4-
ketone to a hydroxy group and prepare the corresponding Mosher ester. However, we did 
not have enough material to prepare the Moshers ester and, furthermore, C-4 is so far away 
from the other stereogenic centres that it would be ifficult to correlate the stereochemistry 
on this carbon with the other stereogenic centres. For this investigation on the structures of 
guaianolides present in Helichrysum species, we have assumed the relative configuration  
C-7 is R. 
 
In the AM1 calculated structure, the distance betwen H-7 and H-8 is 2.31 Å, the distance 
between H-11 and H-7 is 2.35 Å and the distance between H-8 and H-10 is 2.28 Å, 
confirming that at least the calculated distance betwe n these atoms complies with the 
requirements for observing a NOESY correlation (Fig. 4.5). The structure of compound 




















                             
 
Figure 4.5 Structure of 11α,13-dihydroxanthalongin (302) and the AM1 calculated three-
dimensional structure of this compound.   
 
Initial inspection of the 1H and 13C NMR spectra of compound 304 revealed that this 
compound was a sesquiterpene lactone closely related to 302. High-resolution mass 
spectrometry confirmed that the molecular formula C15H22O3 (m/z 251.1659 [M+H]
+) of 
compound 304 was similar to that of compound 302 (m/z 251.1654 [M+H]+). However, 
clear differences were observed in the chemical shifts of certain protons and carbons. C-6, 
7, 10 and 13 (Plate 9) all shifted with 3 ppm or more downfield, while C-5 shifted upfield 
(approximately 3 ppm). In the 1H NMR spectrum (Plate 8) both H-7 and H-11 has shifted 
upfield, while H-13 has shifted downfield. Data obtained from analysis of two-dimensional 
experiments (COSY, HSQC and HMQC, Plates 10, 12, 13) confirmed that the basic 
structure of compound 304 was similar to that of compound 302.  
 
Confirming the relative configuration of compound 304 was less straightforward than for 
compound 302. This was due to the overlapping signals observed for H-10 and H-7 (δH 
2.37), as well as for H-11 and H-6 (δH 2.24). A NOESY correlation (Plate 14, Fig. 4.6a) is 
observed between the protons at δH 2.36 (assigned to H-7, H-10) and H-8 (δH 4.46). This 
could therefore be a correlation between either H-8 and H-7 or H-8 and H-10, but is most 
probably a correlation between H-7 and H-8. Due to the overlapping signals of H-7 and H-
10, a correlation between H-8 and H-10 can however not be excluded. This NOESY 
correlation of H-8 could therefore not be used to determine whether the lactone ring had a 
7,8-cis or 7,8-trans configuration. 
 
If one considers the AM1 calculated model (Fig. 4.6b) of compound 304 in conjunction 
























(assigned as H-7, H-10) and δH 1.22 (H-13) is most likely a correlation between H-13 and 
H-7 as H-10 is spatially too far away from H-13 (6.56 Å in the AM1 calculated structure), 
confirming that H-7 and the H-13 are on the same side of the ring. As no NOESY 
correlation is observed between H-8 (δH 4.46) and the multiplet that is assigned to H-11 
(δH 2.24), it can be concluded that H-8 must also be on the same side of the ring as H-7 and 
H-13, resulting in the 7,8-cis assignment of the lactone ring (Fig 4.6).  







        
Figure 4.6 a) Important NOESY correlations observed for compound 304 and b) AM1 
calculated structure for compound 304. 
 
Cycloheptene, as a pseudo six-membered ring, is beleved to exist in stable chair or boat 
conformers (Leong et al., 1998) (Fig. 4.7). From the AM1 calculated structures of both 
compounds 302 and 304, it appears as if the cycloheptene rings of these compounds adapt 
chair conformations. 
a  b  
 
Figure 4.7 a) Chair conformation of cycloheptene ring b) Boat conformation of 
cycloheptene ring 
 
Compound 304 was previously isolated from Arnica mollis (Marcinek-Hüpen-Bestendonk 
et al., 1990) and H. splendidum (Bohlmann and Suwita, 1979). The relative configuration 
was incorrectly assigned as 7,8-trans in the latter paper (the configuration was assigned 




corrected by Jakupovic and co-workers (1989), althoug  no NMR data was supplied for 
this compound in this particular publication. A compound with NMR data identical to 
compound 304, with the configuration assigned as 7,8-trans, was also isolated from 
Tithonia diversifolia (Kuo and Lin, 1999). However, the authors refer to Bohlmann and 
Suwita (1979), indicating a possible incorrect assignment of configuration at C-8, 
emphasising the importance of independent stereochemi al assignments, even though these 
are known compounds. 
 
The structure of the dimeric helisplendidilactone (306), previously isolated by Jakupovic et 
al. (1989), was based on extensive one- and two-dimensional NMR experiments (Plates 
15-21), high-resolution mass spectrometry, and X-ray structural analysis. The 1H NMR 
assignments (except for H-14 and H-14’) made by Jakupovic et al. (1989) were confirmed. 
Two interesting 1H,1H couplings were observed in the 1H NMR spectrum. The first was a 
homoallylic coupling between Hα-6’ and H-10’. Homoallylic coupling occurs over five 
bonds (5J) and is normally weaker than allylic coupling. In compound 306, both C-6’ and 
C-10’ C-H bonds are co-planar with the π-bond, which allow for maximum overlap of the 
σ-bonds with the π-bond and therefore a detectable homoallylic coupling (Pavia et al., 
1996). A long-range W (4J) coupling is also observed between Ha-3’ and Hα-13. The rigid, 
strained ring system has a favourable geometry for the overlap involved (Pavia et al., 
1996). 
 
Our 13C NMR assignments for helisplendidilactone (306) differ at certain positions from 
those previously reported (Jakupovic et al., 1989). From the HSQC (Plate 19), it was clear 
that the assignments of C-9 and C-9’ had to be interchanged because the carbon signal at 
δC 40.3 (assigned by Jakupuvic et al., 1989 as C-9) showed HSQC correlations with the 
protons at δH 1.54 and δH 2.28 assigned as the H-9’ protons. The assignment of the protons 
is correct as a COSY correlation is observed between th se protons and the signal at δH 
4.14 (H-8’). The HSQC correlation between the proton singlet at δH 1.22 and the carbon at 
δC 13.4 indicates that the carbon signal at δC 13.4 can be assigned to C-15’, while the 
carbon signal at δC 10.6 correlating with the proton doublet at δH 1.23 can be assigned to 
C-13’. Thus, the assignments of C-13’ and C-15’ has to be exchanged as well.  
 
According to Jakupovic et al. (1989), the C-1 carbon has a chemical shift of δC 150.1 while 
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C-1’ appears at δC 144.5. However, the HMQC correlation (Plate 20, Fig. 4.7) observed 
between the carbon at δC 144.5 and the broad proton triplet at δH 2.10 (H-2, which shows a 
COSY correlation with H-3, δH 2.53) indicates that the signal at δC 144.5 should be 
assigned to C-1 and the signal at δC 150.1 to C-1’. This change in assignment is further 
supported by the assignment of the signal at δC 144.7 as C-1 of the dihydroxanthalongin 
monomers (302, 304) by Marcinek-Hüpen-Bestendonk and co-workers (1990). HMQC 
correlations (Fig. 4.8) between the proton doublet at δH 1.11 (H-14’ according to Jakupovic 
et al., 1989) and the carbons at δC 144.7 (C-1) and 35.8 (C-10) resulted in our assignme t 
of this proton as H-14. Similar HMQC correlations between the proton doublet at δC 1.25 
(H-14’ by our assignment) and the carbons at δC 150.1 (C-1’), δC 40.4 (C-9’) and δC  29.3 


































Figure 4.8 Selected HMQC couplings observed for helisplendidilactone (306) to support 
changes in assignments from those of Jakupovic et al. (1989). 
 
Confirmation of the relative configuration of helisplendidilactone (306) was challenging 
due to the complexity of the proton NMR spectrum (Plate 15) in which several overlapping 
signals were observed. The NOESY correlation observed between H-7 (δH 2.44) and H-8 
(δH 4.48), confirmed the cis-configuration of the dihydroxanthalongin lactone ring. A 
NOESY correlation is observed between Hα-9 (δH 1.77) and H-14 (δH 1.11), while a 
NOESY is neither present between Hα-9 (δH 1.77) and H-8 (δH 4.48) nor between H-14 (δH 
1.11) and H-8 (δH 4.48), which indicates that these protons (H-8 andH-14) were on 












































Figure 4.9 Important NOESY correlations observed for helisplendidilactone (306) 
 
The absence of a NOESY correlation between H-7’ (δH 2.10) and H-8’ (δH 4.14) indicated 
7’8’- trans configuration for the second lactone ring, while a clear NOESY correlation is 
observed between H-7’ (δH 2.10) and H-11’ (δH 2.72), showing that these protons are 
cofacial. This is confirmed by the absence of a NOESY correlation between H-8’ (δH 4.14) 
and H-11’ (δH 2.72) (indicating that these protons are on opposite sides of the ring), while 
a NOESY is observed between H-8’ (δH 4.14) and H-13’ (δH 1.23).  
 
The relative configuration at C-14’ could be determined indirectly by using the NOESY 
correlations observed between H-7’ (δH 2.10) and H-14’ (δH 1.25) with Hβ-9’ (δH 1.49). H-
14’ (δH 1.25) is on the same side of the ring as H-7’ (δH 2.10), as both H-7’ and H-14’ 
shows NOESY correlations with Hβ-9’ (δH 1.49), while no correlation is observed between 
H-8’ and Hβ-9’. A NOESY correlation observed between the signal at δH 2.28 (assigned as 
Hb-6, H-10, Hb-3’, Hα-9’, H-10’) and H-8’ (δH 4.14) could either be between H-8’ and Hα-
9’ or H-8’ and H-10’ as these signals (Hα-9’, H-10’) overlap.  
 
The relative configuration of the stereogenic centres of the two monomer moieties could 
therefore be determined with NOESY correlations (Fig. 4.9). However, the orientation of 
the bridge was not absolutely clear from the NMR data obtained and confirmation of the 
complex configurational assignments necessitated the X-ray analysis of 




                          
 
Figure 4.10 Crystal used for data collection  Figure 4.11 b-Axis axial photo 
indicating mirror symmetry 
consistent with monoclinic lattice. 
 
The X-ray structure of helisplendidilactone (306) has not been reported in the literature. 
Crystal data of helisplendidilactone (306) obtained in this study is given in Table 4.1 and 
Table 4.2 and indicates that all bond lengths and bond angles are in agreement with the 
expected values (Table 4.2) for a good X-ray-diffraction structure refinement. The X-ray 
structure is summarised as follows: Monoclinic, P21, a = 9.0738(5), b = 11.4764(7), c = 
12.2960(9) Å, α = 90, β = 96.933(5), γ = 90°, V = 1271.08(14) Å
3
, and Z = 2 (Fig. 4.12, 
4.13).a  
 
The X-ray structure confirmed that both the backbone structure and relative configuration 
(we were unable to determine the absolute configuration) were correctly assigned by NMR 
spectroscopic methods by Jakupovic et al. (1989). In the illustration of helisplendidilactone 
(306) in the paper by Jakupovic and co-workers (1989), the stereochemical assignment at 
C-11 is not clear. Herewith, we provide an unambiguous assignment of the relative 
configuration at C-11.  
 
 
                                               





Figure 4.12 Colour thermal ellipsoid plot for helisplendidilactone (306) (50% probability 
level), with H atoms not labelled for clarity.  
 
Figure 4.13 Unit cell contents. 
The AM1 model of helisplendidilatone was obtained using the atomic coordinates obtained 
from the X-ray structure as input. The calculated structure was overlayed with the X-ray 
structure to determine whether there was a good correlation between the calculated and 
experimental structures. A reasonably good fit was obtained between the calculated and X-
ray structure, illustrating the usefulness of these models (Fig. 4.14). The differences 
observed are possibly due to the fact that the atoms f the side chain are more tightly 
packed in the crystal structure, while more free rotati n is experienced in the gas phase 
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molecular model. In both cases the cycloheptene ring of part A of the dimer adapts a boat-
like conformation, while that of the B unit derived from guaia-1,4-dien-12,8β-olide is more 
chair like.  
 
Figure 4.14 Helisplendidilactone (306) X-ray structure (blue) vs. AM1-calculated 
helisplendidilactone structure 
Biosynthetically, the dimeric guaianolide 306 is most likely formed by a Diels-Alder 
reaction between xanthalongin (tomentosin) (378), and 379 (Scheme 4.1), neither of which 
have been isolated from H. splendidum (Jakupovic et al., 1989). The diene is probably ver  
reactive, as is the diene acting as a precursor for absinthin, another dimeric guaianolide, 
which is only observed in Diels-Alder adducts as repo ted by Jakupovic et al. (1989). 
Dimeric guaianolides, like absinthin, occur in Artemisia species (Bohlmann et al., 1985, 
Kim et al., 2002, Jin et al., 2004, Beauhaire et al., 1981, Wong and Brown, 2002) and in 
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Three guaianolides, were isolated from H. splendidum. The determination of the relative 
configuration proved to be challenging due to overlapping signals. The assignment of the 
configuration as done by Jakupovic et al (1989) for these compounds was confirmed, while 
the NMR assignments for certain peaks of helisplendidilactone (306) was corrected. An X-
ray structure for helisplendidilactone (306) was obtained for the first time. The examples of 
incorrect assignments of configuration associated with these types of compounds 
(Bohlmann and Suwita, 1979; Kuo and Lin, 1999) emphasise that extreme care needs to be 
taken in the assignment of the configuration of these compounds, even if they are known. 
This study has also shown the value of AM1 calculated models during the determination of 
the complex configuration exhibited by these compounds.  
 
4.4 Experimental  
 
4.4.1 General experimental procedures 
1H and 13C NMR spectra of all compounds were recorded on a Varian Unity Inova 500 
spectrometer with a 5 mm SW/Z-PFG probe (all spectra recorded at 25 °C, operating at 
500 MHz for 1H and 125 MHz for 13C spectra). Spectra were measured in CDCl3 for all 
compounds. Structures were determined by analysis of 2D (HSQC, HMQC, COSY and 
NOESY) NMR spectra and by comparison of 1H and 13C NMR spectra with reported. 
Mass spectrometry data was collected on a time-of-flight Waters LCT Premier mass 
spectrometer using electrospray ionization in the positive or negative mode. Optical 
rotation was determined with a Perkin Elmer 241 polarimeter for compound 306. X-ray 
structural analysis were carried out on an Oxford Xcalibur 2 CCD diffractometer, (MoKα) 
radiation.  
 
Separations were done using open column chromatography nd a chromatotron (Model 
7924, Harrison Research). Silica gel (60F254, 40-63 µm, Merck) was used for column 
chromatography, while silica gel Merck 7749 with gypsum binding agent was used for 
preparation of chromatotron plates. Thin-layer chromatography (TLC) was done on 
precoated Kieselgel 60 F254 plates (Merck or Machery-Nagel). Detection was done by UV 
(254 nm) followed by staining with an anisaldehyde solution, prepared as follows: 
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Absolute ethanol (465 ml) was cooled in an ice bath. Acetic acid (5 ml), sulphuric acid (17 
ml) and p-anisaldehyde (13 ml) was added and the solution mixed and stored in the fridge.  
 
4.4.2 Plant material 
H. splendidum was collected on the Steenkampsberg pass in Mpumalang  in January 2004. 
The plant was identified by Ms M. Welmann from the South African National Botanical 
Institute, Pretoria.  Voucher specimens were deposited at the University of Kwazulu-Natal 
herbarium NU (H. splendidum, A. Lourens and A. Viljoen 2). 
 
4.4.3 Extraction and isolation 
Air-dried and ground leaves and stems of H. splendidum (107 g) were extracted with a 
mixture of chloroform:methanol (1:1) at room temperatu e for 48 hours to obtain 
approximately 8 g of extract. After running a column with hexanes:ethyl acetate (2:1), 
thirteen fractions (A1-A13) were obtained. A chromatotron of A9 and A10 using 
dichloromethane:diethyl ether (19:1) as eluent result d in the collection of five fractions 
(B1-B5), B1 being the clean compound 302 (8.4 mg). A chromatotron of A6 and A7, using 
the same eluent, led to the isolation of compound 304 (6.4 mg). A short column was run on 
another 8 g of extract with dichloromethane:methanol (99:1) to obtain 10 fractions (D1-
D17).  Fraction D9-D10 was repeatedly cleaned up with the chromatotron using petroleum 
ether:ethyl acetate (2:1) and finally dichloromethane:diethyl ether (19:2)  to obtain 5.7 mg 
of helisplendidilactone (306). The green solid obtained after purification was slowly 
crystallised at room temperature in an NMR tube with hexanes:dichloromethane to yield 
colourlesss crystals.  
 
4.4.4 Physical data of isolated compounds 
Compound 302, a red brown gum, was identified as 11α, 3-dihydroxanthalongin 
(Jakupovic et al., 1989; Marcinek-Hüpen-Bestendonk et al., 1990), 1H NMR (500 MHz, 
CDCl3): δ 1.13 (3H, d, J14,10 = 7.1 Hz, H-14), 1.15 (3H, d, J13,11 = 7.4 Hz, H-13), 1.86 (1H, 
ddd, J6α,6β = 15.7 Hz, J6α,5 = 9.4 Hz, J6α,7 = 2.7 Hz, Hα-6), 2.04 (2H, m, Hα-9, Hβ-9), 2.14 
(3H, s, H-15), 2.22 (2H, m, H-2, Hβ-6), 2.34 (2H, m, Ha-2, H-10), 2.43 (1H, ddd, J3a,3b = 
16.4 Hz, J3a,2 = 9.1 Hz, J3a,2 = 6.7 Hz, Ha-3), 2.55 (1H, ddd, J3a,3b = 16.4 Hz, J3b,2 = 9.3 Hz, 
J3b,2 = 5.7 Hz, Hb-3), 2.65 (1H, dddd,  J7,11 = 8.9 Hz, J7,6β = 9.1 Hz, J7,8 = 6.2 Hz, J7,6α = 2.7 
Hz, H-7), 2.79 (1H, dq, J11,7 = 8.7 Hz, J11,13 = 7.5 Hz, H-11), 4.61 (1H, ddd, J8,9β = 11.2 
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Hz, J8,7 = 6.2 Hz, H-8), 5.44 (1H, br dd, J5,6α = 9.4 Hz, J5,6β = 2.2 Hz, H-5); 
13C NMR (125 
MHz, CDCl3): δ 10.8 (CH3, C-13), 21.3 (CH3, C-14), 21.8 (CH2, C-6), 29.8 (CH3, C-15), 
31.0 (CH2, C-2), 32.8 (CH, C-10), 36.9 (CH2, C-9), 38.9 (CH, C-11), 42.2 (CH, C-7), 42.7 
(CH2, C-3), 80.5 (CH, C-8), 122.6 (CH, C-5), 144.1 (C, C-1), 179.1 (C, C-12), 208.2 (C, 
C-4); HRESIMS (positive ionization mode),  m/z 251.1654 [M+H]+ (calc. for C15H23O3 
251.1647).  
 
Compound 304, a red-brown gum, was identified as 11β,13-dihydroxanthalongin 
(Bohlmann and Suwita, 1979; Marcinek-Hüpen-Bestendonk et al., 1990, 1H NMR (500 
MHz, CDCl3): δ 1.14 (3H, d, J14,10 = 7.1 Hz, H-14), 1.22 (3H, d, J13,11 = 7.1 Hz, H-13), 
1.85 (1H, ddd, J9β,9α = 13.7, J9β,8 = 12.2 Hz, J9β,10 = 11.1 Hz, Hβ-9), 1.97 (1H, ddd, J9α,9β = 
13.7 Hz, J9α,10 = 6.9 Hz, J9α,8 = 2.6 Hz, Hα-9), 2.15 (3H, s, H-15), 2.17 (1H, m, Ha-6), 2.24 
(3H, m, Hb-6, H-2, H-11), 2.37 (2H, m, H-7, H-10), 2.47 (1H, ddd, J3a,3b = 15.7 Hz, J3a,2 = 
8.9 Hz, J3a,2 = 6.8 Hz, Ha-3), 2.56 (1H, ddd J3b,3a  = 15.2, J3b,2 = 8.7 Hz, J3b,2 = 6.3 Hz, Hb-
3), 4.46 (1H, ddd, J = J8,9β = 10.9 Hz, J8,7 = 8.5 Hz, J8,9α = 2.5 Hz, H-8), 5.36 (1H, br dd, 
J5,6β = 5.8 Hz, J5,6α = 8.7 Hz, H-5); 
13C NMR (125 MHz, CDCl3): δ 14.1 (q, C-13), 20.8 (q, 
C-14),  26.4 (t, C-6), 30.1 (q, C-15), 30.5 (t, C-2), 35.4 (t, C-9), 35.7 (d, C-10), 39.4 (d, C-
11), 42.9 (t, C-3), 45.2 (d, C-7), 79.3 (d, C-8), 119.8 (d, C-5), 144.8 (s, C-1), 179.6 (s, C-
12), 208.3 (s, C-4); HRESIMS (positive ionization mode),  m/z 251.1659 [M+H]+ (calc. for 
C15H23O3 251.1647).                           
 
Compound 306, colourless plates, crystallised from dichloromethane:hexanes was 
identified as helisplendidilactone (Jakupovic et al., 1989). [α]D = -45 (CH2Cl2, c = 0.805) 
[Lit. Jakupovic et al., 1989, -64o (CHCl3, c = 0.21)]; 
1H NMR (500 MHz, CDCl3): δ 1.08 
(1H, dt, J3’a,3’b = 8.5 Hz, J3’a,2’ = J3’a,13α = 2.4 Hz, Ha-3’), 1.11 (3H, d, J14,10 = 7.0 Hz, H-
14), 1.17 (1H, m, Ha-6), 1.22 (3H, s, H-15’), 1.23 (3H, d, J13’,11’ = 7.9 Hz, H-13’), 1.25 
(3H, d, J10’,14’ = 7.0 Hz, H-14’), 1.49 (1H, ddd, J9’β,8’= 9’β,9’α = 9’β,10’ = 12.4 Hz, Hβ-9’), 1.57 
(1H, dd, J13α,13β = 12.1 Hz, J13α,2’ = J13α,3’a = 2.5 Hz, Hα-13), 1.68 (1H, ddd, J6’α,6’β = 15.2 
Hz, J6’α,7’ = 12.0 Hz, J6’α,10’ = 2.6 Hz, Hα-6’), 1.77 (1H, ddd, J9α,8 = 9α,9β = 9α,10 = 12.2 Hz, 
Hα-9), 1.98 (1H, br d, J13β,13α = 13β,2’ = 12.0 Hz, Hβ-13), 1.98 (1H, m, Hβ-9), 2.10 (1H, br 
ddd, J7’,8’ ~J7’,6’α = 11.0 Hz, J7’,11’ =  7.5 Hz, J7’,6’β =  2.8 Hz, H-7’), 2.13 (3H, s, H-15), 2.19 
(2H, br t, J2,3 = 7.7 Hz, H-2), 2.28 (5H, m, Hb-6, H-10, Hb-3’, Hα-9’, H-10’), 2.44 (3H, m, 
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Ha-3, Hβ-6’, H-7), 2.53 (1H, ddd, J2,3 = 7.0 and 6.6 Hz, J3a,3b = 16.5 Hz, Hb-3) 2.72 (1H, 
dq, J11’,13’ = 7.8 Hz, J11’,7’ = 7.5 Hz, H-11’), 2.94 (1H, br s, H-2’), 4.14 (1H, ddd,  J8’,7’= 
J8’,9’β = 11.0 Hz, J8’,9’α = 2.2 Hz, H-8’), 4.48 (1H, ddd, J8,9α =12.3 Hz, J8,7 = 9.0 Hz, J8,9β = 
2.2 Hz, H-8), 5.19 (1H, dd, J5,6 = 9.0 Hz, J5,6  = 5.5 Hz, H-5); 
13C NMR (125 MHz, CDCl3): 
δ 10.6 (q, C-13’), 13.4 (q, C-15’), 20.7 (q, C-14), 21.2 (q, C-14’), 25.0 (t, C-6’), 25.3 (t, C-
6), 29.3 (d, C-10’), 29.8 (q, C-15), 30.3 (t, C-2), 35.8 (d, C-10), 36.2 (t, C-13), 37.1 (t, C-
9), 39.7 (d, C-11’), 40.4 (t, C-9’), 41.8 (d, C-7), 42.5 (t, C-3), 43.2 (d, C-2’), 45.5 (d, C-7’), 
50.7 (t, C-3’), 54.0 (s, C-4’), 63.0 (s, C-11), 78.5 (d, C-8), 84.6 (d, C-8’), 119.7 (d, C-5), 
140.7 (s, C-5’), 144.5 (s, C-1), 150.2 (s, C-1’), 179.1 (s, C-12’), 181.7 (s, C-12), 207.8 (s, 
C-4); HRESIMS (positive ionization mode), m/z 479.280 [M-H]- (calc. for C30H39O5 
479.2797).  
 
4.4.5 Molecular modelling 
AM1 geometry optimisations were performed with Gaussian® 03W, version 6.1 (Gaussian 
Inc. Carnegie Office Park Building 6, Pittsburgh, PA 15106, USA, Copyright 1995-2004), 
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Table 4.1 Crystal data and structure refinement for helisplendidilactone (306).
 
Molecular formula  C30 H40 O5 
Formula weight  480.62 
Temperature  100 (2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 9.0738(5) Å   
 b = 11.4764(7) Å  
 c = 12.2960(9) Å  
 α = 90° 
 β = 96.933(5)˚ 
 γ = 90° 
Volume 1271.08(14) Å3 
Z 2 
Density (calculated) 1.256 mg/m3 
Absorption coefficient 0.084 mm-1 
F(100) 520 
Crystal size 0.40 x 0.30 x 0.25 mm3 
θ Range for data collection 4.43 to 28.06° 
Index ranges -12<=h<=12, -15<=k<=15, -16<=l<=16 
Reflections collected 16002 
Independent reflections 6126 [R(int) = 0.0276] 
Completeness to θ = 25.00° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9935 and 0.9224 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6126 / 13 / 321 
Goodness-of-fit on F2 1.089 
Final R indices [I>2sigma(I)] R1 = 0.0516, wR2 = 0.1073 
R indices (all data) R1 = 0.0524, wR2 = 0.1077 
Absolute structure parameter 0.1(10) 




Table 4.2   Bond lengths [Å] and angles [°] for helisplendidilactone (306). 
 
Bond lengths:                                                                        
  
C(1)-O(1)  1.216(3)                    
C(1)-C(15)  1.496(3) 
C(1)-C(2)  1.519(3) 
C(1')-C(5')  1.346(3) 
C(1')-C(10')  1.522(3) 
C(1')-C(2')  1.525(3) 
C(2)-C(3)  1.487(3) 
C(2')-C(3')  1.527(3) 
C(2')-C(13)  1.558(3) 
C(3)-C(4)  1.524(3) 
C(3')-C(4')  1.541(3) 
C(4')-C(15')  1.518(3) 
C(4')-C(5')  1.537(3) 
C(4')-C(11)  1.593(3) 
C(4)-C(5)  1.320(4) 
C(4)-C(10)  1.505(4) 
C(5')-C(6')  1.504(3) 
C(5)-C(6)  1.527(3) 
C(6)-C(7)  1.539(3) 
C(6')-C(7')  1.517(3) 
C(7')-C(8')  1.524(3) 
C(7')-C(18)  1.533(3) 
C(7)-C(8)  1.536(3) 
C(7)-C(11)  1.557(3) 
C(8')-O(4)  1.463(2) 
C(8')-C(9')  1.515(3) 
C(8)-O(2)  1.455(3) 
C(8)-C(9)  1.525(3) 
C(9')-C(10')  1.534(3) 
C(9)-C(10)  1.534(4) 
C(10')-C(14’)  1.527(3) 
C(10)-C(14)  1.534(3) 
C(11)-C(12)  1.522(3) 
C(11)-C(13)  1.564(3) 
C(12)-O(3)  1.205(3) 
C(12)-O(2)  1.344(3) 
C(13’)-C(11’)  1.532(3) 
C(11’)-C(12’)  1.517(3) 
C(12’)-O(5)  1.197(3) 



















































































Helichrysum montanum DC. is a mat-forming dwarf shrub that occurs mainly at high 
altitudes (1800 - 2500 m) such as the high mountains of KwaZulu-Natal (Drakensberg), 
Lesotho, and the Eastern Cape. Its branches are very sho t, congested and densely leafy, 
and the leaves are distinctly striped and appear greyish-white and woolly. This species is 
morphologically closely related to H. splendidum (Fig. 5.1), both species belonging to 
Hilliard’s morphological Group 22. H. montanum is distinguished from H. splendidum by 
its dense growth pattern and by its leaves, which is always broadest near the tip. It 
generally grows at higher altitudes than H. splendidum and flowers later. H. montanum 
flowers between January and April, while the flowering time of H. splendidum is between 





              a       b    
 
Figure 5.1 a) Flower and leaf of H. montanum         b) Flower and leaf of H. splendidum 
 
A preliminary investigation by thin-layer chromatography (TLC) revealed that extracts of 
both H. montanum and H. splendidum (Fig. 5.2) exhibited red staining of certain 
compounds with anisaldehyde spray reagent. To the best of our knowledge, the 
phytochemistry of H. montanum has not been investigated previously and the TLC results 
of these plant extracts indicated that H. montanum may exhibit an interesting chemical 





Figure 5.2 TLC of extracts of H. montanum (MO1 locality unknown, MO2 collected in the 
Koueveld Mountains) and H. splendidum (SP1 and SP2 both collected in Mpumalanga). 
 
The aims of this chapter are: 
•  To report on the isolation and characterisation of secondary metabolites from H. 
montanum. 
•  To determine whether the phytochemistry of H. montanum supports the close 
morphological relationship observed with H. splendidum. 
 
5.2 Results and discussion 
 
The chloroform:methanol (1:1) extract of H. montanum yielded two new compounds, 13’-
epihelisplendidilactone (307) and the monomeric guaianolide 301, both of which are 
stereoisomers of compounds isolated from H. splendidum. The extract also yielded five 
known compounds, namely spathulenol (286, a sesquiterpene), umbelliferone (348, a 
coumarin), the guaianolide 11β,13-dihydroxanthalongin (304) (also isolated from H. 
splendidum), 1β,5α,7α,8β,11β)-4α-hydroxyguai-10(14)-en-8,12α-olide (300), a 
stereoisomer of a guaianolide isolated from H. splendidum, and a flavone, 4’,5,7-
trihydroxy-3,3’,8-trimethoxyflavone (381).  
 
The 1H NMR (Plate 22) and 13C NMR (Plate 23) spectra of compound 307 indicated that 
the spectra were similar to those of helisplendidilactone (306), previously isolated from H. 
splendidum (Thunb.) Less. (Jakupovic et al., 1989) and reisolated in our laboratory 
(Chapter 4). The multiplicity of each of the 30 carbons of compound 307 was determined 
with a DEPT experiment (Plate 25), which indicated the presence of eight quaternary, nine
CH, eight CH2 and five CH3 carbons, supporting the molecular formula of C30H40O5 as 




determined by high-resolution mass spectrometry. Consideration of two-dimensional 
spectra [(HSQC (Plate 26), COSY (Plate 24) and HMQC (Plate 27, Fig. 5.3)] and 
comparison with the NMR data (Plates 15 - 21) obtained for helisplendidilactone (306) 
(Chapter 4, Jakupovic et al., 1989) revealed that compound 307, which we named 13’-



































Figure 5.3 HMQC correlations observed for 13’-epihelisplendidilactone (307) (arrows 
from 13C to 1H). Arrows in red are probable HMQC correlations as overlap of signals occur 
where these correlations are observed. 
 
Table 5.1 1H and 13C NMR data (CDCl3) of helisplendidilactone (306) and 13’-
epihelisplendidilactone (307)a.  
 Helisplendidilactone 
(306)  














1   144.5 C 144.4 C 
2 2.19 (br t, 7.7) 2.20 (br t, 7.9) 30.3 CH2 30.4 CH2  
3a 2.44 (m) 2.44 (m) 42.5 CH2  42.4 CH2  
3b 2.53 (ddd, 7.0, 6.6 
16.5) 
2.55 (ddd, 6.7, 6.4 
16.5) 
  
4   207.8 C 207.9 C 
5 5.19 (dd, 9.0, 5.5) 5.23 (dd, 8.9, 5.2) 119.7 CH 119.9 CH 
6a 1.17 (m) 1.19 (m) 25.3 CH2 25.3 CH2 
6b 2.28 (m) 2.30 (m)    
7 2.44 (m) 2.44 (m) 41.8 CH 42.02 CH 
8 4.48 (ddd, 12.3, 9.0 
2.2) 
4.48 (ddd, 12.1 Hz, 
8.9, 2.6) 
78.5 CH 78.6 CH 
9α  1.77 (ddd, 12.2) 1.78 (ddd, 12.4) 37.1 CH2  37.1 CH2  
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9β  1.98 (m) 1.98 (ddd, 12.1, 6.7, 
2.3)   
  
10 2.28 (m) 2.30 (m) 35.8 CH 35.6 CH 
11   63.0 C 62.9 C 
12   181.7 C 181.6 C 
13
α 
1.57 (dd, 12.1, 2.5) 1.56 (dd, 12.2, 2.6) 36.2 CH2  36.1 CH2  
13b 1.98 (br d, 12.0) 1.98 (dd, 12.1, 3.8)   
14 1.11 (d, 7.0) 1.11 (d, 6.8) 20.7 CH3 20.7 CH3 
15 2.13 (s) 2.13 (s) 
 
29.8 CH3  29.8 CH3  
1’   150.2 C 150.5 C 
2’ 2.94 (br s) 2.94 (br s) 43.2 CH 43.3 CH 
3’a 1.08 (br dd, 8.5, 2.1) 1.08 (br dd, 8.5, 2.1) 50.7 CH2  50.6 CH2 
3'b 2.28 (m) 2.30 (m)     
4’   54.0 C 54.3 C 
5’   140.7 C 140.3 C 
6’α 1.68 (ddd, 15.2, 2.6) 1.65 (m) 25.0 CH2  28.5 CH2  
6’β  2.44 (m) 2.64 (br d, 13.5)   
7’ 2.10 (br ddd, 11.0 7.5, 
2.8) 
1.65 (m) 45.5 CH 50.7 CH 
8’ 4.14 (ddd, 11.0, 2.2) 3.93 (ddd,  11.0, 2.2) 84.6 CH 84.9 CH 
9’β 1.49 (ddd, 12.4) 1.49 (ddd, 11.5) 40.4 CH2  40.2 CH2  
9’α 2.28 (m) 2.30 (m)    
10’ 2.28 (m) 2.30 (m)  29.3 CH 29.5 CH 
11’ 2.72 (dq, 7.8, 7.5) 2.30 (m) 39.7 CH 42.00 CH 
12’   179.1 C 178.3 C 
13’ 1.23 (d, 7.9) 1.260 (d, 7.0) 10.6 CH3  12.8 CH3  
14’ 1.25 (d, 7.0) 1.257 (d) 21.2 CH3  21.3 CH3  
15’ 1.22 (s) 1.23 (s) 13.4 CH3  13.5 CH3  
a Positions where significant differences in chemical shifts are observed are indicated in red. 
 
The changes observed in the chemical shifts of certain signals in the 1H and 13C NMR 
spectra of helisplendidilactone (306) and 13’-epihelisplendidilactone (307) suggested that a 
stereoisomer of helisplendidilactone was isolated. Significant differences observed in the 
NMR data of the two compounds include those for Hβ-6’ (∆δH = -0.2), H-7’ (∆δH = +0.48), 
H-8’ (∆δH = +0.21), H-11’ (∆δH = +0.42) and C-6’ (∆δc = -3.5 ), C-7’ (∆δC =  -5.2 ), C-11’ 
(∆δC = -2.3), and C-13’ (∆δC = -2.2) (Table 5.1). These differences indicate thwo 
molecules differ in the stereochemistry of the B guaianolide unit (Fig 5.3). 
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Consideration of the NOESY spectrum (Plate 28) and comparison with the NMR data 
obtained for helisplendidilactone (306) revealed that 13’-epihelisplendidilactone (307) had 
a 7,8-cis configuration like helisplendidilactone for the A guaianolide unit and that the 
bridge moiety was identical for the two compounds. The chemical shifts for the “left-hand 
side” of the molecule, which encompasses the A guaianolide monomer as well as the 
bridge, is almost identical for the two compounds. Important NOESY correlations are 
those observed between H-7 (δH 2.44) and H-8 (δH 4.48), confirming the 7,8-cis-
configuration of the A unit, while the absence of a NOESY correlation between H-8 (δH 
4.48) and H-14 (δH 1.11) indicates that this methyl group must be trans to H-8 (δH 4.48). 
This is confirmed by the NOESY correlation observed b tween H-14 (δH 1.11) and Hα-9 
(δH 1.78) and the absence of a correlation between H-8 (δH 4.48) and Hα-9 (δH 1.78), 
similar to what was observed for helisplendidilactone (307).  
 
A NOESY correlation is also observed between H-8 (δH 4.48) and most probably H-10 (δH 
2.30, although the H-10 signal overlaps with one of the H-6 proton signals, which means 
the observed NOESY may also be between H-8 and H-6). The NOESY correlation 
observed between H-7 (δH 2.44) and H-15’ (δH 1.23) for helisplendidilactone (306), is also 
observed for 13’-epihelisplendidilactone (307). The relative configuration of the left-hand 
side of the molecule could therefore be determined with relative ease. 
 
This was not the case for the right-hand side of the molecule. Analysis of the NMR spectra, 
especially the 1H NMR spectrum (Plate 22) of 13’-epihelisplendidilactone (307) proved to 
be more challenging than that of helisplendidilactone (306). For 13’-
epihelisplendidilactone (307), the signals for both H-7’ (δH 1.65) and H-11’ (δH 2.30) 
overlap with the signals of other protons which complicate the assignment of the 
stereochemistry at C-7’ and C-11’.  
 
In an attempt to improve the resolution (in other words, to separate overlapping signals), a 
chiral shift reagent, Eu(fod)3 was added to the compound. This reagent was selected as it 
was used to improve the resolution of the signals of a related guaianolide (Bohlmann et al., 
1977). Although this addition did improve the resolution between Hβ-9 and Hβ-13, the 
signals for H-6α’/7’ and H-10’/11’ were still overlapping (Plate 29). However, the addition 
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did enable us to observe a NOESY correlation between Hβ-9’ and Hα-6’/H-7’ not seen in 
the spectrum where no addition occurred (Plate 28 vs. Plate 30).  
NMR experiments were also performed on a 600 MHz NMR spectrometera in further 
efforts directed at enhancement of resolution. However, there was no significant 
improvement in the spectra when compared to those obtained from the 500 MHz 
instrument. Further specialised NMR experiments, such as a double quantum COSY, a 
gradient multiple quantum filtered COSY, and a homonuclear-2dj-resolved experiment 
were also performed. These experiments were done to de ermine whether coupling 
constants of individual protons belonging to multiplets could not be obtained, but due to 
the complexity of these signals unambiguous conclusions could not be drawn. 
 
Finally, NOESY correlations used in conjunction with AM1 calculated structures of the 
most stable conformations of different possible stereoisomers provided a solution. An 
important correlation that was absent in the NOESY spectrum of 307 was a correlation 
observed for 306 (helisplendidilactone), between H-8’ (δH 3.93) and H-13’ (δH 1.26). This 
indicated that in 13’-epihelisplendidilactone (307), the 13’-methyl group was trans to H-8’. 
Therefore, two alternative structures were proposed for compound 307: a) where the B-
lactone ring has 7’,8’-cis configuration with the 13’-methyl group in the α-position (Fig. 
5.4a) or b) where the B-lactone ring has a 7’,8’-trans configuration as in 



















































































Figure 5.4 Alternative structures possible for 13’-epihelisplendidilactone (307). a) 
Structure with 7’,8’-cis configuration. b) Structure with 7’,8’-trans configuration 
                                               
a NMR experiments on the 600 MHz Varian instrument were performed by Ms. Jean 




As mentioned before, the major difficulty in assigning the relative configuration at C-7’ 
and C-11’ lies in the fact that in the 1H NMR spectrum, the signals for H-11’ and H-10’ as 
well as those of Hα-6’ and H-7’ are overlapping. This extensive overlap of signals was not 
observed for helisplendidilactone (306).  
 
If the AM1 calculated structures of 13’-epihelisplendidilactone (307) (Fig. 5.5, only the B-
unit is displayed for the sake of clarity) is considered, the following arguments can be 
made to differentiate between the stereoisomers: If there was a 7’,8’-cis configuration, the 
NOESY correlations observed for H-8’ (δH 3.93) is most probably with H-11’ (δH 2.30) 
and H-7’ (δH 1.65) (Fig. 5.5a). On the other hand, if one considers the 7’,8’-trans 
possibility, these same NOESY correlations indicate  close proximity of H-8’ and H-
11’/H-10’ and H-8’ and only Hα-6’ (also observed for helisplendidilactone) (Fig. 5.5b). 
These correlations did therefore not allow unambiguous assignment of the relative 
configuration at C-7’ or C-11’ (Fig.5.6).  
 
As direct NOESY correlations could not be used to determine the relative configuration at 
C-7’ and C-11’, correlations observed with other protons had to be considered. A NOESY 
correlation is observed between Hβ-9’ and Hα-6’/7’, which is most likely a correlation 
between H-7’ and Hβ-9’, as a correlation between Hα-6’ and Hβ-9’ does not seem feasible 
for both possible structures. Furthermore, if the model of the 7’,8’-cis structure is 
considered, a NOESY correlation is expected between Hβ-9’ and H-8’, however no 
correlation is seen between these protons which are resolved in the 1H NMR spectrum. It is 
therefore concluded that 13’-epihelisplendidilactone (307) has the 7’,8’-trans structure, 
thus differing from helisplendidilactone only in the orientation of the 13’-methyl group 
(Fig. 5.4b and 5.5b). A NOESY correlation is also observed between H-13’/14’ and Hα-
6’/7’. This is probably a correlation between H-7’ with H-13’, further supporting this 





      a                                       b 
 
Figure 5.5 a) B guaianolide unit with 7’,8’-cis configuration. b) B guaianolide with 7’8’- 











































Figure 5.6 NOESY correlations observed for the second lactone ring of 13’-
epihelisplendidilactone (307). 
 
The AM1 calculated structures were obtained by using the atomic coordinates of the X-ray 
structure of helisplendidilactone (306), then changing the stereochemistry to obtain the 
isomers possible for 13’-epihelisplendidilactone (307), followed by AM1 geometry 
optimisations in GaussianR. These models were then overlayed with the X-ray structure of 
helisplendidilactone (306) in HyperchemR to observe whether any conformational changes 
occurred. A much better fit was obtained with the X-ray structure of helisplendidilactone 
and the AM1 calculated structure of the 7’,8’trans 13’-epihelisplendidilactone structure 




















   a      b 
 
Figure 5.7 a) Overlay of the AM1 calculated structure of the proposed 7’8’-cis 
stereoisomer of 13’-epihelisplendidilactone with the X-ray structure of helisplendidilactone 
(306). b) Overlay of the AM1 calculated structure of the 7’8’-trans stereoisomer of 13’-
epihelisplendidilactone (307) with the X-ray structure of helisplendidilactone (306). 
 
As previously mentioned for helisplendidilactone (306), 13’-epihelisplendidilactone (307) 
is most likely a product of the Diels-Alder reaction between 378 and guaia-1,4-dien-12,8β-















  378       380 
 
Scheme 5.1 Diels-Alder reaction yielding 13’-epihelisplendidilactone (307). 
 
The second new guaianolide isolated from H. montanum was assigned structure 301. A 
known guaianolide 300 (Bohlmann et al., 1982; Rustaiyan, 1987) was also isolated. The 1H 
and 13C NMR spectra of compounds 300 (Plates 37, 38) and 301 (Plates 56, 57) were 
similar. These compounds also exhibited the same blu staining with anisaldehyde spray 
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reagent. Both compounds had 15 carbons (acetone is present as an impurity in 300), 
indicating the presence of two closely related sesquiterpenes.  This was confirmed by high- 
resolution mass spectrometry which indicated that both compounds had a molecular 
formula of C15H22O3. Two characteristic proton signals at approximately δH 5.0 and δH 4.9 
indicating the presence of an exomethylene group were observed, while protons typical of 
those next to the oxygen in a lactone ring occurred at δH 4.26 (300) and δH 4.45 (301). 
 
The normal two-dimensional experiments [(COSY (Plates 39, 58), HSQC (Plates 41, 60), 
HMQC (Plates 42, 61, Fig. 5.8) and NOESY (Plates 43, 62)] were performed and it was 
determined that compounds 300 and 301 are two stereoisomers of 4-hydroxyguai-10(14)-
en-12,8-olide. To our knowledge six stereoisomers of this structure have been described 
(Table 5.2) and these compounds were isolated from H. splendidum (Jakupovic et al., 
1989), Gnephosis brevifolia (Jakupovic et al., 1988), Geigera aspera Harv. var. aspera 
(Bohlmann et al., 1982), and  Dittrichia graveolens (Rustaiyan et al., 1987). A synthetic 
























Figure 5.8 HMQC correlations observed for both compound 300and 301. 
 
The proton NMR shifts observed for compound 300 were an exact match to those observed 
by Bohlmann et al. (1982) for 11β,13-dihydroinoviscolide. The structure of this compound 
was later revised by Rustaiyan and co-workers (1987) who corrected the relative 
configuration from the 1α,8α-stereoisomer to the 1β,8βH-stereoisomer as indicated in 
Figure 5.10. In our hands, NOESY correlations were observed between H-1 and H-8, while 
no correlations were observed between H-8 and H-7 or H-1 and H-5, indicating trans-1,5 
and trans-7,8 configuration. Other correlations confirming this configuration are those 
between Hβ-6 and H-15, Hβ-6 and H-11 and between H-7 and Hα-6 (Fig. 5.9). The NOESY 
correlations observed for compound 300 used in conjunction with the AM1-calculated 
 
129 
models of the structures confirmed the configuration as assigned by Rustaiyan and co-
workers (1987). Therefore, 300 has the same structure as the guaianolide previously 
isolated from Geigera aspera var. aspera (Bohlmann et al., 1982) and Dittrichia 

























Figure 5.9 a) NOESY correlations observed for compound 300 b) AM1 Gaussian model of 
compound 300. 
 
As previously mentioned, compound 301 was identified as a new guaianolide. The shifts of 
several protons (H-1, H-5, Hβ-6, H-7, H-8, H-9) in the 
1H NMR spectrum of compound 
301 differed from those in the proton spectrum of compund 300, although all HSQC, 
COSY and HMQC correlations supported the assignment of a similar carbon backbone. 
The relative configuration was again assigned using NOESY correlations (Fig. 5.9). 
However, as more overlap occurred for signals associated with stereogenic centres in 301, 
determining the configuration was more challenging.  
 
The difference between compound 301 and compound 300 is the relative configuration at 
C-8. If one considers the AM1 calculated models of these compounds, a large difference in 
the most stable conformations is observed, with the fiv -membered lactone ring in 
compound 301 bending up towards the central cycloheptane ring when compared to 
compound 300, providing a possible explanation for the chemical shift changes observed 
between the two compounds. NOESY correlations relevant to the determination of the 
configuration include those observed between H-1 and H-15, H-5 and H-8, Hα-6 and H-13, 
H-8 and H-7/Hα-9 and the absence of a correlation between H-8 and H-1 (Fig. 5.10). 
Compound 301 is a new C-11 epimer of a similar guaianolide previously isolated from H. 
splendidum (Jakupovic et al., 1989).  
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Table 5.2 Structures and 1H NMR shifts of 4-hydroxyguai-10(14)-en-12,8-olide isomers previously isolated and synthesised, compared to  































































































































1 2.04  2.15  2.18 3.03 2.96-3.05e  2.05 2.13 
2 1.77  1.77  1.80 1.75 1.84-1.60e 1.85-1.60e 1.70 1.78 





1.77  1.73 1.73   1.75 1.82, 1.72 
5 1.35  1.59  1.60 2.13   1.67 1.60 
6α 2.14 2.15  2.14 1.80 2.15-2.06e 2.12e 1.85 1.96 
6β 1.35  1.11  1.12 1.08 1.07 1.02 1.70 1.17 
7 2.35  1.77  1.75 1.71 1.92-1.80e 2.20-2.08e 2.50 2.23 
8 4.45  4.26  4.26 3.79 3.78 3.97 4.57 4.40 
9 2.63  3.17 3.17 3.04 3.03 3.04 2.96 3.17 
9’ 2.35  2.51  2.51 2.17 2.14 3.00 2.19 2.54 
11 2.35  2.30  2.30 2.27 2.26 2.65 2.86 2.71 
13 1.29 1.25  1.25 1.24 1.23 1.16 1.22 1.21 
14 4.98  
4.91  
4.94  











15 1.18 s 1.20 s 1.20 1.16 1.14 1.13 1.20 1.20 
 
a Rustaiyan et al., 1987 (revision of Bohlmann et al., 1982); b Rustaiyan et al., 1987, c Blay et al., 2000, d Jakupovic et al., 1989 e Signals interchangeable within column, as 
peaks were not assigned in publication 


















































              
 
Figure 5.10 (a) NOESY correlations observed for compound 301, arrows in identical 
colours (other than black) indicate where overlap of signals occur and more than one 
possibility is likely for the observed NOESY correlation (b) AM1 calculated structure of 
301.  
 
The fourth compound identified in the extract of H. montanum is the seco-guaianolide 
compound 304, which was also isolated from H. splendidum.  It is interesting to note that 
where as both compounds 304 and 302 (with the 13-methyl in the β-position) were isolated 
from H. splendidum, only 304 (with the 13-methyl in the α-position) were isolated from H. 
montanum. The same phenomenon is observed for compounds 300 and 301, which are the 
C-11 α-methyl isomers of similar guaianolides isolated from H. splendidum. 
Helisplendidilactone (306) also differs from 13’-epihelisplendidilactone (307) only in the 
orientation of the 13’-methyl group. Biosynthetically, it therefore seems as though H.
montanum synthesises metabolites with the 13-methyl group cis relative to H-7, while H. 
splendidum is able to synthesise compounds with the 13-methyl in both the α and β 
positions. 
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Except for flavonoid 381, the other compounds isolated from H. montanum have all 
previously been isolated from Helichrysum species. Spathulenol (286) is recognisable by 
the broad singlets at δH 4.67 and δH 4.69 in the 1H NMR spectrum (Plate 31), which are 
characteristic of the exomethylene group. The three singlets upfield (δH 1.04, 1.05 and 
1.25) each integrating for three protons are assigned to the three methyl groups. The 13C 
NMR spectrum (Plate 32) exhibited 15 major peaks, typical of a sesquiterpene, in a pattern 
related to that exhibited by compounds 300, 301 and 304. The compound was further 
identified using the DEPT (Plate 34) and two-dimensio al experiments (Plates 33, 35, 36), 
as well as by comparison with literature values (Tringali et al., 1995, Ulebelen et al., 
1994). Spathulenol was previously isolated from H. splendidum (Bohlmann and Suwita, 
1979), H. dasyanthum, H. petiolare (Jakupovic et al., 1989) and H. heterolasium 
(Bohlmann and Abraham, 1979a).  
 
Umbelliferone (348) was identified by the coupling patterns of protons i  the aromatic 
region, consisting of one set of ABX protons (δH 7.45, 6.79 and 6.71) (Plate 44) and two 
coupled protons typical of a coumarin (δH 6.18, 7.84). The data obtained from the 13C 
(Plate 45), DEPT (Plate 47) and two-dimensional NMR spectra (Plates 46, 48, 49) 
supported this assignment. Coumarins are not very often isolated from Helichrysum 
species. Umbelliferone (348) was previously isolated from H. swynnertonii (Bohlmann et 
al., 1980), while other coumarins were isolated from H. cymosum (Jakupovic et al., 1989) 
and H. acutatum (Bohlmann and Abraham, 1979b).   































  348       381 
 
For the polyoxygenated flavonoid 381 a 1H NMR spectrum (Plate 50) characteristic for a 
flavonoid was obtained (NMR spectra, Plates 52-55). Due to the limited amount of 
material, the quality of the 13C, HMQC and HSQC spectra were not very good. Therefore, 
these spectra played a limited role in the determinatio  of this structure. However, data 
obtained from the NOESY spectrum enabled us to propose a structure. Based on 1H NMR 
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chemical shift data, the compound seemed to be the same as a flavone isolated from H. 
splendidum, 3’,4’,5-trihydroxy-3,7,8-trimethoxyflavone, by Bohlmann and Suwita (1979).  
 
However, for 381, no NOESY correlation was observed between any of the methoxy 
groups, between a methoxy group and the aromatic singlet (δH 6.26), or a methoxy group 
and an ortho-coupled B-ring proton (δH 7.00, 7.75). In the NOESY spectrum, two of the 
methoxy groups (δH 3.83, 3.96), assigned to 3-OMe and 8-OMe correlates with both H-2’ 
and H-6’, whereas the third methoxy group (δH 3.92, assigned as 3’-OMe) correlates with 
only H-2’. These correlations unambiguously confirmed the assignment of the flavone as 
4’,5,7-trihydroxy-3,3’,8-trimethoxyflavone (Seaman et al., 1972). It is possible that the 
flavonoid isolated by Bohlmann and Suwita (1979) from H. splendidum is the same 




The phytochemistry of Helichrysum montanum was investigated for the first time and two 
new guaianolides were isolated. The occurrence of guaianolides is very rare in this genus; 
this type of compound has previously only been isolated from H. dasyanthum (Jakupovic 
et al., 1989) and H. splendidum (Bohlmann and Suwita, 1979; Jakupovic et al., 1989). The 
phytochemistry of H. splendidum and H. montanum is remarkably similar as initial TLC 
results indicated and supports their morphological cl ssification in the same taxonomic 
group. However, interesting differences were observed in the stereochemistry of similar 
compounds isolated from these plants. It is also the configurational assignments of these 
compounds that poses a challenge to the chemist. Overlapping signals and errors in 
literature complicate stereochemical assignments and great care needs to be taken when 
elucidating these structures. The isolation of these r markable compounds again illustrates 
the fascinating chemical diversity exhibited by South African Helichrysum species. 
 
5.4 Experimental  
 
5.4.1 General experimental procedures and instruments 
1H and 13C NMR spectra of all compounds were recorded on a Varian Unity Inova 500 
spectrometer with a 5 mm SW/Z-PFG probe (all spectra recorded at 25 °C, operating at 
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500 MHz for 1H and 125 MHz for 13C spectra). Spectra were measured in CDCl3 for all 
compounds except for umbelliferone and the flavonoid, where spectra were obtained in 
CD3OD. Structures were determined by analysis of 2D (HSQC, HMBC, COSY and 
NOESY) NMR spectra. Mass spectrometry data was colle ted on a time-of-flight Waters 
LCT Premier mass spectrometer using electrospray ionization in the positive or negative 
mode. Optical rotation was determined with a Perkin Elmer 241 polarimeter. Separations 
were done using open column chromatography and a chromatotron (Model 7924, Harrison 
Research). Silica gel (60F254, 40-63 µm, Merck) was used for column chromatography, 
while silica gel MERCK 7749 with gypsum binding agent was used for manufacturing of 
chromatotron plates. Thin-layer chromatography (TLC) was done on precoated Kieselgel 
60 F254 plates (Merck or Machery-Nagel). Detection was done by UV (254 nm) followed 
by staining with an anisaldehyde solution, prepared as follows: Absolute ethanol (465 ml) 
was cooled in an ice bath. Acetic acid (5 ml), sulph ric acid (17 ml) and p-anisaldehyde 
(13 ml) was added and the solution mixed and stored in the fridge.  
 
5.4.2 Plant material 
Leaves and stems of H. montanum were collected in the Koueveld Mountains in 2004. 
These plants were identified by Ms. M. Welmann from the South African National 
Botanical Institute, Pretoria.  Voucher specimens were deposited at the University of 
KwaZulu-Natal herbarium NU (H. montanum, F. van Heerden 1) 
 
5.4.3 Extraction and isolation 
Air dried and ground leaves and stems of H. montanum (216 g) were extracted with a 
mixture of chloroform:methanol (1:1) at room temperatu e for 48 hours to yield 8 g of 
extract. Initial clean up of 4 g of the extract was done by consecutively running a column 
with hexanes:dichloromethane (9:1), dichloromethane:methanol (6:1), dichloromethane: 
methanol (2:1) and methanol to obtain four initial fractions (F1-F4).   Fraction F2 was 
further separated on a column using hexanes:ethyl acetate:methanol (7:5:1) resulting in 
seven fractions (F2.1–F2.7). Centrifugal chromatography (dichloromethane: 
hexanes:diethyl ether (4:2:1) of fraction 2.3 yielded compound 307 (6.5 mg).  
 
A short column of a further 1 g of extract with sequ ntially using 
dichloromethane:methanol (99:1) and dichloromethane:methanol (95:5) resulted in 10 
fractions (G1-G10). A chromatotron of fraction G3 and G4 with hexanes:ethyl acetate 
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(10:2) yielded compound 286 (spathulenol) as a mixture (12.5 mg). A chromatotron an 
with dichloromethane: hexanes:diethyl ether (4:2:1) on fraction G7 followed by a 
hexanes:ethyl acetate (2:1) chromatotron of G7.2 (second of nine fractions) resulted in the 
isolation of compound 304 (1 mg), also isolated from helisplendidilactone.  Compound 301 
was isolated from fraction G8 after a chromatotron using hexanes: ethyl acetate (2:1) as 
eluent (fraction four of six fractions). Compound 348 (umbelliferone, 0.6 mg) was 
obtained by running consecutive chromatotrons on G9 with hexanes:ethyl acetate:methanol 
(9:4:1) and G9.4 (fourth of five fractions) with hexanes:ethyl acetate (4:1).  
 
Compound 376 (the flavonoid, 3 mg) was obtained by consecutive chromatotrons of 
fraction G7.9 and G9.5 with hexanes:ethyl acetate (2:1) and (1:1). Column fractionation of 
another 2 g of extract with hexanes:ethyl acetate (2:1), yielded seven fractions (H1-H7). 
Chromatotrons on H5 with hexanes:ethyl acetate and (H5.3 of three fractions) with 













Figure 5.11 Thin-layer chromatography plate, indicating compounds isolated from H. 
montanum 
 
5.4.4 Physical data of isolated compounds 
Compound 307, a red-brown gum, was identified as 13’-epihelisplendidilactone [α]D = -11 
(CH3OH, c = 0.08); 
1H NMR (500 MHz, CDCl3): δH 1.08 (1H, br dd, J3’a,3’b 8.5 Hz, J3’a,2’ 
= J3’a,13’ = 2.1 Hz, Ha-3’), 1.11 (3H, d, J14,10 = 6.8 Hz, H-14), 1.19 (1H, m, Ha-6), 1.23 (3H, 









1.49 (1H, ddd, J9’β,8’= 9’β,9’α = 9’β,10’ = 11.5 Hz, Hβ-9’), 1.56 (1H, dd, J13α,13β = 12.2 Hz, J13α,2’ 
= 2.6 Hz, Hα-13), 1.65 (2H, m, Hα-6’, H-7’), 1.78 (1H, ddd, J9α,8 = 9α,9β = 9α,10 = 12.4 Hz, 
Hα-9), 1.98 (1H, ddd, J9β,9α =  12.1 Hz, J9β,10 = 6.7  Hz, J9β,8 =  2.3 Hz, Hβ-9), 1.98 (1H, dd, 
J13β13α = 12.1 Hz, J13β2’ = 3.8 Hz, Hβ-13), 2.13 (3H, s, H-15), 2.20 (2H, br t, J2,3 = 7.9 Hz, 
H-2), 2.30 (6H, m, Hb-6, H-10, Hb-3’, Hα-9’, H-10’, H-11’),  2.44 (2H, m, Ha-3, H-7), 
2.55 (1H, ddd, J2,3 = 6.7 and 6.4 Hz, J3a, 3b = 16.5 Hz, Hb-3), 2.64 (1H, br d, J6α6β = J6α7’ = 
13.5 Hz, Hβ-6’), 2.94 (1H, br s, H-2’), 3.93 (1H, ddd,  J8’7’= 8’9’β = 11.0 Hz, J8’,9’α = 2.2 Hz, 
H-8’), 4.48 (1H, ddd, J8,9α =12.1 Hz, J8,7 = 8.9 Hz, J8,9β = 2.6 Hz, H-8), 5.23 (1H, dd, J5,6 = 
8.9 Hz, J5,6  = 5.2 Hz, H-5); 
13C NMR (125 MHz, CDCl3): δC 12.8 (q, C-13’), 13.5 (q, C-
15’), 20.7 (q, C-14), 21.3 (q, C-14’), 25.3 (t, C-6), 28.5 (t, C-6’), 29.5 (d, C-10’), 29.8 (q, 
C-15), 30.4 (t, C-2), 35.6 (d, C-10), 36.1 (t, C-13), 37.1 (t, C-9), 40.2 (t, C-9’), 42.00 (d, C-
11’), 42.02 (d, C-7), 42.4 (t, C-3), 43.3 (d, C-2’), 50.6 (t, C-3’), 50.7 (d, C-7’), 54.3 (s, C-
4’), 62.9 (s, C-11), 78.6 (d, C-8), 84.9 (d, C-8’), 119.9 (d, C-5), 140.3 (s, C-5’), 144.4 (s, 
C-1), 150.5 (s, C-1’), 178.3 (s, C-12’), 181.6 (s, C-12), 207.9 (s, C-4), HRESIMS (negative 
ionization mode), m/z 479.2777 [M-H]- (calc. for C30H39O5 479.2797).  
 
Compound 286, a white amorphous solid was identified as a mixture containing 
spathulenol as the main component (Tringali et al., 1995, Ulubelen et al., 1994), 1H NMR 
(500 MHz, CDCl3): δH  0.47 (1H, dd, J = 11.3 Hz, 9.5 Hz, H-6), 0.70 (1H, m, H-7), 1.04 
(3H, s, H-13), 1.05 (3H, s, H-12), 1.25 (3H, s, H-15), 1.30 (1H, m, H-5), 1.58 (2H, m, H-
2a, H-3a), 1.77 (1H, m, H-3b), 1.89 (1H, m, H-2b), 2.01 (2H, m, H-9a, H-8), 2.20 (1H, m, 
H-1), 2.42 (1H, dd, J = 5.9 Hz, 12.9 Hz, H-9b), 4.67 (1H, br s, H-14), 4.69 (1H, br s, H-
14); 13C NMR (125 MHz, CDCl3): δC 16.3 (q, C-13), 20.3 (s, C-11), 24.8 (t, C-8), 26.1 (q, 
C-15), 26.7 (t, C-2), 27.5 (d, C-7), 28.6 (q, C-12), 29.9 (d, C-6), 38.8 (t, C-9), 41.7 (t, C-3), 
53.4 (d, C-1*), 54.3 (d, C-5*), 80.9 (s, C-4), 106.2 (t, C-14), 153.4 (s, C-10); HRESIMS 
(neagtive ionization mode),  m/z 219.1750 [M-H]- (calc. for C15H23O219.1749). *Signals 
interchangeable.                          
 
Compound 301, a white solid, was identified as 1β,5α,7α,8α,11βH-4α-hydroxyguai-
10(14)-en-8,12α-olide, [α]D = +35 (CH3OH, c = 0.13);  1H NMR (500 MHz, CDCl3): δH 
1.18 (3H, s, H-15), 1.29 (3H, d, J13,11= 6.8 Hz, H-13), 1.35 (2H, m, H-5, Hβ-6), 1.77 (4H, 
m, H-2, H-2, H-3, H-3), 2.04 (1H, br s, H-1), 2.14 (1H, br dd, J6α,6β = 12.6 Hz, J6α,5 = J6α,7  
= 5.3 Hz,  Hα-6), 2.35 (3H, m, H-7, Hβ-9, H-11), 2.63 (1H, dd, J9α,9β =  12.7 Hz, 3.1 Hz, 
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Hα- 9), 4.45 (1H, ddd, J8,9α = 3.0 Hz, J8,7 = 8.2 Hz, J8,9β =12.1 Hz, H-8), 4.91 (1H, s, H-14), 
4.98 (1H, s, H-14); 13C NMR (125 MHz, CDCl3): δC 14.6 (q, C-13), 24.2 (q, C-15), 24.4 (t, 
C-2), 29.3 (t, C-6), 39.4 (t, C-9), 39.5 (t, C-3), 41.1 (d, C-11), 45.2 (d, C-7), 50.9 (d, C-1), 
54.8 (d, C-5), 80.1 (s, C-4), 81.7 (d, C-8), 112.0 (t, C-14), 145.9 (s, C-10), 178.9 (s, C-12); 
HRESIMS (negative ionization mode), m/z 249.1480 [M-H]- (calc. for C15H21O3 
249.1491).                           
 
Compound 304, a red brown gum, was identified as 11β,13-dihydroxanthalongin 
(Bohlmann and Suwita, 1979; Marcinek-Hüpen-Bestendonk et al., 1990), assignment, see 
Chapter 3. 
 
Compound 348, a white amorphous solid was identified as umbelliferone (Nath et al., 
2005), 1H NMR (500 MHz, CD3OD, CDCl3): δH 6.18 (1H, d, J3,4 = 9.5 Hz, H-3), 6.71 (1H, 
d, J8,6 = 2.2 Hz, H-8), 6.79 (1H, dd, J6,5 = 8.5 Hz, J6,8 = 2.3 Hz, H-6), 7.45 (1H, d, J5,6 = 8.5 
Hz, H-5), 7.84 (1H, d, J4,3 = 9.3 Hz, H-4); 
13C NMR (125 MHz, CD3OD, CDCl3): δC 103.4 
(d, C-8), 112.3 (d, C-3), 113.1 (s, 4a), 114.5 (d, C-6), 130.6 (d, C-5), 146.0 (d, C-4), 156.5* 
(s, 8a), 162.5* (s, C-7), 163.5* (s, C-2); HRESIMS (positive ionization mode),  m/z 
163.0398 [M+H]+ (calc. for C9H7O3 163.0395).*Estimated from HMQC.                         
 
Compound 381, a yellow amorphous solid was identified as 4’,5,7-trihydroxy-3,3’,8-
trimethoxyflavone (Wang et al., 1989), 1H NMR (500 MHz, CD3OD: δH 3.83 (3H, s, 3-
OMe), 3.92 (3H, s, 3’-OMe), 3.96 (3H, s, 8-OMe), 4.58 (1H, s, OH), 6.26 (1H, s, H-6), 
7.00 (1H, d, J5’6’ = 8.5 Hz, H-5’), 7.75 (1H, dd, J6’2’ = 2.1 Hz, J6’5’ = 8.5 Hz, H-6’), 7.80 
(1H, d, J2’,6’ = 1.9 Hz, H-2’); 
13C NMR (125 MHz, CD3OD): δC 55.3 (OMe, C-3’), 59.4 
(OMe, C-3), 60.8 (OMe, C-8), 98.9 (d, C-6)*, 102.7 (s, C-10), 111.5 (d, C-2’), 115.8/115.4 
(d, C-5’), 121.8 (s, C-1’), 122.6 (d, C-6’), 128.3 (s, C-8), 138.5 (s, C-3), 147.9 (s, C-4’)*, 
149.1 (s, C-3’), 150.0 (s, C-9)*, 156.3 (C-2)*, 156.9 (s, C-5)*, 157.5 (s, C-7)*, 179.0 (C, 
C-4); HRESIMS (negative ionization mode),  m/z 359.0754 [M-H]- (calc. for C18H15O8 
359.0767). Ambiguous assignment due to poor quality of spectra.               
 
Compound 300, a white solid, was identified as 1β,5α,7α,8β,11βH-4α-hydroxyguai-
10(14)-en-8,12α-olide (Bohlmann et al., 1982; Rustaiyan et al., 1987); [α]D = +47 [lit. 
Bohlmann et al., 1982, +28 o (CHCl3, c = 0.13)]; 
1H NMR (500 MHz, CDCl3): δH 1.11 
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(1H, dd, J6β,6α = J6β,5 = J6β,7  = 12.4 Hz, Hβ-6), 1.20 (3H, s, H-15), 1.24 (3H, d J13,11= 7.2 
Hz, H-13), 1.59 (1H, m, H-5), 1.77 (4H, m, Ha-3, H-7, Ha-2, Hb-3), 1.95 (1H, m, H-2), 
2.15 (2H, m, Hα-6, H-1), 2.30 (1H, ddd, J11,13 = 7.0 Hz, J11,7 = 12.0 Hz, H-11), 2.51 (1H, 
dd, J9α,8 = 10.4 Hz, J9α,9β = 15.8 Hz, Hα-9), 3.17 (1H, dd, J9β,9α = 15.7 Hz, J9β,8 = 5.6 Hz, 
Hβ-9), 4.26 (1H, td, J8,7 = J8,9α = 10.3 Hz, J8,9β, = 5.6 Hz, H-8), 4.94 (1H, br s, H-14), 5.04 
(1H, br s, H-14); 13C NMR (125 MHz, CDCl3): δC 13.0 (q, C- 13), 24.0 (q, C-15), 29.7 (t, 
C-2), 31.1 (t, C-6), 40.8 (t, C-9), 41.2 (t, C-3), 42.3 (d, C-11), 47.6 (d, C-1), 50.3 (d, C-7), 
58.3 (d, C-5), 80.5 (s, C-4), 82.0 (d, C-8), 111.3 (t, C-14), 146.7 (s, C-10), 178.4 (s, C-12); 
HRESIMS (negative ionization mode), m/z 249.1500 [M-H]- (calc. for C15H21O3 
249.1491).                           
 
5.4.5 Molecular modelling 
AM1 geometry optimisations were performed with GaussianR 03W, version 6.1 (Gaussian 
Inc. Carnegie Office Park Building 6, Pittsburgh, PA 15106, USA, Copyright 1995-2004), 
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Helichrysum excisum (Thunb.) Less. (Fig 6.1) is a highly aromatic, densely twiggy dwarf 
shrub with yellow flowers endemic to the Western Cape Province of South Africa (Fig. 
6.1, Fig. 6.2). Based on morphological characters, it i  placed in Group 12 (Hilliard, 1983) 
(Paragraph 2.1). This morphologic group contains sixteen species. The phytochemistry of 
two of these species (H. caespititium and H. asperum var. albidulum) has been 
investigated. H. caespititium is used in traditional medicine to treat colds, headaches, 
gonorrhoea and nausea occurs widely in the central parts of South Africa (Hutchings and 
Van Staden, 1994; Watt and Breyer-Brandwijk, 1962; Hilliard, 1983).  
 
 
   a                b 
Figure 6.1 a) Helichrysum excisum, plant habitat                    b) H. excisum, flower 
(Photos: J. Vlok) 
 
Acylated phloroglucinols were isolated from both H. caespititium (Dekker et al., 1983, 
Mathekga et al., 2000) and H. asperum var. albidulum, a plant found in the Western Cape 
(Jakupovic et al., 1989, Hilliard, 1983). Various phloroglucinols exhibit biological activity 
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such as antibacterial (Gibbons, 2004) and antiviral (Appendino et al., 2007; Nakane et al., 
1991) activity. In a previous study, Lourens et al. (2004) reported on the antimicrobial 
activity of crude extracts of H. excisum against Gram-positive organisms such as 
Staphylococcus aureus and Bacillus cereus. To the best of our knowledge, there is no 
reference in ethnobotanical literature relating to the use of H. excisum. However, the 
interesting chemistry and medicinal use of morphologically related species served as 
motivation for the investigation of this species. Furthermore, apart from the composition of 
the steam-distilled oil (Lourens et al., 2004), no phytochemical studies have been reported 
on H. excisum.  
 
The aims of this chapter are: 
•  To investigate the phytochemistry of H. excisum and to determine which 
compounds are responsible for the antibacterial activity of the extract. 
•  To establish whether the chemistry of H. excisum is similar to the other species 
investigated in the same morphologic group (whether any chemotaxonomic 
conclusions can be drawn). 
 
6.2 Results and discussion 
 
From the aerial parts of H. excisum, five flavonoids, identified as pinocembrin (1), 
gnaphaliin (67), lepidissipyrone (19), 5-hydroxy-7,8-dimethoxyflavone (72) and 
isoscutellarein 7-O-β-glucoside (80), were isolated. Four of these compounds have an 
unsubstituted B-ring, a trend often observed in the flavonoids isolated from Helichrysum 
species (Chapter 2).  
 
The molecular formula of 1, C15H12O4, was confirmed by high-resolution mass 
spectrometry. In the 13C NMR spectrum (Plate 64), the presence of 15 carbon at ms, of 
which 12 are aromatic, two aliphatic, and one carbonyl are observed. This suggests that the 
compound might be a flavonoid.  
 
In the 1H NMR spectrum (Plate 63), the chemical shifts and coupling constants of two 
aromatic protons δH 5.90 (1H, d, J = 2 Hz) and δH 5.94 (1H, d, J  = 2 Hz) are characteristic 
of two meta-coupled protons of the A ring of a 5,7-dioxygenated flavonoid. The remaining 
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five aromatic protons were assigned to a monosubstit ted aromatic ring. In the aliphatic 
region, two non-equivalent methylene protons at δH 2.78 (1H, dd, J = 17 Hz, J = 3 Hz) and 
δH 3.09 (1H, dd, J = 17 Hz, J = 13 Hz) which are coupled to a doublet of doublets at δH 
5.46 (1H, dd, J = 13 Hz, J = 3 Hz) suggests a flavanone structure. From the evidence 
mentioned, the structure was assigned as pinocembrin (1). The assignment was confirmed 
by analysis of two-dimensional NMR data (Plates 65-68) and comparison of  the NMR 






















The compound showed laevorotatory rotation like the majority of natural flavanones and is 
assigned a 2S configuration (Bohlmann and Zdero, 1983; Slade et al., 2005), with the C-2 
phenyl substituent in the α-equatorial position. Taking the configuration of the stereocentre 
at C-2 and the coupling constants of the two H-3 geminal protons into account, the proton 
at δH 2.78 could be assigned as Hβ-3 and the proton at δH 3.09 as Hα-3. It is interesting to 
note that in the HMQC (Plate 68), Hα-3 shows correlations with C-2, C-4 and C-1’, while 









Figure 6.2 Correlations seen in HMQC of pinocembrin (indicated by arrows from 13C to 
1H). 
 
Pinocembrin (1) and its derivatives (often prenyl derivatives) occur frequently in the South 
African Helichrysum species, especially in plants from Hilliard’s morphological Groups 8, 
9, 21, 23 and 27 (Bohlmann et al., 1980; Bohlmann et al., 1979; Bohlmann and Ates, 1984; 
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Bohlmann and Misra, 1984; Jakupovic et al., 1986; Bohlmann and Abraham, 1979c,d; 
Bohlmann and Zdero, 1983). This compound has been isolated from H. cymosum 
(Jakupovic et al., 1989), H. oreophilum, H. zeyheri (Jakupovic et al., 1986), H. oxyphyllum 
(Bohlmann et al., 1980), H. callicomum (Bohlmann and Abraham, 1979a), H. tenuifolium 
(Bohlmann and Abraham, 1979b) and from the roots of H. acutatum (Bohlmann and 
Abraham, 1979c). High concentrations are also found in the Australian species H. stirlingii 
(Jakupovic et al., 1987) and European species such as H. italicum (Sala et al., 2003).  
 
Lepidissipyrone (19) precipated as a white solid from chloroform. Its s ructure was based 
on NMR data (Plates 69-74, Table 6.1), combined with h gh-resolution mass spectrometry 
which indicated a molecular formula of C24H24O7. As for pinocembrin (1), the set of 
doublet of doublet signals at δH 2.84 (1H, dd, J = 17 Hz, J = 3 Hz, H-3) and δH 3.27 (1H, 
dd, J = 17 Hz, J = 13 Hz, H-3), coupling to the doublet of doublets a  δH 5.53 (1H, dd, J = 
13 Hz,  J = 3 Hz, H-2), in the 1H NMR spectrum (Plate 69) indicated the presence of a
flavanone moiety. Integration of the signal at δH 7.51 indicated that there were five 
aromatic protons, suggesting an unsubstituted aromatic B ring. The shift of the proton at δH 






























The presence of a 6-ethyl-4-hydroxy-5-methylpyrone moiety was deduced from the 
appearance of the triplet at δH 1.18 (3H, t, J = 8 Hz) coupled to the quartet at δH  2.54 (2H, 
q, J = 8 Hz), the methyl singlet at δH 1.86 in the 1H NMR spectrum (Plate 69) and the 
presence of a second carbonyl signal at δC 169.0 in the 13C NMR spectrum. This 
substitution pattern is commonly found in pyrones isolated from Helichrysum species 
(Bohlmann et al., 1984; Bohlmann and Zdero, 1980; Hänsel et al., 1980; Jakupovic et al., 
1986). The 13C (Plate 70) and DEPT NMR (Plate 71) spectra showed th  presence of 24 
carbons (the signals at δC 127.0 and δC 129.3 each representing two carbons), which 
included two CH3, three CH2, five CH, and 12 quaternary carbons. Two-dimensional NMR 
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experiments (COSY – Plate 71, HSQC – Plate 73, HMQC - Plate 74) were employed in 
further analysis of the structure (Table 6.1).  
 
Table 6.1 1H and 13C NMR (CDCl3) of lepidissipyrone (19). 
 
Position δHa δCb Correlation (δC) 
observed in HMQC  
13C NMR assignment of 
HMQC correlated carbon 
2 5.53 (dd, 13.3, 
2.8) 
81.5 (CH) 194.8, 136.5, 127.0  4, 1’, 2’ and 6’ 
3a 2.84 (dd, 17.2, 
2.8) 
42.7 (CH2) 194.8, 102.3  4, 10 
3b 3.27 (dd, 17.2, 
13.3) 
42.7 (CH2) 194.8, 136.5,  81.5  4, 1’, 2 
4  194.8 (C)   
5  157.7 (C)   
6  104.9 (C)   
7  163.2 (C)   
8 6.21 (s) 99.7 (CH) 165.8, 163.2, 104.9,  
102.3  
9, 7, 6, 10 
9  165.8 (C)   
10  102.3 (C)   
1’  136.5 (C)   
2’,6’ 7.51 (5H m) 127.0 (CH) 136.5, 129.3, 130.1, 
81.5 
1’, 3’ and 5’, 4’, 2 
3’5’ 7.51 (5H m) 129.3 (CH)   
4’ 7.51 (5H m) 130.1 (CH)   
2”  169.0 (C)   
3”  101.2 (C)   
4”  166.9 (C)   
5”  107.6 (C)   
6”  161.9 (C)   
7” 2.54 (2H q, 7.6) 24.3 (CH2) 161.9, 107.6, 11.5 6”, 5”, 8” 
8” 1.18 (3H t, 7.6)  11.5 (CH3) 161.9, 24.3 6”, 7” 
9” 1.86 (3H s) 9.2 (CH3) 107.6, 161.9, 166.9 5”, 6”, 4” 
10” 3.57 (2H s) 17.4 (CH2) 169.0, 166.9, 157.7, 
104.9, 101.2 
2”, 4”, 5, 6, 3” 
4”-OH 8.09 (s)  166.9, 107.6, 101.2 4”, 5”, 3” 
5-OH 11.89 (s)  102.3 10 
7-OH 10.61 (s)  163.2  7 
 
a Integral (if not 1H), multiplicity and coupling constant(s) (in Hz) indicated in parentheses. 
b Multiplicity determined by DEPT indicated in parentheses. 
 
HMQC (Plate 74) correlations indicated that the methylene group connecting the pyrone 
and flavanone moiety was attached to C-6 of the flavanone A ring and C-3” of the pyrone. 
2J correlations were observed between H-10” δH 3.57 and C-6 δC 104.9 and C-3” δC 101.2, 
while 3J correlations were observed between H-10” δH 3.57 and carbons resonating at δC 
169.0, 166.9 and 157.7, assigned to carbons C-2”, C4  and C-5, respectively.  
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The aromatic proton at δH 6.21 showed HMQC correlations to δC 165.8 (C-9), 163.2 (C-7), 
104.9 (C-6), 102.3 (C-10) confirming its assignment as H-8 of the aromatic A ring. 
Considering the HMQC correlations, the singlet at δH 8.09 could be assigned to the 4”-OH, 
while the singlet at δH 11.89 most likely belongs to the 5-OH and the singlet at δH 10.61 to 
the 7-OH. It may be of interest to note that as for pinocembrin, a HMQC correlation was 
only observed between the more downfield H-3 (δH 3.27) and C-1’ as well as C-2, while 
these correlations were absent for the upfield H-3 (δH 2.84). However, this compound 
decomposed in the chloroform solution before the optical rotation could be obtained. This 
compound was previously only isolated from H. lepidissimum and the proton data is in 
agreement with that reported by Jakupovic et. al (1989). 
 
Similar pyrones were isolated from other plants in this genus, for example H. mixtum, H. 
cephaloideum (Jakupovic et al., 1986), H. auriceps (Bohlmann and Zdero, 1980), H. 
cerastioides (Bohlmann et al., 1984) and H. odoratissimum (Hänsel et al., 1980), although 
the pyrone side chain is usually combined with a phloroglucinol and not with a flavanone 
moiety. The antimicrobial activity of lepidissipyrone (19) is summarised in Table 6.2.  
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Table 6.2 Mean MIC (µg/ml) values for the chloroform:methanol (1:1) extract of Helichrysum excisum,  lepidissipyrone (19) and isoscutellarein 
7-O-glucoside (80).  
 










































DMSO 8000 8000 8000 4000 8000 4000 
 
a MIC values at least determined in duplicate 
b Not susceptible, activity observed equivalent to DMSO control 
c Not determined 


























The structure of gnaphaliin (5,7-dihydroxy-3,8-dimethoxyflavone) (67) could be deduced 
from the 1H and 13C NMR spectra (Plates 75, 76) and is characteristic of a flavone. The 
two singlets at δH 3.88 and δH 4.00 indicated the presence of two methoxy groups, while 
the splitting pattern and the integration of the signals at δH 7.54 and δH 8.10 showed the 
presence of an unsubstitued B-ring. The chemical shift of the aromatic proton at δH 6.44 
was comparable to those of similar flavones (Tomás-Lorente et al., 1991) and its HMQC 
correlations (Plate 79) with C-5/C-7, C-8 and C-10 used to determine its position. Since 
only one aromatic proton was present on the A and C rings, it was proposed that two 
hydroxy and two methoxy substituents were present on these rings. 
 
The singlet at δH 12.4 is typical for a hydrogen-bonded hydroxy, implying the presence of 
a C-5 hydroxy group. The NOESY correlations (Plate 80) observed between both the 
methoxy groups and H-2’and H-6’, confirmed their relative positions as only substitution 
on C-3 and C-8 allowed both methoxy groups to be in close proximity to both the H-2’ and 
6’ protons. The 13C (Plate 76) and DEPT NMR spectra showed 17 carbons, two methyl 
groups, six CH, and nine quaternary carbons. The assignment of our 13C NMR spectrum of 
gnaphaliin differs slightly from that of Tomás-Lorent  (1991), with the signal at δC 62.0 
being assigned as the 8-methoxy group and the signal at δC 60.4 assigned to the 3-methoxy 
group, based on HSQC (Plate 78) and HMQC correlations (Plate 79). Gnaphaliin (67), was 
previously isolated from H. cymosum and H. argyrophyllum (Jakupovic et al., 1989) and 
European species such as H. picardii (Tomás-Lorente et al., 1991) and H. italicum (Sala et 
al., 2003).  
 
The 1H (Plate 81) and 13C NMR (Plate 82) spectra of 5-hydroxy-7,8-dimethoxyflavone 
(72) were similar to those obtained for gnaphaliin (67). For this compound, the 1H NMR 
signals assigned to the two methoxy groups were closer to each other (δH 3.95 and 3.96), 
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while an extra proton was present in the aromatic region (δH 6.68) and an extra CH signal 
present in the DEPT spectrum (Plate 84). This suggested that 72 contains one hydroxy 
substituent less than gnaphaliin (67). This was confirmed by the high-resolution mass data 
(m/z 297.0757 [M-H]-), which indicated a molecular formula of  C17H14O5. The singlet at 
δH 12.6 was again indicative of a hydroxy substitution on C-5, while the presence of an 
unsubstituted B ring could be derived from the integration and splitting pattern of the 
aromatic protons at δH 6.68 and 7.95. Important HMQC correlations (Plate 86) observed 
were those between the proton at δH 6.45 (H-6) and the carbons at δC 105.0 (C-10), 128.9 
(C-8) and 158.7 (C-7) and the proton at δH 6.68 (H-3) and the carbons at δC 105.0 (C-10), 
131.4 (C-1’), 163.9 (C-2), confirming the positions of the unsubstituted aromatic protons 
as H-6 and H-3. The spectroscopic data obtained are identical to that reported by 
Kuroyanagi et al. (1987) for 5-hydroxy-7,8-dimethoxyflavone except for the assignments 
of C-5 and C-7. The HMQC correlation observed betwen the 7 or 8 methoxy signal at δH
3.96 and the carbon at δC 158.7 (thus C-7) resulted in the revised assignment. This change 
is in agreement with the assignments of C-5 and C-7 as reported by Horie et al. (1998) for 
related flavones. An extract of the South African H. petiolare as well as the Kenyan H. 





















The 1H (Plate 88) and 13C NMR (Plate 89) spectral data of compound 80 again suggested 
the presence of a flavone. The substitution pattern in 1H NMR spectrum for compound 80 
differed from the other isolated flavonoids in certain aspects. The presence of two ortho-
coupled doublets (J = 8.8 Hz) at δH 6.98 and δH 8.01 assigned to H-3’,5’ and H-2’,6’ 
respectively, indicated a para-substituted B ring. Several signals in the aliphatic region of 
the 1H NMR indicated the presence of a sugar moiety. The coupling constant of the proton 
at C-1” was calculated as 7.3 Hz which agrees with the value obtained for glucose by 
Lenherr et al. (1984). Further evidence for the presence of a glucose group and its 
localization at C-7 was obtained by comparing and correlating 13C NMR data of our 
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compound with other 7-glycosylated 8-hydroxyapigenins (Albach et al., 2003; Lenherr et 
al., 1984; Nakanishi et al., 2004). The existence of a β-linkage was confirmed by the 
anomeric proton doublet at δH 4.97 with a large coupling constant (J = 7.3 Hz). HMQC 
correlations (Plate 93) confirmed the assignments of the singlet at δH 6.67 as H-6 
(correlations with δC 105.2 (C-10), 127.0 (C-8), 151.2 (C-5), 152.4 (C-7)) and the singlet at 
δH 6.85 as H-3 (correlations with carbons resonating at δC 105.2 (C-10), 101.3 (C-1’), 
164.0 (C-2) and 182.4 (C-4). All other NMR spectroscopic data as well as the high-
resolution mass results (m/z 447.0923 [M-H]-, indicating a molecular formula of C21H20O11 





























Isoscutellarein 7-O-β-glucoside (80) 
 
Isoscutellarein 7-O-glucoside was previously found in different species of the primitive 
order of liverworts, Calobryales, from Antarctic Bryum species (Markham 1977, Markham 
and Given, 1988) and from Rosmarinus officinalis (Del Bano et al., 2003). To the best of 
our knowledge, this is the first time this glycoside has been isolated from the genus 
Helichrysum.  
 
The main class of compounds isolated from H. excisum was therefore not of the acylated 
phloroglucinol type as for H. caespititium (Dekker et al., 1983, Mathekga et al., 2000) and 
H. asperum var. albidulum (Jakupovic et al., 1989) (the other two Group 12 species 
investigated), but mainly flavonoids, indicating tha  H. excisum is chemically not closely 
related to H. caespititium and H. asperum var. albidulum. It would be interesting to 
investigate the other species classified morphologically as Group 12, but collection of plant 
material is hampered by the fact that several of these species are narrowly endemic 
(Hilliard, 1983). 
 
As mentioned previously, H. excisum extracts exhibited antimicrobial activity against 
Gram-positive organisms such as S. aureus, S. epidermidis, and B. cereus. The bio-
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autographic assay of initial column fractions, obtained after fractionation of the extract, as 
well as of the isolated compounds, indicated hat the antibacterial activity of the extract 
could be attributed mainly to the presence of lepidiss pyrone (19). MIC values were 
therefore determined for this compound (Table 6.2). Unfortunately, only moderate activity 
was observed (MIC values of between 78 and 312 µg/ml observed for the screened micro-
organisms). As expected, lepidissipyrone (19) has higher activity towards the Gram-
negative organisms and C. neoformans than the crude extract, but only a slight 
improvement was observed against S. aureus and S. epidermidis. The decrease in activity 
observed against B. cereus, when considering the activity of the crude extract, indicates 
that lepidissipyrone may be acting synergistically with other chemical entities. Although 
none of the other flavonoids exhibited observable activity in the bio-autographic assay, 
varying anti-staphylococcal activity has been recorded for pinocembrin (1) (666 µg/ml, 
Alcaráz et al. 2000; 0.1 µg/plate, Bremner and Meyer, 1998; 125 µg/disc, Fukui et al., 
1988; 50 µg/ml, Hufford and Laswell, 1978).  It was also reported that gnaphaliin (67) 
inhibits the growth of several microorganisms (Tomás-Lorente et al., 1991; Mendoza et al., 
1997). These discrepancies in observed activity maybe due to several factors including 
differences in assays used (Cushnie et al., 2003, Cushnie and Lamb, 2005).  
 
The modest activity observed for lepidissipyrone was unexpected since a much higher 
antimicrobial activity, with MIC’s of 12.5 µg/ml aginst Bacillus species and S. 
epidermidis, was reported for a phloroglucinol with a similar ctone side chain (Tomás-
Barberán, 1990). Other similar lactones also strongly inhibited several Gram-positive 
microorganisms (Ríos et al., 1991). Lepidissipyrone (19) decomposed on standing in 
chloroform, which indicated that the pyrone ring present might be acid sensitive. This 




One of the active antimicrobial components of H. excisum was identified as 
lepidissipyrone (19), a flavanone containing an α-pyrone substituent on the A-ring. The 
phytochemical investigation of this species has shown that, based on chemical evidence, H. 
excisum does not belong in the same taxonomic group as H. caespititium and H. asperum 
var. albidulum. Further investigation of species within morphological Group 12 is required 
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to determine whether this morphological group is characterised by flavonoids or 
phloroglucinols as major chemical constituents. 
 
6.4 Experimental  
 
6.4.1 Plant collection 
Helichrysum excisum (Thunb.) Less was collected on Robinson’s pass (near Oudtshoorn) 
during November 2002 (Jan Vlok, 2830, NU) and August 2004 (Jan Vlok 2830A, NU) in 
the Western Cape, South Africa. The identity of the plant material was confirmed at the 
South African National Biodiversity Institute in Pretoria and voucher specimens deposited 
in the University of KwaZulu-Natal herbarium (NU) in Pietermaritzburg, South Africa. 
 
6.4.2 Instrumentation and chemicals 
Column (silica gel 60) and centrifugal chromatography (chromatotron model 7924, 
Harrison Research) were used for the purification of extracts and fractions. The circular 
plates for use on the chromatotron were coated withpreparative silica gel (1 or 2 mm 
thickness). Thin-layer chromatography (TLC) plates (Kieselgel 60 F254, 0.25 mm) were 
used for examination of fractions and visualization of spots was achieved by staining with 
anisaldehyde/H2SO4 and heating. The anisaldehyde solution was prepared as follows: 465 
ml absolute ethanol was chilled in an ice bath. Acetic acid (5 ml), sulfuric acid (17 ml) and 
p-anisaldehyde (13 ml) was added and the solution mixed and stored in the refrigerator.  
 
1H and 13C-NMR spectra were recorded on a Varian Unity Inova 500 spectrometer with a 5 
mm SW/Z-PFG probe (all spectra recorded at 25 °C) (500 MHz for 1H) at room 
temperature in solutions of either deuterated chloroform or methanol. Spectra for 
isoscutellarein 7-O-glucoside (80) were recorded on a Varian Inova 2000 (300 MHz for 
1H) in DMSO-d6 using TMS as internal standard. Structures were detrmined by analysis 
of 2D (HSQC, HMBC, COSY and NOESY) NMR spectra and by comparison of 1H and 
13C NMR spectra with literature values. Mass spectrometry data was collected on a time-
of-flight Waters LCT Premier mass spectrometer using electrospray ionization in the 
positive mode. Optical rotation was determined with a Perkin Elmer 241 polarimeter.  
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6.4.3 General extraction 
Plant material was air dried (protected from sunlight) and ground. Plant material was 
extracted twice with solvent for 24 hours at room te perature where after the solvent was 
removed under vacuum. Chloroform:methanol (1:1), dichloromethane and methanol 
extracts were prepared. Extraction of the air-dried, ground aerial parts (250 g) of H. 
excisum (Jan Vlok 2830A) with chloroform: methanol (1:1) yielded 16 g of extract. A 
dichloromethane extract (5 g) was obtained by extracting 100 g dried, ground plant 
material (Jan Vlok 2830A) at room temperature. A methanol extract (17.3 g) was prepared 
from ground, air-dried aerial parts (160 g, Jan Vlok, 2830). 
 
6.4.4 Antimicrobial bioassays 
Determination of minimum inhibitory concentration (MIC) values 
See Paragraph 5.2.4. The antimicrobial activity for lepidissipyrone (19) was determined 
against Bacillus cereus (ATCC 11778), Staphylococcus aureus (ATCC 12600), 
Staphylococcus epidermidis (ATCC 2223), Klebsiella pneumoniae (NCTC 9633), 
Pseudomonas aeruginosa (ATCC 9027), and Cryptococcus neoformans (ATCC 90112). 
Antimicrobial activity for isoscutellarein 7-O-glucoside (80) was determined for B. cereus 
(ATCC 11778) and S. aureus (ATCC 12600). 
 
Bio-autography on thin-layer chromatography (TLC) plates  
Bioassay-guided isolation of antibacterial compounds from Helichrysum excisum was done 
by direct bio-autography on TLC (Van Vuuren et al., 2006). The crude chloroform: 
methanol extract, the fractions obtained after initial column chromatography of the crude 
extract and the isolated compounds were spotted on TLC plates and developed with 
hexanes:ethyl acetate 2:1 as solvent system. A duplicate TLC served as reference plate. A 
tryptone soya agar base layer was poured into a sterile Petri dish and the developed TLC 
plates placed onto its surface after setting. A second agar layer, inoculated with S. aureus 
(ATCC 12600) was poured onto the TLC plate. After incubation for 24 hours at 37 °C 
inhibition zones were visualized by spraying with a 0.4 mg/ml INT solution. Clear zones 
on the pink background indicated compounds with anti-staphylococcal activity. The 




Figure 6.3 Bio-autographic assay of compounds isolated from H. excisum. The clear zone 
is observed for lepidissipyrone 
 
6.4.5 Fractionation and isolation of compounds 
The crude chloroform: methanol extract (6 g) was frctionated on silica gel by sequential 
elution with hexanes:ethyl acetate (2:1), hexanes:ethyl acetate (1:1), and ethyl acetate 
(100%) to yield 12 fractions (A1-A12). Fraction A4 (680 mg) was further fractionated 
using chloroform (100%), chloroform:acetone (50:1), chloroform:acetone (25:1), 
chloroform: acetone (10:1), and acetone (100%) to give 7 fractions (B1-B7). Fraction B4 
(51 mg) was purified on a chromatotron with hexanes:ethyl acetate (2:1) as mobile phase 
to yield compound 1 (2 mg), which precipitated when the dried fraction obtained from the 
chromatotron was dissolved in chloroform. Compound 67 (1 mg) was obtained from 
fraction B3 (70 mg) after separation on a chromatotron with hexanes:ethyl acetate (2:1) as 
eluent. Purification of fraction B2 (180 mg) on the chromatotron with hexanes:ethyl 
acetate (2:1) yielded compound 19 (5 mg) which precipitated as a white solid from a 
fraction that contained a mixture of two compounds.  
 
The crude dichloromethane extract (5 g) was fractionated on silica gel using hexanes:ethyl 
acetate (9:1), hexanes:ethyl acetate (8.5:1), hexanes:ethyl acetate (8:2), and hexanes:ethyl 
acetate (6:4) followed by washing the column with methanol as eluent to obtain 8 fractions 
(C1-C8). Fraction C4 was further fractionated with a chromatotron with hexanes:ethyl 
acetate (2:1) as eluent to yield compound 72 as a yellow solid (2 mg). 
 
The methanol extract (17.3 g) was dissolved in methanol and subjected to column 
chromatography using silica gel and subsequent mobile phases consisting of hexanes: 
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dichloromethane (9:1), dichloromethane:methanol (6:1), dichloromethane:methanol (3:1), 
and methanol (100%). Isoscutallarein 7-O-glucoside (80) precipitated as a yellow solid (85 
mg). 
 
6.4.6 Physical data of compounds 
Compound 1, a white amorphous solid, was identified as (S)-pinocembrin (Fukui et al., 
1988; Jung and McLaughlin, 1990).  [α]D = -53 (MeOH, c = 0.09) [lit. Fukui et al., 1988, -
52 (MeOH, c = 0.188); Su et al., 2003, -58.5 (MeOH, c = 0.91); Hsieh et al., 1998, -47.3 
(MeOH, c = 5.48)].1H NMR (500 MHz, CD3OD): δH 2.78 (1H, dd, J3α,3β = 17 Hz, J2,3α = 3 
Hz, Hβ-3), 3.09 (1H, dd, J3α,3β = 17 Hz, J2,3β = 13 Hz, Hα-3), 5.46 (1H, dd, J2,3β = 13 Hz, 
J2,3α = 3 Hz, H-2), 5.90 (1H, d, J6,8 = 2 Hz, H-6), 5.94 (1H, d, J6,8  = 2 Hz, H-8), 7.36-7.43 
(3H, m, H-3’,4’,5’), 7.50 (2H, d, J = 8 Hz, H-2’ and H-6’); 
13C NMR (125 MHz, CD3OD): 
δC 44.2 (t, C-3), 80.5 (d, C-2), 96.3 (d, C-8), 97.2 (d, C-6), 103.4 (s, C-10), 127.4 (d, C-2’ 
and C-6’), 129.6 (d, C-4’), 129.7 (d, C-3’ and C-5’), 140.5 (s, C-1’), 164.7 (s, C-9), 165.5 
(s, C-5), 168.6 (s, C-7), 197.3 (s, C-4); HRESIMS (negative ionization mode),  m/z 
255.0652 [M-H]- (calc. for C15H11O4 255.0657).  
 
Compound 67, a yellow amorphous solid, was identified as gnaphaliin (Tomás-Lorente et 
al., 1991), 1H NMR (500 MHz, CDCl3): δH 3.88 (3H, s, 3-OMe), 4.00 (3H, s, 8-OMe), 
6.28 (1H, s, 7-OH), 6.44 (1H, s, H-6), 7.54 (3H, m, H-3’,H-4’ and H-5’), 8.10 (2H, m, H-2’ 
and H-6’), 12.4 (1H, s, 5-OH); 13C NMR (125 MHz, CDCl3): δC 60.4 (q, 3-OMe), 62.0 (q, 
8-OMe), 98.5 (d, C-6), 105.8 (s, C-10), 126.7 (s, C-8), 128.3 (d, C-2’,C-6’), 128.8 (d, C-3’ 
and C-5’), 130.5 (s, C-1’), 131.1 (d, C-4’), 139.7 (s, C-3), 155.1 (s, C-2), 155.5 (s, C-5), 
157.6 (s, C-7), 179.1 (s, C-4); HRESIMS  (negative ionization mode), m/z 313.0712 [M-
H]- (calc. for C17H13O6 313.0712). 
 
Compound 19, a  white amorphous solid, was identified as lepidiss pyrone (Jakupovic et 
al., 1989; Hua and Wang, 2004), 1H NMR (500 MHz, CDCl3): See Table 6.1; 
13C NMR 
(125 MHz, CDCl3): See Table 6.1; HRESIMS (negative ionization mode), m/z 421.1273 
[M-H] - (calc. for C24H21O7 421.1287). 
 
Compound 72, a  yellow amorphous solid, was identified as 5-hydroxy-7,8-
dimethoxyflavone (Gupta et al., 1983; Kuroyanagi et al., 1987), 1H NMR (500 MHz, 
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CDCl3): δH 3.95 (3H, s, 7 or 8-OMe), 3.96 (3H, s, 7 or 8-OMe), 6.45 (1H, s, H-6), 6.68 
(1H, s, H-3), 7.56 (3H, m, H-3’, H-4’ and H-5’), 7.95 (2H, m, H-2’ and H-6’), 12.6 (1H, s, 
5-OH), 13C NMR (125 MHz, CDCl3): δC 56.4 (q, 7 or 8-OMe), 61.7 (q, 7 or 8-OMe), 95.8 
(d, C-6), 105.0 (s, C-10), 105.4 (d, C-3), 126.3 (d, C-2’and C-6’), 128.9 (s, C-8), 129.2 (d, 
C-3’ and 5’), 131.4 (s, C-1’), 131.9 (d, C-4’), 149.4 (s, C-9), 157.6 (s, C-5), 158.7 (s, C-7), 
163.9 (s, C-2), 182.7 (s, C-4), HRESIMS (negative ionization mode) m/z 297.0757 [M-H]- 
(calc. for C17H13O5 297.0763). 
 
Compound 80, a  yellow amorphous solid, was identified as isoscutellarein 7-O-β-
glucoside (8-hydroxyapigenin 7-O β-glucoside) (Albach et al., 2003). 1H NMR (300 MHz, 
DMSO-d6,): δH 3.22 (1H, t, J3”,4” = J4”,5”  = 8.5 Hz, H-4”), 3.54-3.32 (4H, m, H-2”, H-3”, H-
5” and H-6”), 3.78 (1H, m, H-6”), 4.68 (1H, br s, OH), 4.97 (1H, d, J = 7.3 Hz, H-1”, β-
glucoside), 5.11 (2H, br s, OH), 6.67 (1H, s, H-6), 6.85 (1H, s, H-3), 6.98 (2H, d, J = 8.8 
Hz, H-3’ and H-5’), 8.01 (2H, d, J = 8.8 Hz, H-2’ and H-6’), 13C NMR (75 MHz, DMSO-
d6): δC 60.7 (t, C-6”), 69.7 (d, C-4”), 73.2 (d, C-2”), 75.7 (d, C-3”), 77.3 (d, C-5”), 98.7 (d, 
C-6), 101.3 (s, C-1’’), 102.7 (d, C-3), 105.2 (s, C-10), 116.0 (d, C-3’ and C-5’), 121.3 (s, 
C-1’), 127.0 (s, C-8), 128.7 (d, C-2’ and C-6’), 144.3 (s, C-9), 151.2 (s, C-5), 152.4 (s, C-
7), 161.3 (s, C-4’), 164.0 (s, C-2), 182.4 (s, C-4), HRESIMS (negative ionization mode) 
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Several phloroglucinol α-pyrones have been isolated from South African and European 
Helichrysum species (Fig. 7.1). The phloroglucinol moieties of these compounds are often 
prenylated while the 4-hydroxy-2-pyrone unit is usually alkylated in both the 5- and 6-
positions (Bohlmann et al., 1984; Bohlmann and Zdero, 1980; Hänsel et al., 1980; 
Jakupovic et al., 1986, Vrkoč et al., 1971). These compounds exhibit noticable biological 
activity. Phloroglucinol pyrones isolated from H. decumbens exhibited antifungal (Tomás-
Lorente et al., 1989) and antibacterial activity (Tomás-Barberan et al., 1990), while those 





























Figure 7.1 Phloroglucinol-derived α-pyrones isolated from Helichrysum species 
 
Arzanol (374), isolated from H. italicum showed significant in vitro antioxidant activity 
and had a protective effect against oxidative degradation of linoleic acid and cholesterol, 
oxidisable substances present in membranes. The compound was also found to be non-
toxic in the MTT assay against VERO cells (a line of fibroblasts derived from monkey 
kidney) at concentrations of 0.5-40 µM (Rosa et al., 2007). The most consequential 
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findings are those by Appendino and co-workers (2007) who reported on the NF-ΚB 
inhibitory activity of arzanol (374) as well as its inhibition of HIV-1 replication inT-cells.   
 
Pyrones are an important class of naturally-occurring lactones and the 4-hydroxy-2-pyrone 
(α-pyrone) motif can be found in a wide range of medicinally significant natural products 
(Whang et al., 1990; Carney et al., 2002; Zhang and Danishefsky, 2002; Kurdyumov et al., 
2006). The biological activities associated with pyrones include the inhibition of HIV 
protease (Thaisrivongs et al., 1996; Tummino et al., 1996; De Clercq, 2002), 
acetylcholinesterase, and acyl-CoA-cholesterol acyltransferase (McGlacken and Fairlamb 
2005 and references therein). The 2-pyrones also diplay antimicrobial (Fairlamb et al., 
2004), antiparasitic (Shimamura et al., 2007), and ticancer activity (Ridley and Khosla, 
2007) and have been shown to inhibit cyclo-oxygenas (Rao et al., 2003; McGlacken and 
Fairlamb, 2005) indicating their usefulness as analgesic and anti-inflammatory agents. 
Flavanones on the other hand, also possess a broad a r y of biological activity, which 
include antitumour (Ren et al., 2003), antibacterial (Tsuchiya et al., 1996, Urgaonkar et al., 
2005), and anti-inflammatory activities (Benavente-García and Castillo, 2008). Flavanones 
also exhibit activity as estrogen receptor modulators (Chen et al., 2004).  
 
A limited number of synthetic routes have been published for the synthesis of substituted 
4-hydroxy-2-pyrones. These routes normally involve β-keto ester (Banerjee and Achari, 
1993; Köster and Hoffmann, 1987; Zhang and Danishefsky, 2002; Katritzky et al., 2005; 
Kurdyumov et al., 2006) and/or acid chloride precursors (Ali et al., 1982; Lokot et al., 
1999; Sartori et al., 1991; Kurdyumov et al., 2006). The synthesis of flavanones is well 
established and usually involves one of two routes. The first route involves the coupling of 
a C-6 phenolic unit (e.g. phloroglucinol) to a C3-C6 unit (cinnamic residue) to form the 
flavonoid skeleton (Nay et al., 2000, Solladíe et al., 1999). The more commonly used route 
consists of a condensation between an acetophenone derivative and a benzaldehyde to 
yield the chalcone (Nay et al., 2001; Drexler and Amiridis, 2003, Solladíe et al., 1999). 
Although a number of routes have recently been developed for the asymmetric synthesis of 
flavanones (Hodgetts, 2005, Biddle et al., 2007), the enantioselective synthesis of 
flavanones that controls the C-2 configuration remains  challenge due to the potential for 
reversible phenoxide elimination to form the achiral 2’-hydroxy chalcones (Kabbe and 
Widdig, 1982). 
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One of the compounds isolated from Helichrysum excisum (Thunb.) Less. is a flavanone 
substituted with a 4-hydroxy-2-pyrone moiety (lepidissipyrone, 19) with antimicrobial 
activity (Chapter 6). Although a number of syntheses for α-pyrones have been published, 
only a single reference to the preparation of a phloroglucinol or flavanone substituted α-
pyrone could be found (Vrkoč and Sorm, 1975b). Based on the interesting biological 
activities associated with and the shortage of synthetic routes towards these compounds, 
the decision was made to attempt the synthesis of lepidissipyrone.  
 
The aims of this chapter are: 
•  To investigate a strategy towards the synthesis of lepidissipyrone (19)  
•  To develop synthetic methods that could also lead to the synthesis of the other α-
pyrone derivatives listed in Fig. 7.1. 
 
7.2 Results and discussion 
 
7.2.1 Retrosynthetic analysis of lepidissipyrone (19)
The synthetic challenges associated with the total synthesis of lepidissipyrone (19) are 
obvious. Firstly, there is little literature precedent for the coupling of the 4-hydroxy-2-
pyrone unit via a CH2 bridge to a phloroglucinol moiety. A patent by Vrkoč and Sorm 
(1975a) mentions the preparation of 3-chloromethyl-4-hydroxy-pyrone derivatives that are 
coupled to phloroglucinol derivatives to yield phloroglucinol pyrones with antibacterial 
activity (Scheme 7.1) (Vrkoč and Sorm, 1975b). However, according to Hagiwara et l. 
(2002), introduction of the methyl halide side chain (via formylation) to the 4-
hydroxypyrone is troublesome as the pyrone has a tendency to dimerise in the presence of 




















Phloroglucinols are also notoriously difficult to work with due to the high electron density 
of the phloroglucinol ring and its tendency to degrade (Gissot et al., 2004, Van Vuuren et 
al., 2006). Flavanones are known to undergo ring opening reactions to form chalcones 
under acidic and basic conditions (Cisak and Mielczarek, 1992; Zhang et al., 2008) and in 
this case, the pyrone moiety has to be attached selctively at position 6, and not position 8 
of the A-ring of the flavanone. Therefore, the challenge is to prepare a heavily substituted 
α-pyrone moiety joined to C-6 of the electron-rich phloroglucinol moiety of a flavanone.  
 
Banerjee and Achari (1993) prepared α-pyrone intermediate 382 in the total synthesis of 
lygodinolide, using an alkyl bromide and a β-keto ester (Scheme 7.2). 
 
















Scheme 7.2 Intermediates in the total synthesis of lygodinolide. Reagents (i) NaH, THF, 0-
25 °C, 16 h, then reflux 3 h (ii) Pd(II) chloride-acetonitrile, acetone, rt, 24 h (iii) DBU, 
benzene, reflux, 14 h (Banerjee and Achari, 1993). 
 
Based on this route, the following retrosynthetic analysis (Scheme 7.3) for lepidissipyrone 


























Scheme 7.3 Retrosynthesis of lepidissipyrone (19) 
 
7.2.2 Preparation of ethyl 4-(2-ethyl-1,3-dioxolan-2-yl)-3-oxopentanoate (384) 
The original route selected for the synthesis of the β-keto ester moiety is shown in Scheme 
7.4 and was based on the method used for the preparation of β-keto esters by Lokot and co-
workers (1999) and Scribner et al. (1978). The first step was the acylation of Meldrum’s 
acid (385), followed by alcoholysis in methanol to obtain β-keto ester 386. It was 
anticipated that alkylation of ester 386 would afford the desired methylated β-keto ester 
























Scheme 7.4 Initial route towards synthesis of β-keto ester 387. Reagents. (i) Pyridine, 
CH2Cl2, -15 - 5 °C, 2 h (ii) MeOH, reflux, 3 h, 67% (iii) K2CO3, CH3I. 
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The acidity of Meldrum’s acid (385) (pKa 4.97) allows it to react with electrophiles in the 
absence of strong bases and acylation occurs in the pres nce of pyridine. The methanolysis 
proceeds readily due to the enolization of the acylgroup, which enables nucleophilic attack 














Scheme 7.5 Methanolysis of acylated Meldrum’s acid (Scribner et al., 1978). 
 
Although β-keto ester 386 was synthesised successfully, alkylation resulted in the 
formation of multiple products and this prompted the decision to use an alternative route. 
Claisen condensation is a well-known method for the general synthesis of β-keto esters 
(Clayden et al., 2001). A self condensation of methyl propionate using potassium hydride 
as base was therefore attempted (Kamal et al., 2005). However, this reaction was 
unsuccessful. 
 
In another attempt to synthesise β-keto ester 384, propionyl chloride was treated with 
triethylamine as base according to the method of Sung and Wu (2001). The base removes a 
proton on the α-carbon of the acid chloride to generate a ketene in situ that proceeds with 
the precipitation of triethylammonium chloride. Dimerisation of the unstable ketene results 
in the formation of β-lactone 388. Refluxing of the lactone in the presence of an excess of 
methanol and sodium acetate as catalyst afforded β-keto ester 387 in 52% yield (Sung and 
















Scheme 7.6 Synthesis of β-keto ester 387. Reagents: (i) Et3N, ether, 0 °C - rt, 2 days (ii) 
NaOAc, MeOH, reflux, 1 day, 52%. 
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The ketone functionality in compound 387 was protected by ketalisation to afford the 
protected ester 389 (Bates et al., 1988). This protecting group was select d based on the 
simplicity of the protection procedure and the availability of starting materials. A Claisen 
condensation of ketal ester 389 with ethyl acetate in the presence of LiHMDS (Banerjee 
and Achari, 1993) resulted in an extremely low yield of the desired product and the 
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Scheme 7.7 Synthesis of β-keto ester 384. Reagents: (i) Et3N, ether, 0 °C - rt, 2 days (ii) 
NaOAc, MeOH, reflux, 1 day, 52%; (iii) TsOH, 1,2-ethanediol, toluene, reflux overnight, 
66% (iv)  LDA, EtOAc, THF, 0 °C - 15 °C, 2 h, 37%. 
 
7.2.3 Preparation of the flavanone moiety 
After obtaining β-keto ester 384, the next step was to synthesise a flavanone with a 
“suitable arm” (383), such as an alkyl halide for coupling with the ester (Scheme 7.8). 
Three options were considered for the introduction of the C-6 substituent of the flavanone: 
a) direct methylbromination using reagents such as HBr and formaldehyde, b) 
hydroxymethylation followed by halogenation and c) introduction of a 6-formyl group that 
could be transformed into the required substituent.  
 
In a model reaction on 2,4-dibenzyloxy-6-hydroxyphloroacetophenone (391), direct 
methylbromination using HBr and formaldehyde (Biali et al., 1997; Van der Made et al., 
1993) was unsuccessful. In a second model reaction on the same substrate, employing a 
two step approach to the bromomethylphloroacetophenon , a hydroxymethylation 
followed by bromination was attempted. Although thedesired alcohol was obtained by 
hydroxymethylation under basic conditions (Ducho et al., 2003), the yields for this reaction 
were low. The reaction never went to completion and when left for extended times or 
heated, a product formed that could not be isolated. This was not totally unexpected as the 
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Bakelite-type polymerisation of phenols is well known and the trihydroxylated system is 
electron rich. Subsequently, the introduction of a formyl group at C-6 of the flavanone was 
planned, followed by reduction and bromination. Scheme 7.8 indicates the first proposed 
route for the synthesis of the flavanone moiety, which could be coupled to the β-keto ester. 
 
Starting material for this route was phloroacetophenone (390) (Scheme 7.8). Due to the 
multiple hydroxy groups present on the phloroacetophenone ring, selective protection was 
required. Benzyl protecting groups were chosen based on the ease of formation of benzyl 
ethers, their stability under various conditions and their removal by a variety of 
deprotection methods, including the use of Lewis acds, catalytic hydrogenolysis (Greene, 
1991) and sodium in the presence of butanol (Odejinmi and Wiemer, 2005). MOM-
protection was considered, as it is often utilised in this type of synthesis (Bu et al., 1997, 
Tan et al., 2002, Urgaonkar et al., 2005) but difficulties in obtaining commercial MOM-
chloride and the toxicity associated with these prepa ations (Kishore et al., 2006) ruled out 
the use of this reagent.  
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Scheme 7.8 Flavanone synthesis, deprotection and formylation. Reagents: (i) BnCl, 
K2CO3, DMF, 80 °C, 2 h, 82% (ii) PhCHO, NaH, DMF, 0 °C, 45 min, 100% (iii) AcOH, 
reflux, 6 h, 32% or DBU, CH2Cl2, rt, 2 days, 49% (iv) H2, Pd/C, CH2Cl2/EtOAc, rt, 45 
min, 90% (v) a) POCl3, DMF, CH3CN, 18 h, rt, b) MeOH/H2O, 9% (396), 37%, (397). 
 
It was anticipated that the free hydroxy group would have a stronger ortho-directing effect 
than the benzyloxy group, enabling monosubstitution of the flavanone A-ring. Selective 
benzylation of 2,4,6-trihydroxyacetophenone afforded 391. Condensation of ketone 391 
and benzaldehyde was attempted in the presence of sodium hydroxide (Ali and Ilyas, 1986; 
Suzuki et al., 2004), potassium hydroxide (Ichino et al., 1988) and sodium hydride 
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(Hatakeyama et al., 2005) in order to obtain chalcone 392. The reaction with sodium 
hydride at 0 °C gave quantitative yields of chalcone 392 (Plates 97, 98). Synthesis of 
flavanone 393 was quite problematic since an equilibrium between the flavanone and 
chalcone exists (Urgaonkar et al., 2005). Both the acid (acetic acid) (Solladie et al., 1999) 
and base (DBU) catalysed reactions gave rather low yields, although the starting material 
could be reisolated and the reaction repeated (Scheme 7.8).  
 
Haraldsson and Baldwin (1997) have illustrated that benzyl ethers adjacent to carbonyl 
groups can be selectively cleaved in the presence of other benzyl ethers using magnesium 
bromide. Mechanistically this involves the formation f a six-membered chelated ring 


























Scheme 7.9 Mechanism suggested for selective debenzylation of 5-hydroxy group 
(Haraldsson and Baldwin, 1997). 
 
This method seemed ideally suited for this synthesis, as selective deprotection of the 5-
hydroxy group of flavanone 393 was required. However, debenzylation using magnesium 
bromide led to the formation of an unforeseen side product 394. It is proposed that the 
reactive phloroglucinol ring reacts with the benzyl bromide formed during the deprotection 
reaction, resulting in the C-benzylated (394, Scheme 7.10) as well as the O-debenzylated 
product (395). Selective debenzylation of flavanone 393 was successfully achieved in high 
yields using catalytic hydrogenation over 10% palladium on charcoal to afford flavanone 




























Scheme 7.10 Mechanism suggested for C-benzylation of flavanone 392. 
 
Before formylation of the flavanone was performed, hydroxymethylation was attempted. 
This reaction proved to be even more problematic than the similar benzylated 
phloroacetophenone (391) hydroxymethylation reaction. The yield was very low and 
methylation of the aliphatic hydroxy occurred as a side reaction. Since direct 
hydroxymethylation did not seem to be effective, a Vilsmeier-Haack formylation of the 
flavanone was proposed (Graybill et al., 1999, Scheme 7.11). Alternative formylation 
methods were considered, but as formylation using MgCl2 (Hansen and Skattebol, 2005) 





























































Scheme 7.11 Mechanism of Vilsmeier formylation of flavanone 395. 
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Attempts to use procedures where all the reagents were mixed together simultaneously 
resulted in a solution from which no product could be isolated. The procedure followed 
thus involved the separate preparation of the Vilsmeier reagent, to which the flavanone was 
added. The yields were also low and instead of the major product being substituted in the 
6-position (396), 8-substitution was preferred (397), resulting in the formation of an 
undesired major product (Scheme 7.8). The position of the aldehyde was determined by 
acylation of the free hydroxy groups of the two products and determining the NOESY 
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Condensation of ester 384 and aldehyde 397 was attempted in the presence of sodium 
hydride, which (as expected) resulted in the decomposition of the flavanone to the 
chalcone. The flavanone in general seemed unstable and converted back to the chalcone 
even in the presence of 50% toluenesulfonic acid (when refluxed). Coupling of the 
completed flavanone moiety to the ester therefore des not seem feasible. 
 
7.2.4 Preparation of the pyrone moiety 
As an alternative, the possibility of attaching theside chain necessary for coupling to the 
completed pyrone moiety (obtained from β-keto ester 384) (Scheme 7.12) was 
investigated. Deprotection of ester 384 was first attempted in the presence of 2 M HCl 
(Zong et al. 2006) which resulted in a mixture of products. Stirring with 80% acetic acid 
(Babler et al., 1978) provided much better yields and fforded β-keto ester 400. Lactone 
401 (Plates 103, 104) was obtained in the presence of DBU (Cervello et al., 1990). 
However, chloromethylation with formaldehyde and HCl did not yield the desired 
chloromethylated pyrone, but the dimeric lactone 375 (Plates 105, 106) was obtained. 
Helipyrone (375) was also previously synthesised by Ali and co-workers (1982). Hagiwara 
and co-workers (2001, 2002) experienced similar problems with attaching a halomethyl 
side chain to the 2-pyrone and eventually obtained the 3-hydroxymethylpyrone via a 
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phenylthiomethyl pyrone intermediate (Hagiwara et al., 2001; Hagiwara et al., 2002). As 
this route would add several more steps to the total synthesis, it was not pursued further. 














401 375  
 
Scheme 7.12 Synthesis of helipyrone (375). Reagents: (i) 80% AcOH, 50 °C, 48 h, 67% 
(ii) DBU, benzene, reflux, overnight, 53% (iii) (CH2O)n, HCl, dioxane, rt, 2h, 22%.  
 
7.2.5 Alternative approach towards pyrone synthesis 
A different approach used the route by Kappe and Schmidt (1970) for the synthesis of 3-
benzyl-6-ethyl-4-hydroxy-5-methyl-2-pyrone (Scheme 7.13). Diethyl ketone and bis(2,4,6-
trichlorophenyl) benzylmalonate is reacted by fusion at approximately 250 °C. Similar 
reactions were described by Stadlbauer et al. (2001). The reported yields for this type of 



















Scheme 7.13 Synthesis of 3-benzyl-6-ethyl-4-hydroxy-5-methyl-2-pyrone by Kappe and 
Schmidt (1970). Reagents (i) 240 - 245 °C, 30 min. 
 
Based on this approach, the route below was suggested, using 2,4,6-

































































Scheme 7.14 Synthesis of 2-(2,4-dibenzyloxy-6-isopropoxybenzyl)malonic acid (410). 
Reagents: (i) BnBr, K2CO3, DMF, rt, overnight, 89% (ii) K2CO3, (CH3)2CHBr, DMF, 71% 
(iii) AcOH, pyrrolidine, toluene, reflux, 4 h, 63% (iv) NaBH4, EtOH, 50% (v) NaOH, 
EtOH, H2O, reflux, 6 h, 83%; (vi) POCl3 (vii) diethylketone, 250 °C, 20 min. 
 
Selective benzylation of 2,4,6-trihydroxybenzaldehyde (402) with benzyl bromide in DMF 
afforded protected aldehyde 403 (Anderson et al., 2005) (a small amount of tribenzylated 
benzaldehyde 404, was also isolated). A NOESY experiment was performed on the 
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Since the remaining free hydroxy-group of 403 would attack the ester and result in the 
formation of a coumarin during coupling with the ester, isopropyl protection of this group 
was done to afford 2,4-dibenzyloxy-6-isopropoxybenzaldehyde (406). At first, TBDMS 
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protection in the presence of both diisopropylamine or sodium hydride was attempted for 
the remaining hydroxy group of 403, but possibly due to the bulkiness of the group and the 
hydrogen bonding between this hydroxy and the carbonyl, this protection was not 
successful. A Knoevenagel condensation of 406 was done with diethyl malonate in the 
presence of acetic acid and pyrrolidine (Antonioletti  al., 2002) affording alkene 407 
(Plates 107-108).  
 
The double bond could not be reduced via hydrogenatio , since it would cause cleavage of 
the benzyl ethers, again resulting in the formation of coumarin side products. The double 
bond was therefore reduced with sodium borohydride in thanol. The reaction did not 
proceed at room temperature, as starting material was reisolated after stirring for 24 h. 
Refluxing for 3 hours results in the isolation of a mono ester 408 as major product where 
one of the ester groups is already hydrolysed by the sodium borohydride, while 409 is 
isolated as minor product. Hydrolysis occurs readily and with high yields when refluxing 
any of the esters in ethanol with sodium hydroxide to afford diacid 410. The reaction of the 
diacid and trichlorophenol (411) was attempted, using phosphoryl chloride. This result d 














7.2.6 Synthesis of alkene 415 
Another approach that was investigated involved starting with 2,4,6-
trihydroxybenzaldehyde (402), followed by selective benzylation to yield 403, subsequent 
reduction of the aldehyde to afford alcohol 412, and then a  Friedel-Crafts acylation 
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Scheme 7.15 Route utilising 2,4,6-trihydroxybenzaldehyde as starting material. Reagents: 
(i) BnBr, K2CO3, DMF, rt, 12 h, 89% (ii) NaBH4, EtOH (iii) AcCl, ZnCl2. 
 
Selective benzylation was done in the presence of benzyl bromide in DMF (Anderson et 
al., 2005), to afford the protected aldehyde 403. However, the reduction of the aldehyde 
was problematic. Although two ‘products’ were observed on TLC during the reaction with 
both sodium borohydride and lithium aluminium hydride, quenching with even mild acid 
resulted in a very polar product that could not be isolated. The reaction was only quenched 
with water and the products isolated. The NMR spectra of these products indicated that 
neither was the desired alcohol, but rather a polymerised product. Reduction of 2,4-
dibenzyloxy-6-hydroxybenzaldehyde (403) was thus not feasible. Isopropyl protection of 
the remaining hydroxy was performed to afford 2,4-dibenzyloxy-6-
isopropoxybenzaldehyde (406) and reduction of this aldehyde yielded the desired alcohol 
413 in high yields. However, neither bromination (with several different methods) nor 
tosylation of this alcohol was successful.  
 
Reactions aimed at acylation of the aromatic ring of 406 also did not yield the desired 
product - in one case the debenzylated keto-aldehyde 414 was obtained. Arnaudinaud and 
co-workers (2001) illustrated debenzylation in the pr sence of TiCl4, so the deprotection 
observed with SnCl4 was not surprising. Condensation with ester 384 did give the desired 
alkene 415 (Scheme 7.16, Plates 109, 110). Hydrogenation to reduce the double bond 
selectively in the presence of the benzyl groups waattempted, in the hope that it would be 
possible to reduce the double bond without debenzylation. After hydrogenation for 2 h at 
room temperature at 120 kPa, the starting material was recovered quantitatively. In this 
case reduction with sodium borohydride is not feasible, as it will most probably result in 



































Scheme 7.16 Synthesis of alkene 415. Reagents (i) (CH3)2CHBr, K2CO3, DMF, 71% (ii) 
NaBH4, CH2Cl2, -78 - 0 °C, 1 h, 90% (iii) CBr4, PPh3, CH2Cl2 or TsCl, di-
isopropylamine/NaH (iv) SnCl4, CH2Cl2, v) AcOH, pyrrolidine, toluene, reflux, 4 h, 28% 
 
7.2.7 Coupling of phloroacetophenone and β-keto ester moieties 
Finally, a decision was made to do a Vilsmeier formylation of ketone 391, then to attempt 
selective reduction of the aldehyde of 416 to obtain alcohol 418 followed by bromination 
or tosylation (Scheme 7.17). It was anticipated that e electron withdrawing acyl group 
would decrease the reactivity of the ring, enabling halogenation or tosylation of the 





































Scheme 7.17 Synthetic route illustrating coupling of phloroglucinol moiety to β-keto ester 
moiety. Reagents (i) a) DMF, POCl3, CH3CN, rt 18 h, b) MeOH, H2O, rt, 4 h , 42% (ii) 
K2CO3, (CH3)2CHBr, DMF, 58% (iii) NaBH4, CH2Cl2, -78-0 °C, 1 h, 62% (iv) SOCl2, 
CH2Cl2, 45 minutes, (quantitative) (v) LDA, THF, 0 °C-rt, 2 days, 54%. 
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The Vilsmeier formylation gave keto-aldehyde 416 in a 42% yield, while isopropyl 
protection resulted in the isolation of 417. Selective reduction of the aldehyde in the 
presence of the ketone was successful with sodium borohydride at reduced temperatures in 
the presence of a mixed solvent system. Alcohol 418 (Plates 111-112) was obtained in 
62% yield (Ward and Rhee, 1988). Bromination (using several different reagents) was 
attempted, but failed, as did tosylation. In this case the product from the bromination 
reaction could be isolated and was identified as the et yl ether 419. A possible explanation 
for this ether formation seems to be that the bromide or tosylate does in fact form, but that 
it is so reactive that the solvent (ethanol) is nucleophilic enough to displace the bromide 
and to form the ether. Therefore, it was decided to at empt the formation of a chloride. 
Indeed,, exposure of alcohol 418 to thionyl chloride afforded chloride 420. This chloride 
was not very stable and converts back to the alcoho in the presence of water, or 









           419 
 
A model reaction, using diethyl malonate, was performed to illustrate the coupling between 
the chloride 420 and diethyl malonate. This reaction involved the in situ preparation of 
chloride 420 and its immediate addition to a solution of diethyl malonate and LDA in THF. 
The coupled product 421 (Plates 113-114) was isolated in a 54% yield. It should be 
feasible to synthesise lepidissipyrone (19) by using the route given in Scheme 7.18. We 
have shown that precursors 420 and 384 can be prepared and that a 1,3-dicarbonyl 
derivative can be linked to precursor 420 (Scheme 7.7, Scheme 7.19). However, due to 













































































Scheme 7.18 Synthetic route proposed for the synthesis of lepidiss pyrone (19). Reagents 
(i) a) DMF, POCl3, CH3CN, rt 18 h, b) MeOH, H2O, rt, 4 h , 42% (ii) (CH3)2CHBr, K2CO3, 
DMF, 58% (iii) NaBH4, CH2Cl2, -78-0 °C, 1 h, 62% (iv) SOCl2, CH2Cl2, 45 minutes, 
(quantitative) (v) LDA, THF, 0 °C-rt, (vi) 80% AcOH (vii) DBU, benzene (viii) a) 




The aim of this investigation was to investigate a methodology that would provide access 
to the synthesis of lepidissipyrone (19) and other phloroglucinol-substituted α-pyrones 
(Fig. 7.1). The highly reactive nature of the electon-rich phloroglucinol nucleus posed 
several problems during this synthesis and any proposed synthetic route should take 
cognisance of this problem. One of the pyrones, helipyrone (375), has been prepared 
successfully. A successful strategy towards the coupling of a 1,3-dicarbonyl derivative to 
the benzylic position of a phloroglucinol derivative has been illustrated. Both the flavanone 
and pyrone moieties present in lepidissipyrone (19) have been synthesised successfully. It 
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is believed that this approach can be used to synthesise phloroglucinol-pyrones that are 




7.4.1 General materials and methods 
Solvents were dried by distillation under N2. DMF was distilled from molecular sieves and 
CH2Cl2 and CH3CN from CaH2. These solvents were stored under nitrogen on molecular 
sieves. THF and Et2O were freshly distilled from sodium with benzophenone ketyl as 
indicator for THF. Dry reactions were performed in oven-dried glassware under an 
atmosphere of N2. Reagents were purchased from Sigma Aldrich. Column chromatography 
was performed on Merck silica gel 60. A chromatotron (model 7924, Harrison Research) 
was used for centrifugal chromatography.  Thin-layer chromatography (TLC) was done on 
precoated Kieselgel 60 F254 plates (Merck or Machery-Nagel). Detection was done by UV 
(254 nm) followed by staining with an anisaldehyde solution, prepared as follows: 
Absolute ethanol (465 ml) was cooled in an ice bath. Acetic acid (5 ml), sulphuric acid (17 
ml) and p-anisaldehyde (13 ml) was added and the solution mixed and stored in a fridge.  
 
Melting points were determined with a Kofler hot-stage apparatus and are uncorrected. 
Mass spectrometric data were collected on a time-of-flight Waters LCT Premier mass 
spectrometer using electrospray ionization in the positive or negative mode. Mass 
spectrometric data for some of the ester precursors was obtained using GC-MS (Thermo 
Finnigan PolarisQ Ion Trap with TRACE GC/MS). Infrared spectra were recorded on a 
Perkin-Elmer Spectrum 1 Series FT-IR spectrophotomeer using KBr discs for solids and 
sodium chloride discs for oils or directly on a Bruker Alpha FT-IR. NMR spectra were 
recorded on a Varian Unity Inova 500 spectrometer with a 5 mm SW/Z-PFG probe (all 
spectra recorded at 25 °C) or Bruker Avance III 400 or 500 spectrometers with 5 mm 
BBO-Z probes, all spectra recorded at 30 °C). 1H NMR spectra were recorded at 400 or 
500 MHz and 13C spectra at 100 or 125 MHz. Chemical shifts (δ) are quoted in parts per 
million (ppm) and referenced to a residual solvent peak (CDCl3, 7.26 and 77.0 ppm or 
CD3OD, 3.31 and 49 ppm or DMSO-d6, 2.5 and 39.5 ppm).  
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7.4.2 Experimental procedures and physical data of compounds 







To a solution of Meldrum’s acid (2 g, 13.9 mmol) in 25 ml dichloromethane at -20 °C was 
added pyridine (2.26 ml, 28.0 mmol) and dropwise, propionyl chloride (24 ml, 28.0 mmol) 
under nitrogen. The reaction was stirred for 1 h betwe n -10 °C and -20 °C and then for 
another hour at 5 °C. The reaction mixture was thenacidified with 1 M HCl and extracted 
with dichloromethane. The dichloromethane layers were combined, washed with 1 M HCl 
and dried over anhydrous magnesium sulphate. The solvent was evaporated and the 
unpurified product was used in the next stage. The acylated Meldrum’s acid was refluxed 
for 3 h in methanol and after evaporation of the solvent the crude product was purified on 
silica using dichloromethane:petroleum ether 8:2 as eluent to yield 1.2 g (67%) of β-
oxoester 386 as a yellow oil (method from Scribner et al., 1978; Lokot et al., 1999): 1H 
NMR (lit. Jung and Hagenah, 1987) (500 MHz, CDCl3) δH 1.07 (3H, t, J = 7.3 Hz H-5,), 
2.56 (2H, q, J = 7.30 Hz, H-4), 3.45, (2H, s,H-2), 3.72 (3H, s, OCH3); 
13C NMR (125 
MHz, CDCl3) δC 7.5 (C-5), 36.3 (C-4), 48.7 (C-2), 52.3 (OCH3), 167.7 (C-1), 203.2 (C-3).   
 








The method of Sung and Wu (2001) was modified to synthesise compound 387. To a 
solution of propionyl chloride (3 ml, 34.5 mmol) dissolved in 10 ml anhydrous ether, was 
added triethylamine (4.8 ml, 34.5 mmol) in anhydrous ether (69 ml) dropwise over a 
period of 1 hour with vigorous stirring at 0 °C under nitrogen. The solution was stirred for 
two days at room temperature. Triethylammonium chloride precipitated as a thick white 
solid. The ether was evaporated and the residue dissolved in methanol and sodium acetate 
(4 mg) was added. The resulting solution was then refluxed under nitrogen for one more 
day. After evaporation of the methanol, the residue was dissolved in water and ether. The 
organic and aqueous layers were separated and the aqueous layer extracted twice more 
with ether. After combining of the ether fractions and drying with magnesium sulphate, the 
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product was purified by chromatotron with a mobile phase of hexanes:ethyl acetate 15:1 to 
give β-keto ester 387 as a colourless oil 2.58 g (52%): 1H NMR (500 MHz, CDCl3) δH 1.04 
(3H, t, J = 7.4 Hz, H-5), 1.31 (3H, d, J = 7.2 Hz, 2-CH3), 2.54 (2H, dq, J = 14.5 Hz, 7.2 
Hz, H-4), 3.52 (1H, q, J = 7.2 Hz, H-2), 3.70 (3H, s, OCH3); 
13C NMR (125 MHz, CDCl3) 
δC 7.6 (C-5), 12.8 (2-CH3), 34.6 (C-4), 52.27 (C-2), 52.31 (OCH3), 171.0 (C-1), 206.3 (C-
3); GC-MS m/z 144.03 (calculated for C7H12O3 144.07864); RT = 11.37 min.  
 











A solution of β-keto ester 387 (950 mg, 6.6 mmol), ethane-1,2-diol (1.1 ml, 19.8 mmol) 
and toluene-4-sulfonic acid monohydrate (10 mg) washeated to reflux in toluene using a 
Dean Stark apparatus overnight (a modified method of Bates et al., 1988). The cooled 
solution was neutralised with saturated aqueous sodium hydrogen carbonate and the 
organic and aqueous layers separated. The aqueous layer was further extracted with 
dichloromethane. The combined organic phases were dried over anhydrous magnesium 
sulphate and the solvent evaporated to give the crude acetal. Chromatography of this 
through silica gel, using hexanes:ethyl acetate (15:1) as eluent yielded 819 mg (66%) of 
the desired product 389 as a colourless oil: 1H NMR (500 MHz, CDCl3) δH 0.89 (3H, t, J = 
7.4 Hz, H-5), 1.19 (3H, d, J = 7.2 Hz, 2-CH3), 1.77 (2H, m, H-4), 2.85 (1H, q, J = 7.2 Hz, 
H-2), 3.68 (3H, s, OCH3), 3.95-4.03 (4H, m, OCH2CH2O); 
13C NMR (125 MHz, CDCl3) 
δC 7.2 (C-5), 12.5 (2-CH3), 27.9 (C-4), 46.6 (C-2), 51.7 (OCH3), 65.6 (OCH2CH2O), 65.7, 
111.5 (CCH2CH3), 173.9; HRESIMS (positive ionization mode), m/z 189.1132 [M+H]
+ 
(calc. for C9H17O4 189.11268); IR (NaCl) ν 2981, 1738, 1212, 1078 cm-1. 
 











Ethyl acetate (2.0 ml, 21.2 mmol), in THF (5 ml) was dded dropwise to a solution of 
lithium diisopropylamide (prepared in situ from 4.5 ml of diisopropylamine and 21 ml of a 
1.5 M solution BuLi) in dry THF (50 ml) at -78 °C under nitrogen. The resulting solution 
was stirred for 1 hour at 0 °C and cooled to -78 °C before β-keto-ester 389 (2.0 g, 10.6 
mmol) dissolved in THF (5 ml) was added dropwise. The temperature was allowed to rise 
to 0 °C and the reaction mixture stirred for 4 hours. Thereaction was quenched with water 
(50 ml) and diluted with ether (50 ml). The layers were separated and the aqueous layer 
was extracted twice with 50 ml ether. The aqueous layer was then acidified with 1 M HCl 
and extracted with ether twice more. The combined ether extracts were washed with water, 
brine, dried (over anhydrous magnesium sulphate) and concentrated in vacuo to afford a 
yellow oil. The desired product was obtained after purification on two subsequent 
chromatorons using hexanes:ethyl acetate (199:1) as eluent to afford 962 mg (37%) of the 
colourless oil 384: 1H NMR (500 MHz, CDCl3) δH 0.86 (3H, t, J = 7.4 Hz, CCH2CH3), 
1.13 (3H, d, J = 6.9 Hz, H-5), 1.26 (3H, t J = 7.1 Hz, OCH2CH3), 1.65 (2H, dq, J = 7.3 Hz, 
CCH2CH3), 3.10 (1H, q, J = 6.9 Hz, H-4), 3.61 (2H, dd, J = 15.9 Hz, H-2), 3.95-3.99 (4H, 
m, OCH2CH2O), 4.17 (2H, dq, J = 7.4 Hz, OCH2CH3); 
13C NMR (125 MHz, CDCl3) δC 
7.09 (CCH2CH3), 11.68 (C-5), 14.1 (OCH2CH3), 27.8 (CCH2CH3), 50.1 (C-4), 52.5 (C-2), 
61.1 (OCH2CH3), 65.2, 65.4 (OCH2CH2O), 111.9 (CCH2CH3), 167.6 (C-1), 204.4 (C-3); 
GC-MS m/z 215.13 [M-29]-, (calculated for C10H15O5 215.09); RT = 16.07 min; IR (NaCl) 
ν 2981, 1741, 1713, 1308, 1033 cm-1. 
 
2,4-Dibenzyloxy-6-hydroxyphloroacetophenone (391)    










2,4-Dibenzyloxy-6-hydroxyphloroacetophenone 391 was prepared according to the method 
of Tsukayama et al. (2004). K2CO3 (4 g, 29.8 mmol) was added to a solution of 2,4,6-
trihydroxyphloroacetophenone (1 g, 5.9 mmol, dried by leaving the monohydrate at 120 °C
in an oven for 24 h) in DMF (9 ml), followed by the dropwise addition of a solution of 
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benzyl chloride (1.45 ml, 12.6 mmol) in DMF (2 ml) while stirring under nitrogen. The 
reaction was heated to 80 - 90 °C, stirred for 2 h, cooled down and quenched by the 
addition of 1 M HCl (until the reaction mixture was cidic, as determined with litmus 
paper) and diluted with dichloromethane. The layers were separated and the aqueous phase 
extracted with dichloromethane (3 x). The dichloromethane fractions were pooled and 
washed with copious amounts of water (5 x) to remove the DMF and dried by the addition 
of anhydrous MgSO4. The solvent was evaporated and the resulting product purified with 
column chromatography using hexanes:ethyl acetate (9:1) as eluent to afford 1.7 g (82%) 
of 391 as a white solid, recrystallised from acetone:methanol (1:1) to afford colourless 
needles: mp 93-94 °C, (lit. Tsukayama et al., 1989, 100-102°C); (lit. Kumazawa et al., 
2001, 108-109°C), (lit. Dulcire et al., 1990, 112-115°C); 1H NMR (500 MHz, CDCl3) δH 
2.56 (3H, s, COCH3), 5.060 (2H, s, OCH2Ph), 5.065 (2H, s, OCH2Ph), 6.10 (1H, d, J = 2.3 
Hz, H-3 or H-5), 6.17 (1H, d, J = 2.3 Hz, H-3 or H-5), 7.34 – 7.42 (10H, m ArH), 14.03 
(1H, s, OH); 13C NMR (125 MHz, CDCl3) δC 33.2 (COCH3), 70.2 (OCH2Ph), 71.1 
(OCH2Ph), 92.3 (C-3 or C-5), 94.7 (C-3 or C-5), 106.3 (C-1), 127.6, 127.9, 128.3, 128.4, 
128.66, 128.69 (ArC), 135.6, 135.8 (CH2CAr), 161.9, 165.0, 167.5 (C-2, C-4, C-6), 203.1 
(COCH3); HRESIMS (positive ionization mode), m/z 349.1430 [M+H]
+ (calc. for 
C22H21O4 349.1440); IR (KBr) ν 1619; 1593; 1271; 1171; 1104 cm-1. 
 
















The method of Hatakeyama et al., 2005 was used in the preparation of compound 392. 2,4-
Dibenzyloxy-6-hydroxyacetophenone (391) (6.2 g, 17.8 mmol) was dissolved in 50 ml 
DMF under nitrogen. The solution was cooled down to 0 °C (in an ice bath) and sodium 
hydride (1.28 g, 53.5 mmol) was slowly added while stirring. Benzaldehyde (2.2 ml, 21.4 
mmol) dissolved in 5 ml DMF was added dropwise. The reaction was stirred for a further 
45 minutes at 0 °C. It was quenched by the addition of ice and acidified with 1 M HCl 
(until blue litmus turned red). The bright yellow filtrate that was formed were filtered to 
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quantitatively (7.8 g) yield the product 392 that was recrystallised from hexanes:ethyl 
acetate to afford yellow plates: mp 120-122 °C, (lit. Drewes et al., 2008, 119°C); 1H NMR 
(CDCl3) δH 5.07 (2H, s, OCH2Ph), 5.12 (2H, s, OCH2Ph), 6.18 (1H, d, J = 2.3 Hz, H-3’), 
6.23 (1H, d, J = 2.3 Hz, H-5’), 7.06-7.51 (15H, m, ArH), 7.72 (1H, d, J = 15.7 Hz, H-7), 
7.88 (1H, d, J = 15.7 Hz, H-8), 14.6 (1H, s, ArOH); 13C NMR (CDCl3) δC 70.3 (OCH2Ph), 
71.4 (OCH2Ph), 92.5 (C-3’), 95.0 (C-5’), 106.3 (C-1’), 127.5 (C-8), 127.6, 128.4, 128.6, 
128.71, 128.75, 128.9 (ArC), 135.3, 135.4, 135.8 (C-1, OCH2CAr), 142.7 (C-7), 161.7 (C-
2’), 165.2 (C-4’), 168.8 (C-6’), 192.6 (C=O) (lit. Drewes et al., 2008); HRESIMS (positive 
ionization mode), m/z 437.1747 [M+H]+ (calc. for  C29H25O4  437.1753); IR (KBr) ν 1624; 
1344; 1226; 1207; 1155, 739 cm-1. 
 



















Chalcone 392 (630 mg, 1.44 mmol) was dissolved in acetic acid (40 ml) and refluxed for 6 
hours (Solladíe et al., 1999). The reaction was quench d by the addition of water (40 ml). 
The aqueous phase was extracted five times with dichloromethane. The organic phase was 
washed five times with ice water, the fractions combined and dried with magnesium 
sulphate and the solvent evaporated. Since the starting material was still present, the 
product was purified with a chromatotron using hexanes:ethyl acetate (14:1) to afford 393 
as a white solid  201 mg (32%). 
 
Alternative method: 
Chalcone 392 (7.69 g, 17.6 mmol) was dissolved in dichloromethane (50 ml) and stirred 
for 10 minutes before DBU (2.44 ml, 17.6 mmol) was added dropwise. The reaction was 
stirred for 2 days and was quenched by acidifying with 1 M HCl. The organic and aqueous 
layers were separated and the aqueous layer further extracted with dichloromethane. The 
organic layers were combined, washed with water and brine and dried over magnesium 
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sulphate. The solvent was evaporated and the product cleaned with a chromatotron using 
hexanes:ethyl acetate (14:1) as eluent to yield 3.8 g of compound 393 (49%) (2.5 g of 
chalcone 392 was recovered). Flavanone 393 was recrystallised from dichloromethane: 
hexanes to afford fine white needles: mp 122-124 °C (lit. Drewes et al., 2008, 115°C); 1H 
NMR (CDCl3) δH 2.81 (1H, dd, J = 16.6 Hz, 3.0 Hz, H-3a), 3.05 (1H, dd, J = 16.6 Hz, 13.3 
Hz, H-3b), 5.05 (2H, s, OCH2Ph), 5.17 (2H, s, OCH2Ph), 5.43 (1H, dd, J = 13.3 Hz, 3.0 Hz 
, H-2), 6.24 (1H, d, J = 2.3 Hz, H-6), 6.26 (1H, d, J = 2.3 Hz, H-8), 7.29-7.59 (15H, m, 
ArH); 13C NMR (CDCl3) δC 45.7 (C-3) 70.3 (OCH2Ph), 70.4 (OCH2Ph), 79.3 (C-2), 94.8 
(C-8), 95.2 (C-6), 106.5 (C-10), 126.2, 126.5, 127.6, 127.7, 128.4, 128.6, 128.69, 128.72, 
128.8 (ArC), 135.8, 136.4 (CH2CAr), 138.8 (C-1’), 161.1 (C-5), 164.9 (C-7, C-9), 188.9 
(C-4); HRESIMS (positive ionization mode), m/z 437.1772 [M+H]+ (calc. for  C29H25O4 
437.1753); IR (KBr) ν 1667; 1606; 1572; 1259; 1213; 1164; 1120; 696 cm-1. 
 

















The methods employed by Baldwin et al. (1986) and Haraldsson and Baldwin (1997) were 
employed for the deprotection of flavanone 393. Anhydrous ether (2 ml) and benzene (2 
ml) was added to magnesium turnings (80 mg, 3.3 mmol). The flask was cooled to 0 °C, 
and bromine (84 µl, 1.6 mmol) was added carefully. When the reaction has started 
(effervescence after the addition of a few drops of br mine), stirring was commenced and 
the addition of the bromine continued until complete. The ice bath was removed and the 
solution gently refluxed for several minutes until co ourless, and then allowed to cool. The 
magnesium bromide solution was then slowly added to the protected flavanone 393 (717 
mg, 1.6 mmol) in dry benzene (10 ml) at room temperature. During addition the reaction 
mixture was stirred very efficiently and after completion of the addition the reaction was 
refluxed overnight. The reaction was then cooled down and 1 M HCl (20 ml) was added 
and the resulting solution boiled for 30 minutes. The mixture was allowed to cool and 
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extracted with dichloromethane to yield 343 mg (50% C-benzylated 394 and 50% O-
debenzylated product 395 , yields approximated using NMR); 1H NMR (500 MHz, CDCl3) 
δH 2.87 (1H, dd, J = 17 Hz, 3 Hz, H-3a), 3.07 (1H, dd, J = 17 Hz, 13 Hz, H-3b), 3.97 (2H, 
dd, J = 14.4 Hz, CCH2Ph), 5.10 (2H, s, OCH2Ph), 5.43 (1H, dd, J = 13 Hz, 3.3 Hz, H-2), 
6.20 (1H, s, H-6 or H-8), 7.17-7.48 (10H, m, ArH), 12.18 (1H, s, OH); 13C NMR (125 
MHz, CDCl3) δC 28.4 (CCH2Ph), 70.4 (OCH2Ph), 78.8 (OCH2Ph), 93.7 (C-6 or C-8), 
125.6, 125.9, 127.3, 128.0, 128.1, 128.56, 128.59, 128.60, 128.75 (ArC), 135.8, 138.7, 
141.3 (C-1’, CH2CAr), 159.2, 162.9, 164.8 (C-5, C-7, C-9), 196.3 (CO H3); HRESIMS 
(negative ionization mode), m/z 435.1589 [M-H]- (calc. for  C29H23O4 435.1596). 
 



















The dibenzylated flavanone 393 (1.4 g, 3.2 mmol) was dissolved in dichloromethane:ethyl 
acetate (1:1) (10 ml). A 5% palladium on carbon catalyst was added and the reaction 
stirred at room temperature under an atmosphere of hydrogen (130 kPa) for 25 minutes. 
The catalyst was filtered off and the product cleaned with a chromatotron, using hexanes: 
ethyl actetate (14:1) as solvent system to yield 996 mg (90%) of 395 that was recrystallised 
from hexanes:ethyl acetate to afford colourless needles: mp 84-85 °C; 1H NMR (500 MHz, 
CDCl3) δH 2.82 (1H, dd, J = 17.1 Hz, 3.1 Hz, H-3a), 3.09 (1H, dd, J = 17.1 Hz, 13.0 Hz, 
H-3b), 5.07 (2H, s, OCH2Ph), 5.42 (1H, dd, J = 13.0 Hz, 3.0 Hz, H-2), 6.14 (1H, d J = 2.3 
Hz, H-6 or H-8), 6.16 (1H, d, J = 2.3 Hz, H-6 or H-8), 7.33-7.47 (10 H, m ArH), 12.0 (1H, 
s, ArOH); 13C NMR (125 MHz, CDCl3) δC 43.4 (C-3), 70.3 (OCH2Ph), 79.2 (C-2), 94.9, 
96.0 (C-6 and C-8), 103.3 (C-10), 126.1, 127.4, 128.3, 128.7, 128.8 (ArC), 135.7, 138.3 
(CH2CAr, C-1’), 162.8, 164.1, 167.0 (C-5, C-7, C-9), 195.7 (C-4); HRESIMS (positive 
ionization mode), m/z 347.1286 [M+H]+ (calc. for  C22H19O4 347.1283) IR (KBr) ν 1635; 
1574; 1374; 1301; 1160 cm-1. 
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N,N-Dimethylformamide (250 µl, 3.2 mmol) was cooled to 0 °C and distilled POCl3 (297 
µl, 3.2 mmol) was added. The light orange solution was stirred vigorously for 
approximately 20 minutes until the reagent solidified. Distilled acetonitrile (2 ml) was 
added until the white solid dissolved. The reaction mixture was stirred for a further 45 
minutes at room temperature under nitrogen. Flavanone 395 (552 mg, 1.6 mmol) in 
acetonitrile (2 ml) was added via syringe to the flask and the mixture was stirred for 18 h at 
room temperature, where after 5 ml of a 2:1 methanol:water solution was added for imine 
hydrolysis that occurred over 4 h at room temperature. The product was purified on a 
chromatotron with hexanes:ethyl acetate 14:1 as eluent. Compound 396 was obtained as 
the minor product (53.8 mg, 9% of cream solid). 1H NMR (500 MHz, CDCl3) δH 2.89 (1H, 
dd, J = 17.0 Hz, 3.1 Hz, H-3a), 3.12 (1H, dd, J = 17.0 Hz, 13.2 Hz, H-3b), 5.19 (2H, s, 
OCH2Ph), 5.50 (1H, dd, J = 13.2 Hz, 3.1 Hz, H-2), 6.14 (1H, s, H-8), 7.36-7.46 (10H, m, 
ArH), 10.34 (1H, s, CHO); 13C NMR (125 MHz, CDCl3) 71.0 (OCH2Ph), 79.9 (C-2), 92.4 
(C-8), 126.2, 127.2, 128.6, 128.9, 129.0, 129.2 (ArC), 134.8, 137.5 (C-1’, CH2CAr), 
HRESIMS (positive ionization mode), m/z 375.1227 [M+H]+ (calc. for C23H19O5 
375.12325). 
 



















N,N-Dimethylformamide (250 µl, 3.2 mmol) was cooled to 0 °C and distilled POCl3 (297 
µl, 3.2 mmol) was added. The light orange solution was stirred vigorously for 
approximately 20 minutes until the reagent solidified. Distilled acetonitrile (2 ml) was 
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added until the white solid dissolved. The reaction mixture was stirred for a further 45 
minutes at room temperature under nitrogen. Flavanone 395 (552 mg, 1.6 mmol) in 
acetonitrile (2 ml) was added via syringe to the flask and the mixture was stirred for 18 h at 
room temperature, where after 5 ml of a 2:1 methanol: water solution was added for imine 
hydrolysis that occurred over 4 h at room temperature. The product was purified on a 
chromatotron with hexanes: ethyl acetate 14:1 as eluent. Aldehyde 397 was obtained as an 
amorphous cream solid 195 mg (37 % yield). 1H NMR (500 MHz, CDCl3) δH 3.01 (1H, dd, 
J = 17.2 Hz, 3.6 Hz, H-3a), 3.13 (1H, dd, J = 17.2 Hz, 12.1 Hz, H-3b), 5.21 (2H, s, 
OCH2Ph), 5.62 (1H, dd, J = 12.1 Hz, 3.6 Hz, H-2), 6.17 (1H, s, H-6), 7.33 – 7.51 (10H, m, 
ArH), 10.39 (1H, s, CHO), 12.71 (1H, s, OH); 13C NMR (125 MHz, CDCl3) δC 42.3 (C-3), 
71.0 (OCH2Ph), 79.4 (C-2), 94.1 (C-6), 102.6 (C-10), 125.8, 127.0, 127.2, 127.3, 128.3, 
128.6, 128.8, 128.9, 129.0 (ArC), 135.1, 137.5 (C-1’, CH2CAr), 164.7, 167.9, 168.4 (C-5, 
C-7, C-9), 185.9 (C-4), 196.0 (CHO); HRESIMS (positive ionization mode), m/z 375.1218 
[M+H] + (calc. for C23H19O5 375.1232); IR (directly) ν 1683, 1628, 1572, 732, 693 cm-1. 
 





















Aldehyde 396 (50 mg, 0.2 mmol) was stirred overnight with pyridine (2 ml) and acetic 
anhydride (2 ml). Ice was added to the reaction and the precipitate washed with cold water 
to quantitatively yield 398 as a light brown solid: 1H NMR (500 MHz, CDCl3) δH 2.45 
(3H, s, COCH3), 2.80 (1H, dd, J = 16.6 Hz, 2.6 Hz, H-3a), 3.07 (1H, dd, J = 16.6 Hz, 13.3 
Hz, H-3b), 5.19 (1H, s, OCH2Ph), 5.52 (1H, dd, 13.3 Hz, 2.6 Hz, H-2), 6.57 (1H, s, H-8), 
7.37-7.47 (10H, m, ArH), 10.36 (1H, s, CHO); HRESIMS (negative ionization mode), m/z 

























Aldehyde 397 (100 mg, 0.3 mmol) was stirred overnight with pyridine (2 ml) and acetic 
anhydride (2 ml). Ice was added to the reaction and the precipitate washed with cold water 
to yield 98 mg (79%) of 399 as a light brown solid: 1H NMR (500 MHz, CDCl3) δH 2.41 
(3H, s, COCH3), 2.89 (1H, dd, J = 16.7 Hz, 3.1 Hz, H-3a), 3.04 (1H, dd, J = 16.7 Hz, 13.0 
Hz, H-3b), 5.23 (2H, s, OCH2Ph), 5.61 (1H, dd, J = 13.0 Hz, 3.1 Hz, H-2), 6.43 (1H, s, H-
6), 7.30-7.49 (10H, m, ArH), 10.48 (1H, s, CHO); HRESIMS (positive ionization mode), 
m/z 417.1348 [M+H]+ (calc. for C25H21O6 417.1338). 
 










β-keto-ester 384 (393 mg, 1.6 mmol) was dissolved in 80% acetic acid (10 ml) and stirred 
at 50 °C for 2 days (Reaction progress monitored by GC-MS). Cold water (10 ml) and 
ether (20 ml) was then added and the layers separatd. The aqueous layer was extracted 
twice more with ether. The ether layers were combined and the excess water removed with 
magnesium sulphate. The solvent was evaporated the product purified on the chromatotron 
with petroleum ether:ethyl acetate (19:1) to yield a yellow oil, 397 mg (67%) of 400: 1H 
NMR (500 MHz, CDCl3) δH 0.96 (3H, t, J = 7.2 Hz, H-7), 1.17 (3H, t, J = 7.2 Hz, 
OCH2CH3), 1.24 (3H, d, J = 7.1 Hz, 4-CH3), 2.41 (2H, dq, H-6), 3.41 (2H, dd, J = 15.8 Hz, 
H-2), 3.77 (1H, q, J = 7.0 Hz, H-4), 4.08 (2H, q, OCH2CH3); 
13C NMR (125 MHz, CDCl3) 
δC 7.5 (C-7), 12.6 (4-CH3), 14.0 (OCH2CH3), 34.7 (C-6), 47.7 (C-2), 60.0, 61.4, 
(OCH2CH3, C-4), 167.0 (C-1), 199.8 (C-3), 207.4 (C-5); GC-MS m/z 185.01 [M-15]
- 
(calculated for C9H13O4 185.08), RT = 16.07 min; IR (NaCl) ν 2984, 1727, 1259 cm-1. 
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To β-ketoester 400 (278 mg, 1.4 mmol) in benzene was added 1.2 equivalents of DBU 
(250 µl, 1.7 mmol). The mixture was refluxed overnight and quenched by acidifying with 1 
M HCl. The aqueous phase was extracted with ethyl acetate, the organic fractions 
combined and dried with magnesium sulphate. The product 313 mg (53%) was obtained 
after cleaning with a short silica column using hexanes and then ethyl acetate as eluents. It 
was recrystallised from dioxane to yield 401 as colourless needles: mp 112-113°C (lit.  
Kappe and Schmidt, 1970, 156-157°C;  lit. Ali et al., 1982, 155°C); 1H NMR (400 MHz, 
CDCl3) δH  1.19 (3H, t, J = 7.5 Hz, H-8), 1.93 (3H, s, H-9), 2.56 (2H, q, J = 7.5 Hz, H-7), 
5.70 (1H, s, H-3), 11.19 (1H, s, OH); 13C NMR (100 MHz, CDCl3) δC 9.0 (C-9), 11.4 (C-
8), 24.5 (C-7), 89.7 (C-3), 108.4 (C-5), 163.7 (C-6), 167.9 (C-4), 173.0 (C-2). (Ali et al., 
1982); HRESIMS (negative ionization mode), m/z 153.0550 [M-H]- (calc. for C8H9O3 
153.0552); IR (KBr) ν 1673, 1561, 1334, 762 cm-1. 
 















Lactone 401 (105 mg, 0.7 mmol) was dissolved in dioxane and a 37% solution of 
formaldehyde (277 µl, 3.4 mmol) and HCl (32%, 230 µl, 2 mmol) was added. The solution 
was stirred while HCl gas (H2SO4 added dropwise to NaCl) was bubbled through for 2 h at
room temperature. After completion, ice was added to the reaction mixture and the 
aqueous phase extracted with dichloromethane. The organic phase was washed with brine 
before drying with magnesium sulphate. The solvent was removed under vacuum to yield 
48 mg (22%) of 375 that was recrystallised from ethyl acetate to afford colourless plates: 
mp 191-193°C (lit. Kappe and Schmidt, 1970, 217-218 °C; lit. Ali et al., 1982, 218-220 
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°C); 1H NMR (400 MHz, CDCl3) δH 1.19 (6H, t, J = 7.5 Hz, H-7 (x2)), 1.96 (6H, s, H-9 
(x2)), 2.56 (4H, q, J = 7.5 Hz, H-7 (x2)), 3.54 (2H, s, H-10), 11.19 (2H, s, OH); 13C NMR 
(100 MHz, CDCl3) δC 9.4 (C-9), 11.6 (C-8), 19.1 (C-10), 24.3 (C-7), 101.7 (C-3), 108.8 
(C-5), 161.3 (C-6), 168.7 (C-4), 169.6 (C-2) (Ali et al., 1982, Appendino et al., 2007); 
HRESIMS (positive ionization mode), m/z 321.1331 [M+H]+ (calc. for C17H21O6 
321.1338); IR (KBr) ν 1672, 1561, 1334, 762 cm-1. 
 













Aldehyde 403 was prepared according to the method of Anderson et al. (2005). Anhydrous 
K2CO3 (3.6 g, 26.0 mmol), was added to a stirred solution of 2,4,6-trihydroxybenzaldehyde 
(2.0 g, 13.0 mmol) in DMF (20 ml). Benzyl bromide (3 ml, 26.0 mmol) was added 
dropwise to this solution and the reaction mixture was stirred overnight at 40 °C. The 
mixture was then diluted with ethyl acetate (40 ml)and water (40 ml). The aqueous and 
organic layers were separated and the aqueous layer further extracted with ethyl acetate. To 
ensure complete removal of the product, 40 ml of a 1 M HCl was added to the aqueous 
layer and it was again extracted with ethyl acetate.  The organic layers were combined and 
dried with magnesium sulphate before removal of the solvent under vacuum. The product 
was purified using column chromatography with hexanes:ethyl acetate (9:1) as eluent to 
yield 3.9 g of 403 as a white solid (89%) that was recrystallised from hexanes:ethyl acetate 
(9:1) to afford white needles: mp 82–83 °C; 1H NMR (500 MHz, CDCl3) δH 5.07 (2H, s, 
OCH2Ph), 5.08 (2H, s, OCH2Ph), 6.08 (1H, d, J = 2.0 Hz, H-3 or H-5), 6.11 (1H, d, J = 2.1 
Hz, H-3 or H-5), 7.36 –7.41 (10H, m, ArH), 10.2 (1H, s, CHO), 12.50 (1H, s, OH); 13C 
NMR (125 MHz, CDCl3) δC 70.4 (OCH2Ph), 70.5 (OCH2Ph), 92.3, 94.1 (C-3, C-5), 106.3 
(C-1), 127.4, 127.6, 128.36, 128.42, 128.71, 128.72, 135.57, 135.64 (ArC), 162.6, 166.3, 
167.1 (C-2, C-4, C-6), 191.9 (CHO); HRESIMS (positive ionization mode), m/z 335.1272 
[M+H] + (calc. for  C21H19O4 335.12833); IR (KBr) ν 1644; 1621; 1579; 1279; 1225; 1204; 
1160; 1113; 734 cm-1. 
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For the method of preparation see compound 403. After column chromatography 276 mg 
(5%) of compound 404 was obtained The compound was recrystallised from petroleum 
ether:dichloromethane to afford colourless needles: mp 113-114 °C; 1H NMR (500 MHz, 
CDCl3) δH 5.03 (2H, s, OCH2Ph), 5.14 (4H, s, OCH2Ph), 6.22 (2H, s, H-3, H-5), 7.32 –
7.46 (15H, m, ArH), 10.5 (1H, s, CHO); 13C NMR (125 MHz, CDCl3); δC 70.3 (OCH2Ph), 
70.6 (OCH2Ph), 93.0 (C-3, C-5), 126.9, 127.5, 128.0, 128.4, 128.6, 128.7 (ArC), 135.7, 
136.1 (CH2CAr), 162.6, 164.9, 167.3 (C-2, C-4, C-6), 187.5 (CHO); HRESIMS (positive 
ionization mode), m/z 425.1747 [M+H]+ (calc. for  C28H25O4 425.1753); IR (KBr) ν 1599, 
1236, 1101 cm-1. 
 















2,4-Dibenzyloxy-6-hydroxyabenzaldehyde 403 (205 mg, 0.6 mmol) was refluxed in acetic 
anhydride for 1.5 h. The excess acetic anhydride was removed in vacuo and the crude 
product purified with hexanes:ethyl acetate (9:1) on the chromatotron to yield 96 mg 
(43%) of 405  as amorphous solid: 1H NMR (500 MHz, CDCl3) δ 2.37 (3H, s, OCOCH3), 
5.07 (2H, s, OCH2Ph), 5.11 (2H, s, OCH2Ph, benzyl group on C-2), 6.32 (1H, d, J = 2.2 
Hz, H-5), 6.52 (1H, d, 2.15 Hz, H-3), 7.38 –7.41 (10H, m, ArH), 10.33 (1H, s, CHO); 
HRESIMS (positive ionization mode), m/z 377.1398 [M+H]+ (calc. For C23H21O  
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377.1389). Arrows indicating NOESY correlations used to determine positions of 
benzyloxy groups. 
 










The dibenzylated aldehyde 403 (2 g, 6.0 mmol) was dissolved in 45 ml DMF and stirred 
under nitrogen. Anhydrous potassium carbonate (2.5 g, 18.0 mmol) and 2-bromopropane 
(2 ml, 21.0 mmol) was added. The reaction was stirred for 2 days at 80 - 90 °C and then 
cooled down. It was quenched by the addition of 1 M HCl (until reaction mixture was 
acidic, blue litmus turned red) and 40 ml water. The aqueous layer was extracted five times 
with ethyl acetate. The organic layer was washed copiously with water before drying with 
magnesium sulphate. The solvent was removed under vacuum and the product purified 
with column chromatography using successively hexans:ethyl acetate 9:1, 8:2 and 2:1 to 
afford 1.6 g (71%) of 406 that  was recrystallised from hexanes:ethyl acetate to yield white 
needles: mp 80°C; 1H NMR (400 MHz, CDCl3) δH 1.36 (6H, d, J = 6.1 Hz, CH(CH3)2), 
4.54 (1H, heptet, J = 6.1 Hz, CH(CH3)2), 5.06 (2H, s, OCH2Ph),  5.13 (2H, s, OCH2Ph), 
6.16 (1H, d, J = 2.2 Hz, H-3 or H-5), 6.19 (1H, d, J = 2.2 Hz, H-3 or H-5), 7.29 – 7.48 
(10H, m CH2ArH), 10.42 (CHO); 
13C NMR (100 MHz, CDCl3) δC 22.0 (CH(CH3)2), 70.3, 
70.6, 71.8 (OCH2Ph, (CH(CH3)2), 92.8, 93.9 (C-3, C-5), 110.6 (C-1), 126.9, 127.5, 127.9, 
128.4, 128.6, 128.8 (ArC), 136.0, 136.4 (CH2CAr), 162.5, 163.0, 164.8 (C-2, C-4, C-6), 
187.8 (C=O); HRESIMS (positive ionisation mode), m/z 377.1747 [M+H]+ (calc. for 
C24H25O4377.1753). IR (KBr) ν 2981, 1709, 1604, 1250, 1119 cm-1. 
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Aldehyde 406 (1.6 g, 4.3 mmol) was dissolved in 20 ml toluene. Diethylmalonate (695 mg, 
4.3 mmol), acetic acid (69 mg, 1.2 mmol) and pyrrolidine (40 µL, 0.5 mmol) were added 
to this solution. The reaction was refluxed for 4 h and then cooled. The reaction was 
quenched by the addition of 20 ml water. The organic d aqueous phases were separated 
and the aqueous layer was extracted twice with ethyl acetate. The organic layers were 
combined and washed twice with water before drying with magnesium sulphate. The 
solvent was evaporated and the product purified with column chromatograpy using eluents 
with increasing polarity, hexanes:ethyl acetate 9:1, 8 2, 2:1 to afford 1.38 g (63%) of 407 
as solid that was recrystallised from hexanes:ethyl acetate to afford white needles: mp 77-
78 °C; 1H NMR (400 MHz, CDCl3) δH 1.12 (3H, t, J = 7.1 Hz, OCH2CH3), 1.30 (6H, d, J = 
6.1 Hz, CH(CH3)2), 1.32 (3H, t, J = 7.1 Hz, OCH2CH3), 4.11 (2H, q, J = 7.1 Hz, 
OCH2CH3), 4.29 (2H, q, J = 7.1 Hz, OCH2CH3), 4.44 (1H, heptet, J = 6.1 Hz, CH(CH3)2), 
4.99 (2H, s, OCH2Ph), 5.07 (2H, s, OCH2Ph), 6.16 (1H, d, J = 2.2 Hz, H-3 or H-5),  6.18 
(1H, d, J =2.2 Hz, H-3 or H-5), 7.27 – 7.40 (10H, m CH2ArH), 7.96 (1H, s, CH=C); 
13C 
NMR (100 MHz, CDCl3) δC 13.9 (OCH2CH3), 14.2 (OCH2CH3), 22.0 (CH(CH3)2), 60.4 
OCH2CH3), 61.0 (OCH2CH3), 70.2, 70.6, 72.3 (OCH2Ph, (CH(CH3)2), 93.3, 94.7 (C-3, C-
5), 108.1 (C-1), 125.7, 126.0, 126.9, 127.5, 127.8, 12 .2, 128.5, 128.7, 136.4, 136.6, 137.7 
(ArC, CH=C), 158.4, 158.7, 161.9 (C-2, C-4,C-6), 165.8, 166.1 (COOEt); HRESIMS 
(positive ionisation mode), m/z 519.2368 [M+H]+ (calc. for C31H35O7 519.2383); IR (KBr) 
ν 1711, 1604, 1227, 1102 cm-1. 
 












Alkene 407 (1.3 g, 2.6 mmol) was dissolved in 10 ml ethanol:methanol (1:1). The solution 
was stirred and sodium borohydride (390 mg, 10.3 mmol) was added portion wise. The 
reaction was refluxed for 6 h, cooled down and quench d by the addition of 2 ml of a 1 M 
HCl solution. The solvent was removed under vacuum, and the residue diluted with ethyl 
acetate. This fraction was washed three times with ater and dried over magnesium 
sulphate before removal of the solvent. The product was purified using a chromatotron and 
a mobile phase consisting of hexanes:ethyl acetate 9:1 to afford 635 mg (50%) of 408 as 
yellow gum: 1H NMR (400 MHz, CDCl3) δH 1.12 (3H, t, J = 7.0 Hz, CH2CH3), 1.28 (3H, 
d, J = 6.2 Hz, CH(CH3)2), 1.30 (3H, d, J = 6.2 Hz, CH(CH3)2), 3.29 (2H, dd, J = 7.5 Hz, 
3.6 Hz, CHCH2), 3.77 (1H, t, J = 7.5 Hz, CHCH2), 4.07 (2H, q, J = 7.0 Hz, CH2CH3), 4.47 
(1H, heptet, J = 6.2 Hz, CH(CH3)2), 4.99 (2H, s, OCH2Ph), 5.01 (2H, s, OCH2Ph), 6.17 
(1H, d, J =2.2 Hz, H-3 or H-5), 6.21 (1H, d, J =2.2 Hz, H-3 or H-5), 7.28-7.42 (10H, m, 
ArH); 13C NMR (100 MHz, CDCl3) δC 13.9 (CH2CH3), 21.9 (CHCH2), 22.1 (CH(CH3)2), 
50.7 (CHCH2), 61.4 (CH2CH3), 70.15, 70.22, 70.24 (OCH2Ph, (CH(CH3)2), 92.4, 93.6 (C-
3, C-5), 107.8 (C-1), 126.0, 127.0, 127.5, 127.7, 128.0, 128.5, 128.6, 128.7, 128.9 (ArC), 
137.0, 137.1 (CH2CAr), 157.4, 158.3, 159.2 (C-2, C-4, C-6), 170.4 (COOEt), 173.8 
(COOH); HRESIMS (positive ionisation mode), m/z 493.2215 [M+H]+ (calc. for C29H33O7 
493.2226); IR (KBr) ν 1711, 1605, 1234, 1151, 1112 cm-1. 
 













Alkene 407 (1.3 g, 2.6 mmol) was dissolved in 10 ml ethanol:methanol (1:1). The solution 
was stirred and sodium borohydride (390 mg, 10.3 mmol) was slowly added where after 
the reaction was refluxed for 6 h. The reaction wasquenched by the addition of 2 ml of a 1 
M HCl solution. The organic solvent was removed under vacuum, and the residue diluted 
with ethyl acetate. The organic fraction was washed t ree times with water and dried over 
magnesium sulphate before removal of the solvent. The product was purified using a 
chromatotron and a mobile phase consisting of hexanes:ethyl acetate 9:1 to yield 409 
(28%) as a yellow gum: 1H NMR (500 MHz, CDCl3) δH 1.35 (6H, d, J = 6.1 Hz, 
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CH(CH3)2), 3.36 (2H, d, J = 7.5 Hz, CHCH2), 3.65 (6H, s, OCH3), 3.84 (1H, t, J = 7.5 Hz, 
CHCH2), 4.51 (1H, heptet, J = 6.1 Hz, CH(CH3)2), 5.03 (2H, s, OCH2Ph), 5.06 (2H, s, 
OCH2Ph), 6.23  (1H, d, J = 2.2 Hz, H-3 or H-5), 6.26 (1H, d  J = 2.2 Hz, H-3 or H-5), 7.34 
– 7.47 (10, m, ArH); 13C NMR (125 MHz, CDCl3) δC 21.9 (CH(CH3)2), 22.7 (CHCH2), 
50.9 (CHCH2), 52.0 (OCH3), 70.17 (CH(CH3)2), 70.22 (OCH2Ph), 92.4, 93.6 (C-3, C-5), 
108.1 (C-1), 126.8, 127.4, 127.6, 127.9, 128.3, 128.4 (ArC), 136.8, 137.0 (CH2CAr), 
157.2, 158.1, 158.9 (C-2, C-4, C-6), 169.9 (C=O); HRESIMS (positive ionisation mode), 
m/z 493.2242 [M+H]+ (calc. for C29H33O7 493.22263); IR (KBr) ν 1733, 1602, 1151, 1100 
cm-1. 
 













Di-ester 409 (320 mg, 0.7 mmol) was dissolved in 19 ml ethanol and 1 ml water. Sodium 
hydroxide (54 mg, 1.4 mmol) was added and the reaction refluxed for 6 h. The ethanol was 
removed under vacuum and the residue diluted with ethyl acetate (10 ml). After the 
addition of 10 ml of a 1 M HCl solution and 10 ml water, the organic and aqueous layers 
were separated. The aqueous layer was extracted four times with ethyl acetate. The ethyl 
acetate layers were combined and washed twice with wa er and brine. It was dried using 
magnesium sulphate and the solvent evaporated under vacuum to afford 410 as white solid 
250 mg (83%) (Wu et al., 2004): 1H NMR (500 MHz, CD3OD) δH 1.28 (6H, d, J = 6.0 Hz, 
CH(CH3)2), 3.21 (2H, d, J = 6.9 Hz, CHCH2), 3.67 (1H, t, J = 6.9 Hz, CHCH2), 4.50 (1H, 
heptet, J = 6.0 Hz, CH(CH3)2), 5.00 (2H, s, OCH2Ph),  5.03 (2H, s, OCH2), 6.21 (1H, d, J 
= 2.2 Hz, H-3 or H-5), 6.26 (1H, d, J = 2.2 Hz, H-3 or H-5), 7.26-7.44 (10H, m, ArH); 13C 
NMR (125 MHz, CD3OD) δC 19.4 CH(CH3)2, 20.9 CHCH2, 49.7 (CHCH2), 68.1 
(CH(CH3)2), 68.3 (OCH2Ph), 68.4 (OCH2Ph), 91.0, 91.9 (C-3, C-5), 106.7 (C-1), 125.3, 
125.6, 125.7, 125.9, 126.5, 126.6 (ArC), 135.9, 136.0 (CH2CAr), 155.6, 156.7, 157.5 (C-2, 
C-4, C-6), 170.6 (C=O); HRESIMS (positive ionisation mode), m/z 465.1926 [M+H]+ 
(calc. for C27H29O7 465.1913); IR 9KBr) ν 1702, 1588, 1096 cm-1. 
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To phenol (500 mg, 5.3 mmol) and HCl (3.52 g, 11 ml, 98.0 mmol) in acetonitrile (20 ml) 
in a 100 ml flat bottomed flask, H2O2 (30% v/v, 4.5 g, 15 ml, 0.1 mol) was added dropwise 
(15 minutes) at room temperature.  The solution wasstirred for 4 h and then poured into 
ice cold water. The aqueous phase was extracted with ethyl acetate, the organic phase 
washed with brine and dried with magnesium sulphate to afford 746 mg of 411 as cream 
solid (73%)  (Bhatkhande et al., 2002). The product was recrystallised from chloroform to 
afford white needles: mp 63°C (lit. Bhatkhande et al., 2002, 64-65 °C); 1H NMR (400 
MHz, CDCl3) δH 5.80 (2H, s); 13C NMR (100 MHz, CDCl3) δC 121.6, 125.4, 128.1, 146.9; 
HRESIMS (negative ionization mode), m/z 194.9168 [M-H]- (calc. for C6H2Cl3O 
194.9171). 
 










Aldehyde 406 (1 g, 2.7 mmol) was dissolved in 5 ml dichloromethane and 4 ml ethanol. 
The solution was cooled down to 0 °C in an ice bath before sodium borohydride (151 mg,
4.0 mmol) was slowly added. The reaction was stirred for 1 h at 0 °C before quenching it 
by the addition of brine (10 ml). The aqueous and organic layers were separated, and the 
aqueous layer extracted with dichloromethane (4 x). The dichloromethane layers were 
combined and washed with water (2 x) and brine (2 x) before drying with MgSO4. The 
solvent was evaporated and the white solid 413, 905 mg (90%) was used as is in the next 
step. NB: Do not quench the reaction with acid, as it results in a mixture of products and 
decreases the yield for the reaction: 1H NMR (400 MHz, CDCl3) δH 1.22 (6H, d, J = 6.0 
Hz, CH(CH3)2, 4.39 (1H, heptet, J = 6.0 Hz, CH(CH3)2), 4.66 (2H, s, CH2OH), 4.91 (2H, s, 
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OCH2Ph), 4.93 (2H, s, OCH2Ph), 6.12 (1H, d, J = 2.1 Hz, H-3 or H-5), 6.16 (1H, d, J = 2.1 
Hz, H-3 or H-5), 7.19-7.32 (10H, m, ArH); 13C NMR (100 MHz, CDCl3) δC 22.1 
((CH3)2CH), 54.9 (CH2OH), 70.2, 70.4, 70.9 (OCH2Ph, OCH(CH3)2), 93.0 , 94.4 (C-3, C-
5), 112.0 (C-1). 127.2, 127.4, 127.9, 128.0, 128.5, 128.6, 136.7 (ArC), 157.5, 158.2, 159.8 
(C-2, C-4, C-6); HRESIMS (negative ionisation mode), m/z 377.1748 [M-H]- (calc. for 














Tin(IV)chloride (SnCl4, 195 µl, 0.6 mmol) and acetyl chloride (53 µl, 0.7 mmol) was added 
dropwise at -10 °C to a stirring solution of aldehyde 406 in dry CH2Cl2. The reaction 
mixture was stirred until completion (monitored by TLC) and poured on ice. The separated 
aqueous phase was extracted with dichloromethane and the combined organic phases 
washed with saturated sodium bicarbonate, dried over anhydrous magnesium sulphate and 
the solvent evaporated to afford  compound 414 as part of a mixture: 1H NMR (400 MHz, 
CDCl3) δH 1.41 (6H, d, J = 6.16 Hz, CH(CH3)2), 2.71 (3H, s, CH3O), 4.68 (1H, heptet, J = 
6.10 Hz, CH(CH3)2, 5.90 (1H, s, ArH), 10.03 (1H, s, CHO), 14.57 (1H, s, OH), 14.85 (1H, 


















Aldehyde 406 (870 mg, 2.3 mmol) was dissolved in 20 ml toluene. Ester 384 (577 mg, 2.4 
mmol), acetic acid (40 µl, 0.6 mmol) and pyrrolidine (22 µL, 0.3 mmol) were added to this 
solution. The reaction was refluxed for 4 h and then cooled. The reaction was quenched by 
the addition of 20 ml water. The organic and aqueous phases were separated and the 
aqueous layer was extracted twice with ethyl acetate. The organic layers were combined 
and washed twice with water before drying with magnesium sulphate. The solvent was 
evaporated and the product purified with column chromatograpy using hexanes:ethyl 
acetate 9:1 as eluent to afford 388 mg (28%) of brown gum that contained 415 as major 
component: 1H NMR (400 MHz, CDCl3) δH 0.84 (3H, t, J = 7.3 Hz, CCH2CH3), 1.07 (3H, 
t, J = 7.2 Hz, OCH2CH3), 1.14 (3H, d, J = 6.8 Hz, CHCH3), 1.21 (3H, d, J = 6.1 Hz, 
CH(CH3)2), 1.27 (3H, d, J = 6.14 Hz, CH(CH3)2), 1.67 (2H, m, CCH2CH3), 3.78 (4H, m, 
OCH2CH2O), 3.83 (1H, m, CHCH3), 4.05 (2H, m, OCH2CH3), 4.41 (1H, heptet, J = 6.1 
Hz, CH(CH3)2), 5.01 (4H, br s, OCH2Ph), 6.16 (1H, d, J = 2.1 Hz, H-3 or H-5), 6.19 (1H, 
d, J = 2.1 Hz, H-3 or H-5), 7.28-7.39 (10H, m, ArH), 7.67 (1H, s, CH=C); 13C NMR (100 
MHz, CDCl3) δC 7.2 (CCH2CH3), 12.2 (CHCH3), 14.0 (OCH2CH3), 21.7, 21.9 (CH(CH3)2), 
28.4 (CCH2CH3), 47.8 (CHCH3), 60.1 (OCH2CH3), 65.2, 65.4 (OCH2CH2O), 70.1, 70.5 
(OCH2Ph), 72.0 (CH(CH3)2), 93.1, 94.6 (C-3, C-5), 107.5 (C-1), 112.7 (OC), 126.9, 
127.1, 127.3, 127.4, 127.7, 128.0, 128.3, 128.3, 128.4, 128.52, 128.54 (ArC, CH=C), 136.6 
(C=CH)*, 136.47, 136.43 (CH2CAr)*, 157.4, 158.3, 161.5 (C-2, 4, 6), 167.4 (ester), 200.3 
(ketone); HRESIMS (positive ionisation mode), m/z 603.2946 [M+H]+ (calc. for C36H43O8 
603.2958); IR (KBr) ν 2980, 1700, 1600, 1156, 1101 cm-1.*Signals interchangeable. 
 










The product was prepared according to the method of Graybill et al. (1999). N,N-
Dimethylformamide (553 µl, 7.1 mmol) was cooled to 0 °C and distilled POCl3 (665 µl, 
7.1 mmol) was added. The light orange solution was stirred for approximately 20 minutes 
until the reagent solidified. Distilled acetonitrile (5 ml) was added until the white solid 
dissolved. The reaction mixture was stirred for a further 45 minutes at room temperature 
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under nitrogen. Ketone 377 (1.66 g, 4.8 mmol) in acetonitrile (5 ml) was adde via syringe 
to the flask and the mixture was stirred for 18 h at room temperature. Imine hydrolysis in 
2:1 methanol: water (20 ml) took place over 4 h at room temperature. The solution was 
concentrated and chromatographed on a silica column eluting with increasing polarity 
using hexanes: ethyl acetate 9:1, 8:2, 2:1, 1:1 as mobile phase to yield a cream solid 758 
mg (42%) that was recrystallised from hexanes: ethyl acetate to afford  colourless needles: 
mp 135 -136°C; 1H NMR (400 MHz, CDCl3) δH 2.51 (3H, s, CH3CO), 5.12 (2H, s, 
CH2OPh), 5.13 (2H, s, CH2OPh), 6.05 (1H, s, H-5), 7.34-7.40 (10H, m, ArH), 10.26 (1H, s, 
CHO), 13.34 (1H, s, ArOH); 13C NMR (100 MHz, CDCl3) δC 32.7 (CH3CO), 70.8 
(CH2OPh), 71.0 (CH2OPh), 88.9 (C-5), 106.6 (C-1, C-3), 127.2, 127.3, 128.6, 128.9, 
135.1, 135.2, 164.5, 164.6 (C-2, C-4, C-6), 190.7 (CHO), 200.5 (CH3CO); HRESIMS 
(positive ionisation mode), m/z 377.1386 [M+H]+ (calc. for C23H21O5 377.1389); IR (KBr) 













The dibenzylated keto-aldehyde 416 (1.5 g, 4.0 mmol) was dissolved in 30 ml DMF and 
stirred under nitrogen. Anhydrous potassium carbonate (1.64 g, 11.9 mmol) and 2-
bromopropane (1 ml, 11.9 mmol) was added. The reaction was stirred for 18 hours at 80 -
90 °C and then cooled down. It was quenched by the addition of ice (approximately 30 ml). 
The aqueous layer was extracted five times with CH2Cl2. The dichloromethane layers were 
combined and washed with water (copiously) and brine before drying with anhydrous 
magnesium sulphate. The solvent was removed under vacuum and the product purified 
with column chromatography using hexanes:ethyl acetate 9:1 to afford 970 mg (58%) of 
417 as yellow gum: 1H NMR (400 MHz, CDCl3) δH 1.23 (6H, d, J = 6.10 Hz, CH(CH3)2), 
2.45 (3H, s, CH3CO), 4.31 (1H, heptet, J = 6.11 Hz, CH(CH3)2), 5.06 (2H, s, CH2OPh), 
5.11 ((2H, s, CH2OPh), 6.35 (1H, s, H-5), 7.29-7.40 (10H, m, ArH), 10.34 (1H, s, CHO); 
13C NMR (100 MHz, CDCl3) δC 21.9 (CH(CH3)2), 32.4 (CH3CO), 70.5, 70.8 (CH2OPh), 
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79.4 (CH(CH3)2), 93.8 (C-5), 113.6, 120.4 (C-1, C-3), 126.2, 126.7, 126.87, 126.89, 
128.09, 128.15, 128.6, 128.8, 129.3, 130.2 (ArC), 158.6, 160.6, 163.1 (C-2, C-4, C-6), 
187.3 (CHO), 200.8 (CH3CO); HRESIMS (positive ionisation mode), m/z 419.1870 
[M+H] + (calc. for C26H27O5 419.1858); IR (KBr) ν 1675, 1583, 1385, 1167, 1094 cm-1. 
 










Sodium borohydride (400 mg, 10.6 mmol) was dissolved in 7 ml dichloromethane and 3 
ml ethanol and the solution cooled down to -78 °C. The aldehyde (870 mg, 2.1 mmol) was 
dissolved in 7 ml dichloromethane and 3 ml ethanol and added dropwise to the sodium 
borohydride solution. The reaction was stirred for 1 h at 0 °C before quenching it by the 
addition of brine (10 ml). The aqueous and organic layers were separated, and the aqueous 
layer further extracted with dichloromethane (4 x).The dichloromethane layers were 
combined and washed with water (2 x) and brine (2 x) before drying with MgSO4. The 
product 47 mg (62%) was used as is in the next step. It wascry tallised  from 
hexanes:ethyl acetate to afford 418 as fine white needles: mp 112-114°C; 1H NMR (400 
MHz, CDCl3) δH 1.26 (6H, d, J = 6.04 Hz, CH(CH3)2), 2.49 (3H, s, CH3CO), 4.25 (1H, 
heptet, J = 6.00 Hz, CH(CH3)2), 4.71 (2H, s, CH2OH), 5.03 (2H, s, CH2OPh), 5.06 (2H, s, 
CH2OPh), 6.38 (1H, s, H-5), 7.30-7.39 (10H, m, ArH); 
13C NMR (100 MHz, CDCl3) δC 
22.1 (CH(CH3)2), 32.4 (CH3CO), 55.4 (CH2OH), 70.5, 70.7 (CH2OPh), 78.4 (CH(CH3)2), 
94.2 (C-5), 116.7, 119.8 (C-1, C-3), 127.0, 127.1, 127.9, 128.2, 128.5, 128.6, 136.0, 136.2 
(ArC), 154.4, 156.0, 159.1 9c-2, C-4, C-6), 201.7 (CH3 O); HRESIMS (positive ionisation 
mode), m/z 421.2025 [M+H]+ (calc. for C26H29O5 421.2015); IR (KBr) ν 2977, 1684, 1594, 













Alcohol 418 (500 mg, 1.2 mmol) was dissolved in 2 ml ethanol and hydrobromic acid 
(48%, 1 ml) was added at 0 - 5 °C, where after the reaction mixture was stirred overnight at 
room temperature. The reaction was quenched by the addition of ice and the mixture 
extracted with dichloromethane (3 x 20 ml). The organic layer was washed with NaHCO3, 
water, brine and dried over anhydrous MgSO4. The solvent was removed under reduced 
pressure and the residue chromatographed  with a chromatotron using hexanes:ethyl 
acetate 9:1 as eluent (Kumar et al., 2005) to yield a white solid  353 mg (66%) 419 that 
was recrystallised from hexanes:ethyl acetate to afford ine white needles: mp 51-53°C; 1H 
NMR (400 MHz, CDCl3) δH 1.21 (3H, t, J = 7.04 Hz, OCH2CH3), 1.25 (6H, d, J = 6.01 Hz, 
CH(CH3)2), 2.49 (3H, s, CH3CO), 3.57 (2H, q, J = 7.01 Hz, OCH2CH3), 4.33 (1H, heptet, 
CH(CH3)2), 6.03 Hz, 4.49 (2H, s, CH2OEt), 5.04 (2H, s, OCH2Ph), 5.06 (2H, s, OCH2Ph), 
6.34 (1H, s, H-5), 7.30-7.43 (10H, m, ArH); 13C NMR (100 MHz, CDCl3) δC 15.1 
(CH2CH3), 22.2 (CH(CH3)2), 32.5 (CH3CO), 61.5 (CH2OCH2CH3), 65.7 (CH2OCH2CH3), 
7.03,  70.6 (CH2OPh), 78.3 (CH(CH3)2), 94.3 (C-5), 114.2, 119.9 (C-1, C-3), 127.0, 
127.86, 127.84, 128.4, 128.46, 128.52, 136.3, 136.6 (ArC), 155.7, 156.3, 159.9 (C-2, C-4, 
C-6), 201.9 (C=O); HRESIMS (negative ionisation mode), m/z 447.2167 [M-H]- (calc. for 
C28H31O5 447.2171); IR (KBr) ν 1711, 1604, 1576, 1227, 1102 cm-1. 
 











To a chilled solution of alcohol 418 (300 mg, 0.7 mmol) in dry CH2Cl2 (2 ml) was added 
dropwise under stirring a solution of SOCl2 (0.09 ml, 1.8 mmol) dissolved in dry CH2Cl2 
(2 ml). The reaction was stirred at 0 °C for approximately 45 minutes (followed by TLC) 
until all the starting material was consumed. The solvent and unreacted SOCl2 was 
removed under vacuum and the resulting precipitate dissolved in dry THF. The crude 
product 420 was used without purification in the next step (Amato et al., 2007). 
Quantitative (100%), crude used in next step: 1H NMR (400 MHz, CDCl3) δH 1.28 (6H, d, 
J = 6.02 Hz, CH(CH3)2), 2.48 (3H, s, CH3CO), 4.34 (1H, heptet, J = 6.01 Hz, CH(CH3)2), 
4.72 (2H, s, CH2Cl), 5.02 (2H, s, CH2OPh), 5.10 (2H, s, CH2OPh), 6.33 (1H, s, H-5), 7.31-
7.45 (10H, m, ArH); 13C NMR (100 MHz, CDCl3) δC 22.3 (CH(CH3)2), 32.5 (CH3CO), 
36.6 (CH2Cl), 70.4, 70.8 (CH2OPh), 78.0 (CH(CH3)2), 94.0 (C-5), 113.6, 119.4 (C-1, C-3), 
127.0, 127.1, 128.0, 128.1, 128.6, 136.1, 136.2 (ArC), 155.0, 157.0, 159.3 (C-2, C-4, C-6), 
201.5 (C=O); HRESIMS (positive ionisation mode), m/z 439.1675 [M+H]+ (calc. for 
C26H28O4Cl 439.1676); IR (KBr) ν 1700, 1597, 1168, 1097, 734 cm-1. 
 
















The alcohol 418 (300 mg, 0.7 mmol) was dissolved in 2 ml dry dichloromethane. The 
solution was cooled down to 0 °C in an ice bath and SOCl2 (0.09 ml, 1.8 mmol) dissolved 
in 2 ml dry dichloromethane added dropwise. The reaction was stirred at 0 °C for 
approximately 45 minutes (followed by TLC) until althe starting material was consumed. 
The solvent and unreacted SOCl2 was removed under vacuum and the resulting precipitate 
dissolved in dry THF.  
 
Diisopropyl amine (0.2 ml, 1.4 mmol) was dissolved in 2 ml dry THF and the solution 
cooled down to -78 °C. Butyl lithium (0.95 ml, 1.4 mmol) was slowly added while stirring 
and the solution allowed to warm up to 0 °C. The solution was allowed to stir for 30 
minutes at this temperature to allow the LDA to form and then cooled down to -78 °C 
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again. Diethyl malonate (0.13 ml, 0.9 mmol) was dissolved in 2 ml dry THF and added 
dropwise to the LDA solution. The reaction mixture was stirred for 30 minutes while the 
temperature was allowed to rise to 0 °C. The solution was cooled to -10 °C and the 
chloride, dissolved in THF added. The reaction was stirred at room temperature for 2 days. 
The THF was evaporated and the crude product purified on a chromatotron using 
hexanes:ethyl acetate 4:1 as eluent to afford 421 as cream solid 214 mg (54%) (over 2 
steps). It was recrystalised from acetone to afford cream needles: mp 97-99°C; 1H NMR 
(400 MHz, CDCl3) δH 1.17 (6H, t, J = 7.11 Hz, OCH2CH3), 1.22 (6H, d, J = 6.04 Hz,  
CH(CH3)2), 2.45 (3H, s, CH3CO), 3.27 (2H, d, J = 7.47 Hz, CHCH2,), 3.77 (1H, t, J = 7.47 
Hz, CHCH2,), 4.10 (4H, dd, J = 7.2 Hz, 1.52 Hz, OCH2CH3), 4.14 (1H, heptet, J = 6.08 
Hz, CH(CH3)2), 4.99 (2H, s, CH2OPh), 5.03 (2H, s, CH2OPh), 6.30 (1H, s, H-5), 7.30-7.39 
(10H, m, ArH); 13C NMR (100 MHz, CDCl3) δC 13.9 (OCH2CH3), 22.2 (CH(CH3)2), 23.5 
(CHCH2), 32.4 (CH3CO), 51.3 (CHCH2), 61.07 (OCH2CH3), 70.4, 70.8 (CH2OPh), 77.7 
(CH(CH3)2), 94.2 (C-5), 113.9, 119.6 (C-1, C-3), 127.0, 127., 127.9, 128.0, 128.5, 128.6, 
136.5 (ArC), 154.9, 155.2, 158.7 (C-2, C-4, C-6), 169.4 (COOEt), 202.0 (CH3CO); 
HRESIMS (positive ionisation mode), m/z 563.2643 [M+H]+ (calc. for C33H39O8 
563.2645); IR ν 1735, 1686, 1596, 1254, 1100 cm-1. 
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Species from the morphologically diverse genus Helichrysum are used extensively in 
ethnomedicine in South Africa. The morphological diversity of the genus is mirrored by 
the variety of chemical compounds isolated from its species, which include diterpenes, 
flavonoids, guaianolides, acylated phloroglucinols, and α-pyrone derivatives (Chapter 2). 
Extracts and isolated compounds from this genus are also associated with a variety of 
biological activities. These facts indicate that plants from this genus may be important in 
the search for new plant-derived drugs. 
 
Interesting observations were made regarding correlations observed between morphology 
and traditional use as well as phytochemistry of the South African species: There are 
indications that morphological relationships can serve as a guide towards expected 
phytochemical composition of related species.  
 
Three Helichrysum species were investigated during this study. H. splendidum, a species 
previously studied by Bolmann and Suwita (1979) andJakupovic and co-workers (1989) 
was reinvestigated to clarify the complex stereochemistry associated with its main 
chemical constituents. The phytochemistry of the morph logically related H. montanum 
was explored for the first time. New guaianolides, diastereomers of those found in H.
splendidum were isolated, while several known compounds were also identified. The 
phytochemical similarities observed between H. montanum and H. splendidum supports 
their close morphological relationship. Furthermore, the isolation of guaianolides from H. 
montanum are of taxonomical importance as this type of compund very rarely occur in 
plants of this genus (Jakupovic et al., 1989).  
 
In antimicrobial and cytotoxicity assays, extracts of the thirty-five Helichrysum species 
that were assayed exhibited activity mostly against Gram-positive micro-organisms. There 
are reports on the traditional use of six of the seven most active species relating to 
antimicrobial use, indicating that traditional use hould be taken into account during 
species selection before a phytochemical study. Thepreliminary cytotoxicity results 
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obtained for these extracts are quite disturbing, considering the wide medicinal use of these 
plants. However, the cytotoxicity assays were only performed at one concentration (in 
duplicate) and needs to be explored further before final conclusions can be made regarding 
their toxicity and potential as anticancer agents.  
 
Based on the findings obtained from the antimicrobial assays, H. excisum was selected as a 
suitable candidate for further study. This is the first phytochemical study on the non-
volatile components of this species. Bio-activity guided fractionation led to the isolation of 
lepidissipyrone, a flavanone α-pyrone previously isolated from H. lepidissimum 
(Jakupovic et al., 1989). Several flavonoids, mostly with an unsubstituted B-ring, were also 
identified. The antimicrobial activity of lepidissipyrone was determined and bio-activity 
established for the first time, although the observed antimicrobial activity was a bit 
disappointing. Literature indications are however, that phloroglucinol α-pyrones generally 
exhibit promising antimicrobial activity (Tomás-Barberán, 1990; Ríos et al., 1991) and 
similar compounds (Hänsel et al., 1980; Bohlmann and Zdero, 1980; Jakupovic et al., 
1986; Bohlmann et al., 1984; Jakupovic et al., 1989) that occur in South African 
Helichrysum species, is well worth investigating.  
 
One of the reasons why H. excisum was an exciting candidate was the fact that 
phloroglucinols were previously isolated from other plants belonging to the same 
morphologic group. It was hypothesised that the extract of H. excisum would yield mostly 
phloroglucinols, as this type of compound featured as main chemical constituent in two 
morphologically related species. However, this was not the case, as flavonoids were 
isolated as main chemical component of this species. Although flavonoids and 
acylphloroglucinols are biosynthetically related, in general, the acylphloroglucinols are 
more active as anti-infective compounds. Using the morphological relationship to predict 
the phytochemistry of a particular species was therefore not so successful in this case. 
Further investigation of the phytochemistry of the other ten Group 12 species is required to 
clarify the main chemical constituents of this morphological group. 
 
The biological activity associated with phloroglucinol α-pyrones and the synthetic 
challenges posed by these compounds prompted the development of a strategy towards the 
synthesis of lepidissipyrone. Several different approaches were investigated. A route which 
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involves the coupling of a chloromethylated phloroacetophenone derivative and a β-keto 
ester precursor was developed. We believe this strategy could be used to synthesise other 
phloroglucinol α-pyrone analogues for further biological evaluation. 
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Plate 6: HMQC NMR spectrum of compound 302 in CDCl3 
 

































Plate 7: NOESY NMR spectrum of compound 302 in CDCl3 
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Plate 13: HMQC NMR spectrum of compound 304 in CDCl3 
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Carbon Position Carbon Position
4 207.8 7 41.8
12 181.7 9' 40.4
12' 179.1 11' 39.7
1' 150.2 9 37.1
1 144.5 13 36.2
5' 140.7 10 35.8
5 119.7 2 30.3
8' 84.6 15 29.8
8 78.5 10' 29.3
11 63.0 6 25.3
4' 54.0 6' 25.0
3' 50.7 14' 21.2
7' 45.5 14 20.7
2' 43.2 15' 13.4
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Plate 42: HMQC NMR spectrum of 301 in CDCl3 
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Plate 43: NOESY NMR spectrum of 301 in CDCl3 
 




































M   7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8   
  8.4     8.2     8.0     7.8     7.6     7.4     7.2     7.0     6.8     6.6     6.4     6.2     6.0     5.8     5.6     5.4     5.2 
ppm 






































































ppm   150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0     30.0     20.0   
258 
 259











































  7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   ppm 
  7.82     7.80     7.78     7.76     7.74     7.72   
  7.02     7.00     6.98     6.96     6.94     6.92   



































ppm   180.0    170.0    160.0    150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40




































































































































3’ 3 8 
265 
 266




























6 2’,6’ 5’ 
266 
 267
  5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   
  2.60     2.50     2.40     2.30     2.20     2.10     2.00     1.90     1.80     1.70   
  4.25     4.
  3.25     3.15     3
ppm 























































































































5 1 7 11 
3,9 6 2 
13 15 
  120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0     30.0     20.0     10.0    0.0   ppm 







































14 15 5 8 1 11 
4 












































































































  8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   






























3.16     3.12     3.08     3.04     3.00     2.96     2.92     2.88     2.84     2.80     2.76     2.72    
.96     5.94     5.92     5.90     5.88   
  5.52     5.48     5.44     5.
ppm 






















































ppm   200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   



















































































































  140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0     30.0     20.0     10.0    0.0   




























































































































2 6,8 3 
3’-5’ 




























































































  12.0     11.0     10.0     9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   


















































  3.70     3.60     3.50     3.40     3.30     3.20     3.10     3.00     2.90     2.80     2.70     2.60     2.50     2.40   





















 281   180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   
ppm 





































































































































































































































































































































4 2” 1’ 5 
4’ 
8” 




  12.0     11.0     10.0     9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   































































































































































































































































































































































  12.0     11.0     10.0     9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   































  7.96     7.92   
     7.60     7.56     7.52   
  3.98     3.96     3.94     3.92
















































  180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   ppm 











































7/8-OMe 6 3 





























































  136.0   132.0   128.0   124.0   120.0   116.0   112.0   108.0   104.0   100.0    96.0     92.0     88.0     84.0     80.0     76.0     72.0     68.0     64.0     60.0     56.0     52.0   
ppm 


























































































































































OMe 6 3,10 
2’,6’ 3’,5’ 
4’ 
4 7 5 2 
297 
 298
















































































































































































































































































































































































































































































4 2 4’ 7 5 
304 
 305



















































  8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   ppm 
  4.25     4.15     4.05     3.95     3.85     3.75     3.65     3.55     3.45     3.35     3.25     3.15     3.05     2
  1.8     1.6     1.4     1.2    1.0    0.8    0.6   










  200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   ppm 









  14.0     13.0     12.0     11.0     10.0     9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
  7.90     7.80     7.70     7.60     7.50     7.40     7.30     7.20     7.10     7.00   
ppm 















  190.0    180.0    170.0    160.0    150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.ppm 















M   11.0     10.0     9.0     8.0     7.0     6.0     5.0     4.0     3.0   
  3.20     3.10     3.00     2.90     2.80     2
ppm 


















  200.0    190.0    180.0    170.0    160.0    150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0   ppm 












































































  7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8   ppm 













  200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   ppm 














  11.0     10.0     9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   ppm 

















PM   160.0    150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0     30.0     20.0     10.0    0.0   ppm 

















  8.0     7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   ppm 











  170.0    160.0    150.0    140.0    130.0    120.0    110.0    100.0    90.0     80.0     70.0     60.0     50.0     40.0     30.0     20.0     10.0   ppm 











  9.0     8.0     7.0     6.0     5.0     4.0     3.0     2.0     1.0    0.0   
  1.32     1.28     1.24     1.20     1.16     1.12     1.08     1.04     1.00     0.96     0.92     0.88     0.84     0.80     0.76     0.72     0.68     0.64   












  200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   













  7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   ppm 










  200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   









  7.6     7.2     6.8     6.4     6.0     5.6     5.2     4.8     4.4     4.0     3.6     3.2     2.8     2.4     2.0     1.6     1.2    0.8    0.4   -0.0   -0.4   
















  200.0    180.0    160.0    140.0    120.0    100.0    80.0     60.0     40.0     20.0    0.0   







































1. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for helisplendidilactone.  U(eq) is defined as one third of the trace of the 
orthogonalized Uij  tensor. 
____________________________________________________________________
_______ 
 x y z U(eq) 
___________________________________________________________________________ 
C(1) -2598(2) 3885(2) 6827(2) 23(1) 
C(1') 3548(2) 10665(2) 7422(2) 17(1) 
C(2) -1399(2) 4805(2) 7070(2) 21(1) 
C(2') 5001(2) 10350(2) 6986(2) 20(1) 
C(3) -635(4) 5099(3) 6103(2) 58(1) 
C(3') 6015(2) 10110(2) 8046(2) 20(1) 
C(4') 4909(2) 9282(2) 8512(2) 18(1) 
C(4) 676(3) 5937(2) 6257(2) 33(1) 
C(5') 3511(2) 10048(2) 8349(2) 17(1) 
C(5) 640(3) 6960(2) 6744(2) 33(1) 
C(6) 1840(2) 7900(2) 6822(2) 23(1) 
C(6') 2347(2) 9935(2) 9116(2) 19(1) 
C(7') 1425(2) 11023(2) 9222(2) 16(1) 
C(7) 3259(2) 7556(2) 7567(2) 19(1) 
C(8') 514(2) 11379(2) 8151(2) 18(1) 
C(8) 3795(2) 6340(2) 7267(2) 24(1) 
C(9') 1326(2) 12082(2) 7367(2) 21(1) 
C(9) 3483(3) 6028(2) 6056(2) 30(1) 
C(10') 2331(2) 11339(2) 6728(2) 21(1) 
C(10) 1970(3) 5441(2) 5752(2) 32(1) 
C(11) 4660(2) 8338(2) 7558(2) 18(1) 
C(12) 5914(2) 7449(2) 7695(2) 24(1) 
C(13) 4795(2) 9093(2) 6515(2) 19(1) 
C(14) 1622(3) 5359(3) 4502(2) 37(1) 
C(15') 5360(2) 8792(2) 9650(2) 23(1) 
C(15) -3565(2) 3644(2) 7704(2) 24(1) 
C(14’) 2922(3) 12096(2) 5855(2) 33(1) 
C(13’) -507(2) 9768(2) 10095(2) 22(1) 
C(11’) 254(2) 10952(2) 10020(2) 18(1) 
C(12’) -897(2) 11829(2) 9540(2) 22(1) 
O(1) -2764(2) 3367(2) 5958(2) 43(1) 
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O(2) 5392(2) 6354(1) 7587(1) 31(1) 
O(3) 7232(2) 7612(2) 7884(2) 35(1) 
O(4) -680(2) 12096(1) 8495(1) 23(1) 
O(5) -1886(2) 12257(1) 9964(1) 28(1) 
 
2. Anisotropic displacement parameters (Å2x 103)for helisplendidilactone.  The 
anisotropic displacement factor exponent takes the form: -2p2[ h2a*2U11 + ... + 2 h k 
a* b* U12 ] 
_________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
_________________________________________________________________________ 
C(1) 23(1)  20(1) 24(1)  0(1) 1(1)  -4(1) 
C(1') 18(1)  14(1) 20(1)  0(1) 1(1)  1(1) 
C(2) 18(1)  21(1) 23(1)  -5(1) 5(1)  -3(1) 
C(2') 21(1)  16(1) 22(1)  4(1) 3(1)  -3(1) 
C(3) 75(2)  80(2) 19(1)  2(1) 2(1)  -56(2) 
C(3') 17(1)  18(1) 26(1)  3(1) 0(1)  -4(1) 
C(4') 13(1)  18(1) 21(1)  2(1) 0(1)  2(1) 
C(4) 42(1)  41(1) 16(1)  2(1) 5(1)  -27(1) 
C(5') 17(1)  14(1) 20(1)  0(1) 1(1)  2(1) 
C(5) 21(1)  54(2) 26(1)  -13(1) 11(1)  -14(1) 
C(6) 13(1)  22(1) 35(1)  -8(1) 5(1)  1(1) 
C(6') 19(1)  17(1) 19(1)  4(1) 3(1)  4(1) 
C(7') 18(1)  13(1) 16(1)  -2(1) 1(1)  1(1) 
C(7) 18(1)  17(1) 23(1)  1(1) 5(1)  -3(1) 
C(8') 19(1)  16(1) 19(1)  0(1) 0(1)  4(1) 
C(8) 29(1)  15(1) 28(1)  3(1) -2(1)  -1(1) 
C(9') 27(1)  17(1) 19(1)  3(1) 2(1)  7(1) 
C(9) 36(1)  24(1) 29(1)  -5(1) -2(1)  16(1) 
C(10') 25(1)  17(1) 19(1)  2(1) 0(1)  6(1) 
C(10) 49(2)  16(1) 28(1)  0(1) -7(1)  2(1) 
C(11) 14(1)  16(1) 23(1)  2(1) 4(1)  2(1) 
C(12) 24(1)  23(1) 26(1)  4(1) 5(1)  7(1) 
C(13) 13(1)  19(1) 24(1)  2(1) 5(1)  1(1) 
C(14) 33(1)  49(2) 28(1)  -12(1) -3(1)  13(1) 
C(15') 18(1)  27(1) 23(1)  6(1) -1(1)  1(1) 
C(15) 20(1)  22(1) 31(1)  1(1) 5(1)  0(1) 
C(14’) 41(1)  35(1) 26(1)  14(1) 12(1)  15(1) 
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C(13’) 22(1)  19(1) 24(1)  3(1) 2(1)  2(1) 
C(11’) 19(1)  18(1) 17(1)  -2(1) 1(1)  3(1) 
C(12’) 27(1)  16(1) 22(1)  -2(1) 2(1)  3(1) 
O(1) 58(1)  44(1) 26(1)  -12(1) 7(1)  -25(1) 
O(2) 31(1)  19(1) 41(1)  1(1) -3(1)  9(1) 
O(3) 17(1)  38(1) 50(1)  4(1) 8(1)  10(1) 
O(4) 25(1)  24(1) 22(1)  3(1) 5(1)  12(1) 
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a b s t r a c t
Aims of the study: In South Africa, the genus Helichrysum is widely used in traditional medicine. The uses
are well documented although renaming of species and the resulting confusing taxonomic nomenclature
may cause uncertainty as to which specific species was referred to in some reports. The aim of this paper
is to present a collated and coherent overview of the documented traditional uses of Helichrysum species
and to update the botanical identity of previously studied species.
Materials and methods: Databases (Scifinder, ISI Web of Knowledge) and several books were used to collect
in information on South African Helichrysum species.
Results: The traditional uses, chemistry and biological activity of Helichrysum species have been sum-
marized. It was attempted to give clarity as to exactly which species is refer to in the ethnobotanical
literature.
Conclusions: Although a large number of ethnopharmacological uses have been documented and the chem-
istry of the genus has been studied extensively, only a few South African species have been investigated
for their biological activity.
© 2008 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
The genus Helichrysum Mill. derives its name from the Greek
words helios (sun) and chrysos (gold) which is appropriate con-
sidering the attractive yellow flowers displayed by several species
(Pooley, 2003). The genus belongs to the Asteraceae family, tribe
Inuleae and subtribe Gnaphaliinae (Hilliard, 1983). This large genus
consists of approximately 500–600 species and although Helichry-
sum species are also found in southern Europe, south-west Asia,
southern India, Sri Lanka (previously Ceylon) and Australia, most
species occur in Africa, including Madagascar (Hilliard, 1983). In
South Africa (including Namibia), the ca. 244–250 species are
widely distributed and the tremendous morphological diversity
displayed by these species resulted in their subdivision into 30 mor-
phological groups, using the shape and size of the flower heads
as differentiating characteristics (Hilliard, 1983). The flower heads
are either solitary or occur in compact or spreading inflorescences.
The aerial parts are usually hairy or woolly and plants occur as
herbs or shrublets that are sometimes dwarfed and cushion form-
ing. They are often aromatic (Pooley, 1998, 2003; Van Wyk et al.,
2000).
∗ Corresponding author. Tel.: +27 33 2605886; fax: +27 33 2605009.
E-mail address: vanheerdenf@ukzn.ac.za (F.R. van Heerden).
2. Traditional uses
Several Helichrysums are widely used in Southern African tradi-
tional medicine as summarised in Table 1. The first written record
of the medicinal use of Helichrysum dates back to 1727 when
Boerhaave noted that a Helichrysum species was used to treat ner-
vousness and hysteria. The report of a Helichrysum species in the
early literature could have been based on knowledge acquired from
the local Khoi and San people, but is most probably due to the
fact that European botanists used their knowledge of medicinal
properties of European genera (Scott and Hewett, 2008).
2.1. Ambiguities in nomenclature
As is the case for all ethnobotanical data, the fact that plant
names are changed (Germishuizen and Meyer, 2003) and fre-
quently incorrectly cited (Arnold et al., 2002) is quite problematic.
To complicate matters further, variation in spelling of names also
occurs. Special care needs to be taken when consulting the original
texts to unambiguously confirm that a plant selected for a partic-
ular study is in fact the same species cited by, for example, Watt
and Breyer-Brandwijk (1962). In Table 1, current names are given
and previously accepted names are shown in parenthesis. For the
sake of clarity, the name as it appears in the reference is sometimes
indicated in brackets after the reference.
















































Traditional uses and biological activities reported for Helichrysum species





Helichrysum acutatum DC. 21c Widely used as traditional medicine, sold
commercially in large quantities
NS Arnold et al. (2002), Cunningham (1988),
Hutchings et al. (1996)
Helichrysum adenocarpum DC. 28 Root Decoction Used to treat diarrhoea and vomiting in
children.
GIT Arnold et al. (2002), Jacot Guillarmod (1971),
Neuwinger (1996), Phillips (1917), Pooley
(2003), Walker (1996), Watt and
Breyer-Brandwijk (1962)




Bd , Fd Arnold et al. (2002), Githens (1949), Mathekga
(2001) e , Smith (1895), Smith (1966),
Swanepoel (1997), Walker (1996), Watt and
Breyer-Brandwijk (1962)Plant Smallpox
Plant Anthelmintic
Root Coughs and colds and applied externally on
wounds
Leaf Wound dressing Applied externally to wounds. Ground leaves
are rubbed into areas which cramps or on
wounds
Roots Ground and burnt and smeared on body to
relax body and to reduce swelling
Leaf Used medicinally as tea
Helichrysum argyrophyllum DC. 29 Root Infusion Intestinal troubles GIT Arnold et al. (2002), Batten and Bokelmann
(1966), Smith (1966), Walker (1996), Watt and
Breyer-Brandwijk (1962)
Not grazed by stock, preventing soil erosion in
overgrazed areas
Helichrysum argyrosphaerum DC. 15 Browsed by animals but poisonous if large
quantities is ingested
Poi Bd , Fd Hutchings et al. (1996), Mathekga (2001) e ,
Pooley (1998), Van Wyk et al. (2002)
Helichrysum asperum (Thunb.) Hilliard
and Burtt. (=Helichrysum ericifolium
Less.) (Hilliard, 1983) 12f
The plants are casually browsed by sheep and
said to be a cause of “Geilsiekte”
Poi Smith (1966) (Helichrysum ericaefolium DC.)g
Helichrysum athrixiifolium (Kuntze)
Moeser 9f
Leaf Smoked Chest complaints. Resp Arnold et al. (2002), Jacot Guillarmod (1971)
(Helichrysum athrixifolium O. Hoffm.)g , Phillips
(1917) (Helichrysum athrixiifolium O. Hoffm.)g ,
Watt and Breyer-Brandwijk (1962)
(Helichrysum athrixifolium O. Hoffm.)g
Helichrysum aureonitens Sch. Bip. 8 Leaves and stems Burnt as incense Used to invoke the goodwill of the ancestors
and to induce trances
Psy, Psyc,
Infect, Insect
Bd , Fd , V Afolayan and Meyer (1997) e , Cunningham
(1988), Hutchings et al. (1996), Jacot
Guillarmod (1971), Mathekga (2001) e , Meyer
and Afolayan (1995) e , Meyer et al. (1996) e ,
Meyer et al. (1997) e , Phillips (1917), Pooley
(1998), Pooley (2003), Swanepoel (1997),
Walker (1996), Watt and Breyer-Brandwijk
(1962)
Leaves and stems Commercially sold
Decoction A remedy for inuresis in children
Extracts Used topically for skin infections especially
against Herpes zoster and infections associated
with Herpes simplex
Used to keep red mites away
Used as tinder to start fire, used to make hats.
Helichrysum aureum Houtt. Merr. var.
aureum/monocephalum (=Helichrysum
fulgidum (L.f.) Willd.) 30h
Decoction Used for washing sore eyes Eye Arnold et al. (2002) (Helichrysum fulgidum L.f.)
Willd.)g , Batten and Bokelmann (1966)
(Helichrysum fulgidum Willd.)g , Jacot
Guillarmod (1971) (Helichrysum fulgidum (L.)















































Table 1 (Continued )





Helichrysum bellum Hilliard 28 Bd , Fd Mathekga (2001) e
Helichrysum caespititium (DC.) Harv 12f Plant Crushed and burnt and
smoke inhaled




Bd , Fd , I, My Arnold et al. (2002), Dekker et al. (1983) e ,
Gelfand et al. (1985) (Helichrysum caespitium
Sond.)g , Hutchings and Van Staden (1994),
Jacot Guillarmod (1971) (Helichrysum
caespitium Sond.)g , Mathekga et al. (2000) e ,
Mathekga (2001) e , Meyer et al. (2002) e ,
Neuwinger (1996), Phillips (1917) (Helichrysum
caespitium Sond)g , Pooley (1998), Pooley
(2003), Swanepoel (1997) e , Watt and
Breyer-Brandwijk (1962)




Plant Ointment Ointment is applied to the roof of the
mouth for a depressed fontanelle
Used as dressing for open wounds
during circumcision rites
Helichrysum callicomum Harv 2 Protective charm. Mixed with Aster
bakerianus (hispidis) and Helichrysum
rugulosum
M, GIT Bd , Fd Arnold et al. (2002), Jacot Guillarmod (1971),
Mathekga and Meyer (1998) e , Mathekga
(2001) e , Phillips (1917), Pooley (2003), Watt
and Breyer-Brandwijk (1962)
Used for fuel in winter
Enema Used as an ingredient in an enema for
colic
Helichrysum calocephalum Klatt 23 Arnold et al. (2002) refers to others using
Helichrysum calocephalum Schltr, which is
classified as Helichrysum ecklonis Sond
(Germishuizen and Meyer, 2003)
Helichrysum calophalum Klatt 23 Root Used for hyperfunction of the lower
gastro-intestinal tract
GIT Swanepoel (1997), information obtained from
TRAMED database. It is not clear to these
authors whether this use pertains to
Helichrysum calocephalum Klatt or Helichrysum
ecklonis Sond
Helichrysum candolleanum Buek 15 Bd , Fd Mathekga (2001) e
Helichrysum chionosphaerum DC. 25 Bd , Fd Mathekga (2001) e
Helichrysum cephaloideum DC.
(=Helichrysum adscendens Less. var.
cephaloideum Moes.) 24
Irritant poisoning in sheep
demonstrated. Known to be poisonous
to sheep (symptoms similar to that of
poisoning caused by Geigera)
Poi Van Wyk et al. (2002), Watt and
Breyer-Brandwijk (1962)
Helichrysum cochleariforme DC.
(=Helichrysum imbricatum Less.) 15
Tea, infusion Demulcent in coughs and other
pulmonary affections. In the Western
Cape area the plant is used to treat
whooping cough, other coughs,
bronchial catarrh and bronchitis
Resp Arnold et al. (2002), Neuwinger (1996), Smith
(1966), Swanepoel (1997), Watt and
Breyer-Brandwijk (1962)
Whole plant Decoction Drunk for infections of the respiratory
tract
Helichrysum cooperi Harv. 30 Leaf Ointment, applied after
bathing
Used as love charm. The ointment is
applied after bathing and as a result the
desired lady finds the man irresistible
M, Fum,
Snakebite
Arnold et al. (2002), Hutchings et al. (1996),
Pooley (1998), Pooley (2003), Walker (1996),
Watt and Breyer-Brandwijk (1962)
Leaves Used to make Zulu headdress
distinctive to married women
Used as a fumigant and as part of a














































Helichrysum crispum (L.) D. Don. 17 Used medicinally as a calming tea
Coughs, bronchitis, urinary tract
infections and tuberculosis.
Resp, Renal B Arnold et al. (2002) (with reference to Smith,
1966), Kling as quoted by Salie et al., 1996e ,
Roberts (1990) (Helichrysum crispum)g
These authors are not certain whether Kling is
referring to Helichrysum crispum (L.) D. Don. or
Helichrysum crispum Less.
Helichrysum cymosum (L.) D. Don. 8 Used to invoke the goodwill of the
ancestors and to induce trances
M, Psy, Resp,
GIT, P
Bd , Fd , Pl Arnold et al. (2002), Bhat and Jacobs (1995),
Kokwaro as quoted by Neuwinger (1996),
Neuwinger (1996), Pooley (2003), Van Vuuren
et al. (2006) e , Van Wyk et al. (2000)
Leaf Decoction/tea Used to treat colds and coughs
Root Extract Used as emetic and purgative
Leaf Filtrate drunk to treat colds and fever
Leaf Boiled, and vapours from
boiling leaves inhaled
Vapour bath used to treat headaches
Helichrysum dasymallum Hilliard
(=Helichrysum lanatum Harv.) 21
Used as medicinal tea. Woolly coat
used for tinder boxes
NS Arnold et al. (2002), Lucas and Pike (1971),
Smith (1966)
Helichrysum decorum DC. 30 Plant Burned and smoked
inhaled
Used to induce trances Psy Bd , Fd Arnold et al. (2002), Hutchings et al. (1996),
Mathekga (2001) e , Neuwinger (1996)
Helichrysum dregeanum Sond. and Harv. 9 Leaf Smoked Used to treat head colds Resp, GIT Arnold et al. (2002), Hutchings and Van Staden
(1994), Jacot Guillarmod (1971), Neuwinger
(1996), Phillips (1917), Smith (1966), Watt and
Breyer-Brandwijk (1962)
Infusion Used to treat hiccups
Browsed by stock
Helichrysum ecklonis Sond (=Helichrysum
calocephalum Schltr.) 28
Used by the Xhosas to ward of evil
magic spells, which follow on seeing
iChanti, the water snake
M, GIT Batten and Bokelmann (1966), Jacot
Guillarmod (1971), Phillips (1917), Pooley
(2003), Watt and Breyer-Brandwijk (1962)
Root Decoction Used to treat diarrhoea in children.
Helichrysum epapposum Bolus 3 Leaves and stems Burned as incense Used to invoke the goodwill of the
ancestors
M Arnold et al. (2002), Cunningham (1988),
Hutchings et al. (1996)
Leaves and stems Commercially sold
Helichrysum excisum (Thunb.) Less. 12 Bd , I Lourens et al. (2004) e
Helichrysum felinum Less. 17 Bd , I Lourens et al. (2004) e
Helichrysum flanaganii Bolus 13 Leaves Burned Incense M Walker (1996)
Helichrysum foetidum (L.) Moench 30f Plant Extract is drunk/smoke
inhaled
Used to induce trances Psy, Infect,
Resp, W, Eye, P
B Arnold et al. (2002), Batten and Bokelmann
(1966) (Helichrysum foetidum Cass.)g , Gerstner
(1938) (Helichrysum foetidum Cass)g , Hulme
(1954), Hutchings et al. (1996), Kokwaro
quoted by Neuwinger (1996), Neuwinger
(1996) Roberts (1990), Rwangabo, quoted by
Neuwinger (1996), Steenkamp et al. (2004) e ,
Swanepoel (1997), Van Wyk and Gericke
(2000), Watt and Breyer-Brandwijk (1962)
(Helichrysum foetidum Cass.)g
Leaf Extract Used to treat flu (influenza)
Leaf Wound dressing Used to treat circumcision and infected
wounds (festering sores)
Leaf Preparation Applied to treat Herpes
Root Extract Eye problems, used to bath eyes
Leaf Used in making headdress distinctive
of married women
Plant Aromatic and astringent (used to draw
out infection).
Used to treat menstrual pain
Helichrysum glomeratum Klatt 6 B, Fd Mathekga and Meyer (1998) e , Mathekga
(2001) e
Helichrysum griseum Sond (=Helichrysum
agrostophilum Klatt) 23h
Preventative charm against illness.
Burnt as fuel in winter
M Arnold et al. (2002), Phillips (1917)
Helichrysum gymnocomum DC. 4 Stems and leaves Burned as incense Used to invoke the goodwill of the
ancestors
Skin, M, Fum Bd , Fd Cunningham (1988), Drewes and Van Vuuren
(2008) e , Hutchings et al. (1996), Phillips (1917)
Ointment Mixed with fat, only the wives of chiefs
were previously allowed to use it
Used to fumigate sick rooms
Commercially sold
Helichrysum herbaceum (Andrews) Sweet 29 Stems and leaves Burned as incense Used to invoke the goodwill of the
ancestors
M Bd , Fd Arnold et al. (2002), Cunningham (1988),
Hutchings et al. (1996), Mathekga (2001) e ,
Neuwinger (1996), Pooley (1998), Pooley
(2003)
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Helichrysum hypoleucum Harv 16 Bd , Fd Mathekga and Meyer (1998) e , Mathekga
(2001) e
Helichrysum indicum (L.) Grierson
(=Helichrysum expansum (Thunb.)
Less.) 15
Plant Burned and crushed Mixed with Conyza pinnata. Crushed
and burnt to drive sickness from a
room
M Arnold et al. (2002), Jacot Guillarmod (1971)
Helichrysum kraussii Sch. Bip 8 Leaf Decoction Use to wash keloid scars Skin, M, Resp,
Infect
Bd , Fd Arnold et al. (2002), Arnold and Gulumian as
quoted by Neuwinger (1996), Bremner and
Meyer (2000) e , Mathekga (2001) e , Gelfand et
al. (1985), Mabogo (1990), Neuwinger (1996),
Swanepoel (1997), Walker (1996), Watt and
Breyer-Brandwijk (1962)
Root and leaves Infusion Used to drive bad spirits away, used to
wash body
Dried flower and seed Smoked in a pipe The Karanga smoke this as a remedy
for coughs and pulmonary tuberculosis
Plant Burnt, salt is added to ash
and ingested by mouth
Cough
Root Venereal disease
Root Mixed with salt and other
ingredients
Applied to child’s side with small
amount given orally
Helichrysum lepidissimum S. Moore 19 Powder or ointment Used as a body perfume Skin Dlamini (1981), Watt and Breyer-Brandwijk
(1962)
Helichrysum litorale Bolus (=Leontonyx
angustifolius DC. =Leontonyx spathulatus
Less.) 14
Plant Dried and pounded or mixed with lard
or fat, was used for applying to ulcers.
W, Skin Smith (1966), Swanepoel (1997), Watt and
Breyer-Brandwijk (1962)
In the Western Cape province an
ointment for boils, carbuncles and
abscesses is made from this plant,
Cyanella lutea and
“tiendaegeneesbossie”
Helichrysum longifolium DC. 24 Leaf Used by the Pondos to treat
circumcision wounds. The leaves are
heated over very hot ash before being
used as a bandage for the treatment of
wounds after circumcision
W Bd , Fd Dilika et al. (1997) e , Mathekga (2001) e
Helichrysum lucilioides Less. 12 Excellent stock feed Smith (1966)
Helichrysum melanacme DC. 8 Used as bedding. Used medicinally as
tea. Used for cough, fever, headache,
colds and chest pain
Resp, P Bd , Fd , My,
V
Arnold et al. (2002), Lall and Meyer (1999) e ,
Lall et al. (2006) e , Mathekga (2001) e , Smith
(1966)
Helichrysum miconiifolium DC. 23 Tea Used medicinally as tea P, Anthel Bd , Fd Smith (1966) (Helichrysum miconiaefolium
DC.)g , Arnold et al. (2002), Mathekga (2001) e ,
Swanepoel (1997)
Leaf The Xhosa grind and boil the leaves
and use it as a wash for pain after
circumcision
Root The powdered root is used for
intestinal parasites and for ticks on
poultry
Helichrysum montanum DC. 22 B, Fd Mathekga (2001) e
Helichrysum monticola Hilliard 28 B, Fd Mathekga (2001) e
Helichrysum mundtii Harv. 23 Plant Decoction Chest complaints Resp Arnold et al. (2002), Jacot Guillarmod (1971),
Pooley (1998), Pooley (2003), Phillips (1917)
(Helichrysum mundii, Harv.)g , Watt and
Breyer-Brandwijk (1962)
Helichrysum natalitium DC. 3 Leaves and stems Burnt as incense Used to invoke the goodwill of the
ancestors
M Arnold et al. (2002), Cunningham (1988),
Hutchings et al. (1996), Pooley (2003)














































Helichrysum nudifolium (L.) Less. var.
nudifolium =H coriaceum Harv.f =also
Helichrysum gerberifolium A. Rich, =also
Helichrysum leiopodium DC. =also
Helichrysum nudifolium var.
quinquenerve =also Helichrysum
nudifolium var. leiopodium) 23
Leaf Burnt as incense To invoke the goodwill of the ancestors M, Resp, W,
Infect, P, Skin,
GIT
Bd , Fd , I Arnold et al. (2002), Gerstner (1938)
(Helichrysum undifolium, also Helichrysum
leiopodium DC.)g , Githens (1949) (Helichrysum
nudifolium, also Helichrysum leiopodium)g ,
Glover et al. quoted by Neuwinger (1996),
Hulme (1954), Hutchings et al. (1996),
Hutchings and Johnson (1986), Hutchings and
Van Staden (1994), Jacot Guillarmod (1971)
(Helichrysum nudifolium var. leiopodium)g , Jäger
et al. (1996) e , Mabogo (1990), Phillips (1917)
(Helichrysum leiopodium DC.)g , Rood (1994),
Smith (1895) (Helichrysum nudiflorum)g , Smith
(1966) (Helichrysum coriaceum Sond. and
Helichrysum nudifolium var. quinquenerve)g ,
Swanepoel (1997) e (Helichrysum
gerberifolium)g , Van Wyk et al. (2000),
Neuwinger (1996) (also Helichrysum
gerberifolium Sch. Bip)g , Watt and
Breyer-Brandwijk (1962) (Helichrysum
gerberaefolium Sch. Bip. Ex A.Rich)g
Infusion Colds (Zulu and Khoi—administration
route not indicated)
Leaf Eaten raw Used to treat colds by the Xhosa
Plant Infusion Regarded as demulcent, used to treat
catarrh, phthisis and other pulmonary
affections
Leaf/plant Respiratory infections
Root Coughs and colds
Leaf Wound dressing Wounds
Root/Leaf Applied to sores on the genitalia by the
Xhosa
Plant/leaf Smoke inhaled Headache
Leaf Infusion Rectal prolapse
Powder mixed with butter
and eaten
Protection of children from illness
Root Decoction Chest problems, used as emetic by the
Zulu
Leaf Decoction To encourage weaning in babies
Leaf Infusion Diseases in goats
Plant Infusion on hot stones Used as steam bath to treat fever and
nightmares
Plant Poultice Swellings
Decoction Colic in children (administered as
enema)
Rubbed into scarifications over bruises.
Used as tea
Root Decoction Internal sores (intestinal ulceration)
Helichrysum nudifolium var. oxyphyllum
(=Helichrysum oxyphyllum DC. =also
Helichrysum undatum Less.) 23
Protective charm against thunder M Arnold et al. (2002), Gertsner (1938),
Hutchings et al. (1996)
Helichrysum nudifolium var. pilosellum
(=Helichrysum latifolium (Thunb.) Less.
=Helichrysum pilosellum (L.f.) Less.) 23
Used for “doctoring’ people who wish
some deed concealed and who are
afraid of being found out
M, GIT B, Fd Arnold et al. (2002) (H. pilosellum)g , Hulme
(1954) (Helichrysum latifolium)g , Hutchings et
al. (1996) (Helichrysum pilosellum (L.f.) Less.)g ,
Jacot Guillarmod (1971) (Helichrysum latifolium
(Thunb.) Less.)g , Mathekga and Meyer (1998) e ,
Mathekga (2001) e , Neuwinger (1996)
(Helichrysum pilosellum (L.f.) Less.)g , Phillips
(1917) (Helichrysum latifolium Less.)g , Phillips
(1917) (Helichrysum latifolium Less.)g , Pooley
(2003) (Helichrysum pilosellum)g , Swanepoel
(1997), Walker (1996) (Helichrysum pilosellum
(L.f.) Less.)g , Watt and Breyer-Brandwijk (1962)
(Helichrysum latifolium Less.)g
Ingredient in colic remedy
Leaf Infusion Stomach ache in children
Roots Ground and burnt Ground and burnt near cattle suffering
from black leg
Helichrysum nudifolium var. pilosellum
(=Helichrysum pilosellum (L.f.) Less.
=Helichrysum pedunculare (L.) DC. var.
pilosellum) 23h
As an antiseptic and to induce fast
healing: used after circumcision to
prevent inflammation externally
W, Resp, GIT Arnold et al. (2002), the sources below are
indicated in Arnold et al., under Helichrysum
pedunculare DC.: Batten and Bokelmann (1966)
(isicwe, isiGqutsi)i , Githens (1949) (Helichrysum
pedunculare)g , Smith (1895) (isi-Cwe.)i , Smith
(1966)
Also externally applied to wounds and
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Helichrysum odoratissimum (L.) Sweet 4 Leaf/ground plants Used as wound
dressing/leaf pulp
Wounds and burns W, Fum, Psy,
Psyc, M, Resp,
Eye, GIT, P
Bd , Fd , My Adjanohoun quoted by Neuwinger (1996),
Arnold et al. (2002), Baerts and Lehmann
quoted by Neuwinger (1996), Cunningham
(1988), Dlamini (1981), Hutchings and Johnson
(1986), Hutchings et al. (1996), Hutchings and
Van Staden (1994), Jacot Guillarmod (1971),
Kokwaro quoted by Neuwinger (1996), Lall and
Meyer (1999) e , Lourens et al. (2004) e ,
Mathekga and Meyer (1998) e , Mathekga
(2001) e , Neuwinger (1996), Pooley (1998),
Pooley (2003), Rwangabo quoted by
Neuwinger (1996), Smith (1966), Swanepoel
(1997), Van Puyvelde et al., 1989, Van Wyk et
al. (2000), Van Wyk and Gericke (2000), Watt
and Breyer-Brandwijk (1962)
Plant The Southern Sotho use this plant to
fumigate huts
Ointment It is mixed with fat to form pleasantly
smelling ointment, formerly only used
by wives of chiefs
Leaf Ash is rubbed into
scarifications
Insanity, possession
Burnt as incense Used to invoke the goodwill of the
ancestors, protective charm
Tea Aids sleep, relieves muscle tension and
cramps
Plant, leaf, stems Smoke inhaled Used as a sedative and to treat
insomnia and as protective cleanser.
Root Colds, coughs
Leafy twigs Ash is eaten Coughs




Aerial parts Extract Used to treat dehydration
Leaf Sap Heartburn, flatulence
Root Extract Purgative (extract is drunk)
Leaf Ash is eaten Vomiting
Tea Colic and stitch
Leaf Decoction Febrile convulsions (part of
preparation)
Leaf Smoke inhaled Headache
Leaf Infusion Fever (also used as wash)
Leaf and twigs Decoction Used to treat female sterility,
menstrual pain and eczema in Rwanda
Leafy twigs Decoction Tonic for pregnant women
Leaf Decoction Galactagoque
Used a bedding material since it is an
effective insect repellent. Sold
commercially. The Xhosa also use the
plant for spiritual purposes, as a
fumigant when a baby is born
Helichrysum oreophilum Klatt 21 B, Fd Mathekga and Meyer (1998) e , Mathekga
(2001) e
Helichrysum pallidum DC. (=Helichrysum
agrostophilum Klatt (in part) =Helichrysum
undatum (Thunb.) Less. var. agrostophilum
(Klatt) Moeser =Helichrysum undatum var.
pallidum 23h
Preventative charm for illness M Arnold et al. (2002), Jacot Guillarmod (1971)
(Helichrysum undatum var. agrostophilum)g ,
Phillips (1917) (Helichrysum undatum Less., var.
pallidum and Helichrysum agrostophilum Klatt)g
Burnt as fuel in winter
Roots Bathing in decoction The act of forgetting, The bath is
suppose to make a person invisible/or
forgotten by his enemies, witchcraft
Helichrysum panduratum O. Hoffm. 18 Leaf Decoction Febrile convulsions in children (part of
a preparation)
P, Infect A, I Adjanohoun quoted by Neuwinger (1996),
Haerdi quoted by Neuwinger (1996),
Neuwinger (1996), Neuwinger (1996), Pooley
(1998), Swanepoel (1997) e
Plant Sap Used to treat malaria in children
Used to make herbal tea
Helichrysum pandurifolium Schrank.
(=Helichrysum auriculatum Less.) 18
Infusion, demulcent Respiratory conditions Resp, P, Ca,
Renal
Arnold et al. (2002), Roberts (1990)
(Helichrysum auriculatum Less.)g , Rood (1994),
Smith (1966) (Helichrysum auriculatum Less.)g ,
Swanepoel (1997), Watt and Breyer-Brandwijk
(1962) (Helichrysum auriculatum Less.)g
Backpain, heart trouble, kidney
disease, kidney stones














































Helichrysum patulum (L.). Don. (=Helichrysum
crispum Less.) 18
Heart trouble, backache, kidney
disease, also ‘heart weakness’ (also




Neuwinger (1996) (Helichrysum crispum Less.)g ,
Roberts (1990) (Helichrysum crispum)g , Scott et
al. (2004), Smith (1966) (Helichrysum crispum
Less.)g , Watt and Breyer-Brandwijk (1962)
(Helichrysum crispum Less.)gInfusion Hyperpiesa, (hyperpepsia is probably a






Helichrysum pedunculatum Hilliard and Burtt
(=Helichrysum pedunculare DC.) 23
Leaf and root As an antiseptic and to induce fast




B Arnold et al. (2002), Batten and Bokelmann
(1966) (Helichrysum pedunculare DC.g , isiCwei ,
isiGqutsii , Xhosa), Bhat and Jacobs (1995)
(Helichrysum pedunculatum Hilliard and Burttg ,
isiCwei , siGgutsii , Xhosa), Dilika et al. (1997) e ,
Gerstner (1938) (Helichrysum pedunculare DC.g ,
isiCwei , Zulu), Githens (1949) (Helichrysum
pedunculareg , isicwei , Zulu), Hutchings et al.
(1996) (Helichrysum pedunculatum Hilliard et
Burtt)g , Meyer and Dilika (1996) e , Rood (1994)
(Helichrysum pedunculatumg , ery’kuei , Fingo),
Smith (1895) (Helichrysum pedunculare DC.g ,
isiCwee), Smith (1966) (Helichrysum
pedunculare DC.)g , Neuwinger (1996)
(Helichrysum pedunculatum Hilliard and
Burtt)g , Swanepoel (1997), Watt and
Breyer-Brandwijk (1962) (Helichrysum
pedunculare DC.)g
Also externally applied to wounds and




Helichrysum petiolare Hilliard and Burtt 18 Coughs, colds, catarrh, headache, fever,
menstrual disorders, urinary tract
infections
Bd Arnold et al. (2002), Lourens et al. (2004) e ,
Kirstenbosch Botanical Garden, Neuwinger
(1996), Roberts (1990) (Helichrysum
peteolatum)g , Scott et al. (2004), Smith (1966)
(Helichrysum petiolatum DC.)g , Van Wyk et al.
(2000)
Leaf Antiseptic wound dressing




Helichrysum platypterum DC. 20 Root Decoction Renew virility in men Vi Arnold et al. (2002), Jacot Guillarmod (1971),
Phillips (1917), Watt and Breyer-Brandwijk
(1962), Jakupovic et al., 1987Root Crushed and sucked
Helichrysum psilolepis Harv. 22 Root Decoction Dysmenorrhoea P Bd , Fd Arnold et al. (2002), Jacot Guillarmod (1971),
Mathekga (2001) e , Phillips (1917), Neuwinger
(1996), Watt and Breyer-Brandwijk (1962)Used to weave hats
Helichrysum rotundatum (=H coriaceum
(DC.) Harv.)f
Used as tea NS Smith (1966) (Helichrysum coriaceum Sond.)g
Helichrysum rugulosum Less. 9 Protective charm (with Helichrysum
callicomum and Aster bakerianus
M, GIT, Fum Bd , Fd Arnold et al. (2002), Dlamini (1981), Jacot
Guillarmod (1971), Mathekga and Meyer
(1998) e , Mathekga (2001) e , Phillips (1917),
Pooley (1998), Pooley (2003), Watt and
Breyer-Brandwijk (1962)
Enema Colic (an ingredient)
Used to fumigate huts when children
are ill (cold)
Helichrysum setosum Harv. 30 Love potion M, Epilepsy,
Fum, Snakebite
Chabra quoted by Neuwinger (1996), Jacot
Guillarmod (1971), Lucas and Pike (1971),




Root Powdered and rubbed into
the wound
Snakebite, roots are also mixed with
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Helichrysum simillimum DC. 8 Bd , Fd Mathekga (2001) e
Helichrysum splendidum (Thunb.) Less. 22 Roots Used to treat rheumatism P, Skin Arnold et al. (2002), Dlamini (1981), Jacot
Guillarmod (1971), Pooley (2003), Swanepoel
(1997)
Fuel plant in the mountains
Leaf The leaves are boiled and the steam
inhaled to induce sweating
It is used together with Senecio species
to treat pimples
Helichrysum subglomeratum Less. 6 Aerial parts Smoke inhaled Headaches P I Jäger et al. (1996) e
Helichrysum sutherlandii Harv. 17 Plant Burnt, powdered plant
material
Powder applied to cuts in the skin of a
sick person
M Bd , Fd Arnold et al. (2002), Jacot Guillarmod (1971),
Mathekga (2001) e , Phillips (1917), Pooley
(1998), Pooley (2003), Watt and
Breyer-Brandwijk (1962)
Helichrysum tenax M.D. Hend var. tenax
(=Helichrysum fulgidum (L.f) Willd. 30h
Decoction Used for washing sore eyes Eye Bd , Fd Arnold et al. (2002) (Helichrysum fulgidum (L.f)
Willd.)g , Batten and Bokelmann (1966)
(Helichrysum fulgidum Willd.)g , Drewes et al.
(2006) e , Jacot Guillarmod (1971) (Helichrysum
fulgidum (L.) Willd.)g , Phillips (1917)
(Helichrysum fulgidum Willd.)g
Helichrysum tomentosulum (Klatt) Merxm 1 Used as a perfume (subsp.) aromaticum P, Renal Neuwinger (1996), Van Wyk and Gericke
(2000), Von Koenen (2001)Twigs Extract Twigs are pounded in water and used
as mouth wash for tooth ache
Plant Smoke inhaled The entire plant is placed on red hot
coals and smoke inhaled for body pain.
The same treatment is used by
pregnant women suffering from
antepartum haemorrhage
Root Decoction Bladder problems (dribbling)
Used as thatching.
Helichrysum trilineatum DC. 22 Bd , Fd Bremner and Meyer (1998) e , Mathekga
(2001) e
Helichrysum umbraculigerum Less. 5 Heavily grazed Bd , Fd Mathekga (2001) e , Pooley (1998)
Helichrysum uninervium Burtt Davy 12 The Swazi use the plant as a purgative
or an emetic. They add one teaspoon of
the plant to soft porridge which is then
eaten by the patient
GIT Swanepoel (1997)
a Where the species name has been changed, the previously accepted name is given in brackets. The following species are no longer classified as Helichrysum: Helichrysum capillaceum (Thunb.) Less. (Phillips, 1917; Jacot
Guillarmod, 1971; Watt and Breyer-Brandwijk, 1962) accepted name now Troglophyton capillaceum subsp. capillaceum (Thunb.) Hilliard and B.L. Burtt (Gibbs Russell et al., 1987); Helichrysum orbiculare (Thunb.) Druce (Smith,
1966) accepted name now Plecostachys serpyllifolia (P.J, Bergius) Hilliard and B.L.Burtt (Gibbs Russell et al., 1987); Helichrysum sesamoides Willd. (Smith, 1966) accepted name now Edmondia sesamoides (L.) Hilliard (Gibbs Russell
et al., 1987); Helichrysum vestitum (L.) Willd. (Smith, 1966) accepted name now Syncarpha vestita (L.) B. Nord. (Gibbs Russell et al., 1987); Helichrysum hochstetteri (A. Rich) Hook. F. (Githens, 1949) and Helichrysum stenopterum
DC. (Dlamini, 1981) accepted name now Achyrocline stenoptera (DC.) Hilliard (Gibbs Russell et al., 1987).
b Abbreviations used: A = analgesic activity determined; Anth = anthelmintic; B = antibacterial activity determined; Ca = cardiac conditions; Eye = used in eye conditions; F = antifungal activity determined; Fum = used as fumi-
gant, often plants are burnt in room of a sick person; GIT = gastrointestinal conditions, which include mainly colic, nausea and vomiting, diarrhoea and stomach pain; I = anti-inflammatory activity determined; Infect = conditions
associated with infections, such as gonorrhoea and smallpox; Inflam = conditions associated with inflammation such as swelling, menstrual pain; Insect = plants are used to deter insects such as red mites; M = used in a magical
sense, to invoke the goodwill of the ancestors and as charms (protective, love); My = antimycobacterial activity determined; NS = not specified; P = conditions associated with pain, inflammation and fever, which include
headache, convulsions and dysmenorrhoea; Pl = antiplasmodial (antimalarial) activity determined; Psy = psychotropic use—plants that are used to induce trances; Psyc = psychological conditions such as inuresis in children
and insomnia; Poi = possible poison, mainly when stock ingest excessive amounts; Renal = conditions associated with kidney and bladder problems; Resp = respiratory conditions, which include colds, coughs, flu, tuberculosis;
Skin = used for skin conditions such as keloid scars, abscesses, as ointments; W = used to dress wounds; V = antiviral activity determined; Vi = used for virility in men.
c The number refers to the morphological group according to Hilliard (1983).
d Antimicrobial activity of 1 mg/ml or less observed for one or more micro-organisms.
e Reference associated with biological activity.
f In some cases the author name, as indicated in the source, is not present in either Hilliard (1983) or Germishuizen and Meyer (2003). The current author is then chosen.
g In cases where the name in the source and the current name differ, the name used in the source is indicated in brackets for clarification.
h In cases where the old name is used to describe two different species in the current system, the uses are indicated under both the current names.
i Vernacular name.
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In some cases, one species name was changed to another, for
example Helichrysum adscendens Less. var. cephaloideum Moeser.
in Watt and Breyer-Brandwijk (1962) is now known as Helichry-
sum cephaloideum DC. In other instances, a Helichrysum species
now belongs to a different genus for example, Helichrysum capil-
laceum (Thunb.) Less. (Watt and Breyer-Brandwijk, 1962) is now
classified as Troglophyton capillaceum subsp. capillaceum (Hilliard,
1983).
Sometimes the same species name with only a different author
name refers to a different species, for example Helichrysum calo-
cephalum Schltr, which is now classified as Helichrysum ecklonis
and not Helichrysum calocephalum Klatt (Gibbs Russell et al., 1987;
Germishuizen and Meyer, 2003). Batten and Bokelmann (1966),
Jacot Guillarmod (1971), Phillips (1917) and Watt and Breyer-
Brandwijk (1962) all used Helichrysum calocephalum Schltr., which
is now recognised as Helichrysum ecklonis, but in Arnold et al.
(2002) there is no reference to Helichrysum ecklonis yet the above-
mentioned sources are used as references under Helichrysum
calocephalum Klatt.
The specific Helichrysum species referred to when Helichrysum
crispum is used in ethnobotanical literature is also ambigu-
ous. Germishuizen and Meyer (2003) stated that Helichrysum
crispum of authors other than (L.) D. Don. is Helichrysum pat-
ulum (L.) D. Don. and not Helichrysum crispum (L.) D. Don.
In Watt and Breyer-Brandwijk (1962) and Smith (1966), the
name appears as Helichrysum crispum Less. therefore indicat-
ing Helichrysum patulum, although Arnold et al. (2002) cited
the name Helichrysum crispum (L.) D. Don. (with reference to
Smith, 1966) as well as Helichrysum patulum with reference to
Watt and Breyer-Brandwijk (1962). Roberts (1990) used Helichry-
sum crispum without an author name, causing uncertainty as
to which particular species is referred to; the cited medici-
nal uses are however similar to those indicated by Watt and
Breyer-Brandwijk (1962) for Helichrysum crispum Less. Salie and
co-workers (1996) determined that Helichrysum crispum (L.) D.
Don. had weak (10 mg/ml) antimicrobial activity against Pseu-
domonas aeruginosa. Both Salie et al. (1996) and Swanepoel (1997)
use the name Helichrysum crispum (L.) D. Don., but when indi-
cating its traditional uses refer to Watt and Breyer-Brandwijk
(1962). Scott et al. (2004) showed that Helichrysum patulum had
antimicrobial activity against Staphylococcus aureus in the disc
diffusion assay that was comparable to that of the ciprofloxacin
control, while the traditional uses indicated correspond very
well to those reported in Watt and Breyer-Brandwijk (1962) for
Helichrysum crispum Less. Both species occur in the same region
making exclusion of one species on the basis of distribution
impossible.
Helichrysum pedunculare DC. is another name with an unfor-
tunate and confusing history. In this case, it seems that
Helichrysum pedunculare DC. in ethnobotanical literature could
refer to either Helichrysum pedunculatum Hilliard and Burtt
or Helichrysum nudifolium var. pilosellum (previously known as
Helichrysum pedunculare (L.) DC. var. pilosellum) (Hilliard, 1983;
Arnold et al., 2002; Germishuizen and Meyer, 2003). The ver-
nacular name and uses indicated by for example Watt and
Breyer-Brandwijk (1962) for Helichrysum pedunculare DC. and Bhat
and Jacobs (1995) for Helichrysum pedunculatum Hilliard and Burtt.
is similar. According to Hilliard (1983), Helichrysum pedunculare
(L.) DC. is also a synonym for Helichrysum odoratissimum (L.)
Sweet.
In some instances it is impossible to decide to which species
an author refers, for example Helichrysum agrostophilum Klatt
(Watt and Breyer-Brandwijk, 1962) that was in part changed to
Helichrysum pallidum DC. and in part to Helichrysum griseum Sond
(Germishuizen and Meyer, 2003).
2.2. Administration routes
Plant parts used include the leaves, stems, flowers, roots and
sometimes the whole plant. The plant remedies are administered
in different ways, including the preparation of teas, inhalation of
smoke and vapours and placement of leaves in the form of a poultice
on wounds to prevent infection (Table 1). Several of these species
are known by the same vernacular names, for example Helichry-
sum cymosum, Helichrysum nudifolium, Helichrysum odoratissimum
and Helichrysum petiolare are all known as imphepho which indi-
cates that they can be used interchangeably, as Van Wyk et al.
(2000), noted that “use often depends on local availability rather
than preference for a particular species”.
2.3. Traditional uses of South African Helichrysum species
The traditional uses of Helichrysum in South Africa are sum-
marised in Table 1. There are several recurring South African
traditional uses for plants from this genus. Smoke is often inhaled
to induce trances or to invoke the goodwill of the ancestors. They
are often used to treat respiratory conditions and leaves are often
applied as wound dressings. They are used in the treatment of
gastro-intestinal disorders such as abdominal pain and colic and
also eye conditions. They also seem to have an effect on the relief
of pain and inflammation as they are used to treat menstrual pain,
rheumatism and headaches. The plants are used to fumigate huts
and also used as bedding to repel insects.
2.4. Correlation between medicinal uses and morphological
groups
Plants from almost all morphological groups are used medic-
inally and the broad spectrum of uses are not restricted to a
specific morphological group. In some cases there does seem to
be a relationship between the morphological group (according to
Hilliard, 1983) or adjacent morphological classes and the traditional
uses of these plants. Helichrysum epapposum (group 3), Helichry-
sum natalitium (group 3), Helichrysum gymnocomum (group 4) and
Helichrysum odoratissimum (group 4) all share the Zulu/Xhosa name
imphepho and all are burnt as incense to invoke the goodwill of the
ancestors. However, this particular use applies to many species such
as, Helichrysum cymosum (group 8), Helichrysum petiolare (group
18), Helichrysum dregeanum (30) and in some sources Helichrysum
nudifolium (23) share the same vernacular name and use. Helichry-
sum cymosum (group 8), Helichrysum kraussii (group 8), Helichrysum
melanacme (group 8), Helichrysum athrixiifolium (group 9) and
Helichrysum dregeanum (group 9) are all used to treat respiratory
complaints such as coughs and colds. The administration route of
these remedies do however vary; for Helichrysum arthrixiifolium the
leaf is smoked, for Helichrysum kraussii the dried flowers and seeds
are smoked in a pipe, for Helichrysum cymosum a decoction of leaves
is drunk, for Helichrysum dregeanum the leaf is smoked and the
administration route is not indicated in the source for Helichrysum
melanacme.
South African species are not often used to treat heart and kidney
ailments. Both Helichrysum pandurifolium and Helichrysum patulum
belongs to group 18, and are indicated in the treatment of kidney
disease and heart disorders. Both are also used to treat backpain
and respiratory conditions by the same administration route. Plants
from groups 23 and 24 are often used to treat wounds. The leaves
of Helichrysum miconiifolium (group 23), Helichrysum nudifolium
(group 23), Helichrysum pedunculatum (group 23), Helichrysum
appendiculatum (group 24) and Helichrysum longifolium (group 24)
are all used as wound dressings. However, Helichrysum foetidum
(group 30) is mentioned as a replacement for Helichrysum pedun-
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culatum in the treatment of circumcision wounds (Gerstner, 1938).
The species constituting group 23 are also used for respiratory
conditions including, Helichrysum mundtii, Helichrysum nudifolium
and Helichrysum pedunculatum. Root decoctions of both Helichry-
sum adenocarpum and Helichrysum ecklonis belonging to group 28
are used to treat diarrhoea in children, while a root infusion from
Helichrysum argyrophyllum (group 29) is used to treat intestinal
troubles. It is interesting to note that the only two species indicated
for the treatment of snakebite both belong to group 30, namely
Helichrysum cooperi and Helichrysum setosum.
3. Phytochemistry
The chemistry of this genus is complex with a wide variety
of chemical classes occurring as is evident from the three major
publications by Bohlmann and Jakupovic (Bohlmann and Zdero,
1980a; Jakupovic et al., 1986; Jakupovic et al., 1989) in which a
total of 63 South African Helichrysum species were investigated
chemically. The classes of compounds isolated from the South
African Helichrysum species are summarised in Table 2 and Fig. 1.
Acylphloroglucinols (1–3) are common, often with prenyl or ger-
anyl side chains. The replacement of the cinnamic moiety by other
acyl CoA derivatives in the biosynthesis of the main constituents
seem to be characteristic (Jakupovic et al., 1989). The presence of
humulone derivatives, such as helihumulone (4) is also widespread
(Jakupovic et al., 1989).
Flavonoids (5–11) derived from phloroglucinol are very com-
mon and often have unsubstituted B rings (Bohlmann and Abraham,
1979a,d; Jakupovic et al., 1986) which is a characteristic feature of
plants from the Inuleae tribe (Harborne, 1977). The presence of 6-
and 8-hydroxyflavonols and their methyl ethers (7) are also fre-
quent as in other members of the tribe (Harborne, 1977). A wide
variety of chalcones (8–10) are also found, including dihydrochal-
cones (11), pyranochalcones (10) and those substituted with prenyl
(9) or geranyl groups. As in other Inuleae species, these chalcones
are often accompanied by their structurally and biogenetically
related flavanones (Harborne, 1977) as can be seen for Helichrysum
acutatum (5 and 8) (Bohlmann and Abraham, 1979c), Helichry-
sum cymosum (Jakupovic et al., 1989) and Helichrysum oreophilum
(Jakupovic et al., 1986).
The presence of a-pyrones (12) is rather common (they occur
in plants from morphologic groups 1, 2, 4, 12, 15, 18, 19 and 24)
and they are often isolated from the roots of these plants (Hänsel
et al., 1980; Jakupovic et al., 1986, 1989). Different types of diter-
penes occur; these include the kaurenoic acid type (15, Jakupovic
et al., 1989) as well as those derived from helifulvanic acid (13,
Bohlmann et al., 1980b). Sesquiterpenes representing a variety of
skeletal types occur, as is characteristic for the rest of the family
(Hegnauer, 1977). Some skeletal types, such as the humulenes, are
widely distributed across the genus, whereas others such as the
guaianolides (16) are restricted to a few species (morphological
groups 10 and 22). Helichrysum species are known for their aro-
maticity and a variety of monoterpenes are reported in the essential
oils of some species (Lourens et al., 2004; Frum and Viljoen, 2006;
Van Vuuren et al., 2006; Asekun et al., 2007). Squalene is the most
common triterpene found and is often in high concentration.
Another unusual type of compound that occurs is thiophene
derivatives (17, 18) which have been isolated from the roots of
species such as Helichrysum acutatum and Helichrysum tenuifolium.
These thiophenes are the result of addition reactions of a common
chloro-acetylene precursor with H2S (Bohlmann and Abraham,
1979b,c). Simple polyacetylenes (20) are widespread. Acetylenics
with pyran (19) and furan moieties, some with epoxy and/or chlo-
rine substitution, occur in these plants and is characteristic of the
Gnaphaliineae (Harborne, 1977).
As for the traditional uses, one particular class of compound is
not restricted to a particular morphologic group. However, there
are some compounds that occur mainly in a specific morphologi-
cal class. For example, phloroglucinols (excluding those belonging
to the flavonoid class) feature as major compounds in morpholog-
ical classes 2, 3, 4, 12, 14, 15, 20, 24 and 28. Flavonoids are present
in almost all of the morphological groups, but a large number are
found in plants from groups 8, 9 and 27. Diterpenes were isolated in
large quantities from species in groups 23, 25 and 30 (all 10 plants
investigated in this group had this type of compound as the major
chemical species). Helichrysum umbraculigerum from group 5 seems
to be the only species investigated that contains compounds of the
cannabigerol type (21) as the major constituent and Helichrysum
dasyanthum (group 10) and Helichrysum splendidum (group 22) con-
tain mainly sesquiterpenes of the guaianolide type (which is absent
in the other species). Plants from groups 6, 18 and 19 are also rich
in sesquiterpenes (Table 2).
Although there seem to be similarities in the chemistry of
the European and South African species, the Australian species
are chemically different from their South African counterparts
(Jakupovic et al., 1989, 1989a).
4. Biological activity
4.1. Anti-infective activity
Considering the traditional uses of this genus (specifically the
treatment of wounds and respiratory tract infections and the
application as a fumigant for example), there seems to be a
strong indication that these plants and their compounds should
exhibit antimicrobial activity. Several studies on the antimicrobial
activity of Helichrysum species was done by the group of Meyer
from the University of Pretoria, South Africa. Extracts of several
species (Table 1) were submitted to antibacterial testing using
a group of randomly selected bacteria which normally included
the Gram-positive bacteria: Bacillus cereus, Bacillus pumilis, Bacil-
lus subtilis, Micrococcus kristinae, Staphylococcus aureus and the
Gram-negatives: Enterobacter cloaceae, Escherichia coli, Klebsiella
pneumoniae, Pseudomonas aeruginosa and Serratia marcescens. Ace-
tone extracts were mostly tested, but in a few cases methanol,
water and dichloromethane extracts were used. Assays involv-
ing agar dilution and direct autobiography were employed (Meyer
and Afolayan, 1995; Meyer and Dilika, 1996; Afolayan and Meyer,
1997; Dilika et al., 1997; Mathekga and Meyer, 1998; Bremner and
Meyer, 2000; Mathekga et al., 2000; Mathekga, 2001). Antifungal
activity was also determined for fungi such as Aspergillus flavus,
Aspergillus niger, Cladosporium cladosporioides, Cladosporium cuc-
umerinum, Cladosporium sphaerospermum and Phytophthora capsici
(Mathekga, 2001).
Reports on antimicrobial activities from other laboratories
include the relatively weak antimicrobial activity (Gibbons, 2004)
documented for extracts of Helichrysum foetidum (MIC’s of more
than 4 mg/ml against all selected bacteria in the 96-well plate assay,
Steenkamp et al. (2004) and Helichrysum crispum (L.) D. Don. where
MIC’s of 10 mg/ml were reported against Pseudomonas aeruginosa
and Candida albicans (Salie et al., 1996). Activities ranging from
0.078 to 0.3 mg/ml against Gram-positive bacteria, Gram-negative
bacteria and yeasts were also reported for a Helichrysum cymosum
extract (Van Vuuren et al., 2006). Acetone and methanol extracts
of Helichrysum odoratissimum (incorrectly identified as Helichrysum
dasyanthum in Lourens et al., 2004), Helichrysum excisum, Helichry-
sum felinum and Helichrysum petiolare displayed activity against
















































Classes of compounds isolated from South African Helichrysum species
Species Morphologic group Flavonoid derivativesa,b Phloroglucinolsb Pyronesb Diterpenesb Terpenesb Otherb Reference
A B C D E F
Helichrysum acutatum DC.c 21 X X X X X Bohlmann and Abraham (1979c)
Roots and aerial parts
Helichrysum adenocarpum DC.c 28 X Bohlmann et al. (1980a)
Roots and aerial parts
Helichrysum albirosulatum Killick 6 X X Bohlmann et al. (1980a), Bohlmann
et al. (1978a)Roots and aerial parts
Helichrysum allioides Less. 23 X Bohlmann and Zdero (1973)
Roots








28 X X X Bohlmann et al. (1980a)
Roots
Helichrysum argyrolepis MacOwan 29 X X Bohlmann et al. (1984)
Aerial parts
Helichrysum argyrophyllum DC.c 29 X X X XX Jakupovic et al. (1989), Bohlmann
and Zdero (1973)Aerial parts and roots
Helichrysum asperum (Thunb.)
Hilliard et Burtt. var. albidulum
(DC.) Hilliard




9 X X Bohlmann and Ates (1984)
Moeser
Aerial parts and roots
Helichrysum aureonitens Sch. Bip.c 8 X XX X Bohlmann and Ziesche (1979),
Afolayan and Meyer (1997), Meyer
et al. (1997)
Roots and aerial parts
Helichrysum aureum (Houtt.) Merr.c 30 XX X Jakupovic et al. (1989)
Aerial parts and roots
Helichrysum aureum (Houtt.) Merr.
var. monocephalum (DC.) Hilliard
30 XX X Bohlmann et al. (1978a)
Aerial parts and roots
Helichrysum auriceps Hilliard 24 X X X Bohlmann and Zdero (1980)
Roots
Helichrysum bellum Hilliard 28 X X X X Bohlmann and Zdero (1979a)
Aerial parts and roots

















































Table 2 (Continued )
Species Morphologic group Flavonoid derivativesa,b Phloroglucinolsb Pyronesb Diterpenesb Terpenesb Otherb Reference
A B C D E F
Helichrysum callicomum Harv.c 2 X XX X X XX X Bohlmann and Abraham (1979a)
(Helichrysum calliconumd)
Bohlmann et al. (1984)
Aerial parts and roots
Helichrysum candolleanum H. Buek 15 X X Jakupovic et al. (1989)
Aerial parts
Helichrysum cephaloideum DC. 24 X XXX XX X Hänsel et al. (1980), Bohlmann and
Zdero (1980), Jakupovic et al.
(1986)
Roots and aerial parts
Helichrysum cerastioides DC. 15 X X X Bohlmann et al. (1984), Jakupovic
et al. (1989) (Helichrysum
cerastroides DC. supsp. aurosicum
Merxm. et A. Schreiberd)
Aerial parts
Helichrysum chionosphaerum DC. 25 X XXX XX X Bohlmann et al. (1980b), Jakupovic
et al. (1989)Aerial parts and roots
Helichrysum chrysargyrum Moeser 22 X XX X Bohlmann et al. (1979a)
Aerial parts and roots
Helichrysum confertum N.E.Br 17 XX Bohlmann et al. (1978a)
Roots
Helichrysum cooperi Harv.c 30 X X Bohlmann et al. (1978a)
Roots and aerial parts
Helichrysum cooperi ps. aff.
Helichrysum cooperi Harv.
? X Wright (1976)
Helichrysum cymosum (L.) D. Don.c 8 XX X X X X Jakupovic et al. (1989)
Aerial parts
Helichrysum cymosum (L.) Don.
ssp.c calvum
8 XX X X Bohlmann et al. (1979b)
Roots and aerial parts
Helichrysum cymosum (L.) D. Don.c
ssp. cymosum
8 X Van Vuuren et al. (2006)





21 X Bohlmann and Zdero (1973)
(Helichrysum lanatum DC.d)
Roots
Helichrysum decorum DC.c 30 X Bohlmann et al. (1980a)
Aerial parts
Helichrysum drakensbergense Killick 19 X X XX X Bohlmann and Suwita (1979)
Roots and aerial parts
Helichrysum dregeanum Sond. and
Harv.c
9 X X X X Jakupovic et al. (1989)
Aerial parts
















































Helichrysum flanaganii Bolusc 13 X Bohlmann et al. (1980a)
Aerial parts and roots
Helichrysum foetidum (L.) Moench.c 30 X Bohlmann and Zdero (1973)
Roots
Helichrysum fulvum N. E. Br. 30 XX X Bohlmann et al. (1979c)
Aerial parts and roots
Helichrysum glaciale Hilliard 27 X Bohlmann et al. (1980a)
Aerial parts
Helichrysum glomeratum Klatt 6 X X XX Bohlmann and Suwita (1979)
Aerial parts
Helichrysum grandiflorum (L.) D.
Don.
17 X Bohlmann and Zdero (1973)
Roots
Helichrysum gymnocomum DC.c 4 XX X Bohlmann and Mahanta (1979)
(Helichrysum gymnoconum DC.d)Roots and aerial parts




29 X XX X Bohlmann et al. (1979a)
Aerial parts




27 XX X X X Bohlmann and Abraham (1979d)
(Helichrysum hypocephalum
Hilliardd)Aerial parts and roots
Helichrysum indicum (L.) Griersonc 15 X Jakupovic et al. (1989)
Aerial parts
Helichrysum infaustum J.M. Wood.
and M.S. Evans
4 X X Bohlmann and Suwita (1979)
Aerial parts
Helichrysum kraussii Sch. Bip.c 8 X X X X X XX Jakupovic et al. (1989), Bremner
and Meyer (2000), Candy et al.
(1975), Candy and Wright (1975)
Aerial parts, flowers and roots
Helichrysum krebsianum Less. 23 X Bohlmann et al. (1980a)
Aerial parts
Helichrysum krookii Moeser 5 XX X X Bohlmann et al. (1980a)
Roots and aerial parts






















































Table 2 (Continued )
Species Morphologic group Flavonoid derivativesa,b Phloroglucinolsb Pyronesb Diterpenesb Terpenesb Otherb Reference
A B C D E F
Helichrysum melanacme (DC.)
Harv.c
8 X X Lall et al. (2006)
Shoots
Helichrysum miconiifolium DC.c 23 X Bohlmann et al. (1980a)
Roots




24 XX XX Jakupovic et al. (1986)
Roots
Helichrysum moeseranium Thell. 22 X X Jakupovic et al. (1989)
Aerial parts
Helichrysum monticola Hilliard 28 X XX X Jakupovic et al. (1989), Bohlmann
and Zdero (1980a)Aerial parts and roots
Helichrysum mundtii Harv.c
(=Helichrysum mundii Harv.)d
23 X X X X Bohlmann et al. (1978b), Bohlmann
et al. (1980a)
Roots and aerial parts
Helichrysum nanum Klatt 6 X X X Bohlmann and Suwita (1979)
Aerial parts
Helichrysum natalitium DC.c 3 XX X X Bohlmann and Zdero (1979a)
Aerial parts and roots
Helichrysum nudifolium L. Less. var.
nudifoliumc
23 XX X XXX X Jakupovic et al. (1986), Bohlmann
et al. (1978a) (Helichrysum
nudifolium L. Less.d) Bohlmann and
Zdero (1973) (Helichrysum
nudifolium L. Less.d)




















4 X X XX X X X Van Puyvelde et al. (1989), Hänsel
et al. (1980), Bohlmann and Zdero
(1973)Aerial parts and roots
Helichrysum oreophilum Klatt. 21 X X X X X Jakupovic et al. (1986), Bohlmann
et al. (1980a)Aerial parts
Helichrysum pagophilum M.D.
Hend.
















































Helichrysum pallidum DC.c 23 XX X Bohlmann et al. (1980a)
Aerial parts and roots
Helichrysum panduratum O.Hoffm.c 18 X Bohlmann and Abraham (1979b)
Aerial parts
Helichrysum patulum (L.) D. Don.c
(=Helichrysum crispum Less.)





23 X Dilika et al. (2000)
Leaves
Helichrysum petiolare Hilliard and
B.L. Burtt.c
18 X X X X XX X Jakupovic et al. (1989), Bohlmann
and Zdero (1973) (Helichrysum
petiolatum DC.d)Aerial parts
Helichrysum platypterum DC.c 20 X X X XXX X X Jakupovic et al. (1986), Bohlmann
et al. (1980a), Bohlmann and Zdero
(1979a), Jakupovic et al., 1987
Aerial parts and roots
Helichrysum polycladum Klatt 8 X X X X X Bohlmann et al. (1980a)
Aerial parts and roots
Helichrysum populifolium DC. 16 X Bohlmann et al. (1980a)
Roots
Helichrysum reflexum N. E. Br. 29 XX XX Bohlmann et al. (1985)
(Helichrysum refluxum N. E. Br.d)Aerial parts
Helichrysum revolutum (Thunb.)
Less.
9 X X X Jakupovic et al. (1989)
Aerial parts
Helichrysum retortoides N.E. Br. 26 X Bohlmann et al. (1980a)
Aerial parts
Helichrysum rosum (Berg.) Less. 9 X X Jakupovic et al. (1989)
Aerial parts
Helichrysum nudifolium L. Less. var.
nudifolium (=Helichrysum
coriaceum Harv.)
23 XX X X Bohlmann et al. (1984a)
(Helichrysum coriaceum Harv.d)
Roots
Helichrysum ruderale Hilliard and
B.L. Burtt.
30 X Bohlmann et al. (1980a)
Aerial parts
Helichrysum rugulosum Less.c 9 XX XX Bohlmann and Misra (1984)
Aerial parts and roots
Helichrysum scabrum (Thunb.) Less. 9 X X Jakupovic et al. (1989)
Aerial parts
Helichrysum setosum Harv.c 30 XX Jakupovic et al. (1986)
Aerial parts
Helichrysum spiralepis Hilliard and
Burtt. (=Leontonyx squarrosus)
















































Table 2 (Continued )
Species Morphologic group Flavonoid derivativesa,b Phloroglucinolsb Pyronesb Diterpenesb Terpenesb Otherb Reference
A B C D E F
Helichrysum splendidum (Thunb.)
Less.c
22 X X XXX X Bohlmann and Suwita (1979a),
Jakupovic et al. (1989)
Aerial parts and roots
Helichrysum subfalcatum Hilliard 6 X X Bohlmann et al. (1980a)
Aerial parts




17 X X X X Bohlmann et al. (1978b), Bohlmann
et al. (1980a)
Aerial parts and roots
Helichrysum swynnertonii S. Moore
Aerial parts and roots
25 X Bohlmann et al. (1980a)
Helichrysum tenax var. tenax M.D.
Hend.
30 XX Drewes et al. (2006)
Leaves
Helichrysum tenuiculum DC. 8 X X X X Bohlmann et al. (1979b)
Aerial parts and roots
Helichrysum tenuifolium Killick. 22 X X X X X X XX Bohlmann and Abraham (1979b)
Aerial parts and roots
Helichrysum thapsus (O. Kuntze)
Moeser









11 X Jakupovic et al. (1989)
Aerial parts
Helichrysum trilineatum DC. 22 X X Bremner and Meyer (1998),
Bohlmann et al. (1980a)Shoots and roots
Helichrysum umbraculigerum Less. 5 X X XXX Bohlmann and Hoffmann (1979)
Aerial parts
Helichrysum vernum Hilliard 28 X X Bohlmann et al. (1980a)
Roots
Helichrysum zeyheri Less. 1 X X X Jakupovic et al. (1986)
Aerial parts
a A = flavanone, B = chalcone, C = dihydrochalcone, D = flavonol, E = flavone, F = other flavonoids.
b X = 3 or less compounds isolated; XX = 4–9 compounds isolated; XXX = 10 or more compounds isolated, XXXX = more than 20 compounds isolated.
c Used in traditional medicine.
d Name as used in reference.
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Fig. 1. Compounds isolated from South African Helichrysum species.
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activity was the acetone extract of Helichrysum odoratissimum with
an MIC of 0.016 mg/ml against Staphylococcus aureus (which corre-
lates well with the values obtained by Mathekga and Meyer, 1998).
Helichrysum species are often used to treat respiratory con-
ditions and tuberculosis (Table 1). Extracts of Helichrysum
odoratissimum and Helichrysum melanacme showed activity against
Mycobacterium tuberculosis at concentrations of 0.5 mg/ml (Lall and
Meyer, 1999; Lall et al., 2006). The acetone extract of Helichry-
sum caespititium inhibited a drug sensitive-strain of Mycobacterium
tuberculosis at a concentration of 0.5 mg/ml in the agar plate
method and a MIC of 0.1 mg/ml was observed using the rapid radio-
metric method (Meyer et al., 2002). The water extract caused partial
inhibition at the highest concentration of 5 mg/ml.
In some cases the antimicrobial activity of isolated compounds
was determined. Flavonoids are generally one of the largest classes
of antibacterial compounds (Gibbons, 2004). Galangin (3,5,7-
trihydroxyflavone) isolated from Helichrysum aureonitens (Meyer
and Afolayan, 1995), inhibited the growth of four Gram-positive
bacteria (three Bacillus species and Micrococcus kristinae) as well
as the Gram-negative Enterobacter cloaceae (Afolayan and Meyer,
1997). The highest activity observed was against Bacillus cereus,
Micrococcus kristinae and Enterobacter cloaceae at 0.1 mg/ml. In
other studies by Cushnie et al. (2003) and Cushnie and Lamb
(2006), the activity of galangin was shown against six strains of
b-lactam sensitive and resistant strains of Staphylococcus aureus
and 16 strains of 4-quinolone resistant strains of the bacterium at
MIC’s of approximately 50 mg/ml. Galangin also displays some anti-
fungal activity against fungi such as Aspergillus tamari (35% growth
inhibition at 0.5 mg/ml) (Afolayan and Meyer, 1997). These results
support the use of Helichrysum aureonitens in the treatment of skin
infections, often caused by Staphylococcus aureus.
Another flavonoid, 3-O-methylquercetin was isolated from
Helichrysum odoratissimum and antimicrobial activity determined
for a broad range of micro-organisms including Gram-negative
bacteria such as Salmonella typhimurium (MIC = 50 mg/ml), Gram-
positive bacteria, such as Staphylococcus aureus (MIC = 6.25 mg/ml)
and fungi, for example Candida albicans (MIC = 12.5 mg/ml), in the
microdilution method (Van Puyvelde et al., 1989). Bremner and
Meyer (1998) also reported on the anti-staphylococcal activity
for pinocembrin chalcone (8, isolated from Helichrysum trilin-
eatum), as well as pinocembrin (5) that was obtained as an
artifact during the isolation procedure. Flavonoids isolated from
the flowers of Helichrysum gymnocomum exhibited promising
antimicrobial activity against a wide variety of Gram-positive and
Gram-negative organisms as well as yeasts. An MIC of 8 mg/ml
was for example observed against Cryptococcus neoformans for
5,7-dibenzyloxyflavanone (Drewes and Van Vuuren, 2008). Two
chalcones isolated from Helichrysum melanacme (9, 10) exhib-
ited MIC’s of 0.05 mg/ml against the drug sensitive H37Rv strain
of Mycobacterium tuberculosis. The activity of the chalcones was
higher than that of the crude extract but a combination of the
two chalcones did not result in an improved MIC (Lall et al.,
2006).
There are also reports on the antimicrobial activity of com-
pounds other than flavonoids. Activity against Gram-positive
bacteria was observed for both linoleic and oleic acids, isolated from
antibacterial extracts of Helichrysum pedunculatum (a plant used to
treat circumcision wounds, Dilika et al., 2000). The MIC of both
fatty acids was 1.0 mg/ml for Staphylococcus aureus and Micrococ-
cus kristinae in the agar diffusion assay. The MIC’s was 0.05 mg/ml
of each fatty acid when they were administered at the same time
(Dilika et al., 2000).
Kaurenoic acid (15, a diterpene), isolated from Helichrysum
kraussii, exhibited a MIC as low as 1 mg/ml against Escherichia
coli and MIC’s of 10 mg/ml against Bacillus cereus, Bacillus sub-
tilis, Staphylococcus aureus and Serratia marcescens (Bremner and
Meyer, 2000). Significant antimicrobial activity was also observed
for monomeric (14) and dimeric diterpenes from Helichrysum tenax
var. tenax. MIC values as low as 3.1 and 3.6 mg/ml were determined
against Bacillus cereus whereas MIC’s as low as 41.5 mg/ml were
determined for a Gram-negative organism such as Pseudomonas
aeruginosa (Drewes et al., 2006).
MIC’s of 100 mg/ml were observed for prenylated
butyrylphloroglucinol (3) isolated from Helichrysum kraussii
against Bacillus cereus, Bacillus pumilis, Bacillus subtilis, Micrococcus
kristinae, Staphylococcus aureus, Serratia marcescens and Escherichia
coli in an agar diffusion assay (Bremner and Meyer, 2000). The
same phloroglucinol was isolated from Helichrysum gymnocomum
and MIC’s of below 100 mg/ml (6–45 mg/ml) were reported for
Enterococcus faecalis, Staphylococcus epidermidis, Staphylococcus
aureus, Bacillus cereus, Pseudomonas aeruginosa, Cryptococcus
neoformans and Candida albicans (Drewes and Van Vuuren, 2008).
A difference in assays employed, inoculum size and possibly
different strains of the same micro-organism used may account
for the observed difference in activity. A structurally related
phloroglucinol also exhibited promising antibacterial activity
against Enterococcus faecalis, Staphylococcus aureus, Pseudomonas
aeruginosa and Cryptococcus neoformans (Drewes and Van Vuuren,
2008). Caespitin (1) and caespitate (2) (both phloroglucinols)
exhibited antimicrobial activity against several bacteria as well as
fungi (Dekker et al., 1983; Mathekga et al., 2000). Caespitin (1)
was active against Staphylococcus aureus, Streptococcus pyogenes,
Cryptococcus neoformans, Trichophyton rubrum, Trichophyton men-
tagrophytes and Microsporum canis although neither the method
used nor the level of activity, are indicated in the relevant article
(Dekker et al., 1983). Caespitate (2), exhibited antibacterial activity
against the Gram-positive Bacillus cereus, Bacillus pumilis, Bacillus
subtilis, Micrococcus kristinae and Staphylococcus aureus at con-
centrations of 0.5 mg/ml in the agar dilution method (Mathekga
et al., 2000). This compound also exhibited antifungal activity
which ranged from 0.5 to 1.0 mg/ml against Aspergillus flavus,
Aspergillus niger, Cladosporium cladosporioides, Cladosporium cuc-
umerinum, Cladosporium sphaerospermum and Phytophtora capsici
(Mathekga et al., 2000). Caespitate (2) was also active against
several Mycobacterium tuberculosis strains at a concentration of
0.1 mg/ml which was similar to the MIC observed for the crude
extract of Helichrysum caespititium (Meyer et al., 2002).
Several caespitin derivatives were synthesised with MIC values
as low as 2 mg/ml against Staphylococcus aureus and Streptococ-
cus pyogenes. These compounds also exhibit antifungal activity.
The possible development of antimicrobial resistance was exam-
ined as well as the development of cross resistance with known
antimicrobials (Van der Schyf et al., 1986). For helihumulone (4), a
phloroglucinol of the humulone type, activity was exhibited for a
broad range of micro-organisms with some promising results, for
example 16 mg/ml against Pseudomonas aeruginosa. The antimalar-
ial activity of this compound was determined to be 15 mg/ml (Van
Vuuren et al., 2006). As previously mentioned, the South African
Helichrysums contain a large amount of phloroglucinol derivatives
and considering the promising antimicrobial activity observed for
this type of compound, it seems a class well worth investigating.
Aqueous extracts of Helichrysum aureonitens exhibited antivi-
ral activity against the Herpes simplex virus type I in vitro at
a concentration of 1.35 mg/ml (Meyer et al., 1996). The flavone,
galangin, isolated from this plant also exhibited antiviral activity
against Herpes simplex virus type I and the Coxsackie virus at con-
centrations of 6 mg/ml (Meyer et al., 1997). The antiviral activity
was also determined for a crude ethanolic extract of Helichrysum
melanacme and its isolated constituents. The activity of the iso-
lated prenylated chalcone (9) and a pyranochalcone (10) was lower
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(IC50 = 0.1 mg/ml) against the Influenza A virus than that of the crude
extract (0.01 mg/ml) although a combination of the two chalcones
resulted in an improved IC50 (0.01 mg/ml, Lall et al., 2006).
In summary, the crude extracts generally show some degree
of antimicrobial activity, which is usually higher against Gram-
positive organisms than against Gram-negative organisms.
Although the antibacterial and antifungal activities of these plants
are well documented, antimalarial, antimycobacterial and antiviral
data are scarce. Isolated compounds sometimes exhibit more
superior activity when compared to the crude extract, but often
the crude extract has similar activity. Correct identification of plant
material is crucial as misidentification of plant material can lead
to incorrect reporting (Lourens et al., 2004). The selected range of
concentrations is often on the high side (Gibbons, 2004, considered
values of below 1 mg/ml for extracts and 64 mg/ml for single chem-
ical entities as significant); for example a range of 10–100 mg/ml
was used for Helichrysum pedunculatum extracts (Meyer and Dilika,
1996). Positive controls (antibiotics) are absent in some of the
assays (Mathekga et al., 2000), making it difficult to comparatively
assess the activity of a particular extract or compound. The fact that
different assays are employed impairs comparison of data between
different laboratories (assays relying on diffusion are especially
suspect since a low rate of diffusion would present a low activity,
which is not always a true representation). Microbial strains are
often not referenced and the number of colony forming units not
mentioned (Meyer and Afolayan, 1995). Extracts also often do not
dissolve completely in the solvents used and as Cushnie illustrated
with galangin (2003) this can have a profound effect on the MIC’s
observed (Cushnie et al., 2003). Chemical classes such as the
flavonoids, acylphloroglucinols and diterpenes from South African
Helichrysum species exhibit promising antimicrobial activity and
plants that contain these compounds seems potential candidates
for further study.
4.2. Other biological data
Unpublished work done by Noristan laboratories indicates
that fractions of the extract of Helichrysum caespititium exhibits
anti-inflammatory activity of up to 82% at 360 mg/kg in the car-
rageenan test done on rats and prevents platelet aggregation
(Swanepoel, 1997). Ethanolic extracts of Helichrysum subglomera-
tum and Helichrysum nudifolium inhibited prostaglandin synthesis
in vitro by 69 and 96% (50 mg of plant extract used), respectively
(Jäger et al., 1996). The group at Noristan determined that frac-
tions of a Helichrysum nudifolium extract also reduced edema in
the carrageenan assay by approximately 30% at 300 mg/kg in rats
(Swanepoel, 1997). These results indicate that Helichrysum nud-
ifolium has both in vitro and in vivo anti-inflammatory activity,
possibly due to the inhibition of the cyclooxygenase enzymes.
The group at Noristan observed that the second of three fractions
obtained after gradient column chromatography (using petroleum
ether, ethyl acetate and methanol) of a dichloromethane/methanol
extract from Helichrysum panduratum showed a 79% reduction
in pain experienced in the writhing pain test at 500 mg/kg.
Edema was also reduced by 50% in the carrageenan test indi-
cating that this plant has both anti-inflammatory and analgesic
properties. It was also antihypertensive (a reduction of 6% in
mean blood pressure was observed after administering a dose
of 300 mg/kg) and weakly antimicrobial (Swanepoel, 1997). A
fraction from a dichloromethane/methanol extract of Helichry-
sum petiolare investigated by the group from Noristan determined
that administration of 300 mg/kg of extract to mice reduced
mean blood pressure by 21% and resulted in a 6% reduction in
heart rate (Swanepoel, 1997). Acetone extracts of Helichrysum
excisum (IC50 = 35 mg/ml) and Helichrysum felinum (IC50 = 39 mg/ml)
inhibited the 5-lipoxygenase enzyme which also plays a role in
inflammation. Antioxidant activity (as indicated with the DPPH
assay) of acetone and methanol extracts of Helichrysum odoratis-
simum, Helichrysum excisum, Helichrysum felinum and Helichrysum
petiolare was comparable to that of vitamin C, as expected for
species rich in phenolic compounds (Lourens et al., 2004).
European research further highlights the antioxidant and anti-
inflammatory effects displayed by plants from this genus. It is
quite often the flowers that are investigated, a plant part that are
seldom investigated in South African research (Drewes and Van
Vuuren, 2008; Table 2). Antioxidant activity was reported for flower
extracts from Helichrysum stoechas (Carini et al., 2001), Helichry-
sum arenarium (Czinner et al., 2000; Czinner et al., 2001) and
Helichrysum italicum (Facino et al., 1990). In vivo (topical) anti-
inflammatory activity comparable to that of the indomethacin
standard was observed for an acetophenone derivative, gnaphaliin
(a flavonoid) and ursolic acid isolated from Helichrysum stoechas
(Recio et al., 1991). In vivo and in vitro anti-inflammatory activ-
ity was also observed for acetophenone glucosides, flavonoids and
other compounds isolated from Helichrysum italicum (Sala et al.,
2001, 2002, 2003a,b) as well as for extracts from Helichrysum com-
pactum (Süzgeç et al., 2005). These promising results indicate that
more research should be undertaken on the anti-inflammatory
activity of South African species, as many similar compounds
appear in the South African and European species.
As previously mentioned, Helichrysum species are often burnt
as incense to invoke the goodwill of the ancestors, in protec-
tive and other charms and to induce trances. It is also used in
the treatment of insanity, possession, used as a sedative to treat
insomnia and as a protective cleanser (Table 1). Their traditional
uses indicate that these plants may exhibit psychotropic effects.
Stafford et al. (2005) determined the GABA-receptor binding effect
of extracts from Helichrysum argyrolepis, Helichrysum herbaceum,
Helichrysum nudifolium, Helichrysum ruderale, Helichrysum rugu-
losum, Helichrysum simillimum and Helichrysum umbraculigerum
by using the 3H-Ro 15-1788 binding assay. Helichrysum ruderale
and Helichrysum umbraculigerum exhibited the most pronounced
effects, while Helichrysum herbaceum, Helichrysum rugulosum and
Helichrysum simillimum showed moderate to good dose dependant
activity.
There appears to be a large divide between the rich chemical
data available and biological testing on compounds isolated from
the South African species. One chemical class, the a-pyrones will
be discussed as an example. By our rough estimate, 28 different
pyrones were isolated from South African Helichrysum species. The
same type of compounds was isolated from European species and
rather interesting biological activity was observed. Italipyrone, pli-
catipyrone, a mixture of helipyrones and a mixture of homoarenol
and arenol were all active against Bacillus subtilis, Staphylococcus
aureus, S. epidermidis and Mycobacterium phlei using the agar diffu-
sion method with the highest MIC being 25 mg/ml and the lowest
3 mg/ml (Ríos et al., 1991). Antifungal activity was also reported for
a-pyrones isolated from Helichrysum decumbens (Tomás-Lorente et
al., 1989). Pyrones (like arzanol and helipyrone) showed significant
antioxidant activity and arzanol was not toxic at all concentrations
tested (Rosa et al., 2007). Most interesting though is the findings by
Appendino et al. (2007) that arzanol inhibits HIV-I replication in T-
cells and inhibited NF-kB (IC50 = 5 mg/ml) indicating that this group
of compounds may exhibit both antiviral and anti-inflammatory
properties. To our knowledge, none of the unique pyrones isolated
from South African species were evaluated for biological activity.
Most concerning is the almost complete absence of toxicity data
for the South African species of this genus. In very few cases, for
example where antiviral and antimalarial activities were deter-
mined (Meyer et al., 1996, 1997; Lall et al., 2006; Van Vuuren
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et al., 2006) toxicity is mentioned. Toxicity of the diterpenes
is well known (for example IC50 values of below 4 mg/ml was
reported for three diterpene lactones from Parinari capensis; Uys et
al., 2002), and several Helichrysum species contain high amounts
of these compounds, to name but one example. Furthermore,
Reid et al. (2006) screened 42 medicinal South African plants for
mutagenicity, which included Helichrysum herbaceum, Helichrysum
nudifolium, Helichrysum ruderale, Helichrysum rugulosum, Helichry-
sum simillimum and Helichrysum umbraculigerum. The only three
plants that showed mutagenic activity were all Helichrysums,
namely Helichrysum herbaceum (at 5 mg/ml), Helichrysum rugu-
losum (at 5 mg/ml) and Helichrysum simillimum (at 0.05 mg/ml).
These results highlight both the need and importance of toxicity
and safety data for plants of this genus. In general, there also seems
to be a large need for in vivo validation of in vitro results since the
effectiveness of these extracts and their compounds have not been
validated in living organisms.
5. Conclusion
Helichrysum species are used extensively in ethnomedicine
in South Africa and many of the uses are associated with the
treatment of infections, e.g. it is used widely for treatment of
respiratory diseases and wound dressing (Table 1). The large mor-
phological diversity of the genus is complemented by chemical
diversity as illustrated by the range of novel compounds isolated
from the genus. Despite the extensive past and present tradi-
tional uses, the unrivalled botanical diversity, and the chemical
complexity, it remains ironic that explorations of the biological
activities of indigenous species are comparatively poorly studied.
The genus is notoriously challenging from a taxonomic perspec-
tive and several examples have been highlighted to emphasise
the importance of correct botanical identification when embark-
ing on ethnopharmacological and phytochemical studies. There
is an interesting relationship between the morphological clas-
sification and the classes of chemical compounds isolated from
a specific morphological group and there are certain classes of
compounds, e.g. diterpenes, guaianolides, acylated phlorogluci-
nols and a-pyrone derivatives, for which one can predict in which
species they are most likely to occur. This may be important in the
search of new plant-derived drugs, e.g. acylated phloroglucinols
show potential as anti-staphylococcal drug leads (Gibbons, 2004)
and a-pyrone derivatives have anti-HIV properties (McGlacken
and Fairlamb, 2005; Appendino et al., 2007). It is clear that
Helichrysum is an interesting genus from an ethnobotanical, phy-
tochemical and pharmacological perspective but that biological
data to correlate the ethnobotany to the chemistry are often
still lacking. To advance our knowledge on this fascinating genus
a multidisciplinary approach involving botanists, chemists and
ethnopharmacologists is required.
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